data_2ka2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ka2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 C--O 1.23 0.109 0 CA-C-O 120.829 0.262 . . . . 1.3 112.276 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.5 m -55.06 -47.79 74.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 1.8700000000000001 110.895 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.19 -46.61 88.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 1.4099999999999999 110.754 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 79.7 mt -52.48 -50.05 63.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.337 -0.392 . . . . 1.3300000000000001 110.655 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 98.5 mt -57.91 -46.17 85.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.505 . . . . 1.1399999999999999 110.783 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.446 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 73.0 m -55.11 -53.38 56.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.882 0.373 . . . . 0.39000000000000001 111.261 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.432 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 77.2 m80 -63.21 -52.78 60.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.35999999999999999 111.222 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 98.4 mt -59.85 -52.96 63.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.415 -0.357 . . . . 1.1799999999999999 111.321 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 67.6 mt -53.52 -41.81 66.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.035 0.445 . . . . 1.1499999999999999 110.306 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.443 ' CB ' ' HB2' ' B' ' 176' ' ' ALA . . . -58.24 -44.56 88.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.885 -0.598 . . . . 1.0600000000000001 110.369 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 173' ' ' HIS . 47.6 mm -55.79 -43.28 73.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.252 -0.431 . . . . 1.29 109.883 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.03 -45.37 92.46 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.718 -0.754 . . . . 0.29999999999999999 111.823 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 47.8 mt -54.41 -51.36 65.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.852 0.358 . . . . 1.1399999999999999 110.459 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.57 -43.06 67.61 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.631 -0.795 . . . . 0.31 112.291 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 50.2 mm -61.28 -46.98 95.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.361 . . . . 1.5600000000000001 110.885 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -56.97 -45.68 82.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 2.4700000000000002 110.615 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 56.5 mt -62.76 -48.48 87.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.077 -0.51 . . . . 1.4399999999999999 110.956 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.25 -52.34 50.24 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.929 -0.653 . . . . 0.64000000000000001 112.92 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -22.62 62.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.73 0.3 . . . . 3.0299999999999998 111.188 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.356 -0.384 . . . . 4.4299999999999997 111.205 179.701 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.466 -0.106 0 CA-C-O 120.827 0.261 . . . . 1.4199999999999999 112.363 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 79.1 p -55.31 -41.99 73.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 1.99 111.198 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 83.2 mt -57.58 -50.74 72.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.367 -0.378 . . . . 1.6899999999999999 111.331 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.5 mp -57.66 -44.94 86.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.477 -0.329 . . . . 1.3899999999999999 111.126 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 93.0 mt -61.91 -41.61 98.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.354 -0.385 . . . . 1.24 110.857 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 172' ' ' SER . . . . . 0.432 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 58.8 m -57.64 -52.34 65.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.41999999999999998 111.358 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.446 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 73.9 m80 -62.03 -52.72 62.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.332 -0.395 . . . . 0.37 111.1 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 55.4 mt -55.64 -51.47 67.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.43 -0.35 . . . . 1.1899999999999999 110.976 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 94.2 mt -60.84 -42.02 96.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.362 -0.381 . . . . 1.21 110.772 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.443 ' HB2' ' CB ' ' A' ' 176' ' ' ALA . . . -59.74 -52.9 63.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 1.1100000000000001 111.04 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 73.3 mt -53.79 -42.85 54.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.863 0.363 . . . . 1.0900000000000001 110.059 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.0 -43.55 82.94 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.554 -0.832 . . . . 0.29999999999999999 111.649 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 94.9 mt -56.5 -50.59 71.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.972 0.415 . . . . 1.1799999999999999 110.363 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.44 -46.29 81.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.676 -0.774 . . . . 0.28000000000000003 112.579 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 56.9 mt -55.32 -45.62 77.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.831 0.348 . . . . 1.6299999999999999 111.05 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . 0.419 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 63.1 t80 -59.58 -51.54 69.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 2.4100000000000001 110.892 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 61.6 mt -62.26 -44.08 98.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 1.6100000000000001 111.201 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.31 -46.36 94.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.906 -0.664 . . . . 0.71999999999999997 113.092 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . 0.419 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 12.6 ptm180 . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.675 0.274 . . . . 2.4700000000000002 111.403 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo . . . . . 0 C--O 1.231 0.167 0 CA-C-O 120.822 0.259 . . . . 1.3 112.396 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 70.1 m -58.86 -43.73 90.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.298 -0.41 . . . . 1.8700000000000001 110.955 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 73.0 mt -59.7 -48.7 80.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.424 . . . . 1.4099999999999999 110.926 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 86.4 mt -52.28 -52.08 54.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 1.3300000000000001 110.99 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.5 mt -55.13 -43.11 73.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 1.1399999999999999 110.927 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.42 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 75.2 m -55.23 -52.16 64.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.352 -0.385 . . . . 0.39000000000000001 111.016 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.427 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 73.7 m80 -62.37 -51.12 68.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.35999999999999999 111.037 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.27 -52.06 66.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 1.1799999999999999 111.089 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 84.9 mt -58.66 -44.06 90.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 1.1499999999999999 110.952 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.445 ' CB ' ' HB1' ' B' ' 176' ' ' ALA . . . -51.9 -52.19 51.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.421 . . . . 1.0600000000000001 110.625 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 65.9 mt -54.08 -46.24 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.076 -0.511 . . . . 1.29 110.205 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.58 -42.68 85.02 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.614 -0.803 . . . . 0.29999999999999999 111.899 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 53.4 mt -55.26 -50.38 69.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.397 . . . . 1.1399999999999999 110.298 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.21 -46.05 86.73 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.596 -0.812 . . . . 0.31 112.18 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 39.6 mm -60.58 -48.4 88.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.82 0.343 . . . . 1.5600000000000001 110.95 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.42 ' OH ' ' NH2' ' A' ' 186' ' ' ARG . 52.1 t80 -53.31 -51.94 60.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 2.4700000000000002 110.982 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.96 -48.81 86.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.295 -0.412 . . . . 1.4399999999999999 111.471 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.27 -51.48 56.26 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 121.162 -0.542 . . . . 0.64000000000000001 113.713 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.421 ' HG3' ' N ' ' A' ' 186' ' ' ARG . 0.1 OUTLIER -51.62 -31.79 26.56 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.648 -0.325 . . . . 3.0299999999999998 111.231 -179.15 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.421 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 83.3 mtt180 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.461 -0.336 . . . . 4.4299999999999997 111.233 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.462 -0.348 0 CA-C-O 120.821 0.259 . . . . 1.4199999999999999 112.654 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 59.0 m -63.18 -43.99 96.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 1.99 111.455 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.411 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 89.3 mt -59.19 -51.46 69.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 1.6899999999999999 111.462 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.89 -49.52 75.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.464 -0.334 . . . . 1.3899999999999999 111.149 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.76 -41.61 82.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 1.24 110.913 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 172' ' ' SER . . . . . 0.427 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 74.8 m -56.5 -52.95 62.82 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.41999999999999998 111.117 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.42 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 63.0 m80 -62.57 -52.23 64.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.345 -0.389 . . . . 0.37 110.806 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 97.4 mt -54.14 -52.11 62.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 1.1899999999999999 111.095 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.23 -50.97 69.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 1.21 111.181 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.445 ' HB1' ' CB ' ' A' ' 176' ' ' ALA . . . -53.17 -52.78 57.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.424 -0.353 . . . . 1.1100000000000001 111.225 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 62.3 mt -61.94 -41.77 92.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.836 0.35 . . . . 1.0900000000000001 110.394 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.48 -50.23 48.81 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.585 -0.817 . . . . 0.29999999999999999 111.836 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 83.8 mt -57.17 -44.84 83.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.901 0.382 . . . . 1.1799999999999999 110.224 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.02 -46.26 85.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.615 -0.802 . . . . 0.28000000000000003 112.209 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 34.1 mm -55.76 -50.99 64.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.882 0.372 . . . . 1.6299999999999999 110.716 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -52.71 -52.18 57.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 2.4100000000000001 110.891 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 54.0 mt -62.18 -44.13 98.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.02 -0.537 . . . . 1.6100000000000001 110.994 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.05 -50.39 65.92 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.767 -0.73 . . . . 0.71999999999999997 112.692 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.789 0.328 . . . . 2.4700000000000002 110.864 -179.898 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 C--O 1.23 0.114 0 CA-C-O 120.756 0.232 . . . . 1.3 112.35 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.8 t -63.9 -49.44 72.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 1.8700000000000001 110.825 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 45.9 mt -59.46 -45.7 90.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.226 -0.443 . . . . 1.4099999999999999 110.874 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 86.9 mt -51.79 -50.24 61.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.337 -0.392 . . . . 1.3300000000000001 110.58 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 93.9 mt -58.89 -41.45 87.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 1.1399999999999999 110.591 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.474 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 68.9 m -56.45 -52.23 65.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.39000000000000001 110.777 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.432 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 75.7 m80 -61.39 -51.86 67.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.35999999999999999 110.723 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.3 mt -58.89 -52.0 67.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 1.1799999999999999 110.88 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.0 mt -61.54 -43.35 99.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 1.1499999999999999 110.901 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.431 ' CB ' ' HB2' ' B' ' 176' ' ' ALA . . . -52.81 -52.51 56.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 1.0600000000000001 110.876 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 71.4 mt -56.91 -43.0 79.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 1.29 110.307 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.13 -42.03 80.27 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.524 -0.846 . . . . 0.29999999999999999 111.927 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 45.2 mt -60.0 -51.59 69.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.927 0.394 . . . . 1.1399999999999999 110.306 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.17 -42.98 56.24 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.602 -0.808 . . . . 0.31 112.395 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 49.9 mm -62.06 -51.9 66.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.836 0.351 . . . . 1.5600000000000001 111.102 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -56.59 -50.64 71.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 2.4700000000000002 110.813 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 63.6 mt -60.3 -43.19 93.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.49 . . . . 1.4399999999999999 111.047 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.2 -48.65 81.36 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.815 -0.707 . . . . 0.64000000000000001 112.93 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -62.2 -38.1 87.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.593 0.235 . . . . 3.0299999999999998 111.606 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 . . . . . 0 C--N 1.328 -0.34 0 N-CA-C 111.64 0.237 . . . . 4.4299999999999997 111.64 -179.771 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo . . . . . 0 C--O 1.231 0.138 0 CA-C-O 120.766 0.236 . . . . 1.4199999999999999 112.398 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.1 t -46.87 -42.24 17.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.292 -0.413 . . . . 1.99 111.32 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 72.5 mt -62.4 -49.54 75.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 1.6899999999999999 110.955 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.5 mp -57.71 -42.31 83.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 1.3899999999999999 110.626 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 71.9 mt -59.48 -43.11 93.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 1.24 110.434 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 172' ' ' SER . . . . . 0.432 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 69.6 m -54.74 -52.09 63.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.41999999999999998 110.709 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.474 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 60.1 m80 -58.77 -52.29 66.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.049 -0.523 . . . . 0.37 110.882 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 96.5 mt -57.78 -50.32 73.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.41 . . . . 1.1899999999999999 111.056 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 78.0 mt -62.11 -47.28 85.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 1.21 110.991 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.431 ' HB2' ' CB ' ' A' ' 176' ' ' ALA . . . -55.15 -52.98 61.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 1.1100000000000001 111.076 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 66.1 mt -62.13 -42.84 96.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.359 -0.382 . . . . 1.0900000000000001 110.609 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.57 -49.86 50.93 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.616 -0.802 . . . . 0.29999999999999999 111.97 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 89.0 mt -57.91 -46.17 85.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.898 0.38 . . . . 1.1799999999999999 110.455 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.01 -50.38 61.83 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.547 -0.835 . . . . 0.28000000000000003 112.191 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 67.4 mt -53.91 -46.93 64.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 1.6299999999999999 110.849 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -54.45 -51.63 64.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 2.4100000000000001 110.73 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 69.5 mt -63.27 -48.79 85.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.178 -0.465 . . . . 1.6100000000000001 111.16 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.29 -52.74 47.37 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.957 -0.64 . . . . 0.71999999999999997 113.4 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.757 0.278 . . . . 2.4700000000000002 111.214 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo . . . . . 0 C--O 1.23 0.108 0 CA-C-O 120.806 0.253 . . . . 1.3 112.511 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.6 m -78.01 -51.97 9.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 1.8700000000000001 111.334 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.08 -50.16 74.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.454 -0.339 . . . . 1.4099999999999999 111.218 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 96.2 mt -52.13 -52.41 51.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.417 -0.356 . . . . 1.3300000000000001 111.1 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.8 mt -62.44 -41.86 99.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.305 -0.407 . . . . 1.1399999999999999 111.219 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.427 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 69.1 m -60.59 -53.28 59.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.42 -0.354 . . . . 0.39000000000000001 111.352 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.445 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 66.2 m80 -62.92 -52.58 62.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.745 0.307 . . . . 0.35999999999999999 110.889 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.6 mt -57.72 -52.86 63.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.412 -0.358 . . . . 1.1799999999999999 110.591 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 83.5 mt -62.88 -44.82 95.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 1.1499999999999999 110.803 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.53 -52.32 47.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.428 . . . . 1.0600000000000001 110.933 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.41 -45.03 97.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 1.29 110.477 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.4 -49.5 51.27 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.655 -0.783 . . . . 0.29999999999999999 111.99 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 43.3 mt -55.58 -49.04 73.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 1.1399999999999999 110.227 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.453 ' HA2' ' CG1' ' B' ' 181' ' ' ILE . . . -51.77 -46.16 54.64 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.524 -0.846 . . . . 0.31 112.45 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 41.7 mm -62.63 -48.24 89.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.748 0.308 . . . . 1.5600000000000001 111.192 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -62.07 -52.21 64.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 2.4700000000000002 111.242 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 94.6 mt -51.79 -51.1 29.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.286 -0.415 . . . . 1.4399999999999999 110.986 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.01 -52.56 45.98 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.49 -0.862 . . . . 0.64000000000000001 112.321 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.441 ' HG3' ' N ' ' A' ' 186' ' ' ARG . 10.9 ptp180 -62.93 -41.78 99.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.956 0.408 . . . . 3.0299999999999998 110.721 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.441 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 4.4299999999999997 111.21 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo . . . . . 0 C--O 1.231 0.148 0 CA-C-O 120.838 0.266 . . . . 1.4199999999999999 112.374 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 74.2 p -54.53 -41.67 69.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 1.99 111.009 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.417 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 59.7 mt -60.8 -52.66 64.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.329 -0.396 . . . . 1.6899999999999999 111.132 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.1 mp -62.89 -44.59 95.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.756 0.312 . . . . 1.3899999999999999 110.918 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 94.7 mt -59.95 -43.89 94.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.329 -0.396 . . . . 1.24 110.824 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 172' ' ' SER . . . . . 0.445 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 61.4 m -60.6 -48.97 79.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.41999999999999998 111.012 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.427 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 41.9 m80 -61.42 -52.08 66.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.37 110.917 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 64.7 mt -59.67 -51.54 69.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.39 -0.368 . . . . 1.1899999999999999 110.845 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.51 -51.99 65.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 1.21 111.483 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.93 -53.94 35.28 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.758 0.313 . . . . 1.1100000000000001 111.3 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 67.4 mt -62.97 -44.59 99.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 1.0900000000000001 110.703 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.97 -48.01 82.57 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.631 -0.795 . . . . 0.29999999999999999 112.062 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 88.9 mt -53.96 -48.79 69.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 1.1799999999999999 110.457 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.17 -48.24 81.39 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.704 -0.76 . . . . 0.28000000000000003 112.654 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.453 ' CG1' ' HA2' ' A' ' 180' ' ' GLY . 52.5 mt -62.06 -48.82 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.735 0.302 . . . . 1.6299999999999999 111.521 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -51.59 -52.25 48.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.321 -0.399 . . . . 2.4100000000000001 111.297 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 58.6 mt -62.05 -46.65 95.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.321 -0.399 . . . . 1.6100000000000001 111.203 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.39 -45.51 95.78 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.782 -0.723 . . . . 0.71999999999999997 113.024 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 . . . . . 0 C--N 1.329 -0.29 0 N-CA-C 111.685 0.254 . . . . 2.4700000000000002 111.685 -179.337 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo . . . . . 0 N--CA 1.464 -0.259 0 CA-C-O 120.806 0.252 . . . . 1.3 112.528 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 53.8 m -48.14 -52.37 20.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 1.8700000000000001 111.32 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 69.0 mt -61.3 -48.88 79.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.439 . . . . 1.4099999999999999 111.008 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 89.2 mt -58.56 -49.77 76.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 1.3300000000000001 111.077 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.31 -42.1 94.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 1.1399999999999999 111.382 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.471 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 67.1 m -56.16 -53.39 57.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.739 0.304 . . . . 0.39000000000000001 111.193 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.436 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 69.0 m80 -62.96 -51.69 65.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.351 -0.386 . . . . 0.35999999999999999 110.765 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 95.7 mt -57.83 -51.88 67.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 1.1799999999999999 111.241 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.69 -49.46 77.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 1.1499999999999999 111.275 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.436 ' CB ' ' HB1' ' B' ' 176' ' ' ALA . . . -51.51 -52.92 42.83 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.854 0.359 . . . . 1.0600000000000001 111.042 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 68.6 mt -57.45 -44.25 84.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 1.29 110.243 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.95 -44.01 82.42 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.719 -0.753 . . . . 0.29999999999999999 111.916 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 75.6 mt -56.17 -52.54 64.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.958 0.409 . . . . 1.1399999999999999 110.221 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.62 -45.11 68.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.566 -0.826 . . . . 0.31 112.07 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 48.0 mm -60.95 -42.44 92.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 1.5600000000000001 110.806 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -55.14 -42.21 72.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 2.4700000000000002 110.662 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 183' ' ' ILE . 3.7 mm -62.87 -52.99 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 1.4399999999999999 110.864 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -63.43 -52.86 43.26 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.023 -0.608 . . . . 0.64000000000000001 113.356 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.28 -26.44 12.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.701 0.286 . . . . 3.0299999999999998 111.184 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.406 -0.361 . . . . 4.4299999999999997 110.977 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo . . . . . 0 C--O 1.231 0.161 0 CA-C-O 120.772 0.238 . . . . 1.4199999999999999 112.25 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 63.5 m -49.75 -44.92 48.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 1.99 110.973 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.42 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 26.0 mt -52.73 -49.45 65.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 1.6899999999999999 110.673 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.3 mp -59.96 -44.45 94.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 1.3899999999999999 110.452 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.17 -41.72 98.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 1.24 110.605 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 172' ' ' SER . . . . . 0.436 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 72.2 m -54.1 -49.73 68.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.41999999999999998 110.637 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.471 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 66.9 m80 -60.26 -52.17 66.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.37 110.692 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.41 -52.41 65.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 1.1899999999999999 110.994 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 76.6 mt -62.5 -43.83 97.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 1.21 110.937 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.436 ' HB1' ' CB ' ' A' ' 176' ' ' ALA . . . -53.41 -53.43 51.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 1.1100000000000001 110.965 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 41.4 mt -62.64 -44.95 99.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 1.0900000000000001 110.413 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.82 -51.15 46.82 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.674 -0.774 . . . . 0.29999999999999999 111.892 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 97.0 mt -55.12 -42.95 73.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 1.1799999999999999 110.092 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.23 -42.6 93.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.667 -0.777 . . . . 0.28000000000000003 112.042 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 41.4 mm -58.18 -52.21 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.729 0.299 . . . . 1.6299999999999999 110.601 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -51.71 -52.5 47.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 2.4100000000000001 110.575 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 64.3 mt -62.89 -45.16 99.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.96 -0.564 . . . . 1.6100000000000001 110.912 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.16 -52.36 50.28 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.979 -0.629 . . . . 0.71999999999999997 112.999 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.82 0.343 . . . . 2.4700000000000002 110.87 -179.699 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.464 -0.236 0 CA-C-O 120.775 0.24 . . . . 1.3 112.516 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 79.9 p -65.67 -42.41 91.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 1.8700000000000001 110.922 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 80.1 mt -60.65 -49.87 75.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 1.4099999999999999 110.846 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 95.2 mt -54.88 -51.1 67.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.297 -0.41 . . . . 1.3300000000000001 110.769 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.5 -41.5 85.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 1.1399999999999999 111.042 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.469 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 68.3 m -55.98 -52.88 62.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.76 0.314 . . . . 0.39000000000000001 111.097 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.447 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 66.6 m80 -62.94 -52.57 62.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.35999999999999999 110.905 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.0 mt -58.31 -52.23 66.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 1.1799999999999999 110.841 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.4 -44.94 95.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.0 -0.546 . . . . 1.1499999999999999 110.933 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.424 ' CB ' ' HB2' ' B' ' 176' ' ' ALA . . . -52.12 -52.37 52.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 1.0600000000000001 110.822 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 68.9 mt -57.31 -42.64 80.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.268 -0.424 . . . . 1.29 110.128 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.3 -41.43 87.1 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.788 -0.72 . . . . 0.29999999999999999 111.755 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 76.8 mt -59.45 -49.26 78.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.949 0.404 . . . . 1.1399999999999999 110.199 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.8 -47.36 65.41 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.671 -0.776 . . . . 0.31 112.072 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 32.6 mm -56.25 -46.45 81.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 1.5600000000000001 110.841 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.401 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 88.8 t80 -57.59 -49.45 76.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 2.4700000000000002 110.989 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 54.7 mt -62.78 -43.83 99.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.23 -0.441 . . . . 1.4399999999999999 111.353 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.34 -52.21 51.02 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.039 -0.601 . . . . 0.64000000000000001 113.469 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -61.34 -20.78 63.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.767 0.284 . . . . 3.0299999999999998 111.395 -179.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.576 -0.284 . . . . 4.4299999999999997 111.676 179.758 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 N--CA 1.463 -0.278 0 CA-C-O 120.783 0.243 . . . . 1.4199999999999999 112.383 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 91.5 p -54.36 -42.8 70.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 1.99 110.87 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.406 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 81.8 mt -58.78 -49.6 77.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 1.6899999999999999 110.643 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . 0.423 ' N ' HD13 ' B' ' 170' ' ' LEU . 7.0 mp -62.17 -47.11 85.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.046 -0.525 . . . . 1.3899999999999999 110.724 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 79.6 mt -59.65 -43.63 93.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 1.24 110.822 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 172' ' ' SER . . . . . 0.447 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 75.6 m -54.24 -50.2 67.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.269 -0.423 . . . . 0.41999999999999998 110.607 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.469 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 56.6 m80 -62.26 -52.47 63.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.37 110.931 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 89.2 mt -58.62 -52.49 65.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.373 -0.376 . . . . 1.1899999999999999 111.083 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 64.7 mt -62.3 -46.15 90.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 1.21 111.051 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.424 ' HB2' ' CB ' ' A' ' 176' ' ' ALA . . . -53.49 -53.02 57.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 1.1100000000000001 110.907 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 72.6 mt -62.22 -42.02 93.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.188 -0.46 . . . . 1.0900000000000001 110.533 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.06 -45.44 92.44 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.565 -0.826 . . . . 0.29999999999999999 111.951 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.93 -46.0 85.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 1.1799999999999999 110.236 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.62 -44.38 79.12 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.584 -0.817 . . . . 0.28000000000000003 112.183 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 60.3 mt -60.91 -46.88 95.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.721 0.296 . . . . 1.6299999999999999 111.034 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -55.58 -47.46 76.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 2.4100000000000001 111.083 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 59.4 mt -61.25 -50.37 80.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 1.6100000000000001 111.07 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -58.15 -51.29 59.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.83 -0.7 . . . . 0.71999999999999997 112.712 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 . . . . . 0 C--N 1.33 -0.25 0 CA-C-O 120.701 0.286 . . . . 2.4700000000000002 111.285 -179.617 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo . . . . . 0 C--O 1.23 0.119 0 CA-C-O 120.771 0.238 . . . . 1.3 112.329 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.5 t -74.21 -52.82 11.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 1.8700000000000001 110.911 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 60.2 mt -62.61 -46.27 89.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 1.4099999999999999 110.914 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.79 -52.36 49.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.27 -0.423 . . . . 1.3300000000000001 110.635 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.4 mt -57.67 -43.66 85.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.243 -0.435 . . . . 1.1399999999999999 110.745 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.432 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 75.6 m -57.51 -52.79 63.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.39000000000000001 110.706 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.446 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 64.9 m80 -62.87 -51.89 65.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.35999999999999999 110.746 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.49 -52.3 66.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 1.1799999999999999 111.109 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 81.8 mt -53.71 -50.82 65.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.465 -0.334 . . . . 1.1499999999999999 110.781 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.438 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -53.36 -52.28 59.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 1.0600000000000001 110.697 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 81.4 mt -58.43 -42.86 85.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 1.29 110.232 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.0 -43.77 55.84 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.627 -0.797 . . . . 0.29999999999999999 111.796 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.0 -43.27 99.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.007 0.432 . . . . 1.1399999999999999 109.914 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -61.13 -45.59 96.25 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.657 -0.783 . . . . 0.31 112.137 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 48.7 mm -60.33 -46.04 95.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.891 0.377 . . . . 1.5600000000000001 110.924 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -54.52 -50.2 68.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.063 -0.517 . . . . 2.4700000000000002 110.844 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.79 -47.17 94.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.171 -0.468 . . . . 1.4399999999999999 111.224 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.42 -52.69 47.41 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.818 -0.706 . . . . 0.64000000000000001 112.969 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -15.48 43.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.563 0.221 . . . . 3.0299999999999998 111.329 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.68 0.276 . . . . 4.4299999999999997 110.984 179.645 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo . . . . . 0 C--O 1.231 0.129 0 N-CA-C 112.782 0.262 . . . . 1.4199999999999999 112.782 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 67.3 m -50.45 -43.28 55.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.431 -0.35 . . . . 1.99 111.071 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.13 -44.07 97.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.301 -0.409 . . . . 1.6899999999999999 111.249 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.7 mp -60.74 -50.11 74.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 1.3899999999999999 110.776 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 89.2 mt -53.65 -42.69 68.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 1.24 110.903 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 172' ' ' SER . . . . . 0.446 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 74.7 m -58.44 -49.59 76.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.196 -0.456 . . . . 0.41999999999999998 110.998 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.432 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 66.5 m80 -58.72 -52.61 64.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.37 111.101 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 82.5 mt -59.91 -52.46 65.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.369 -0.378 . . . . 1.1899999999999999 111.13 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.58 -42.56 99.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 1.21 110.952 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.438 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -52.39 -52.76 51.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 1.1100000000000001 111.338 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 31.6 mt -61.43 -42.64 94.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 1.0900000000000001 110.628 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.46 -49.95 54.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.536 -0.84 . . . . 0.29999999999999999 111.787 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 77.0 mt -55.86 -46.1 78.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 1.1799999999999999 110.272 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.96 -41.89 69.18 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.639 -0.791 . . . . 0.28000000000000003 112.019 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 41.9 mm -59.8 -52.13 64.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.866 0.365 . . . . 1.6299999999999999 110.835 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . 0.425 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 47.9 t80 -54.96 -50.82 67.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 2.4100000000000001 110.803 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 57.1 mt -62.01 -45.98 97.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 1.6100000000000001 111.322 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -56.01 -49.82 64.99 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.825 -0.703 . . . . 0.71999999999999997 112.481 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . 0.425 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 10.6 ptp180 . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 120.55 0.214 . . . . 2.4700000000000002 111.255 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo . . . . . 0 N--CA 1.466 -0.138 0 CA-C-O 120.845 0.269 . . . . 1.3 112.435 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 49.6 m -60.78 -45.7 93.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 1.8700000000000001 111.216 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 26.0 mt -58.99 -46.23 88.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.389 -0.369 . . . . 1.4099999999999999 111.12 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 65.6 mt -54.36 -52.06 62.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.329 -0.396 . . . . 1.3300000000000001 110.639 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 86.9 mt -57.76 -43.89 85.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 1.1399999999999999 110.688 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 58.2 m -56.1 -52.54 63.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.39000000000000001 110.811 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.434 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 80.8 m80 -62.6 -52.09 64.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.35999999999999999 110.978 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.9 mt -58.02 -52.53 65.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.361 -0.382 . . . . 1.1799999999999999 110.951 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.4 mt -56.69 -45.49 81.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.299 -0.41 . . . . 1.1499999999999999 110.832 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.433 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -56.49 -52.32 65.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 1.0600000000000001 110.904 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 75.7 mt -57.83 -42.98 83.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 1.29 110.648 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.51 -45.06 67.54 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.697 -0.763 . . . . 0.29999999999999999 112.255 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 79.5 mt -61.98 -49.8 74.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.836 0.35 . . . . 1.1399999999999999 110.525 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.426 ' CA ' HG13 ' B' ' 181' ' ' ILE . . . -55.96 -51.76 53.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.727 -0.749 . . . . 0.31 112.595 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 47.7 mt -59.19 -43.62 89.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.786 0.327 . . . . 1.5600000000000001 111.172 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -53.75 -47.88 70.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.026 0.441 . . . . 2.4700000000000002 110.577 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 72.9 mt -62.78 -48.0 90.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.069 -0.514 . . . . 1.4399999999999999 111.099 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.06 -46.35 94.73 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.93 -0.652 . . . . 0.64000000000000001 112.967 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -61.8 -28.69 69.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.029 0.442 . . . . 3.0299999999999998 110.851 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 115.6 -0.727 . . . . 4.4299999999999997 111.583 -179.512 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 0 N--CA 1.466 -0.137 0 N-CA-C 112.727 0.241 . . . . 1.4199999999999999 112.727 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 48.7 m -51.53 -42.41 61.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.901 0.381 . . . . 1.99 110.767 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 65.7 mt -62.31 -46.91 86.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 1.6899999999999999 111.016 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.52 -49.1 79.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.423 -0.353 . . . . 1.3899999999999999 110.571 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 85.3 mt -52.56 -41.81 63.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.42 . . . . 1.24 110.387 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 172' ' ' SER . . . . . 0.434 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 58.5 m -60.51 -51.81 67.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.52 . . . . 0.41999999999999998 110.597 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.443 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 54.8 m80 -61.52 -51.95 66.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.122 -0.49 . . . . 0.37 110.809 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 93.1 mt -59.77 -52.23 66.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.33 -0.396 . . . . 1.1899999999999999 110.794 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.23 -43.91 97.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 1.21 110.976 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.433 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -51.95 -52.47 50.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 1.1100000000000001 111.074 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 52.3 mt -61.99 -46.78 95.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.434 -0.348 . . . . 1.0900000000000001 110.591 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.23 -47.15 76.25 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.624 -0.798 . . . . 0.29999999999999999 111.858 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 93.4 mt -54.23 -49.49 69.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 1.1799999999999999 110.491 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.41 -44.43 89.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.554 -0.831 . . . . 0.28000000000000003 112.142 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.426 HG13 ' CA ' ' A' ' 180' ' ' GLY . 66.3 mt -61.43 -52.44 61.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.809 0.338 . . . . 1.6299999999999999 110.791 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . 0.416 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 46.5 t80 -56.7 -51.99 66.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.023 -0.535 . . . . 2.4100000000000001 110.964 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 62.6 mt -62.39 -48.58 87.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.397 -0.365 . . . . 1.6100000000000001 110.832 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.68 -52.36 48.82 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.839 -0.696 . . . . 0.71999999999999997 112.973 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . 0.416 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 1.4 ptp180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.634 0.254 . . . . 2.4700000000000002 111.521 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo . . . . . 0 C--O 1.231 0.135 0 CA-C-O 120.906 0.294 . . . . 1.3 112.505 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.6 t -51.03 -51.94 48.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.456 . . . . 1.8700000000000001 111.118 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 39.8 mt -59.68 -51.35 70.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.365 -0.38 . . . . 1.4099999999999999 110.912 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 91.7 mt -53.63 -49.59 67.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 1.3300000000000001 110.75 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.2 mt -62.09 -43.0 99.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 1.1399999999999999 110.921 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.434 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 69.3 m -57.3 -52.61 64.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.39000000000000001 111.019 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.413 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 65.4 m80 -62.78 -52.52 62.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 0.35999999999999999 111.242 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.8 mt -61.28 -52.1 66.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 1.1799999999999999 111.354 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 81.5 mt -57.49 -46.44 83.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.35 -0.386 . . . . 1.1499999999999999 111.14 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.443 ' CB ' ' HB2' ' B' ' 176' ' ' ALA . . . -54.48 -52.57 61.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.927 0.394 . . . . 1.0600000000000001 110.907 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 68.9 mt -58.01 -43.87 85.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.244 -0.435 . . . . 1.29 110.336 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.68 -47.08 65.45 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.495 -0.86 . . . . 0.29999999999999999 111.923 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 70.0 mt -55.82 -50.1 71.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.381 . . . . 1.1399999999999999 110.398 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.43 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -54.74 -43.29 80.07 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.561 -0.828 . . . . 0.31 112.354 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 40.7 mm -62.38 -49.2 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.912 0.387 . . . . 1.5600000000000001 111.101 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -56.74 -50.4 72.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.952 -0.567 . . . . 2.4700000000000002 111.343 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.87 -46.36 93.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 1.4399999999999999 111.305 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.19 -47.98 86.01 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.775 -0.726 . . . . 0.64000000000000001 112.899 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -58.78 -28.88 66.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.661 0.267 . . . . 3.0299999999999998 111.108 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.372 . . . . 4.4299999999999997 110.853 179.904 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.463 -0.281 0 N-CA-C 112.852 0.289 . . . . 1.4199999999999999 112.852 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 48.1 t -79.91 -44.8 19.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.865 0.364 . . . . 1.99 111.258 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 59.6 mt -62.31 -45.77 91.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 1.6899999999999999 111.396 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.48 -51.67 68.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.324 -0.398 . . . . 1.3899999999999999 111.247 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 92.8 mt -58.56 -41.71 86.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.385 -0.37 . . . . 1.24 111.05 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 172' ' ' SER . . . . . 0.413 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 68.9 m -54.04 -52.32 61.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.41999999999999998 111.382 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.434 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 62.9 m80 -61.55 -52.53 64.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.383 -0.371 . . . . 0.37 111.324 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 80.1 mt -55.74 -52.72 62.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.371 -0.377 . . . . 1.1899999999999999 110.922 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.91 -47.41 83.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.114 -0.494 . . . . 1.21 111.362 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.443 ' HB2' ' CB ' ' A' ' 176' ' ' ALA . . . -55.09 -53.32 57.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 1.1100000000000001 111.751 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 53.4 mt -62.58 -43.29 98.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 1.0900000000000001 110.862 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.28 -47.99 83.68 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.611 -0.804 . . . . 0.29999999999999999 112.126 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 93.6 mt -55.14 -51.85 65.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.759 0.314 . . . . 1.1799999999999999 110.583 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.47 -41.82 49.58 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.613 -0.803 . . . . 0.28000000000000003 112.017 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.437 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 27.2 mm -59.43 -48.88 85.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.755 0.312 . . . . 1.6299999999999999 110.624 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -51.68 -52.51 47.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 2.4100000000000001 111.269 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 4.0 mp -63.57 -52.47 57.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.451 -0.341 . . . . 1.6100000000000001 111.228 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.47 -52.57 48.11 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.905 -0.664 . . . . 0.71999999999999997 113.469 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . 0.437 ' CG ' ' O ' ' B' ' 181' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.546 0.213 . . . . 2.4700000000000002 111.515 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo . . . . . 0 C--O 1.23 0.12 0 CA-C-O 120.78 0.242 . . . . 1.3 111.951 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.4 t -47.73 -47.47 30.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.28 -0.418 . . . . 1.8700000000000001 110.992 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.415 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 29.3 mt -61.99 -51.32 68.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 1.4099999999999999 110.724 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 87.6 mt -57.79 -51.94 67.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 1.3300000000000001 110.634 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 95.2 mt -53.05 -47.13 68.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 1.1399999999999999 110.484 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.423 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 70.3 m -51.96 -51.96 53.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.035 -0.529 . . . . 0.39000000000000001 110.831 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.455 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 58.3 m80 -61.51 -52.33 64.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.35999999999999999 110.749 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 84.9 mt -57.19 -50.67 72.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 1.1799999999999999 111.003 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.9 mt -59.78 -44.8 93.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 1.1499999999999999 110.811 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.428 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -57.34 -52.68 64.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.429 . . . . 1.0600000000000001 110.716 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 71.0 mt -58.99 -42.66 86.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.48 . . . . 1.29 110.332 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.7 -43.15 53.52 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.587 -0.816 . . . . 0.29999999999999999 111.796 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.02 -47.7 83.59 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.736 -0.468 . . . . 1.1399999999999999 109.736 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -58.44 -49.23 78.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 0.31 112.224 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 35.2 mm -53.27 -45.95 56.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.763 0.316 . . . . 1.5600000000000001 110.88 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -58.4 -44.3 88.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 2.4700000000000002 110.993 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 72.4 mt -62.7 -48.92 85.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.395 -0.366 . . . . 1.4399999999999999 111.199 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.15 -52.11 52.1 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.927 -0.654 . . . . 0.64000000000000001 112.846 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.423 ' HD3' ' N ' ' A' ' 186' ' ' ARG . 0.0 OUTLIER -60.56 -28.1 68.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.789 0.328 . . . . 3.0299999999999998 110.97 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.423 ' N ' ' HD3' ' A' ' 185' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 4.4299999999999997 110.713 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 C--O 1.231 0.158 0 CA-C-O 120.703 0.21 . . . . 1.4199999999999999 112.414 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 51.7 m -62.26 -41.57 98.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.333 -0.394 . . . . 1.99 110.787 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.411 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 78.2 mt -60.39 -45.06 94.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 1.6899999999999999 110.927 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . 0.406 ' N ' HD13 ' B' ' 170' ' ' LEU . 7.1 mp -62.34 -50.95 69.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 1.3899999999999999 110.836 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.6 mt -58.15 -41.54 83.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 1.24 110.599 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 172' ' ' SER . . . . . 0.455 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 73.0 m -55.02 -52.19 63.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.031 -0.531 . . . . 0.41999999999999998 111.1 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.423 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 71.6 m80 -60.58 -52.53 64.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.37 111.139 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 87.8 mt -59.98 -52.49 65.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.339 -0.392 . . . . 1.1899999999999999 111.019 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.69 -42.88 99.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.134 -0.485 . . . . 1.21 111.021 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.428 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -53.04 -52.57 58.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 1.1100000000000001 111.478 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 53.1 mt -62.23 -41.86 93.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.358 . . . . 1.0900000000000001 110.9 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.08 -49.9 68.36 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.71 -0.757 . . . . 0.29999999999999999 112.387 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 83.1 mt -58.47 -42.38 87.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 1.1799999999999999 110.668 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.7 -49.88 63.54 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.723 -0.751 . . . . 0.28000000000000003 112.36 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 55.7 mt -57.97 -45.15 87.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.859 0.362 . . . . 1.6299999999999999 110.959 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -53.32 -50.9 64.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 2.4100000000000001 110.693 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 64.5 mt -62.3 -41.97 93.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.031 -0.531 . . . . 1.6100000000000001 111.136 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.91 -49.07 79.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.904 -0.665 . . . . 0.71999999999999997 112.842 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.706 0.289 . . . . 2.4700000000000002 111.373 -179.594 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 N--CA 1.463 -0.274 0 CA-C-O 120.865 0.277 . . . . 1.3 112.298 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.1 t -56.77 -42.74 79.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 1.8700000000000001 110.57 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.61 -51.49 68.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.962 -0.563 . . . . 1.4099999999999999 110.782 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 85.9 mt -52.57 -48.7 66.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.985 -0.552 . . . . 1.3300000000000001 110.823 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.9 mt -55.97 -42.87 76.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.322 -0.399 . . . . 1.1399999999999999 110.764 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.481 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 67.9 m -57.21 -52.47 65.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.39000000000000001 110.871 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.417 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 73.0 m80 -62.2 -52.27 64.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.35999999999999999 110.87 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.8 mt -59.0 -51.64 69.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.066 -0.516 . . . . 1.1799999999999999 111.005 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.1 mt -60.56 -42.41 96.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 1.1499999999999999 111.008 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.44 ' CB ' ' HB1' ' B' ' 176' ' ' ALA . . . -56.06 -52.36 64.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.995 0.426 . . . . 1.0600000000000001 110.875 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.45 -41.52 81.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.551 . . . . 1.29 110.469 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.04 -44.58 83.27 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.772 -0.728 . . . . 0.29999999999999999 112.129 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 70.8 mt -61.06 -47.11 87.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.949 0.404 . . . . 1.1399999999999999 110.355 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.435 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -52.68 -52.42 38.36 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.676 -0.773 . . . . 0.31 112.587 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 39.3 mt -61.96 -42.88 96.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 1.5600000000000001 111.032 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.409 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 83.5 t80 -51.9 -52.08 52.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.016 0.436 . . . . 2.4700000000000002 110.695 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 65.8 mt -63.5 -48.03 88.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.133 -0.485 . . . . 1.4399999999999999 111.203 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.78 -52.85 45.4 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.983 -0.627 . . . . 0.64000000000000001 113.692 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -54.98 -24.41 23.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.866 0.333 . . . . 3.0299999999999998 110.801 -179.292 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 18.7 mtp-105 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 4.4299999999999997 110.865 179.485 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 N--CA 1.462 -0.326 0 CA-C-O 120.74 0.225 . . . . 1.4199999999999999 112.633 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 66.3 m -53.22 -44.13 67.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 1.99 111.08 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.413 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 84.5 mt -54.6 -51.13 66.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.28 -0.418 . . . . 1.6899999999999999 111.177 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 mp -62.17 -46.14 90.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.387 -0.37 . . . . 1.3899999999999999 110.854 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.3 -42.65 91.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.336 -0.393 . . . . 1.24 110.847 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 172' ' ' SER . . . . . 0.417 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 68.3 m -56.87 -52.21 66.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.483 . . . . 0.41999999999999998 111.005 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.481 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 66.8 m80 -62.54 -52.6 62.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.37 111.289 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.78 -52.56 64.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.359 . . . . 1.1899999999999999 111.24 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 69.4 mt -62.46 -43.32 99.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.316 -0.402 . . . . 1.21 111.032 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.44 ' HB1' ' CB ' ' A' ' 176' ' ' ALA . . . -58.36 -52.7 64.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 1.1100000000000001 111.142 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 82.7 mt -60.07 -42.34 89.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.428 -0.351 . . . . 1.0900000000000001 110.418 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.57 -49.75 59.86 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.564 -0.827 . . . . 0.29999999999999999 111.97 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 88.7 mt -56.25 -46.76 79.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 1.1799999999999999 110.397 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.03 -42.98 55.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.526 -0.845 . . . . 0.28000000000000003 111.812 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.435 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 17.7 mm -60.05 -51.87 67.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.836 0.35 . . . . 1.6299999999999999 110.611 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -51.3 -49.48 61.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.792 -0.64 . . . . 2.4100000000000001 111.224 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 61.1 mt -58.73 -52.45 59.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.212 -0.449 . . . . 1.6100000000000001 111.324 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.0 -52.38 53.72 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.882 -0.675 . . . . 0.71999999999999997 113.098 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' B' ' 181' ' ' ILE . 6.1 ptp180 . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.366 . . . . 2.4700000000000002 111.141 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo . . . . . 0 C--O 1.231 0.175 0 CA-C-O 120.808 0.253 . . . . 1.3 111.515 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 60.3 m -50.23 -48.96 54.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 1.8700000000000001 110.68 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 78.1 mt -54.71 -50.7 67.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.507 . . . . 1.4099999999999999 110.173 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.31 -42.92 96.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.05 -0.523 . . . . 1.3300000000000001 110.208 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 76.5 mt -62.17 -41.27 98.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.961 -0.563 . . . . 1.1399999999999999 110.635 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.429 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 73.6 m -55.85 -52.72 63.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.359 -0.382 . . . . 0.39000000000000001 110.855 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.434 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 73.3 m80 -62.6 -52.09 64.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.35999999999999999 110.929 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.5 mt -59.88 -52.55 64.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.226 -0.443 . . . . 1.1799999999999999 111.21 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 75.0 mt -56.2 -46.02 79.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 1.1499999999999999 110.542 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.428 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -52.41 -52.01 56.08 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.142 -0.481 . . . . 1.0600000000000001 110.15 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 69.1 mt -58.85 -42.56 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 115.975 -0.557 . . . . 1.29 109.81 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.23 -43.65 64.18 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.654 -0.784 . . . . 0.29999999999999999 111.724 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 78.5 mt -60.21 -46.01 91.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.95 0.405 . . . . 1.1399999999999999 110.115 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -58.59 -43.59 96.04 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.554 -0.832 . . . . 0.31 112.029 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 45.6 mm -58.31 -44.41 88.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.899 0.381 . . . . 1.5600000000000001 110.749 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -60.03 -49.54 77.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 2.4700000000000002 110.741 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 57.9 mt -62.23 -48.92 86.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 1.4399999999999999 111.31 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.2 -52.67 51.35 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.768 -0.729 . . . . 0.64000000000000001 113.046 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.12 -17.93 59.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.707 0.289 . . . . 3.0299999999999998 111.224 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 . . . . . 0 CA--C 1.532 0.258 0 CA-C-N 116.544 -0.298 . . . . 4.4299999999999997 111.417 179.346 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.835 0.264 . . . . 1.4199999999999999 112.176 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.5 t -50.87 -42.29 58.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 1.99 110.98 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.414 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 46.0 mt -54.13 -50.68 66.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.435 . . . . 1.6899999999999999 110.68 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . 0.409 HD11 ' N ' ' B' ' 170' ' ' LEU . 7.0 mp -61.14 -44.12 97.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 1.3899999999999999 110.386 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.05 -41.56 98.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 1.24 110.279 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 172' ' ' SER . . . . . 0.434 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 73.6 m -55.06 -44.24 74.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.081 -0.509 . . . . 0.41999999999999998 110.502 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.429 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 68.7 m80 -61.74 -52.54 63.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.37 110.846 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 94.4 mt -58.44 -52.56 65.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.862 0.363 . . . . 1.1899999999999999 110.723 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.8 -42.2 99.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.073 -0.512 . . . . 1.21 111.204 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.428 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -59.11 -52.46 65.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.426 . . . . 1.1100000000000001 111.573 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 87.0 mt -56.97 -45.54 83.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 1.0900000000000001 110.648 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.8 -45.89 77.85 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.511 -0.852 . . . . 0.29999999999999999 111.855 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 95.8 mt -55.78 -46.26 78.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.942 0.401 . . . . 1.1799999999999999 110.143 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.15 -41.62 79.1 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.744 -0.741 . . . . 0.28000000000000003 112.051 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 53.4 mt -61.11 -46.86 95.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.878 0.371 . . . . 1.6299999999999999 110.803 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . 0.403 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 89.0 t80 -59.7 -46.92 87.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.05 -0.523 . . . . 2.4100000000000001 110.963 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 47.8 mt -62.99 -47.71 91.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.326 -0.397 . . . . 1.6100000000000001 111.511 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.09 -51.92 50.57 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 121.284 -0.484 . . . . 0.71999999999999997 113.624 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.388 0 CA-C-O 120.788 0.328 . . . . 2.4700000000000002 111.366 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo . . . . . 0 C--O 1.231 0.155 0 CA-C-O 120.803 0.251 . . . . 1.3 112.237 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 57.7 m -53.69 -42.26 67.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 1.8700000000000001 110.841 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.41 -51.01 69.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 1.4099999999999999 110.915 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 89.5 mt -55.33 -48.57 73.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 1.3300000000000001 110.905 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.9 mt -59.07 -42.72 91.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 1.1399999999999999 111.082 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.482 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 67.9 m -55.97 -53.1 60.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.311 -0.404 . . . . 0.39000000000000001 111.025 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.416 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 70.8 m80 -62.77 -52.5 62.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.35999999999999999 110.832 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 78.9 mt -57.83 -51.72 68.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 1.1799999999999999 111.309 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 73.9 mt -60.77 -45.54 93.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.367 -0.379 . . . . 1.1499999999999999 111.175 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -56.1 -52.7 63.36 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.017 0.437 . . . . 1.0600000000000001 110.67 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 63.2 mt -59.55 -42.49 88.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.128 -0.487 . . . . 1.29 109.861 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.78 -42.06 52.14 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.639 -0.791 . . . . 0.29999999999999999 111.553 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 83.7 mt -61.35 -46.2 91.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.075 0.464 . . . . 1.1399999999999999 109.751 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -61.55 -44.08 98.45 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.643 -0.789 . . . . 0.31 112.291 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 47.5 mm -60.81 -51.32 74.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.331 . . . . 1.5600000000000001 110.958 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.408 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 81.1 t80 -51.85 -52.21 51.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 2.4700000000000002 110.747 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 54.8 mt -62.53 -41.91 93.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.204 -0.453 . . . . 1.4399999999999999 111.312 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.74 -44.92 97.37 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.957 -0.639 . . . . 0.64000000000000001 113.347 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.408 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 8.0 ptp180 -61.18 -32.64 72.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.894 0.347 . . . . 3.0299999999999998 111.384 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.654 0.264 . . . . 4.4299999999999997 111.144 179.803 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.69 0.204 . . . . 1.4199999999999999 112.456 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 35.4 t -65.41 -45.96 81.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.417 -0.356 . . . . 1.99 110.943 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 55.3 mt -54.86 -48.71 72.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 1.6899999999999999 110.786 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.6 mp -57.87 -50.33 73.7 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.199 -0.455 . . . . 1.3899999999999999 110.631 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 61.6 mt -59.05 -41.48 87.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.485 . . . . 1.24 110.651 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 172' ' ' SER . . . . . 0.416 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 73.5 m -51.93 -50.32 61.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.41999999999999998 110.889 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.482 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 60.6 m80 -61.18 -52.32 65.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.37 111.181 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 98.0 mt -60.91 -52.35 65.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.361 -0.381 . . . . 1.1899999999999999 111.002 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.28 -43.73 98.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 1.21 111.039 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.429 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -53.41 -52.35 59.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 1.1100000000000001 111.342 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 60.4 mt -60.95 -47.76 92.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.426 -0.352 . . . . 1.0900000000000001 110.918 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.28 -51.1 43.87 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.639 -0.791 . . . . 0.29999999999999999 112.164 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 97.3 mt -55.25 -46.86 76.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.973 0.416 . . . . 1.1799999999999999 110.796 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.96 -42.9 82.08 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.669 -0.777 . . . . 0.28000000000000003 112.545 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 58.2 mt -61.89 -51.1 76.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 1.6299999999999999 111.019 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -58.67 -49.85 76.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 2.4100000000000001 110.812 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 73.7 mt -61.93 -46.02 97.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 1.6100000000000001 111.101 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -58.88 -49.54 77.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.639 -0.791 . . . . 0.71999999999999997 112.415 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.781 0.324 . . . . 2.4700000000000002 111.08 179.99 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 C--O 1.23 0.121 0 CA-C-O 120.747 0.228 . . . . 1.3 112.406 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 65.9 m -51.14 -50.73 58.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.265 -0.425 . . . . 1.8700000000000001 110.839 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 85.5 mt -61.78 -51.91 66.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.151 -0.477 . . . . 1.4099999999999999 111.005 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 83.7 mt -52.88 -51.45 61.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.27 -0.423 . . . . 1.3300000000000001 110.987 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 79.3 mt -58.28 -42.32 86.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.339 -0.391 . . . . 1.1399999999999999 111.011 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.4 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 65.2 m -59.7 -52.13 66.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.39000000000000001 111.002 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.434 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 74.8 m80 -60.44 -51.83 67.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.35999999999999999 111.02 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.3 mt -57.02 -52.25 66.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 1.1799999999999999 111.12 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 74.1 mt -58.12 -49.46 76.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 1.1499999999999999 111.137 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.439 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -51.34 -52.24 47.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.935 0.398 . . . . 1.0600000000000001 110.673 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 70.6 mt -59.2 -41.97 85.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 1.29 110.13 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.66 -46.05 89.64 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.666 -0.778 . . . . 0.29999999999999999 111.834 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 44.4 mt -55.71 -47.82 76.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.004 0.43 . . . . 1.1399999999999999 110.077 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.427 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -55.18 -43.75 83.87 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.792 -0.718 . . . . 0.31 112.339 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 49.4 mm -58.34 -52.28 61.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.837 0.351 . . . . 1.5600000000000001 111.068 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -53.95 -48.25 70.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 2.4700000000000002 110.784 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 68.7 mt -62.1 -42.62 95.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 1.4399999999999999 111.191 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.5 -47.14 91.59 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.867 -0.682 . . . . 0.64000000000000001 112.984 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.428 ' HG3' ' N ' ' A' ' 186' ' ' ARG . 13.5 ptp180 -62.18 -40.8 97.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.552 0.215 . . . . 3.0299999999999998 111.407 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.428 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 15.9 ptm180 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.654 -0.248 . . . . 4.4299999999999997 111.46 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo . . . . . 0 N--CA 1.466 -0.141 0 CA-C-O 120.881 0.284 . . . . 1.4199999999999999 112.564 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 42.5 t -57.86 -41.51 82.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.164 -0.471 . . . . 1.99 111.098 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.416 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 27.2 mt -59.24 -51.23 70.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.317 -0.401 . . . . 1.6899999999999999 111.364 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . 0.42 ' N ' HD13 ' B' ' 170' ' ' LEU . 7.7 mp -59.86 -49.01 79.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.738 0.304 . . . . 1.3899999999999999 110.972 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.99 -41.49 98.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 1.24 110.904 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 172' ' ' SER . . . . . 0.434 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 73.0 m -57.95 -52.35 65.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.41999999999999998 111.37 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 60.9 m80 -62.24 -52.45 63.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.333 -0.394 . . . . 0.37 111.358 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 97.5 mt -54.77 -53.07 59.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.921 0.391 . . . . 1.1899999999999999 110.703 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.37 -49.33 74.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.962 -0.563 . . . . 1.21 110.993 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.439 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -51.74 -52.58 47.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.0 -0.546 . . . . 1.1100000000000001 111.635 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.402 HG13 ' HB2' ' A' ' 176' ' ' ALA . 70.7 mt -62.04 -46.66 95.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.919 0.39 . . . . 1.0900000000000001 110.668 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.16 -46.46 91.56 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.598 -0.81 . . . . 0.29999999999999999 111.963 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 94.4 mt -55.24 -46.06 76.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.987 0.422 . . . . 1.1799999999999999 110.212 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.14 -42.18 80.85 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.644 -0.789 . . . . 0.28000000000000003 111.777 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.427 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 40.4 mm -58.0 -50.73 76.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.883 0.373 . . . . 1.6299999999999999 110.589 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -58.66 -49.76 76.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.008 -0.542 . . . . 2.4100000000000001 111.237 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 50.4 mt -59.59 -51.34 73.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.367 -0.379 . . . . 1.6100000000000001 111.335 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.37 -52.24 50.74 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.755 -0.736 . . . . 0.71999999999999997 112.866 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . 0.419 ' CG ' ' O ' ' B' ' 181' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 N-CA-C 111.667 0.247 . . . . 2.4700000000000002 111.667 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.809 0.254 . . . . 1.3 112.048 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.2 t -59.29 -43.81 92.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 1.8700000000000001 110.904 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 65.3 mt -59.4 -50.15 75.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.514 . . . . 1.4099999999999999 110.877 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 97.3 mt -55.39 -49.12 73.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.426 . . . . 1.3300000000000001 110.734 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.9 mt -56.28 -41.97 76.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 1.1399999999999999 110.755 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.473 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 72.9 m -57.49 -52.04 67.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 0.39000000000000001 110.862 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.432 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 70.1 m80 -61.17 -50.55 72.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.35999999999999999 110.815 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 92.8 mt -61.42 -52.14 65.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 1.1799999999999999 111.119 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 66.6 mt -62.03 -43.62 98.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.332 -0.395 . . . . 1.1499999999999999 111.089 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.425 ' CB ' ' HB1' ' B' ' 176' ' ' ALA . . . -51.84 -52.47 49.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.9 0.381 . . . . 1.0600000000000001 110.623 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 66.4 mt -58.15 -41.95 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 1.29 110.246 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.64 -44.53 60.08 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.621 -0.799 . . . . 0.29999999999999999 111.893 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 72.1 mt -61.32 -48.44 81.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.987 0.423 . . . . 1.1399999999999999 110.322 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.66 -52.05 50.88 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.579 -0.82 . . . . 0.31 112.338 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 56.1 mt -53.66 -49.37 57.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.868 0.366 . . . . 1.5600000000000001 110.954 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.422 ' O ' ' CG ' ' A' ' 186' ' ' ARG . 92.1 t80 -51.95 -51.43 57.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.507 . . . . 2.4700000000000002 110.777 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 59.4 mt -62.7 -41.9 94.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.112 -0.494 . . . . 1.4399999999999999 111.165 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.19 -52.62 48.41 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.941 -0.647 . . . . 0.64000000000000001 113.265 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.07 -22.86 66.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.822 0.311 . . . . 3.0299999999999998 111.005 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.422 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 1.5 mmp_? . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.392 . . . . 4.4299999999999997 110.935 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo . . . . . 0 N--CA 1.464 -0.259 0 CA-C-O 120.782 0.243 . . . . 1.4199999999999999 112.524 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 81.1 p -57.22 -48.56 78.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 1.99 110.929 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.424 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 84.0 mt -52.23 -49.4 64.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 1.6899999999999999 111.049 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . 0.412 HD11 ' N ' ' B' ' 170' ' ' LEU . 7.2 mp -61.88 -47.99 82.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.36 -0.382 . . . . 1.3899999999999999 111.082 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 90.2 mt -61.87 -44.74 96.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 1.24 111.141 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 172' ' ' SER . . . . . 0.432 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 71.0 m -53.04 -52.11 59.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.318 -0.401 . . . . 0.41999999999999998 110.979 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.473 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 61.6 m80 -60.48 -52.5 64.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.37 111.201 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 86.6 mt -60.29 -52.35 65.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.844 0.354 . . . . 1.1899999999999999 111.236 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.17 -45.3 94.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.43 . . . . 1.21 111.208 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.425 ' HB1' ' CB ' ' A' ' 176' ' ' ALA . . . -53.28 -52.53 58.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 1.1100000000000001 111.51 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 69.8 mt -59.14 -42.83 87.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.827 0.346 . . . . 1.0900000000000001 110.799 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.56 -51.11 50.4 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.508 -0.853 . . . . 0.29999999999999999 111.963 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 66.3 mt -56.38 -42.48 77.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.911 0.386 . . . . 1.1799999999999999 110.256 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.56 -47.35 70.45 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.673 -0.775 . . . . 0.28000000000000003 112.069 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 49.7 mt -57.4 -48.64 82.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.868 0.366 . . . . 1.6299999999999999 110.69 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -54.0 -47.07 71.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 2.4100000000000001 110.502 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 72.3 mt -62.4 -51.53 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.079 -0.51 . . . . 1.6100000000000001 110.934 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.19 -52.51 49.18 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.808 -0.71 . . . . 0.71999999999999997 112.8 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.724 0.297 . . . . 2.4700000000000002 111.073 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 C--O 1.232 0.206 0 CA-C-O 120.813 0.256 . . . . 1.3 112.391 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.8 t -57.34 -50.07 74.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 1.8700000000000001 110.88 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 40.8 mt -62.16 -48.97 77.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 1.4099999999999999 111.053 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 64.6 mt -52.26 -51.8 56.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.875 0.369 . . . . 1.3300000000000001 110.757 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.6 mt -56.43 -42.35 77.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 1.1399999999999999 110.856 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.426 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 74.8 m -58.38 -52.55 65.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.42 . . . . 0.39000000000000001 110.85 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.426 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 72.4 m80 -62.48 -51.97 65.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.35999999999999999 110.744 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.65 -51.78 68.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 1.1799999999999999 110.987 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.7 mt -60.19 -44.11 95.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 1.1499999999999999 110.98 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.419 ' CB ' ' HB1' ' B' ' 176' ' ' ALA . . . -53.75 -52.37 60.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 1.0600000000000001 110.788 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 68.5 mt -55.47 -45.42 78.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 1.29 110.162 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.91 -42.15 59.84 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.505 -0.855 . . . . 0.29999999999999999 111.825 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 68.2 mt -59.06 -48.09 82.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.979 0.419 . . . . 1.1399999999999999 110.105 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.421 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -58.64 -46.51 93.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.677 -0.773 . . . . 0.31 112.344 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 48.0 mm -59.73 -49.93 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.878 0.371 . . . . 1.5600000000000001 111.081 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -51.88 -49.93 62.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 2.4700000000000002 110.915 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 71.9 mt -62.56 -42.55 96.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 1.4399999999999999 111.186 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.2 -52.51 49.17 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.849 -0.691 . . . . 0.64000000000000001 112.951 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -24.17 67.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 3.0299999999999998 111.017 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.445 . . . . 4.4299999999999997 111.044 179.772 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo . . . . . 0 N--CA 1.455 -0.786 0 CA-C-O 120.708 0.211 . . . . 1.4199999999999999 112.405 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 55.0 m -114.07 -43.61 3.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.414 -0.357 . . . . 1.99 110.891 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.419 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 82.4 mt -61.5 -41.92 98.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 1.6899999999999999 110.944 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 6.3 mp -60.48 -47.25 86.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 1.3899999999999999 110.979 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 48.5 mt -61.02 -41.74 97.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.303 -0.408 . . . . 1.24 110.731 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 172' ' ' SER . . . . . 0.426 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 70.8 m -54.92 -51.36 66.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.41999999999999998 110.937 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.426 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 67.0 m80 -61.66 -52.41 64.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.229 -0.441 . . . . 0.37 111.131 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 90.6 mt -55.39 -52.93 61.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.445 -0.343 . . . . 1.1899999999999999 110.8 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.8 -45.04 94.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 1.21 110.979 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.419 ' HB1' ' CB ' ' A' ' 176' ' ' ALA . . . -54.67 -53.02 60.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 1.1100000000000001 111.268 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 56.9 mt -62.19 -42.62 95.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.359 -0.382 . . . . 1.0900000000000001 110.585 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.55 -46.51 81.11 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.61 -0.805 . . . . 0.29999999999999999 111.9 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 94.9 mt -57.44 -47.94 80.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.37 . . . . 1.1799999999999999 110.346 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.31 -43.53 64.95 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.572 -0.823 . . . . 0.28000000000000003 112.34 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.421 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 40.0 mm -60.29 -49.87 82.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.872 0.367 . . . . 1.6299999999999999 110.993 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -59.36 -47.97 83.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.54 . . . . 2.4100000000000001 110.986 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 65.6 mt -62.17 -44.52 99.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 1.6100000000000001 111.147 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.38 -46.83 93.05 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.831 -0.7 . . . . 0.71999999999999997 112.92 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 . . . . . 0 C--N 1.328 -0.339 0 N-CA-C 111.923 0.342 . . . . 2.4700000000000002 111.923 -179.518 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo . . . . . 0 N--CA 1.463 -0.299 0 CA-C-O 120.783 0.243 . . . . 1.3 112.339 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 80.8 p -51.34 -47.56 62.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 1.8700000000000001 110.89 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 96.7 mt -61.75 -47.66 84.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.419 . . . . 1.4099999999999999 110.766 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 88.4 mt -55.21 -50.52 69.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 1.3300000000000001 110.938 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.8 mt -57.29 -45.18 84.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 1.1399999999999999 110.881 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.423 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 75.8 m -55.43 -51.93 65.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.288 -0.414 . . . . 0.39000000000000001 110.703 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.431 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 77.2 m80 -61.95 -48.71 79.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.033 -0.53 . . . . 0.35999999999999999 110.844 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 88.8 mt -58.99 -49.8 76.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.314 -0.403 . . . . 1.1799999999999999 110.921 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 82.6 mt -59.92 -51.09 71.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 1.1499999999999999 111.086 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.441 ' CB ' ' HB2' ' B' ' 176' ' ' ALA . . . -52.03 -52.65 49.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 1.0600000000000001 110.933 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.28 -42.28 90.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.044 -0.525 . . . . 1.29 110.274 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.66 -44.64 60.22 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.579 -0.82 . . . . 0.29999999999999999 112.102 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 50.8 mt -62.61 -52.53 63.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.859 0.361 . . . . 1.1399999999999999 110.494 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.01 -52.14 45.28 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.732 -0.747 . . . . 0.31 112.545 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 59.3 mt -55.76 -41.56 66.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.813 0.339 . . . . 1.5600000000000001 110.582 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -55.39 -43.27 75.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.123 -0.49 . . . . 2.4700000000000002 110.596 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 4.7 mm -61.67 -48.71 87.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.938 0.399 . . . . 1.4399999999999999 110.843 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -58.79 -50.8 63.66 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.963 -0.637 . . . . 0.64000000000000001 112.933 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -55.43 -26.53 42.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.667 0.27 . . . . 3.0299999999999998 111.387 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 4.7 ptm85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.875 0.369 . . . . 4.4299999999999997 110.978 179.927 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo . . . . . 0 N--CA 1.465 -0.168 0 CA-C-O 120.739 0.225 . . . . 1.4199999999999999 112.587 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 51.0 m -52.13 -42.93 63.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.865 0.364 . . . . 1.99 111.175 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 49.8 mt -61.99 -49.93 74.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 1.6899999999999999 111.216 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.6 mp -61.68 -49.77 75.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.463 -0.335 . . . . 1.3899999999999999 110.885 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 88.8 mt -57.34 -41.82 80.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.379 -0.373 . . . . 1.24 110.775 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 172' ' ' SER . . . . . 0.431 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 67.5 m -57.21 -51.3 69.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.41999999999999998 110.976 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.423 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 69.0 m80 -61.17 -52.47 64.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.335 -0.393 . . . . 0.37 111.017 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 88.2 mt -60.49 -52.3 65.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.907 0.384 . . . . 1.1899999999999999 110.92 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.17 -42.61 99.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.065 -0.516 . . . . 1.21 110.948 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.441 ' HB2' ' CB ' ' A' ' 176' ' ' ALA . . . -53.6 -52.03 61.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.055 -0.52 . . . . 1.1100000000000001 111.333 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 59.8 mt -60.44 -44.41 96.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.75 0.31 . . . . 1.0900000000000001 110.853 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.58 -51.78 49.82 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.608 -0.806 . . . . 0.29999999999999999 112.263 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.8 -41.98 78.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.756 0.312 . . . . 1.1799999999999999 110.651 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.47 -49.32 74.2 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.712 -0.756 . . . . 0.28000000000000003 112.197 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 60.3 mt -54.83 -50.98 56.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 1.6299999999999999 110.756 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . 0.418 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 80.3 t80 -53.05 -52.31 58.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.077 -0.51 . . . . 2.4100000000000001 110.812 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 63.3 mt -62.26 -45.17 99.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 1.6100000000000001 110.974 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -58.81 -48.66 84.13 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.764 -0.731 . . . . 0.71999999999999997 112.688 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . 0.418 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 6.9 ptp180 . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.576 0.227 . . . . 2.4700000000000002 111.376 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.71 0.213 . . . . 1.3 112.534 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.9 t -52.96 -52.74 57.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.445 -0.343 . . . . 1.8700000000000001 111.169 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 42.0 mt -62.74 -51.4 67.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.324 -0.398 . . . . 1.4099999999999999 111.569 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 93.0 mt -51.49 -52.17 48.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.475 -0.329 . . . . 1.3300000000000001 111.153 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 83.5 mt -62.22 -42.78 99.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.395 -0.366 . . . . 1.1399999999999999 111.137 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.42 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 72.2 m -62.13 -53.0 61.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.436 -0.347 . . . . 0.39000000000000001 111.491 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.431 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 64.7 m80 -62.62 -53.11 59.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.496 -0.32 . . . . 0.35999999999999999 111.185 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 95.8 mt -57.0 -52.48 65.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.416 -0.356 . . . . 1.1799999999999999 111.098 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 74.3 mt -56.53 -41.44 76.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.404 -0.362 . . . . 1.1499999999999999 110.297 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.428 ' CB ' ' HB1' ' B' ' 176' ' ' ALA . . . -57.61 -48.58 79.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.151 -0.477 . . . . 1.0600000000000001 110.746 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 173' ' ' HIS . 18.2 mm -54.11 -46.35 66.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.934 0.397 . . . . 1.29 110.394 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.31 -42.02 81.47 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.673 -0.775 . . . . 0.29999999999999999 111.882 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 80.6 mt -57.45 -48.78 78.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.8 0.333 . . . . 1.1399999999999999 110.433 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -61.28 -51.78 55.9 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.827 -0.701 . . . . 0.31 112.551 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 56.1 mt -53.89 -48.73 62.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.788 0.328 . . . . 1.5600000000000001 111.136 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.404 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 52.8 t80 -53.74 -49.79 67.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 2.4700000000000002 110.876 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 70.5 mt -63.17 -42.23 95.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.151 -0.477 . . . . 1.4399999999999999 111.385 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.4 -53.11 44.41 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.8 -0.714 . . . . 0.64000000000000001 113.507 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -62.68 -17.26 60.29 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.712 0.264 . . . . 3.0299999999999998 111.712 -179.711 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.592 0.234 . . . . 4.4299999999999997 111.525 -179.79 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo . . . . . 0 N--CA 1.464 -0.213 0 CA-C-O 120.855 0.273 . . . . 1.4199999999999999 112.638 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.6 m -56.35 -41.7 76.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.065 -0.516 . . . . 1.99 110.967 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 14.4 mt -62.1 -48.06 81.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.314 -0.403 . . . . 1.6899999999999999 111.192 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 8.1 mp -59.62 -49.66 76.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.743 0.306 . . . . 1.3899999999999999 110.761 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 97.8 mt -54.32 -41.74 69.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 1.24 110.663 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 172' ' ' SER . . . . . 0.431 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 59.8 m -59.95 -48.21 82.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.41999999999999998 111.249 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.42 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 68.2 m80 -60.4 -52.08 66.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.37 110.958 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 74.0 mt -61.03 -52.46 64.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.359 . . . . 1.1899999999999999 110.86 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.0 -44.12 97.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 1.21 110.901 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.428 ' HB1' ' CB ' ' A' ' 176' ' ' ALA . . . -52.81 -52.47 56.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.486 . . . . 1.1100000000000001 110.897 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 88.2 mt -55.38 -44.6 76.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.177 -0.465 . . . . 1.0900000000000001 110.285 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.77 -41.84 58.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.531 -0.842 . . . . 0.29999999999999999 111.479 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 80.0 mt -59.2 -48.13 82.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.02 0.438 . . . . 1.1799999999999999 110.288 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.51 -51.17 38.93 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.81 -0.709 . . . . 0.28000000000000003 112.565 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 58.3 mt -57.59 -52.15 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.735 0.302 . . . . 1.6299999999999999 110.946 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -52.6 -50.12 63.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 2.4100000000000001 111.182 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 57.2 mt -62.75 -52.31 61.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 1.6100000000000001 111.362 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.03 -50.72 64.82 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.983 -0.627 . . . . 0.71999999999999997 113.333 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 N-CA-C 112.031 0.382 . . . . 2.4700000000000002 112.031 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo . . . . . 0 C--O 1.231 0.171 0 CA-C-O 120.828 0.262 . . . . 1.3 112.521 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 36.4 t -69.59 -41.96 75.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 1.8700000000000001 111.048 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.403 ' CD2' ' CD2' ' B' ' 169' ' ' LEU . 53.1 mt -61.96 -44.22 97.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 1.4099999999999999 110.669 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 96.8 mt -53.67 -51.29 63.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 1.3300000000000001 110.651 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 83.9 mt -59.06 -45.24 91.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.126 -0.488 . . . . 1.1399999999999999 111.087 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.435 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 69.9 m -53.53 -53.11 56.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.39000000000000001 110.874 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.424 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 74.5 m80 -63.03 -52.12 64.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.35999999999999999 110.939 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.4 mt -54.62 -52.56 61.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 1.1799999999999999 110.932 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.55 -48.92 77.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.315 -0.402 . . . . 1.1499999999999999 111.027 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.429 ' CB ' ' HB2' ' B' ' 176' ' ' ALA . . . -51.92 -52.99 46.11 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.215 -0.448 . . . . 1.0600000000000001 111.165 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.431 HG21 ' CD1' ' A' ' 181' ' ' ILE . 62.8 mt -58.14 -46.85 88.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.411 . . . . 1.29 110.058 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.08 -41.89 53.88 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.671 -0.776 . . . . 0.29999999999999999 111.861 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 99.5 mt -58.94 -49.12 79.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.029 0.442 . . . . 1.1399999999999999 110.458 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.427 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -55.03 -50.69 58.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.764 -0.731 . . . . 0.31 112.876 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.437 HD13 ' CA ' ' B' ' 180' ' ' GLY . 4.0 mp -62.58 -46.01 97.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.802 0.334 . . . . 1.5600000000000001 110.628 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -51.82 -52.73 47.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 2.4700000000000002 110.975 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.76 -45.41 97.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.369 -0.378 . . . . 1.4399999999999999 111.405 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.7 -52.48 50.5 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.928 -0.653 . . . . 0.64000000000000001 113.263 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -19.53 61.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.76 0.314 . . . . 3.0299999999999998 110.98 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 116.397 -0.365 . . . . 4.4299999999999997 110.988 179.313 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 N--CA 1.464 -0.248 0 N-CA-C 113.172 0.412 . . . . 1.4199999999999999 113.172 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 45.0 t -54.11 -44.83 71.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.565 -0.289 . . . . 1.99 111.403 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.403 ' CD2' ' CD2' ' A' ' 169' ' ' LEU . 26.6 mt -62.81 -48.37 79.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.009 0.374 . . . . 1.6899999999999999 112.009 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 8.1 mp -54.22 -51.97 62.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.736 0.303 . . . . 1.3899999999999999 111.19 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.4 mt -62.34 -43.88 97.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.358 -0.383 . . . . 1.24 111.143 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 172' ' ' SER . . . . . 0.424 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 75.1 m -58.18 -52.55 65.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.282 -0.417 . . . . 0.41999999999999998 111.635 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.435 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 62.5 m80 -60.78 -52.55 64.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.446 -0.343 . . . . 0.37 111.378 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.5 mt -56.49 -51.4 68.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.408 -0.36 . . . . 1.1899999999999999 111.272 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.38 -46.24 89.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.291 -0.413 . . . . 1.21 111.49 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.429 ' HB2' ' CB ' ' A' ' 176' ' ' ALA . . . -59.62 -53.03 62.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.394 -0.366 . . . . 1.1100000000000001 111.606 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 40.5 mt -62.19 -42.89 96.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.813 0.34 . . . . 1.0900000000000001 110.726 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.34 -51.79 51.93 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.552 -0.832 . . . . 0.29999999999999999 112.194 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 95.5 mt -53.91 -51.23 64.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.787 0.327 . . . . 1.1799999999999999 110.487 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . 0.437 ' CA ' HD13 ' A' ' 181' ' ' ILE . . . -51.29 -42.49 49.77 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.58 -0.819 . . . . 0.28000000000000003 112.422 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.427 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 29.6 mm -59.81 -47.65 90.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.711 0.291 . . . . 1.6299999999999999 110.69 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -57.19 -52.14 66.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 2.4100000000000001 110.912 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 13.1 mm -62.37 -44.69 99.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 1.6100000000000001 111.201 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.84 -52.21 53.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.833 -0.698 . . . . 0.71999999999999997 113.013 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 2.4700000000000002 111.036 -179.714 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo . . . . . 0 C--O 1.232 0.201 0 CA-C-O 120.785 0.244 . . . . 1.3 112.308 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 86.7 p -53.18 -48.78 67.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 1.8700000000000001 111.092 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.432 ' CD2' HD21 ' B' ' 169' ' ' LEU . 46.8 mt -62.08 -51.93 65.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 1.4099999999999999 110.986 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 88.2 mt -55.42 -50.37 69.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.11 -0.495 . . . . 1.3300000000000001 110.952 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.32 -45.43 84.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 1.1399999999999999 111.151 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.438 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 73.1 m -56.56 -53.23 60.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.872 0.368 . . . . 0.39000000000000001 110.986 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.425 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 77.7 m80 -63.02 -52.36 63.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.35999999999999999 110.949 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.6 mt -58.86 -52.14 67.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 1.1799999999999999 111.147 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 77.1 mt -59.44 -46.93 87.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.39 . . . . 1.1499999999999999 110.788 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.428 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -53.37 -52.24 59.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.262 -0.426 . . . . 1.0600000000000001 110.781 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 86.1 mt -58.69 -41.78 83.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.255 -0.43 . . . . 1.29 110.332 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.96 -45.98 55.8 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.672 -0.775 . . . . 0.29999999999999999 111.943 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 50.9 mt -62.14 -48.05 81.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.835 0.35 . . . . 1.1399999999999999 110.516 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.06 -52.42 47.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.551 -0.833 . . . . 0.31 112.306 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 47.7 mt -60.35 -43.34 93.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.811 0.339 . . . . 1.5600000000000001 111.091 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.412 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 78.5 t80 -53.72 -48.25 69.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.13 -0.486 . . . . 2.4700000000000002 110.659 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.54 -41.55 92.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 1.4399999999999999 111.106 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.09 -44.11 98.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.99 -0.624 . . . . 0.64000000000000001 113.208 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.412 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 10.9 ptp180 -62.44 -39.09 92.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.83 0.315 . . . . 3.0299999999999998 111.581 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.4 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 10.5 ptm180 . . . . . 0 C--N 1.329 -0.285 0 N-CA-C 111.656 0.243 . . . . 4.4299999999999997 111.656 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.462 -0.345 0 N-CA-C 113.011 0.35 . . . . 1.4199999999999999 113.011 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 48.8 m -60.32 -44.8 95.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.238 -0.437 . . . . 1.99 111.615 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.432 HD21 ' CD2' ' A' ' 169' ' ' LEU . 7.1 mp -62.9 -49.08 76.22 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.238 0.459 . . . . 1.6899999999999999 112.238 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 mp -52.01 -50.51 61.21 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.759 -0.377 . . . . 1.3899999999999999 110.661 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 89.9 mt -57.77 -41.57 82.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 1.24 110.462 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 172' ' ' SER . . . . . 0.425 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 63.6 m -54.29 -45.8 72.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.435 . . . . 0.41999999999999998 110.731 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.438 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 77.0 m80 -60.0 -52.29 66.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.454 . . . . 0.37 110.905 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 83.2 mt -57.81 -52.66 64.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.412 . . . . 1.1899999999999999 110.71 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 87.3 mt -62.69 -42.34 99.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.094 -0.503 . . . . 1.21 110.857 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.428 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -52.2 -52.37 52.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 1.1100000000000001 111.352 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 53.9 mt -61.85 -45.59 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.421 . . . . 1.0900000000000001 111.039 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.69 -51.24 53.95 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.565 -0.826 . . . . 0.29999999999999999 112.109 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 94.3 mt -54.46 -47.63 72.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.779 0.323 . . . . 1.1799999999999999 110.349 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.32 -43.41 51.45 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.602 -0.808 . . . . 0.28000000000000003 111.919 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 58.7 mt -58.57 -49.68 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.898 0.38 . . . . 1.6299999999999999 110.456 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . 0.423 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 55.7 t80 -54.88 -50.94 67.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.943 -0.572 . . . . 2.4100000000000001 111.078 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 16.0 mm -62.85 -44.82 99.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.968 0.413 . . . . 1.6100000000000001 111.328 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.28 -50.84 62.64 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.114 -0.565 . . . . 0.71999999999999997 113.203 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . 0.423 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 5.6 ptp180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.752 0.31 . . . . 2.4700000000000002 111.344 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.126 0 N-CA-C 112.507 -0.237 . . . . 7.8200000000000003 112.507 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -89.5 175.81 42.7 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.839 -0.696 . . . . 6.0599999999999996 112.408 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 65.2 mt -70.63 -62.89 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.884 0.373 . . . . 7.0599999999999996 111.074 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' A' ' 159' ' ' ALA . 73.8 m-85 -76.75 -39.19 52.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 5.9500000000000002 110.893 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 71.4 m 42.41 -89.66 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.779 -0.646 . . . . 5.5499999999999998 112.089 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.89 -53.6 56.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.715 0.293 . . . . 4.21 111.634 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -55.76 -57.63 11.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.811 0.339 . . . . 5.3600000000000003 111.078 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -59.85 -49.87 76.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 3.6200000000000001 111.08 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.3 mt -62.31 -36.7 82.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.349 -0.387 . . . . 3.54 110.886 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -56.91 -29.46 63.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 3.5699999999999998 111.045 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 35.5 m -119.37 31.09 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 3.2000000000000002 111.315 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -135.89 -44.98 0.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 2.77 110.754 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.473 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 81.1 mt -62.69 -49.41 82.82 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 2.29 111.442 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 61.5 Cg_endo -74.05 -35.0 4.52 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.065 1.843 . . . . 1.3 112.276 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.5 m -55.06 -47.79 74.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 1.8700000000000001 110.895 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.19 -46.61 88.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 1.4099999999999999 110.754 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 79.7 mt -52.48 -50.05 63.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.337 -0.392 . . . . 1.3300000000000001 110.655 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 98.5 mt -57.91 -46.17 85.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.505 . . . . 1.1399999999999999 110.783 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.446 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 73.0 m -55.11 -53.38 56.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.882 0.373 . . . . 0.39000000000000001 111.261 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.432 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 77.2 m80 -63.21 -52.78 60.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.35999999999999999 111.222 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 98.4 mt -59.85 -52.96 63.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.415 -0.357 . . . . 1.1799999999999999 111.321 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 67.6 mt -53.52 -41.81 66.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.035 0.445 . . . . 1.1499999999999999 110.306 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.443 ' CB ' ' HB2' ' B' ' 176' ' ' ALA . . . -58.24 -44.56 88.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.885 -0.598 . . . . 1.0600000000000001 110.369 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 173' ' ' HIS . 47.6 mm -55.79 -43.28 73.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.252 -0.431 . . . . 1.29 109.883 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.03 -45.37 92.46 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.718 -0.754 . . . . 0.29999999999999999 111.823 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 47.8 mt -54.41 -51.36 65.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.852 0.358 . . . . 1.1399999999999999 110.459 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.57 -43.06 67.61 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.631 -0.795 . . . . 0.31 112.291 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 50.2 mm -61.28 -46.98 95.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.361 . . . . 1.5600000000000001 110.885 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -56.97 -45.68 82.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 2.4700000000000002 110.615 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 56.5 mt -62.76 -48.48 87.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.077 -0.51 . . . . 1.4399999999999999 110.956 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.25 -52.34 50.24 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.929 -0.653 . . . . 0.64000000000000001 112.92 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.431 ' HB3' ' CD1' ' B' ' 187' ' ' LEU . 0.0 OUTLIER -59.66 -22.62 62.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.73 0.3 . . . . 3.0299999999999998 111.188 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -80.63 -22.04 40.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.356 -0.384 . . . . 4.4299999999999997 111.205 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 31.1 mt -57.79 -85.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.443 -0.344 . . . . 1.8100000000000001 111.183 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.202 -0.904 . . . . 3.6200000000000001 111.275 179.867 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.559 -0.216 . . . . 7.6200000000000001 112.559 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -141.79 -172.06 13.23 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.718 -0.753 . . . . 6.9500000000000002 112.517 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 24.3 mm -70.35 -66.54 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.075 0.464 . . . . 8.1300000000000008 110.874 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.441 ' O ' ' N ' ' B' ' 159' ' ' ALA . 91.9 m-85 -77.44 -65.39 0.97 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.6 -0.727 . . . . 7.2300000000000004 111.011 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 32.3 t 45.69 -89.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.098 -0.501 . . . . 5.6299999999999999 111.42 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -54.17 -60.95 2.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.806 0.336 . . . . 4.6200000000000001 110.79 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . 0.405 ' HA ' ' CE ' ' B' ' 163' ' ' LYS . 37.4 tt0 -58.21 -24.55 59.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 5.7300000000000004 110.841 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . 0.432 ' HB2' ' CB ' ' B' ' 157' ' ' PHE . 92.0 t80 -77.61 -48.92 15.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.297 -0.411 . . . . 4.0599999999999996 111.059 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 33.6 mt -62.67 -37.25 85.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.213 -0.448 . . . . 3.73 111.08 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . 0.405 ' CE ' ' HA ' ' B' ' 160' ' ' GLU . 49.2 mtmt -56.86 -22.86 40.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.388 -0.369 . . . . 4.2599999999999998 111.102 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 28.2 m -129.6 29.17 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.446 -0.343 . . . . 3.27 111.287 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -126.71 -44.66 1.65 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 3.1899999999999999 110.913 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.495 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 73.3 mt -67.34 -44.35 46.57 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 2.5299999999999998 111.522 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 6.1 Cg_exo -74.67 -34.9 3.87 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.614 2.209 . . . . 1.4199999999999999 112.363 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 79.1 p -55.31 -41.99 73.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 1.99 111.198 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 83.2 mt -57.58 -50.74 72.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.367 -0.378 . . . . 1.6899999999999999 111.331 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.5 mp -57.66 -44.94 86.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.477 -0.329 . . . . 1.3899999999999999 111.126 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 93.0 mt -61.91 -41.61 98.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.354 -0.385 . . . . 1.24 110.857 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' SER . . . . . 0.432 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 58.8 m -57.64 -52.34 65.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.41999999999999998 111.358 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.446 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 73.9 m80 -62.03 -52.72 62.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.332 -0.395 . . . . 0.37 111.1 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 55.4 mt -55.64 -51.47 67.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.43 -0.35 . . . . 1.1899999999999999 110.976 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 94.2 mt -60.84 -42.02 96.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.362 -0.381 . . . . 1.21 110.772 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.443 ' HB2' ' CB ' ' A' ' 176' ' ' ALA . . . -59.74 -52.9 63.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 1.1100000000000001 111.04 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 73.3 mt -53.79 -42.85 54.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.863 0.363 . . . . 1.0900000000000001 110.059 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.0 -43.55 82.94 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.554 -0.832 . . . . 0.29999999999999999 111.649 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 94.9 mt -56.5 -50.59 71.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.972 0.415 . . . . 1.1799999999999999 110.363 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.44 -46.29 81.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.676 -0.774 . . . . 0.28000000000000003 112.579 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 56.9 mt -55.32 -45.62 77.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.831 0.348 . . . . 1.6299999999999999 111.05 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . 0.419 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 63.1 t80 -59.58 -51.54 69.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 2.4100000000000001 110.892 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 61.6 mt -62.26 -44.08 98.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 1.6100000000000001 111.201 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.31 -46.36 94.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.906 -0.664 . . . . 0.71999999999999997 113.092 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . 0.419 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 12.6 ptm180 -58.07 -21.91 47.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.675 0.274 . . . . 2.4700000000000002 111.403 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -103.79 36.88 2.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.956 0.408 . . . . 4.25 110.684 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . 0.431 ' CD1' ' HB3' ' A' ' 185' ' ' ARG . 24.1 mt -89.68 -82.83 0.25 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.973 -0.558 . . . . 2.1499999999999999 111.191 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 30.7 p . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.186 -0.912 . . . . 2.54 111.239 -179.632 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.151 0 N-CA-C 112.443 -0.263 . . . . 7.8200000000000003 112.443 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -94.35 161.46 24.2 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.743 -0.742 . . . . 6.0599999999999996 112.622 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 41.5 mt -71.16 -56.75 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.372 . . . . 7.0599999999999996 111.112 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.439 ' O ' ' N ' ' A' ' 159' ' ' ALA . 46.2 m-85 -76.69 -70.34 0.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.08 -0.509 . . . . 5.9500000000000002 111.154 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 74.6 m 44.23 -90.73 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.297 -0.41 . . . . 5.5499999999999998 111.369 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -57.78 -49.33 76.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.897 0.38 . . . . 4.21 110.942 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.25 -56.41 22.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.516 . . . . 5.3600000000000003 110.873 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -59.03 -48.67 80.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 3.6200000000000001 111.209 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 97.5 mt -62.35 -31.04 71.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.368 -0.378 . . . . 3.54 111.094 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.1 -38.12 75.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.937 0.398 . . . . 3.5699999999999998 110.797 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.6 t -98.05 22.7 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.101 -0.499 . . . . 3.2000000000000002 111.315 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.472 ' CE2' HD11 ' A' ' 169' ' ' LEU . 89.0 t80 -125.2 -41.89 2.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.372 -0.377 . . . . 2.77 110.761 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.47 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 94.5 mt -52.03 -56.9 17.56 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.986 -0.552 . . . . 2.29 111.545 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 30.1 Cg_endo -63.0 -31.65 76.62 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.212 1.941 . . . . 1.3 112.396 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 70.1 m -58.86 -43.73 90.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.298 -0.41 . . . . 1.8700000000000001 110.955 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.472 HD11 ' CE2' ' A' ' 165' ' ' PHE . 73.0 mt -59.7 -48.7 80.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.424 . . . . 1.4099999999999999 110.926 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 86.4 mt -52.28 -52.08 54.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 1.3300000000000001 110.99 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.5 mt -55.13 -43.11 73.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 1.1399999999999999 110.927 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.42 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 75.2 m -55.23 -52.16 64.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.352 -0.385 . . . . 0.39000000000000001 111.016 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.427 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 73.7 m80 -62.37 -51.12 68.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.35999999999999999 111.037 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.27 -52.06 66.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 1.1799999999999999 111.089 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 84.9 mt -58.66 -44.06 90.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 1.1499999999999999 110.952 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.445 ' CB ' ' HB1' ' B' ' 176' ' ' ALA . . . -51.9 -52.19 51.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.421 . . . . 1.0600000000000001 110.625 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 65.9 mt -54.08 -46.24 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.076 -0.511 . . . . 1.29 110.205 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.58 -42.68 85.02 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.614 -0.803 . . . . 0.29999999999999999 111.899 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 53.4 mt -55.26 -50.38 69.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.397 . . . . 1.1399999999999999 110.298 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.21 -46.05 86.73 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.596 -0.812 . . . . 0.31 112.18 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 39.6 mm -60.58 -48.4 88.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.82 0.343 . . . . 1.5600000000000001 110.95 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.42 ' OH ' ' NH2' ' A' ' 186' ' ' ARG . 52.1 t80 -53.31 -51.94 60.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 2.4700000000000002 110.982 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.96 -48.81 86.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.295 -0.412 . . . . 1.4399999999999999 111.471 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.27 -51.48 56.26 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 121.162 -0.542 . . . . 0.64000000000000001 113.713 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.421 ' HG3' ' N ' ' A' ' 186' ' ' ARG . 0.1 OUTLIER -51.62 -31.79 26.56 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.648 -0.325 . . . . 3.0299999999999998 111.231 -179.15 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.421 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 83.3 mtt180 -84.23 -22.93 30.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.461 -0.336 . . . . 4.4299999999999997 111.233 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.06 -81.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 1.8100000000000001 110.777 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.185 -0.912 . . . . 3.6200000000000001 111.763 179.83 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 112.42 -0.272 . . . . 7.6200000000000001 112.42 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -154.62 157.2 27.39 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.715 -0.755 . . . . 6.9500000000000002 112.448 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 53.1 mt -70.58 -60.38 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.77 0.319 . . . . 8.1300000000000008 111.093 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' B' ' 159' ' ' ALA . 97.3 m-85 -76.66 -54.14 7.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 7.2300000000000004 111.045 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 80.3 p 41.65 -91.62 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.233 -0.44 . . . . 5.6299999999999999 111.457 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -60.02 -52.26 66.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.118 0.485 . . . . 4.6200000000000001 110.84 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -56.25 -27.84 56.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.855 -0.612 . . . . 5.7300000000000004 111.032 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -87.53 -53.93 4.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 4.0599999999999996 111.193 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.28 -38.48 89.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 3.73 111.026 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -56.09 -25.64 46.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 4.2599999999999998 111.024 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.72 35.78 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 3.27 111.143 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -129.16 -45.98 1.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 3.1899999999999999 110.949 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.487 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 88.0 mt -70.53 -45.59 18.51 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 2.5299999999999998 111.426 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 71.6 Cg_endo -84.44 -22.81 3.05 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.465 2.11 . . . . 1.4199999999999999 112.654 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 59.0 m -63.18 -43.99 96.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 1.99 111.455 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.411 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 89.3 mt -59.19 -51.46 69.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 1.6899999999999999 111.462 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.89 -49.52 75.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.464 -0.334 . . . . 1.3899999999999999 111.149 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.76 -41.61 82.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 1.24 110.913 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' SER . . . . . 0.427 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 74.8 m -56.5 -52.95 62.82 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.41999999999999998 111.117 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.42 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 63.0 m80 -62.57 -52.23 64.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.345 -0.389 . . . . 0.37 110.806 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 97.4 mt -54.14 -52.11 62.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 1.1899999999999999 111.095 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.23 -50.97 69.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 1.21 111.181 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.445 ' HB1' ' CB ' ' A' ' 176' ' ' ALA . . . -53.17 -52.78 57.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.424 -0.353 . . . . 1.1100000000000001 111.225 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 62.3 mt -61.94 -41.77 92.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.836 0.35 . . . . 1.0900000000000001 110.394 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.48 -50.23 48.81 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.585 -0.817 . . . . 0.29999999999999999 111.836 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 83.8 mt -57.17 -44.84 83.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.901 0.382 . . . . 1.1799999999999999 110.224 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.02 -46.26 85.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.615 -0.802 . . . . 0.28000000000000003 112.209 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 34.1 mm -55.76 -50.99 64.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.882 0.372 . . . . 1.6299999999999999 110.716 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -52.71 -52.18 57.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 2.4100000000000001 110.891 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 54.0 mt -62.18 -44.13 98.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.02 -0.537 . . . . 1.6100000000000001 110.994 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.05 -50.39 65.92 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.767 -0.73 . . . . 0.71999999999999997 112.692 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . 0.426 ' HG3' ' N ' ' B' ' 186' ' ' ARG . 13.7 ptp180 -58.13 -38.91 77.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.789 0.328 . . . . 2.4700000000000002 110.864 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . 0.426 ' N ' ' HG3' ' B' ' 185' ' ' ARG . 66.3 mtt180 -100.97 50.54 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 4.25 111.151 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 12.0 mt -91.03 -80.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 2.1499999999999999 110.862 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 32.9 p . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.255 -0.879 . . . . 2.54 111.171 -179.922 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.427 -0.269 . . . . 7.8200000000000003 112.427 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -136.85 163.71 25.26 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.819 -0.705 . . . . 6.0599999999999996 112.401 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 21.2 mm -71.3 -61.93 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.056 0.455 . . . . 7.0599999999999996 110.906 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.436 ' O ' ' N ' ' A' ' 159' ' ' ALA . 88.8 m-85 -76.25 -73.2 0.29 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.772 -0.649 . . . . 5.9500000000000002 110.995 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 75.1 m 47.62 -88.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.987 -0.552 . . . . 5.5499999999999998 111.498 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.0 -50.58 70.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.76 0.314 . . . . 4.21 111.189 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -57.13 -64.99 0.7 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.273 -0.422 . . . . 5.3600000000000003 110.939 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -50.79 -50.06 56.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 3.6200000000000001 110.826 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 97.7 mt -62.58 -40.89 98.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 3.54 110.944 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -56.68 -35.38 68.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.457 . . . . 3.5699999999999998 111.014 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 31.0 m -96.07 30.98 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.991 0.424 . . . . 3.2000000000000002 110.859 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.483 ' CZ ' HD12 ' A' ' 169' ' ' LEU . 93.6 t80 -147.07 -44.57 0.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.002 -0.545 . . . . 2.77 110.914 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.468 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 93.8 mt -57.66 -51.96 77.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 2.29 111.593 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 56.1 Cg_endo -70.03 -27.38 25.23 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.078 1.852 . . . . 1.3 112.35 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.8 t -63.9 -49.44 72.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 1.8700000000000001 110.825 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.483 HD12 ' CZ ' ' A' ' 165' ' ' PHE . 45.9 mt -59.46 -45.7 90.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.226 -0.443 . . . . 1.4099999999999999 110.874 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 86.9 mt -51.79 -50.24 61.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.337 -0.392 . . . . 1.3300000000000001 110.58 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 93.9 mt -58.89 -41.45 87.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 1.1399999999999999 110.591 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.474 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 68.9 m -56.45 -52.23 65.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.39000000000000001 110.777 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.432 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 75.7 m80 -61.39 -51.86 67.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.35999999999999999 110.723 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.3 mt -58.89 -52.0 67.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 1.1799999999999999 110.88 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.0 mt -61.54 -43.35 99.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 1.1499999999999999 110.901 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.431 ' CB ' ' HB2' ' B' ' 176' ' ' ALA . . . -52.81 -52.51 56.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 1.0600000000000001 110.876 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 71.4 mt -56.91 -43.0 79.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 1.29 110.307 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.13 -42.03 80.27 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.524 -0.846 . . . . 0.29999999999999999 111.927 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 45.2 mt -60.0 -51.59 69.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.927 0.394 . . . . 1.1399999999999999 110.306 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.17 -42.98 56.24 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.602 -0.808 . . . . 0.31 112.395 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 49.9 mm -62.06 -51.9 66.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.836 0.351 . . . . 1.5600000000000001 111.102 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -56.59 -50.64 71.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 2.4700000000000002 110.813 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 63.6 mt -60.3 -43.19 93.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.49 . . . . 1.4399999999999999 111.047 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.2 -48.65 81.36 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.815 -0.707 . . . . 0.64000000000000001 112.93 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -62.2 -38.1 87.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.593 0.235 . . . . 3.0299999999999998 111.606 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -74.82 -9.41 58.52 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.64 0.237 . . . . 4.4299999999999997 111.64 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 24.8 mt -56.8 -80.88 0.02 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.106 0.479 . . . . 1.8100000000000001 110.695 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 70.3 p . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.272 -0.871 . . . . 3.6200000000000001 111.173 179.946 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.581 -0.208 . . . . 7.6200000000000001 112.581 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.23 174.96 11.94 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.847 -0.692 . . . . 6.9500000000000002 112.665 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 33.2 mm -69.81 -64.99 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.239 0.542 . . . . 8.1300000000000008 111.228 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' B' ' 159' ' ' ALA . 84.8 m-85 -74.62 -69.86 0.44 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.321 -0.854 . . . . 7.2300000000000004 111.049 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 28.9 t 51.72 -88.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.489 . . . . 5.6299999999999999 111.164 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -57.54 -52.58 64.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.884 0.374 . . . . 4.6200000000000001 111.307 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . 0.437 ' HA ' ' CD ' ' B' ' 163' ' ' LYS . 45.5 mt-10 -57.27 -23.07 45.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 5.7300000000000004 111.561 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -93.95 -50.22 5.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.886 0.374 . . . . 4.0599999999999996 111.312 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 60.5 mt -63.0 -37.03 85.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.057 -0.519 . . . . 3.73 111.282 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . 0.437 ' CD ' ' HA ' ' B' ' 160' ' ' GLU . 14.6 ptmm? -57.15 -36.42 70.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.453 -0.34 . . . . 4.2599999999999998 110.925 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 6.4 m -117.11 41.76 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.415 . . . . 3.27 111.071 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -144.99 -47.06 0.23 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 3.1899999999999999 110.728 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.482 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 84.5 mt -65.43 -55.12 26.7 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.029 -0.532 . . . . 2.5299999999999998 111.589 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 32.9 Cg_endo -63.96 -40.37 28.0 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.124 1.883 . . . . 1.4199999999999999 112.398 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.1 t -46.87 -42.24 17.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.292 -0.413 . . . . 1.99 111.32 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 72.5 mt -62.4 -49.54 75.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 1.6899999999999999 110.955 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.5 mp -57.71 -42.31 83.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 1.3899999999999999 110.626 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 71.9 mt -59.48 -43.11 93.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 1.24 110.434 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' SER . . . . . 0.432 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 69.6 m -54.74 -52.09 63.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.41999999999999998 110.709 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.474 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 60.1 m80 -58.77 -52.29 66.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.049 -0.523 . . . . 0.37 110.882 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 96.5 mt -57.78 -50.32 73.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.41 . . . . 1.1899999999999999 111.056 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 78.0 mt -62.11 -47.28 85.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 1.21 110.991 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.431 ' HB2' ' CB ' ' A' ' 176' ' ' ALA . . . -55.15 -52.98 61.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 1.1100000000000001 111.076 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 66.1 mt -62.13 -42.84 96.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.359 -0.382 . . . . 1.0900000000000001 110.609 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.57 -49.86 50.93 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.616 -0.802 . . . . 0.29999999999999999 111.97 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 89.0 mt -57.91 -46.17 85.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.898 0.38 . . . . 1.1799999999999999 110.455 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.01 -50.38 61.83 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.547 -0.835 . . . . 0.28000000000000003 112.191 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 67.4 mt -53.91 -46.93 64.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 1.6299999999999999 110.849 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -54.45 -51.63 64.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 2.4100000000000001 110.73 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 69.5 mt -63.27 -48.79 85.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.178 -0.465 . . . . 1.6100000000000001 111.16 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.29 -52.74 47.37 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.957 -0.64 . . . . 0.71999999999999997 113.4 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.68 -20.31 32.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.757 0.278 . . . . 2.4700000000000002 111.214 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . 0.43 ' NE ' ' HA ' ' B' ' 186' ' ' ARG . 3.9 mmp_? -94.17 40.25 1.08 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.846 0.355 . . . . 4.25 110.572 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 41.2 mt -101.08 -85.39 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.039 -0.528 . . . . 2.1499999999999999 111.218 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.256 -0.878 . . . . 2.54 111.221 -179.843 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.457 -0.257 . . . . 7.8200000000000003 112.457 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 161.02 173.25 29.41 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.758 -0.734 . . . . 6.0599999999999996 112.31 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 55.7 mt -70.72 -57.54 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.672 0.272 . . . . 7.0599999999999996 111.078 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.454 ' O ' ' N ' ' A' ' 159' ' ' ALA . 96.6 m-85 -75.97 -42.44 48.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.384 . . . . 5.9500000000000002 110.674 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 33.6 t 42.84 -87.58 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.844 -0.616 . . . . 5.5499999999999998 112.346 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -54.57 -53.05 59.68 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.791 0.293 . . . . 4.21 111.791 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.23 -55.61 31.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.765 0.317 . . . . 5.3600000000000003 111.144 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -64.18 -48.43 75.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.351 -0.386 . . . . 3.6200000000000001 111.322 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 47.1 mt -61.42 -29.02 69.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.273 -0.421 . . . . 3.54 110.906 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -57.0 -49.21 76.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 3.5699999999999998 110.778 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.6 m -105.48 42.81 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.491 . . . . 3.2000000000000002 111.348 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.477 ' CZ ' HD11 ' A' ' 169' ' ' LEU . 7.5 t80 -145.17 -51.75 0.27 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.337 -0.392 . . . . 2.77 110.975 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.494 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 81.1 mt -55.48 -44.66 99.76 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.49 -0.323 . . . . 2.29 111.414 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 68.8 Cg_exo -50.48 -37.74 52.43 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.239 1.959 . . . . 1.3 112.511 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.6 m -78.01 -51.97 9.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 1.8700000000000001 111.334 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.477 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 19.5 mt -61.08 -50.16 74.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.454 -0.339 . . . . 1.4099999999999999 111.218 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 96.2 mt -52.13 -52.41 51.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.417 -0.356 . . . . 1.3300000000000001 111.1 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.8 mt -62.44 -41.86 99.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.305 -0.407 . . . . 1.1399999999999999 111.219 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.427 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 69.1 m -60.59 -53.28 59.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.42 -0.354 . . . . 0.39000000000000001 111.352 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.445 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 66.2 m80 -62.92 -52.58 62.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.745 0.307 . . . . 0.35999999999999999 110.889 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.6 mt -57.72 -52.86 63.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.412 -0.358 . . . . 1.1799999999999999 110.591 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 83.5 mt -62.88 -44.82 95.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 1.1499999999999999 110.803 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.53 -52.32 47.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.428 . . . . 1.0600000000000001 110.933 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.41 -45.03 97.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 1.29 110.477 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.4 -49.5 51.27 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.655 -0.783 . . . . 0.29999999999999999 111.99 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 43.3 mt -55.58 -49.04 73.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 1.1399999999999999 110.227 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.453 ' HA2' ' CG1' ' B' ' 181' ' ' ILE . . . -51.77 -46.16 54.64 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.524 -0.846 . . . . 0.31 112.45 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 41.7 mm -62.63 -48.24 89.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.748 0.308 . . . . 1.5600000000000001 111.192 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -62.07 -52.21 64.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 2.4700000000000002 111.242 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 94.6 mt -51.79 -51.1 29.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.286 -0.415 . . . . 1.4399999999999999 110.986 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.01 -52.56 45.98 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.49 -0.862 . . . . 0.64000000000000001 112.321 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.441 ' HG3' ' N ' ' A' ' 186' ' ' ARG . 10.9 ptp180 -62.93 -41.78 99.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.956 0.408 . . . . 3.0299999999999998 110.721 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.441 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -64.38 -14.26 55.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 4.4299999999999997 111.21 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 41.7 mt -50.92 -83.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.907 0.384 . . . . 1.8100000000000001 111.031 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.354 -0.831 . . . . 3.6200000000000001 111.27 -179.977 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.427 -0.269 . . . . 7.6200000000000001 112.427 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -166.97 -144.83 4.25 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.782 -0.723 . . . . 6.9500000000000002 112.467 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 52.1 mt -68.38 -54.21 23.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.804 0.335 . . . . 8.1300000000000008 110.627 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.404 ' O ' ' HB3' ' B' ' 158' ' ' SER . 58.8 m-85 -76.39 -39.61 53.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 7.2300000000000004 110.414 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' B' ' 157' ' ' PHE . 10.2 t 80.71 -164.51 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.76 -0.655 . . . . 5.6299999999999999 111.39 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.37 -25.2 48.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 4.6200000000000001 111.531 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -51.38 -61.0 2.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.415 -0.357 . . . . 5.7300000000000004 110.822 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . 0.558 ' CZ ' ' CD1' ' B' ' 165' ' ' PHE . 32.1 t80 -56.59 -35.92 68.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.313 -0.403 . . . . 4.0599999999999996 110.443 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 60.4 mt -63.72 -31.91 73.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 3.73 111.19 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -56.74 -36.88 70.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.346 . . . . 4.2599999999999998 110.85 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 34.8 m -118.26 26.78 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 3.27 111.431 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . 0.558 ' CD1' ' CZ ' ' B' ' 161' ' ' PHE . 50.4 t80 -101.8 -65.84 0.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.416 -0.357 . . . . 3.1899999999999999 111.027 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.492 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 60.4 mt -55.08 -44.91 99.87 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.304 -0.407 . . . . 2.5299999999999998 111.446 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 55.9 Cg_exo -51.45 -54.09 5.96 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.258 1.972 . . . . 1.4199999999999999 112.374 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 74.2 p -54.53 -41.67 69.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 1.99 111.009 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.417 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 59.7 mt -60.8 -52.66 64.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.329 -0.396 . . . . 1.6899999999999999 111.132 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . 0.416 ' CD1' ' O ' ' B' ' 166' ' ' LEU . 7.1 mp -62.89 -44.59 95.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.756 0.312 . . . . 1.3899999999999999 110.918 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 94.7 mt -59.95 -43.89 94.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.329 -0.396 . . . . 1.24 110.824 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' SER . . . . . 0.445 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 61.4 m -60.6 -48.97 79.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.41999999999999998 111.012 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.427 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 41.9 m80 -61.42 -52.08 66.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.37 110.917 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 64.7 mt -59.67 -51.54 69.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.39 -0.368 . . . . 1.1899999999999999 110.845 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.51 -51.99 65.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 1.21 111.483 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.93 -53.94 35.28 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.758 0.313 . . . . 1.1100000000000001 111.3 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 67.4 mt -62.97 -44.59 99.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 1.0900000000000001 110.703 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.97 -48.01 82.57 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.631 -0.795 . . . . 0.29999999999999999 112.062 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 88.9 mt -53.96 -48.79 69.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 1.1799999999999999 110.457 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.17 -48.24 81.39 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.704 -0.76 . . . . 0.28000000000000003 112.654 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.453 ' CG1' ' HA2' ' A' ' 180' ' ' GLY . 52.5 mt -62.06 -48.82 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.735 0.302 . . . . 1.6299999999999999 111.521 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -51.59 -52.25 48.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.321 -0.399 . . . . 2.4100000000000001 111.297 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 58.6 mt -62.05 -46.65 95.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.321 -0.399 . . . . 1.6100000000000001 111.203 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.39 -45.51 95.78 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.782 -0.723 . . . . 0.71999999999999997 113.024 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -60.95 -17.76 53.21 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.685 0.254 . . . . 2.4700000000000002 111.685 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -109.2 45.56 1.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.851 0.358 . . . . 4.25 110.859 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 62.4 mt -137.84 -85.2 0.3 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.059 -0.519 . . . . 2.1499999999999999 111.214 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.277 -0.868 . . . . 2.54 111.217 -179.813 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.535 -0.226 . . . . 7.8200000000000003 112.535 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -130.08 -178.69 15.55 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.864 -0.684 . . . . 6.0599999999999996 112.483 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 57.3 mt -69.18 -59.3 3.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.897 0.38 . . . . 7.0599999999999996 110.834 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -77.15 -62.41 1.66 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 5.9500000000000002 110.727 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.434 ' O ' ' CG ' ' A' ' 162' ' ' LEU . 40.0 t 69.08 -77.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.964 -0.562 . . . . 5.5499999999999998 111.17 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.35 -58.18 9.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.37 -0.377 . . . . 4.21 111.192 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -57.23 -59.8 4.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.437 -0.347 . . . . 5.3600000000000003 110.853 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.46 ' CZ ' ' CD1' ' A' ' 165' ' ' PHE . 91.5 t80 -51.95 -51.63 55.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.894 0.378 . . . . 3.6200000000000001 110.549 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.434 ' CG ' ' O ' ' A' ' 158' ' ' SER . 53.6 mt -61.98 -26.47 68.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 3.54 110.35 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -56.39 -41.15 75.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.954 -0.566 . . . . 3.5699999999999998 110.446 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 26.2 m -125.22 55.51 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.792 -0.64 . . . . 3.2000000000000002 111.184 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.46 ' CD1' ' CZ ' ' A' ' 161' ' ' PHE . 83.7 t80 -144.25 -51.21 0.3 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.274 -0.421 . . . . 2.77 111.051 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.474 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 95.9 mt -52.75 -46.23 96.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 2.29 111.48 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 91.5 Cg_endo -81.64 -37.77 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.338 2.025 . . . . 1.3 112.528 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 53.8 m -48.14 -52.37 20.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 1.8700000000000001 111.32 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.427 HD13 ' CZ ' ' A' ' 165' ' ' PHE . 69.0 mt -61.3 -48.88 79.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.439 . . . . 1.4099999999999999 111.008 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 89.2 mt -58.56 -49.77 76.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 1.3300000000000001 111.077 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.31 -42.1 94.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 1.1399999999999999 111.382 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.471 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 67.1 m -56.16 -53.39 57.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.739 0.304 . . . . 0.39000000000000001 111.193 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.436 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 69.0 m80 -62.96 -51.69 65.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.351 -0.386 . . . . 0.35999999999999999 110.765 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 95.7 mt -57.83 -51.88 67.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 1.1799999999999999 111.241 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.69 -49.46 77.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 1.1499999999999999 111.275 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.436 ' CB ' ' HB1' ' B' ' 176' ' ' ALA . . . -51.51 -52.92 42.83 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.854 0.359 . . . . 1.0600000000000001 111.042 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 68.6 mt -57.45 -44.25 84.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 1.29 110.243 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.95 -44.01 82.42 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.719 -0.753 . . . . 0.29999999999999999 111.916 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 75.6 mt -56.17 -52.54 64.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.958 0.409 . . . . 1.1399999999999999 110.221 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.62 -45.11 68.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.566 -0.826 . . . . 0.31 112.07 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 48.0 mm -60.95 -42.44 92.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 1.5600000000000001 110.806 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -55.14 -42.21 72.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 2.4700000000000002 110.662 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 183' ' ' ILE . 3.7 mm -62.87 -52.99 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 1.4399999999999999 110.864 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -63.43 -52.86 43.26 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.023 -0.608 . . . . 0.64000000000000001 113.356 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.28 -26.44 12.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.701 0.286 . . . . 3.0299999999999998 111.184 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.76 -22.11 65.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.406 -0.361 . . . . 4.4299999999999997 110.977 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 35.7 mt -55.25 -84.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.414 -0.357 . . . . 1.8100000000000001 110.717 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.166 -0.921 . . . . 3.6200000000000001 111.769 179.638 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.172 0 N-CA-C 112.498 -0.241 . . . . 7.6200000000000001 112.498 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.65 165.46 28.73 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 6.9500000000000002 112.52 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 52.0 mt -71.81 -65.9 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.921 0.391 . . . . 8.1300000000000008 110.86 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.441 ' O ' ' N ' ' B' ' 159' ' ' ALA . 82.8 m-85 -77.73 -70.57 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.016 -0.538 . . . . 7.2300000000000004 110.909 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 73.5 m 40.08 -90.04 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.106 -0.497 . . . . 5.6299999999999999 112.137 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -56.31 -55.11 37.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.825 0.345 . . . . 4.6200000000000001 111.101 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -54.69 -43.63 72.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 5.7300000000000004 111.004 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -59.5 -57.73 11.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 4.0599999999999996 110.997 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 45.0 mt -63.29 -37.31 86.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 3.73 110.952 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -56.42 -37.81 70.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.462 . . . . 4.2599999999999998 110.885 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 21.8 m -101.36 30.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 3.27 111.014 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -128.4 -52.2 1.28 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.121 -0.491 . . . . 3.1899999999999999 110.908 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.507 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 64.8 mt -57.83 -43.72 98.86 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 2.5299999999999998 111.684 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 22.8 Cg_exo -64.77 -40.0 23.86 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.277 1.985 . . . . 1.4199999999999999 112.25 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 63.5 m -49.75 -44.92 48.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 1.99 110.973 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.42 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 26.0 mt -52.73 -49.45 65.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 1.6899999999999999 110.673 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.3 mp -59.96 -44.45 94.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 1.3899999999999999 110.452 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.17 -41.72 98.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 1.24 110.605 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' SER . . . . . 0.436 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 72.2 m -54.1 -49.73 68.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.41999999999999998 110.637 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.471 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 66.9 m80 -60.26 -52.17 66.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.37 110.692 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.41 -52.41 65.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 1.1899999999999999 110.994 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 76.6 mt -62.5 -43.83 97.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 1.21 110.937 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.436 ' HB1' ' CB ' ' A' ' 176' ' ' ALA . . . -53.41 -53.43 51.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 1.1100000000000001 110.965 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 41.4 mt -62.64 -44.95 99.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 1.0900000000000001 110.413 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.82 -51.15 46.82 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.674 -0.774 . . . . 0.29999999999999999 111.892 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 97.0 mt -55.12 -42.95 73.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 1.1799999999999999 110.092 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.23 -42.6 93.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.667 -0.777 . . . . 0.28000000000000003 112.042 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 41.4 mm -58.18 -52.21 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.729 0.299 . . . . 1.6299999999999999 110.601 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -51.71 -52.5 47.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 2.4100000000000001 110.575 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 64.3 mt -62.89 -45.16 99.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.96 -0.564 . . . . 1.6100000000000001 110.912 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.16 -52.36 50.28 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.979 -0.629 . . . . 0.71999999999999997 112.999 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -53.37 -27.4 23.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.82 0.343 . . . . 2.4700000000000002 110.87 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -111.24 58.11 0.62 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 4.25 111.124 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 16.7 mt -105.02 -83.17 0.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.124 -0.489 . . . . 2.1499999999999999 110.874 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.302 -0.856 . . . . 2.54 111.192 179.941 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.62 -0.192 . . . . 7.8200000000000003 112.62 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -131.74 172.08 21.05 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.736 -0.745 . . . . 6.0599999999999996 112.637 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 56.7 mt -70.9 -60.51 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.911 0.386 . . . . 7.0599999999999996 110.963 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.417 ' O ' ' N ' ' A' ' 159' ' ' ALA . 89.7 m-85 -76.75 -56.16 4.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.979 -0.555 . . . . 5.9500000000000002 110.927 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.415 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 74.7 m 47.89 -90.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.994 -0.548 . . . . 5.5499999999999998 111.545 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -52.77 -57.01 11.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.599 0.238 . . . . 4.21 111.528 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.36 -54.2 49.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.77 0.319 . . . . 5.3600000000000003 110.71 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.404 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 20.9 t80 -46.22 -58.57 3.54 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.165 -0.47 . . . . 3.6200000000000001 111.228 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 158' ' ' SER . 32.6 mt -60.27 -47.81 84.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 3.54 110.143 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -58.66 -21.01 53.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.904 -0.589 . . . . 3.5699999999999998 110.814 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.9 p -118.42 25.68 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.406 -0.361 . . . . 3.2000000000000002 111.152 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -131.84 -61.27 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.374 -0.376 . . . . 2.77 111.365 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.476 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 85.3 mt -63.25 -47.09 85.52 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.441 -0.345 . . . . 2.29 111.786 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 72.7 Cg_endo -76.53 -24.69 10.26 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.185 1.923 . . . . 1.3 112.516 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 79.9 p -65.67 -42.41 91.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 1.8700000000000001 110.922 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 80.1 mt -60.65 -49.87 75.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 1.4099999999999999 110.846 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 95.2 mt -54.88 -51.1 67.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.297 -0.41 . . . . 1.3300000000000001 110.769 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.5 -41.5 85.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 1.1399999999999999 111.042 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.469 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 68.3 m -55.98 -52.88 62.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.76 0.314 . . . . 0.39000000000000001 111.097 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.447 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 66.6 m80 -62.94 -52.57 62.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.35999999999999999 110.905 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.0 mt -58.31 -52.23 66.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 1.1799999999999999 110.841 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.4 -44.94 95.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.0 -0.546 . . . . 1.1499999999999999 110.933 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.424 ' CB ' ' HB2' ' B' ' 176' ' ' ALA . . . -52.12 -52.37 52.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 1.0600000000000001 110.822 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 68.9 mt -57.31 -42.64 80.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.268 -0.424 . . . . 1.29 110.128 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.3 -41.43 87.1 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.788 -0.72 . . . . 0.29999999999999999 111.755 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 76.8 mt -59.45 -49.26 78.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.949 0.404 . . . . 1.1399999999999999 110.199 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.8 -47.36 65.41 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.671 -0.776 . . . . 0.31 112.072 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 32.6 mm -56.25 -46.45 81.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 1.5600000000000001 110.841 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.401 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 88.8 t80 -57.59 -49.45 76.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 2.4700000000000002 110.989 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 54.7 mt -62.78 -43.83 99.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.23 -0.441 . . . . 1.4399999999999999 111.353 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.34 -52.21 51.02 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.039 -0.601 . . . . 0.64000000000000001 113.469 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -61.34 -20.78 63.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.767 0.284 . . . . 3.0299999999999998 111.395 -179.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -74.35 -5.68 43.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.576 -0.284 . . . . 4.4299999999999997 111.676 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 22.6 mt -57.57 -83.44 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.902 0.382 . . . . 1.8100000000000001 111.085 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 81.5 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.188 -0.91 . . . . 3.6200000000000001 111.136 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.53 -0.228 . . . . 7.6200000000000001 112.53 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -157.21 -174.74 27.31 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.653 -0.784 . . . . 6.9500000000000002 112.694 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 26.5 mm -70.66 -66.05 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.265 0.555 . . . . 8.1300000000000008 111.057 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.429 ' O ' ' N ' ' B' ' 159' ' ' ALA . 65.4 m-85 -75.84 -59.61 2.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.341 -0.845 . . . . 7.2300000000000004 111.13 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 31.3 t 43.97 -91.29 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.134 -0.484 . . . . 5.6299999999999999 111.351 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -60.03 -48.85 80.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.928 0.394 . . . . 4.6200000000000001 110.992 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -57.98 -34.15 69.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.925 -0.579 . . . . 5.7300000000000004 111.368 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -86.14 -44.43 12.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.711 0.291 . . . . 4.0599999999999996 111.309 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.5 -43.69 98.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.408 -0.36 . . . . 3.73 111.105 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . 0.409 ' O ' ' CG ' ' B' ' 167' ' ' PRO . 17.9 ptpt -57.26 -28.45 62.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.374 -0.375 . . . . 4.2599999999999998 110.633 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.91 25.49 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 3.27 110.725 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -126.41 -47.54 1.58 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 3.1899999999999999 110.858 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.487 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 85.9 mt -61.24 -45.55 95.39 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 2.5299999999999998 111.272 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 94.2 Cg_endo -81.02 -27.26 3.07 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.31 2.007 . . . . 1.4199999999999999 112.383 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 91.5 p -54.36 -42.8 70.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 1.99 110.87 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.406 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 81.8 mt -58.78 -49.6 77.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 1.6899999999999999 110.643 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . 0.423 ' N ' HD13 ' B' ' 170' ' ' LEU . 7.0 mp -62.17 -47.11 85.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.046 -0.525 . . . . 1.3899999999999999 110.724 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 79.6 mt -59.65 -43.63 93.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 1.24 110.822 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' SER . . . . . 0.447 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 75.6 m -54.24 -50.2 67.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.269 -0.423 . . . . 0.41999999999999998 110.607 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.469 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 56.6 m80 -62.26 -52.47 63.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.37 110.931 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 89.2 mt -58.62 -52.49 65.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.373 -0.376 . . . . 1.1899999999999999 111.083 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 64.7 mt -62.3 -46.15 90.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 1.21 111.051 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.424 ' HB2' ' CB ' ' A' ' 176' ' ' ALA . . . -53.49 -53.02 57.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 1.1100000000000001 110.907 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 72.6 mt -62.22 -42.02 93.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.188 -0.46 . . . . 1.0900000000000001 110.533 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.06 -45.44 92.44 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.565 -0.826 . . . . 0.29999999999999999 111.951 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.93 -46.0 85.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 1.1799999999999999 110.236 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.62 -44.38 79.12 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.584 -0.817 . . . . 0.28000000000000003 112.183 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 60.3 mt -60.91 -46.88 95.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.721 0.296 . . . . 1.6299999999999999 111.034 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -55.58 -47.46 76.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 2.4100000000000001 111.083 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 59.4 mt -61.25 -50.37 80.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 1.6100000000000001 111.07 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -58.15 -51.29 59.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.83 -0.7 . . . . 0.71999999999999997 112.712 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -62.07 -22.87 66.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.701 0.286 . . . . 2.4700000000000002 111.285 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -93.55 43.08 1.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.935 0.397 . . . . 4.25 110.764 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 56.5 mt -138.03 -85.68 0.28 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 2.1499999999999999 111.293 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 30.3 p . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.226 -0.892 . . . . 2.54 111.207 -179.59 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.368 -0.293 . . . . 7.8200000000000003 112.368 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.04 179.62 38.47 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.656 -0.783 . . . . 6.0599999999999996 112.604 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.408 ' O ' ' CD2' ' A' ' 157' ' ' PHE . 13.6 mm -69.04 -19.24 23.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.793 0.33 . . . . 7.0599999999999996 111.158 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.438 ' O ' ' N ' ' A' ' 159' ' ' ALA . 30.1 m-85 -159.5 -67.66 0.08 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.18 -0.464 . . . . 5.9500000000000002 110.53 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.401 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 74.9 m 40.19 -90.83 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.034 -0.53 . . . . 5.5499999999999998 112.067 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.7 -52.45 64.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.752 0.31 . . . . 4.21 111.435 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.414 ' OE1' ' CE1' ' A' ' 157' ' ' PHE . 40.2 tt0 -55.94 -65.61 0.57 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.419 -0.355 . . . . 5.3600000000000003 110.876 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.403 ' CB ' ' HB3' ' A' ' 157' ' ' PHE . 77.5 t80 -51.73 -51.11 58.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 3.6200000000000001 110.856 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 158' ' ' SER . 87.7 mt -62.75 -33.28 74.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 3.54 111.297 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -57.16 -35.15 69.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.453 -0.34 . . . . 3.5699999999999998 110.863 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 34.5 m -106.9 28.89 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.265 -0.425 . . . . 3.2000000000000002 110.992 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.489 ' CZ ' HD12 ' A' ' 169' ' ' LEU . 61.8 t80 -133.06 -63.0 0.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 2.77 110.838 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.47 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 73.8 mt -49.12 -57.79 10.55 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 2.29 111.407 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 26.0 Cg_endo -61.8 -21.71 72.79 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.291 1.994 . . . . 1.3 112.329 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.5 t -74.21 -52.82 11.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 1.8700000000000001 110.911 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.489 HD12 ' CZ ' ' A' ' 165' ' ' PHE . 60.2 mt -62.61 -46.27 89.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 1.4099999999999999 110.914 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.79 -52.36 49.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.27 -0.423 . . . . 1.3300000000000001 110.635 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.4 mt -57.67 -43.66 85.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.243 -0.435 . . . . 1.1399999999999999 110.745 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.432 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 75.6 m -57.51 -52.79 63.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.39000000000000001 110.706 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.446 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 64.9 m80 -62.87 -51.89 65.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.35999999999999999 110.746 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.49 -52.3 66.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 1.1799999999999999 111.109 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 81.8 mt -53.71 -50.82 65.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.465 -0.334 . . . . 1.1499999999999999 110.781 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.438 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -53.36 -52.28 59.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 1.0600000000000001 110.697 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 81.4 mt -58.43 -42.86 85.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 1.29 110.232 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.0 -43.77 55.84 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.627 -0.797 . . . . 0.29999999999999999 111.796 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.0 -43.27 99.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.007 0.432 . . . . 1.1399999999999999 109.914 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -61.13 -45.59 96.25 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.657 -0.783 . . . . 0.31 112.137 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 48.7 mm -60.33 -46.04 95.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.891 0.377 . . . . 1.5600000000000001 110.924 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -54.52 -50.2 68.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.063 -0.517 . . . . 2.4700000000000002 110.844 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.79 -47.17 94.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.171 -0.468 . . . . 1.4399999999999999 111.224 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.42 -52.69 47.41 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.818 -0.706 . . . . 0.64000000000000001 112.969 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -15.48 43.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.563 0.221 . . . . 3.0299999999999998 111.329 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -92.25 20.94 5.54 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.68 0.276 . . . . 4.4299999999999997 110.984 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 49.0 mt -99.92 -83.64 0.43 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.914 0.387 . . . . 1.8100000000000001 110.836 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.361 -0.828 . . . . 3.6200000000000001 111.128 179.816 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.522 -0.231 . . . . 7.6200000000000001 112.522 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 155.87 -159.63 29.43 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.7 -0.762 . . . . 6.9500000000000002 112.536 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 53.3 mt -70.7 -49.97 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.916 0.389 . . . . 8.1300000000000008 111.246 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' B' ' 159' ' ' ALA . 29.9 m-85 -75.85 -65.05 0.95 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.086 -0.507 . . . . 7.2300000000000004 111.24 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 31.2 t 54.2 -87.53 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.107 -0.497 . . . . 5.6299999999999999 110.905 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -56.55 -54.71 42.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.825 0.345 . . . . 4.6200000000000001 111.023 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -55.79 -34.19 65.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 5.7300000000000004 111.117 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -76.55 -55.23 5.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.353 -0.385 . . . . 4.0599999999999996 111.018 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 72.8 mt -62.96 -29.64 70.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 3.73 111.152 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -56.41 -36.7 69.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.411 . . . . 4.2599999999999998 111.066 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 33.0 m -98.84 28.55 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 3.27 111.15 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -142.81 -46.78 0.32 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.319 -0.4 . . . . 3.1899999999999999 111.147 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.476 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 82.8 mt -55.83 -59.03 12.69 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.168 -0.469 . . . . 2.5299999999999998 111.823 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 10.5 Cg_endo -54.02 -44.41 49.55 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.418 2.079 . . . . 1.4199999999999999 112.782 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 67.3 m -50.45 -43.28 55.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.431 -0.35 . . . . 1.99 111.071 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.13 -44.07 97.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.301 -0.409 . . . . 1.6899999999999999 111.249 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.7 mp -60.74 -50.11 74.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 1.3899999999999999 110.776 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 89.2 mt -53.65 -42.69 68.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 1.24 110.903 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' SER . . . . . 0.446 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 74.7 m -58.44 -49.59 76.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.196 -0.456 . . . . 0.41999999999999998 110.998 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.432 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 66.5 m80 -58.72 -52.61 64.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.37 111.101 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 82.5 mt -59.91 -52.46 65.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.369 -0.378 . . . . 1.1899999999999999 111.13 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.58 -42.56 99.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 1.21 110.952 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.438 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -52.39 -52.76 51.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 1.1100000000000001 111.338 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 31.6 mt -61.43 -42.64 94.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 1.0900000000000001 110.628 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.46 -49.95 54.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.536 -0.84 . . . . 0.29999999999999999 111.787 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 77.0 mt -55.86 -46.1 78.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 1.1799999999999999 110.272 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.96 -41.89 69.18 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.639 -0.791 . . . . 0.28000000000000003 112.019 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 41.9 mm -59.8 -52.13 64.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.866 0.365 . . . . 1.6299999999999999 110.835 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . 0.425 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 47.9 t80 -54.96 -50.82 67.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 2.4100000000000001 110.803 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 57.1 mt -62.01 -45.98 97.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 1.6100000000000001 111.322 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -56.01 -49.82 64.99 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.825 -0.703 . . . . 0.71999999999999997 112.481 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . 0.425 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 10.6 ptp180 -61.0 -18.73 59.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.55 0.214 . . . . 2.4700000000000002 111.255 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -113.6 42.14 2.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.884 0.374 . . . . 4.25 110.675 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 28.9 mt -91.77 -85.05 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 2.1499999999999999 111.267 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.259 -0.877 . . . . 2.54 111.281 -179.906 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.403 -0.279 . . . . 7.8200000000000003 112.403 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -82.27 158.22 37.72 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.678 -0.772 . . . . 6.0599999999999996 112.577 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.7 mp -74.28 -68.23 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.949 0.404 . . . . 7.0599999999999996 110.562 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' A' ' 159' ' ' ALA . 85.9 m-85 -76.74 -56.06 4.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.963 -0.562 . . . . 5.9500000000000002 110.776 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.402 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 74.2 m 41.16 -91.36 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.983 -0.553 . . . . 5.5499999999999998 111.766 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -57.05 -51.86 67.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.771 0.319 . . . . 4.21 111.285 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -56.46 -48.89 76.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.442 . . . . 5.3600000000000003 110.972 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.538 ' CZ ' ' CD1' ' A' ' 165' ' ' PHE . 76.5 t80 -61.57 -56.7 17.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 3.6200000000000001 110.957 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 158' ' ' SER . 61.0 mt -61.01 -35.54 77.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 3.54 111.082 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -57.49 -27.25 62.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 3.5699999999999998 111.384 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 34.8 m -134.26 25.97 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.76 0.314 . . . . 3.2000000000000002 111.615 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.538 ' CD1' ' CZ ' ' A' ' 161' ' ' PHE . 81.7 t80 -120.68 -52.16 2.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.058 0.456 . . . . 2.77 110.16 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.505 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 84.5 mt -60.1 -43.97 95.35 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.834 -0.621 . . . . 2.29 111.421 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 88.2 Cg_exo -44.92 -53.1 5.53 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.23 1.953 . . . . 1.3 112.435 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 49.6 m -60.78 -45.7 93.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 1.8700000000000001 111.216 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.485 HD13 ' CE2' ' A' ' 165' ' ' PHE . 26.0 mt -58.99 -46.23 88.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.389 -0.369 . . . . 1.4099999999999999 111.12 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 65.6 mt -54.36 -52.06 62.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.329 -0.396 . . . . 1.3300000000000001 110.639 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 86.9 mt -57.76 -43.89 85.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 1.1399999999999999 110.688 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 58.2 m -56.1 -52.54 63.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.39000000000000001 110.811 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.434 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 80.8 m80 -62.6 -52.09 64.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.35999999999999999 110.978 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.9 mt -58.02 -52.53 65.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.361 -0.382 . . . . 1.1799999999999999 110.951 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.4 mt -56.69 -45.49 81.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.299 -0.41 . . . . 1.1499999999999999 110.832 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.433 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -56.49 -52.32 65.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 1.0600000000000001 110.904 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 75.7 mt -57.83 -42.98 83.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 1.29 110.648 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.51 -45.06 67.54 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.697 -0.763 . . . . 0.29999999999999999 112.255 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 79.5 mt -61.98 -49.8 74.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.836 0.35 . . . . 1.1399999999999999 110.525 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.426 ' CA ' HG13 ' B' ' 181' ' ' ILE . . . -55.96 -51.76 53.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.727 -0.749 . . . . 0.31 112.595 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 47.7 mt -59.19 -43.62 89.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.786 0.327 . . . . 1.5600000000000001 111.172 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -53.75 -47.88 70.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.026 0.441 . . . . 2.4700000000000002 110.577 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 72.9 mt -62.78 -48.0 90.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.069 -0.514 . . . . 1.4399999999999999 111.099 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.06 -46.35 94.73 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.93 -0.652 . . . . 0.64000000000000001 112.967 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -61.8 -28.69 69.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.029 0.442 . . . . 3.0299999999999998 110.851 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -84.64 11.68 8.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.6 -0.727 . . . . 4.4299999999999997 111.583 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 68.6 mt -79.15 -77.07 0.18 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.153 0.501 . . . . 1.8100000000000001 110.818 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 68.0 p . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.261 -0.876 . . . . 3.6200000000000001 111.109 179.924 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.557 -0.217 . . . . 7.6200000000000001 112.557 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 159.55 -153.95 25.0 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.869 -0.681 . . . . 6.9500000000000002 112.363 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 42.1 mt -70.15 -58.37 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.893 0.378 . . . . 8.1300000000000008 110.823 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' B' ' 159' ' ' ALA . 49.4 m-85 -77.66 -75.32 0.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.05 -0.523 . . . . 7.2300000000000004 110.918 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 28.7 t 39.91 -92.36 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.234 -0.439 . . . . 5.6299999999999999 111.542 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -60.07 -46.34 89.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.939 0.4 . . . . 4.6200000000000001 110.925 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -58.04 -34.68 70.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.84 -0.618 . . . . 5.7300000000000004 111.54 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -87.64 -44.75 10.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.803 0.335 . . . . 4.0599999999999996 111.496 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 69.8 mt -62.35 -35.97 80.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.305 -0.407 . . . . 3.73 111.457 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -57.75 -22.38 46.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.707 0.289 . . . . 4.2599999999999998 111.17 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . 0.403 HG11 ' O ' ' B' ' 164' ' ' VAL . 3.8 t -106.16 26.34 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.902 0.382 . . . . 3.27 110.932 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -142.34 -45.48 0.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 3.1899999999999999 111.009 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.476 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 76.1 mt -59.64 -47.29 97.95 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 2.5299999999999998 111.922 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 68.2 Cg_endo -75.67 -32.46 4.65 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.141 1.894 . . . . 1.4199999999999999 112.727 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 48.7 m -51.53 -42.41 61.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.901 0.381 . . . . 1.99 110.767 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 65.7 mt -62.31 -46.91 86.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 1.6899999999999999 111.016 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.52 -49.1 79.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.423 -0.353 . . . . 1.3899999999999999 110.571 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 85.3 mt -52.56 -41.81 63.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.42 . . . . 1.24 110.387 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' SER . . . . . 0.434 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 58.5 m -60.51 -51.81 67.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.52 . . . . 0.41999999999999998 110.597 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.443 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 54.8 m80 -61.52 -51.95 66.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.122 -0.49 . . . . 0.37 110.809 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 93.1 mt -59.77 -52.23 66.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.33 -0.396 . . . . 1.1899999999999999 110.794 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.23 -43.91 97.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 1.21 110.976 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.433 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -51.95 -52.47 50.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 1.1100000000000001 111.074 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 52.3 mt -61.99 -46.78 95.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.434 -0.348 . . . . 1.0900000000000001 110.591 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.23 -47.15 76.25 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.624 -0.798 . . . . 0.29999999999999999 111.858 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 93.4 mt -54.23 -49.49 69.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 1.1799999999999999 110.491 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.41 -44.43 89.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.554 -0.831 . . . . 0.28000000000000003 112.142 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.426 HG13 ' CA ' ' A' ' 180' ' ' GLY . 66.3 mt -61.43 -52.44 61.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.809 0.338 . . . . 1.6299999999999999 110.791 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . 0.518 ' CE2' ' NH2' ' B' ' 186' ' ' ARG . 46.5 t80 -56.7 -51.99 66.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.023 -0.535 . . . . 2.4100000000000001 110.964 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 62.6 mt -62.39 -48.58 87.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.397 -0.365 . . . . 1.6100000000000001 110.832 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.68 -52.36 48.82 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.839 -0.696 . . . . 0.71999999999999997 112.973 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . 0.416 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 1.4 ptp180 -53.68 -26.62 23.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.634 0.254 . . . . 2.4700000000000002 111.521 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . 0.518 ' NH2' ' CE2' ' B' ' 182' ' ' TYR . 68.9 mtm180 -104.62 57.0 0.7 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.901 0.381 . . . . 4.25 110.921 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 75.9 mt -150.37 -85.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.556 . . . . 2.1499999999999999 111.375 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 29.8 p . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.365 -0.826 . . . . 2.54 111.222 -179.712 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.525 -0.23 . . . . 7.8200000000000003 112.525 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -125.85 -176.6 14.57 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.838 -0.696 . . . . 6.0599999999999996 112.425 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 28.6 mt -67.76 -59.65 3.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.82 0.343 . . . . 7.0599999999999996 110.255 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.41 ' O ' ' HB3' ' A' ' 158' ' ' SER . 95.7 m-85 -78.14 -48.34 16.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.494 . . . . 5.9500000000000002 110.361 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 157' ' ' PHE . 14.6 t 76.2 -157.91 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.991 -0.549 . . . . 5.5499999999999998 111.178 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -53.05 -22.59 6.11 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.552 -0.294 . . . . 4.21 111.406 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -56.05 -48.16 76.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.427 -0.351 . . . . 5.3600000000000003 110.76 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -73.48 -45.43 54.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 3.6200000000000001 110.777 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.43 -31.66 72.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.412 -0.358 . . . . 3.54 110.705 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -56.92 -23.93 48.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 3.5699999999999998 110.936 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 32.7 m -121.22 27.4 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 3.2000000000000002 110.837 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.467 ' CZ ' HD12 ' A' ' 169' ' ' LEU . 88.8 t80 -135.4 -51.03 0.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 2.77 111.115 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.502 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 84.3 mt -62.08 -44.38 89.21 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.386 . . . . 2.29 111.614 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 57.3 Cg_exo -51.76 -57.88 1.91 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.156 1.904 . . . . 1.3 112.505 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.6 t -51.03 -51.94 48.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.456 . . . . 1.8700000000000001 111.118 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.467 HD12 ' CZ ' ' A' ' 165' ' ' PHE . 39.8 mt -59.68 -51.35 70.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.365 -0.38 . . . . 1.4099999999999999 110.912 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 91.7 mt -53.63 -49.59 67.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 1.3300000000000001 110.75 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.2 mt -62.09 -43.0 99.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 1.1399999999999999 110.921 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.434 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 69.3 m -57.3 -52.61 64.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.39000000000000001 111.019 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.413 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 65.4 m80 -62.78 -52.52 62.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 0.35999999999999999 111.242 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.8 mt -61.28 -52.1 66.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 1.1799999999999999 111.354 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 81.5 mt -57.49 -46.44 83.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.35 -0.386 . . . . 1.1499999999999999 111.14 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.443 ' CB ' ' HB2' ' B' ' 176' ' ' ALA . . . -54.48 -52.57 61.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.927 0.394 . . . . 1.0600000000000001 110.907 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 68.9 mt -58.01 -43.87 85.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.244 -0.435 . . . . 1.29 110.336 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.68 -47.08 65.45 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.495 -0.86 . . . . 0.29999999999999999 111.923 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 70.0 mt -55.82 -50.1 71.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.381 . . . . 1.1399999999999999 110.398 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.43 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -54.74 -43.29 80.07 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.561 -0.828 . . . . 0.31 112.354 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 40.7 mm -62.38 -49.2 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.912 0.387 . . . . 1.5600000000000001 111.101 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -56.74 -50.4 72.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.952 -0.567 . . . . 2.4700000000000002 111.343 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.87 -46.36 93.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 1.4399999999999999 111.305 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.19 -47.98 86.01 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.775 -0.726 . . . . 0.64000000000000001 112.899 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -58.78 -28.88 66.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.661 0.267 . . . . 3.0299999999999998 111.108 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -93.99 37.49 1.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.372 . . . . 4.4299999999999997 110.853 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 27.4 mt -112.73 -73.87 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.164 0.507 . . . . 1.8100000000000001 110.668 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.318 -0.849 . . . . 3.6200000000000001 111.768 179.886 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 112.535 -0.226 . . . . 7.6200000000000001 112.535 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -161.47 -151.36 6.24 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.804 -0.712 . . . . 6.9500000000000002 112.457 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 57.9 mt -69.95 -57.46 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.848 0.356 . . . . 8.1300000000000008 110.905 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.408 ' O ' ' HB3' ' B' ' 158' ' ' SER . 53.3 m-85 -77.87 -71.58 0.41 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 7.2300000000000004 110.75 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' B' ' 157' ' ' PHE . 21.7 t 72.17 -160.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.388 -0.369 . . . . 5.6299999999999999 110.974 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.24 -23.71 15.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.371 -0.377 . . . . 4.6200000000000001 110.997 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.66 -61.23 2.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.964 0.411 . . . . 5.7300000000000004 110.511 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . 0.405 ' CB ' ' HB3' ' B' ' 157' ' ' PHE . 25.8 t80 -56.99 -35.35 69.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.094 -0.503 . . . . 4.0599999999999996 110.465 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 74.5 mt -64.69 -30.72 71.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 3.73 111.283 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -56.08 -29.05 60.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.76 0.314 . . . . 4.2599999999999998 110.897 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 34.0 m -126.88 44.3 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 3.27 111.214 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -141.51 -67.62 0.4 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.327 -0.397 . . . . 3.1899999999999999 111.154 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.477 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 74.0 mt -60.41 -59.4 13.96 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.112 -0.494 . . . . 2.5299999999999998 111.816 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 6.1 Cg_exo -39.06 -31.84 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.791 2.327 . . . . 1.4199999999999999 112.852 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 48.1 t -79.91 -44.8 19.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.865 0.364 . . . . 1.99 111.258 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 59.6 mt -62.31 -45.77 91.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 1.6899999999999999 111.396 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.48 -51.67 68.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.324 -0.398 . . . . 1.3899999999999999 111.247 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 92.8 mt -58.56 -41.71 86.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.385 -0.37 . . . . 1.24 111.05 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' SER . . . . . 0.413 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 68.9 m -54.04 -52.32 61.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.41999999999999998 111.382 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.434 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 62.9 m80 -61.55 -52.53 64.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.383 -0.371 . . . . 0.37 111.324 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 80.1 mt -55.74 -52.72 62.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.371 -0.377 . . . . 1.1899999999999999 110.922 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.91 -47.41 83.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.114 -0.494 . . . . 1.21 111.362 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.443 ' HB2' ' CB ' ' A' ' 176' ' ' ALA . . . -55.09 -53.32 57.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 1.1100000000000001 111.751 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 53.4 mt -62.58 -43.29 98.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 1.0900000000000001 110.862 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.28 -47.99 83.68 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.611 -0.804 . . . . 0.29999999999999999 112.126 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 93.6 mt -55.14 -51.85 65.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.759 0.314 . . . . 1.1799999999999999 110.583 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.47 -41.82 49.58 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.613 -0.803 . . . . 0.28000000000000003 112.017 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.437 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 27.2 mm -59.43 -48.88 85.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.755 0.312 . . . . 1.6299999999999999 110.624 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -51.68 -52.51 47.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 2.4100000000000001 111.269 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 4.0 mp -63.57 -52.47 57.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.451 -0.341 . . . . 1.6100000000000001 111.228 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.47 -52.57 48.11 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.905 -0.664 . . . . 0.71999999999999997 113.469 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . 0.438 ' CD ' ' HG3' ' B' ' 186' ' ' ARG . 0.7 OUTLIER -55.19 -20.21 9.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.546 0.213 . . . . 2.4700000000000002 111.515 -179.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . 0.438 ' HG3' ' CD ' ' B' ' 185' ' ' ARG . 49.9 mtp180 -108.07 37.03 2.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.817 0.341 . . . . 4.25 110.838 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 19.7 mt -89.78 -84.0 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 2.1499999999999999 111.174 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.203 -0.903 . . . . 2.54 111.218 -179.911 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 112.505 -0.238 . . . . 7.8200000000000003 112.505 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -98.48 162.2 20.61 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 6.0599999999999996 112.504 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 50.2 mt -71.33 -63.08 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.826 0.346 . . . . 7.0599999999999996 111.114 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 159' ' ' ALA . 91.7 m-85 -76.49 -44.38 35.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 5.9500000000000002 110.724 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 79.8 p 43.24 -88.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.849 -0.614 . . . . 5.5499999999999998 112.129 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.56 -56.25 23.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.753 0.311 . . . . 4.21 111.454 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -55.69 -52.45 63.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.305 -0.407 . . . . 5.3600000000000003 110.972 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -62.4 -50.84 69.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.883 0.373 . . . . 3.6200000000000001 110.793 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.47 -28.16 69.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.063 -0.517 . . . . 3.54 110.807 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -57.39 -38.85 74.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 3.5699999999999998 110.87 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 34.5 m -112.06 20.03 6.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 3.2000000000000002 111.569 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -97.72 -49.32 4.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.757 0.313 . . . . 2.77 110.637 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.499 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 75.6 mt -62.44 -44.25 87.08 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 2.29 111.173 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 31.5 Cg_exo -59.07 -47.56 17.32 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.121 1.881 . . . . 1.3 111.951 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.4 t -47.73 -47.47 30.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.28 -0.418 . . . . 1.8700000000000001 110.992 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.415 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 29.3 mt -61.99 -51.32 68.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 1.4099999999999999 110.724 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 87.6 mt -57.79 -51.94 67.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 1.3300000000000001 110.634 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 95.2 mt -53.05 -47.13 68.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 1.1399999999999999 110.484 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.423 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 70.3 m -51.96 -51.96 53.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.035 -0.529 . . . . 0.39000000000000001 110.831 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.455 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 58.3 m80 -61.51 -52.33 64.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.35999999999999999 110.749 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 84.9 mt -57.19 -50.67 72.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 1.1799999999999999 111.003 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.9 mt -59.78 -44.8 93.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 1.1499999999999999 110.811 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.428 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -57.34 -52.68 64.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.429 . . . . 1.0600000000000001 110.716 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 71.0 mt -58.99 -42.66 86.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.48 . . . . 1.29 110.332 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.7 -43.15 53.52 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.587 -0.816 . . . . 0.29999999999999999 111.796 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.02 -47.7 83.59 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.736 -0.468 . . . . 1.1399999999999999 109.736 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -58.44 -49.23 78.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 0.31 112.224 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 35.2 mm -53.27 -45.95 56.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.763 0.316 . . . . 1.5600000000000001 110.88 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -58.4 -44.3 88.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 2.4700000000000002 110.993 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 72.4 mt -62.7 -48.92 85.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.395 -0.366 . . . . 1.4399999999999999 111.199 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.15 -52.11 52.1 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.927 -0.654 . . . . 0.64000000000000001 112.846 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.423 ' HD3' ' N ' ' A' ' 186' ' ' ARG . 0.0 OUTLIER -60.56 -28.1 68.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.789 0.328 . . . . 3.0299999999999998 110.97 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.423 ' N ' ' HD3' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -61.79 -31.87 72.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 4.4299999999999997 110.713 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.436 HD21 ' N ' ' A' ' 187' ' ' LEU . 3.8 mt -72.1 -59.14 2.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.036 -0.529 . . . . 1.8100000000000001 110.64 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.398 -0.81 . . . . 3.6200000000000001 111.665 -179.958 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.087 0 N-CA-C 112.484 -0.246 . . . . 7.6200000000000001 112.484 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 149.99 175.39 22.12 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.73 -0.748 . . . . 6.9500000000000002 112.58 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 15.9 mm -69.93 -63.25 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.948 0.404 . . . . 8.1300000000000008 111.082 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -76.53 -69.53 0.51 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.864 -0.607 . . . . 7.2300000000000004 110.781 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.419 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 43.4 t 43.86 -97.19 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.215 -0.448 . . . . 5.6299999999999999 110.899 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.88 -36.77 70.49 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.961 0.41 . . . . 4.6200000000000001 110.492 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.89 -35.15 74.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.0 -0.546 . . . . 5.7300000000000004 110.497 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -77.7 -38.97 46.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.807 -0.633 . . . . 4.0599999999999996 110.793 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' B' ' 158' ' ' SER . 14.6 mt -63.01 -33.34 75.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 3.73 110.87 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -56.31 -26.83 53.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.874 0.369 . . . . 4.2599999999999998 110.966 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.48 47.25 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 3.27 111.055 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -142.03 -54.47 0.44 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 3.1899999999999999 110.993 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.455 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 3.1 mm? -71.46 -59.22 3.28 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 2.5299999999999998 111.563 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 19.2 Cg_endo -59.43 -26.75 83.02 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.286 1.991 . . . . 1.4199999999999999 112.414 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 51.7 m -62.26 -41.57 98.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.333 -0.394 . . . . 1.99 110.787 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.411 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 78.2 mt -60.39 -45.06 94.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 1.6899999999999999 110.927 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . 0.406 ' N ' HD13 ' B' ' 170' ' ' LEU . 7.1 mp -62.34 -50.95 69.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 1.3899999999999999 110.836 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.6 mt -58.15 -41.54 83.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 1.24 110.599 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' SER . . . . . 0.455 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 73.0 m -55.02 -52.19 63.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.031 -0.531 . . . . 0.41999999999999998 111.1 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.423 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 71.6 m80 -60.58 -52.53 64.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.37 111.139 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 87.8 mt -59.98 -52.49 65.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.339 -0.392 . . . . 1.1899999999999999 111.019 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.69 -42.88 99.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.134 -0.485 . . . . 1.21 111.021 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.428 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -53.04 -52.57 58.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 1.1100000000000001 111.478 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 53.1 mt -62.23 -41.86 93.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.358 . . . . 1.0900000000000001 110.9 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.08 -49.9 68.36 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.71 -0.757 . . . . 0.29999999999999999 112.387 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 83.1 mt -58.47 -42.38 87.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 1.1799999999999999 110.668 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.7 -49.88 63.54 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.723 -0.751 . . . . 0.28000000000000003 112.36 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 55.7 mt -57.97 -45.15 87.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.859 0.362 . . . . 1.6299999999999999 110.959 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -53.32 -50.9 64.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 2.4100000000000001 110.693 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 64.5 mt -62.3 -41.97 93.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.031 -0.531 . . . . 1.6100000000000001 111.136 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.91 -49.07 79.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.904 -0.665 . . . . 0.71999999999999997 112.842 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -61.14 -28.77 69.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.706 0.289 . . . . 2.4700000000000002 111.373 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -95.36 28.86 2.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.881 0.372 . . . . 4.25 110.832 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 35.9 mt -84.61 -84.29 0.15 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 2.1499999999999999 111.269 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 31.0 p . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.167 -0.921 . . . . 2.54 111.161 -179.62 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.475 -0.25 . . . . 7.8200000000000003 112.475 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -143.15 164.89 27.14 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.681 -0.771 . . . . 6.0599999999999996 112.355 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 61.8 mt -72.56 -66.35 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.797 0.332 . . . . 7.0599999999999996 110.814 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.43 ' O ' ' N ' ' A' ' 159' ' ' ALA . 63.0 m-85 -78.09 -43.43 29.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.097 -0.501 . . . . 5.9500000000000002 110.892 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.3 t 42.55 -90.66 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.95 -0.568 . . . . 5.5499999999999998 111.923 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -57.35 -51.62 68.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.754 0.312 . . . . 4.21 111.371 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -56.2 -56.02 26.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 5.3600000000000003 110.93 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -61.39 -50.62 72.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.147 -0.479 . . . . 3.6200000000000001 111.022 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.15 -32.42 73.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 3.54 111.144 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -56.49 -21.93 29.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 3.5699999999999998 111.221 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 31.9 m -139.31 40.45 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.493 -0.321 . . . . 3.2000000000000002 111.319 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -133.42 -61.8 0.8 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.32 -0.4 . . . . 2.77 111.025 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.472 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 91.7 mt -52.01 -46.37 92.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 2.29 111.628 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 74.1 Cg_endo -77.38 -32.16 3.12 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.059 1.839 . . . . 1.3 112.298 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.1 t -56.77 -42.74 79.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 1.8700000000000001 110.57 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.61 -51.49 68.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.962 -0.563 . . . . 1.4099999999999999 110.782 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 85.9 mt -52.57 -48.7 66.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.985 -0.552 . . . . 1.3300000000000001 110.823 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.9 mt -55.97 -42.87 76.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.322 -0.399 . . . . 1.1399999999999999 110.764 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.481 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 67.9 m -57.21 -52.47 65.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.39000000000000001 110.871 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.417 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 73.0 m80 -62.2 -52.27 64.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.35999999999999999 110.87 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.8 mt -59.0 -51.64 69.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.066 -0.516 . . . . 1.1799999999999999 111.005 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.1 mt -60.56 -42.41 96.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 1.1499999999999999 111.008 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.44 ' CB ' ' HB1' ' B' ' 176' ' ' ALA . . . -56.06 -52.36 64.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.995 0.426 . . . . 1.0600000000000001 110.875 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.45 -41.52 81.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.551 . . . . 1.29 110.469 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.04 -44.58 83.27 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.772 -0.728 . . . . 0.29999999999999999 112.129 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 70.8 mt -61.06 -47.11 87.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.949 0.404 . . . . 1.1399999999999999 110.355 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.435 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -52.68 -52.42 38.36 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.676 -0.773 . . . . 0.31 112.587 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 39.3 mt -61.96 -42.88 96.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 1.5600000000000001 111.032 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.409 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 83.5 t80 -51.9 -52.08 52.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.016 0.436 . . . . 2.4700000000000002 110.695 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 65.8 mt -63.5 -48.03 88.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.133 -0.485 . . . . 1.4399999999999999 111.203 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.78 -52.85 45.4 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.983 -0.627 . . . . 0.64000000000000001 113.692 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -54.98 -24.41 23.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.866 0.333 . . . . 3.0299999999999998 110.801 -179.292 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 18.7 mtp-105 -81.98 -24.9 35.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 4.4299999999999997 110.865 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 60.3 mt -65.68 -85.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.492 . . . . 1.8100000000000001 111.015 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.357 -0.83 . . . . 3.6200000000000001 111.206 -179.983 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.427 -0.269 . . . . 7.6200000000000001 112.427 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -105.16 -144.17 12.52 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.835 -0.697 . . . . 6.9500000000000002 112.594 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 44.8 mt -68.67 -39.74 80.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.889 0.376 . . . . 8.1300000000000008 110.832 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.545 ' CD1' ' N ' ' B' ' 158' ' ' SER . 8.4 p90 -159.41 -48.63 0.05 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.998 -0.546 . . . . 7.2300000000000004 110.724 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.545 ' N ' ' CD1' ' B' ' 157' ' ' PHE . 90.4 p 44.92 -172.56 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.01 -0.541 . . . . 5.6299999999999999 112.024 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -51.37 -24.12 4.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.931 0.396 . . . . 4.6200000000000001 110.933 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -53.67 -43.06 68.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.241 0.543 . . . . 5.7300000000000004 110.735 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . 0.565 ' CZ ' ' CD1' ' B' ' 165' ' ' PHE . 42.8 t80 -86.15 -33.2 20.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.524 -0.762 . . . . 4.0599999999999996 110.753 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.24 -42.32 99.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 3.73 111.122 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -57.4 -24.55 56.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.429 -0.351 . . . . 4.2599999999999998 111.249 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 22.7 m -123.67 32.77 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 3.27 111.323 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . 0.565 ' CD1' ' CZ ' ' B' ' 161' ' ' PHE . 85.8 t80 -137.93 -61.95 0.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 3.1899999999999999 111.336 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.478 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 73.6 mt -52.18 -46.03 93.85 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.366 -0.379 . . . . 2.5299999999999998 111.809 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 87.0 Cg_endo -79.59 -35.48 0.79 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.257 1.972 . . . . 1.4199999999999999 112.633 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 66.3 m -53.22 -44.13 67.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 1.99 111.08 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.413 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 84.5 mt -54.6 -51.13 66.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.28 -0.418 . . . . 1.6899999999999999 111.177 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 mp -62.17 -46.14 90.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.387 -0.37 . . . . 1.3899999999999999 110.854 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.3 -42.65 91.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.336 -0.393 . . . . 1.24 110.847 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 172' ' ' SER . . . . . 0.417 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 68.3 m -56.87 -52.21 66.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.483 . . . . 0.41999999999999998 111.005 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.481 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 66.8 m80 -62.54 -52.6 62.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.37 111.289 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.78 -52.56 64.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.359 . . . . 1.1899999999999999 111.24 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 69.4 mt -62.46 -43.32 99.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.316 -0.402 . . . . 1.21 111.032 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.44 ' HB1' ' CB ' ' A' ' 176' ' ' ALA . . . -58.36 -52.7 64.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 1.1100000000000001 111.142 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 82.7 mt -60.07 -42.34 89.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.428 -0.351 . . . . 1.0900000000000001 110.418 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.57 -49.75 59.86 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.564 -0.827 . . . . 0.29999999999999999 111.97 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 88.7 mt -56.25 -46.76 79.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 1.1799999999999999 110.397 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.03 -42.98 55.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.526 -0.845 . . . . 0.28000000000000003 111.812 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.435 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 17.7 mm -60.05 -51.87 67.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.836 0.35 . . . . 1.6299999999999999 110.611 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -51.3 -49.48 61.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.792 -0.64 . . . . 2.4100000000000001 111.224 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 61.1 mt -58.73 -52.45 59.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.212 -0.449 . . . . 1.6100000000000001 111.324 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . 0.428 ' HA2' ' CD1' ' B' ' 187' ' ' LEU . . . -59.0 -52.38 53.72 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.882 -0.675 . . . . 0.71999999999999997 113.098 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . 0.42 ' HG3' ' N ' ' B' ' 186' ' ' ARG . 6.1 ptp180 -55.37 -31.25 61.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.366 . . . . 2.4700000000000002 111.141 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . 0.42 ' N ' ' HG3' ' B' ' 185' ' ' ARG . 72.6 mtp85 -102.54 56.2 0.78 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.041 -0.527 . . . . 4.25 110.846 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . 0.428 ' CD1' ' HA2' ' B' ' 184' ' ' GLY . 50.1 mt -113.03 -84.55 0.59 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.944 -0.571 . . . . 2.1499999999999999 111.266 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 27.7 p . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.258 -0.877 . . . . 2.54 111.327 -179.499 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.454 -0.258 . . . . 7.8200000000000003 112.454 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -161.93 175.54 38.44 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.813 -0.708 . . . . 6.0599999999999996 112.479 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 23.4 mm -69.82 -52.73 28.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.94 0.4 . . . . 7.0599999999999996 111.07 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.446 ' HB2' ' CB ' ' A' ' 161' ' ' PHE . 63.1 m-85 -76.22 -29.83 57.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.88 -0.6 . . . . 5.9500000000000002 111.056 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.8 p 81.26 -158.94 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.055 -0.521 . . . . 5.5499999999999998 111.43 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -51.78 -25.19 7.09 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.461 -0.336 . . . . 4.21 111.262 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -56.79 -44.84 82.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.368 -0.378 . . . . 5.3600000000000003 110.425 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.539 ' CZ ' ' CD1' ' A' ' 165' ' ' PHE . 85.3 t80 -86.17 -40.2 15.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 3.6200000000000001 110.685 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 75.2 mt -61.72 -32.94 73.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.298 -0.41 . . . . 3.54 110.507 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -58.37 -24.9 61.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 3.5699999999999998 110.898 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.9 m -131.68 43.56 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.194 -0.457 . . . . 3.2000000000000002 111.116 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.539 ' CD1' ' CZ ' ' A' ' 161' ' ' PHE . 88.6 t80 -127.59 -53.86 1.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 2.77 110.692 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.474 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 87.3 mt -48.59 -55.69 18.28 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.182 -0.463 . . . . 2.29 111.175 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 32.7 Cg_endo -63.99 -37.66 42.17 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 121.895 1.73 . . . . 1.3 111.515 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 60.3 m -50.23 -48.96 54.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 1.8700000000000001 110.68 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 78.1 mt -54.71 -50.7 67.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.507 . . . . 1.4099999999999999 110.173 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.31 -42.92 96.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.05 -0.523 . . . . 1.3300000000000001 110.208 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 76.5 mt -62.17 -41.27 98.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.961 -0.563 . . . . 1.1399999999999999 110.635 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.429 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 73.6 m -55.85 -52.72 63.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.359 -0.382 . . . . 0.39000000000000001 110.855 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.434 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 73.3 m80 -62.6 -52.09 64.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.35999999999999999 110.929 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.5 mt -59.88 -52.55 64.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.226 -0.443 . . . . 1.1799999999999999 111.21 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 75.0 mt -56.2 -46.02 79.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 1.1499999999999999 110.542 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.428 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -52.41 -52.01 56.08 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.142 -0.481 . . . . 1.0600000000000001 110.15 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 69.1 mt -58.85 -42.56 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 115.975 -0.557 . . . . 1.29 109.81 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.23 -43.65 64.18 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.654 -0.784 . . . . 0.29999999999999999 111.724 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 78.5 mt -60.21 -46.01 91.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.95 0.405 . . . . 1.1399999999999999 110.115 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -58.59 -43.59 96.04 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.554 -0.832 . . . . 0.31 112.029 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 45.6 mm -58.31 -44.41 88.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.899 0.381 . . . . 1.5600000000000001 110.749 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -60.03 -49.54 77.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 2.4700000000000002 110.741 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 57.9 mt -62.23 -48.92 86.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 1.4399999999999999 111.31 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.2 -52.67 51.35 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.768 -0.729 . . . . 0.64000000000000001 113.046 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.12 -17.93 59.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.707 0.289 . . . . 3.0299999999999998 111.224 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -82.05 4.94 21.01 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.544 -0.298 . . . . 4.4299999999999997 111.417 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 51.1 mt -75.8 -84.66 0.05 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.912 0.387 . . . . 1.8100000000000001 111.063 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.4 HG21 ' O ' ' A' ' 188' ' ' THR . 2.2 t . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.336 -0.84 . . . . 3.6200000000000001 111.227 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 112.482 -0.247 . . . . 7.6200000000000001 112.482 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -142.96 169.35 25.69 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.665 -0.779 . . . . 6.9500000000000002 112.409 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 51.9 mt -70.77 -55.55 13.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.949 0.404 . . . . 8.1300000000000008 110.907 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -76.14 -41.34 50.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 7.2300000000000004 110.686 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.406 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 67.9 m 40.13 -94.1 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.944 -0.571 . . . . 5.6299999999999999 111.578 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.423 ' O ' ' CD ' ' B' ' 163' ' ' LYS . . . -58.96 -54.84 42.61 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.679 0.276 . . . . 4.6200000000000001 111.195 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -53.95 -26.09 23.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.175 -0.466 . . . . 5.7300000000000004 111.361 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -80.16 -42.6 23.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.818 0.342 . . . . 4.0599999999999996 110.792 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 158' ' ' SER . 22.4 mt -63.88 -26.1 68.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.421 . . . . 3.73 111.096 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . 0.423 ' CD ' ' O ' ' B' ' 159' ' ' ALA . 20.5 mmmt -56.98 -36.87 70.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.017 0.437 . . . . 4.2599999999999998 110.578 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 31.7 m -114.18 30.17 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.937 -0.574 . . . . 3.27 111.239 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -120.06 -46.55 2.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.425 -0.352 . . . . 3.1899999999999999 110.903 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.463 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 91.0 mt -50.32 -54.37 35.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 2.5299999999999998 111.267 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 53.3 Cg_endo -68.6 -35.77 16.28 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.136 1.891 . . . . 1.4199999999999999 112.176 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.5 t -50.87 -42.29 58.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 1.99 110.98 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.414 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 46.0 mt -54.13 -50.68 66.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.435 . . . . 1.6899999999999999 110.68 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . 0.409 HD11 ' N ' ' B' ' 170' ' ' LEU . 7.0 mp -61.14 -44.12 97.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 1.3899999999999999 110.386 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.05 -41.56 98.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 1.24 110.279 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 172' ' ' SER . . . . . 0.434 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 73.6 m -55.06 -44.24 74.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.081 -0.509 . . . . 0.41999999999999998 110.502 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.429 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 68.7 m80 -61.74 -52.54 63.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.37 110.846 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 94.4 mt -58.44 -52.56 65.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.862 0.363 . . . . 1.1899999999999999 110.723 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.8 -42.2 99.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.073 -0.512 . . . . 1.21 111.204 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.428 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -59.11 -52.46 65.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.426 . . . . 1.1100000000000001 111.573 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 87.0 mt -56.97 -45.54 83.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 1.0900000000000001 110.648 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.8 -45.89 77.85 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.511 -0.852 . . . . 0.29999999999999999 111.855 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 95.8 mt -55.78 -46.26 78.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.942 0.401 . . . . 1.1799999999999999 110.143 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.15 -41.62 79.1 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.744 -0.741 . . . . 0.28000000000000003 112.051 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 53.4 mt -61.11 -46.86 95.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.878 0.371 . . . . 1.6299999999999999 110.803 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . 0.403 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 89.0 t80 -59.7 -46.92 87.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.05 -0.523 . . . . 2.4100000000000001 110.963 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 47.8 mt -62.99 -47.71 91.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.326 -0.397 . . . . 1.6100000000000001 111.511 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . 0.429 ' HA2' ' CD1' ' B' ' 187' ' ' LEU . . . -55.09 -51.92 50.57 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 121.284 -0.484 . . . . 0.71999999999999997 113.624 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.8 OUTLIER -60.07 -22.42 62.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.788 0.328 . . . . 2.4700000000000002 111.366 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -96.28 38.41 1.2 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.38 -0.373 . . . . 4.25 111.441 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . 0.429 ' CD1' ' HA2' ' B' ' 184' ' ' GLY . 23.3 mt -127.0 -65.09 0.97 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.486 0.66 . . . . 2.1499999999999999 110.426 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 34.7 p . . . . . 0 C--O 1.249 1.049 0 CA-C-N 114.882 -1.054 . . . . 2.54 111.325 -179.83 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.516 -0.234 . . . . 7.8200000000000003 112.516 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -113.82 160.04 13.37 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.743 -0.741 . . . . 6.0599999999999996 112.486 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 56.8 mt -71.4 -65.16 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 7.0599999999999996 110.992 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.43 ' O ' ' N ' ' A' ' 159' ' ' ALA . 34.1 m-85 -77.69 -63.63 1.34 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.013 -0.54 . . . . 5.9500000000000002 111.087 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 33.7 t 44.12 -90.55 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.095 -0.502 . . . . 5.5499999999999998 111.569 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.7 -52.63 64.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.744 0.307 . . . . 4.21 110.932 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -57.28 -44.76 84.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 5.3600000000000003 111.018 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -68.23 -51.61 43.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 3.6200000000000001 111.102 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.5 mt -62.83 -29.74 70.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 3.54 111.192 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -57.91 -41.92 83.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.389 -0.369 . . . . 3.5699999999999998 110.568 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 5.2 t -98.99 40.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.049 -0.523 . . . . 3.2000000000000002 110.756 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -131.3 -67.04 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 2.77 110.849 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.455 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 70.7 mt -50.66 -58.21 10.8 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.109 -0.496 . . . . 2.29 111.532 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 23.7 Cg_endo -61.67 -38.54 60.45 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.187 1.925 . . . . 1.3 112.237 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 57.7 m -53.69 -42.26 67.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 1.8700000000000001 110.841 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.41 -51.01 69.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 1.4099999999999999 110.915 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 89.5 mt -55.33 -48.57 73.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 1.3300000000000001 110.905 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.9 mt -59.07 -42.72 91.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 1.1399999999999999 111.082 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.482 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 67.9 m -55.97 -53.1 60.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.311 -0.404 . . . . 0.39000000000000001 111.025 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.416 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 70.8 m80 -62.77 -52.5 62.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.35999999999999999 110.832 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 78.9 mt -57.83 -51.72 68.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 1.1799999999999999 111.309 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 73.9 mt -60.77 -45.54 93.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.367 -0.379 . . . . 1.1499999999999999 111.175 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -56.1 -52.7 63.36 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.017 0.437 . . . . 1.0600000000000001 110.67 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 63.2 mt -59.55 -42.49 88.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.128 -0.487 . . . . 1.29 109.861 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.78 -42.06 52.14 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.639 -0.791 . . . . 0.29999999999999999 111.553 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 83.7 mt -61.35 -46.2 91.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.075 0.464 . . . . 1.1399999999999999 109.751 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -61.55 -44.08 98.45 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.643 -0.789 . . . . 0.31 112.291 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 47.5 mm -60.81 -51.32 74.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.331 . . . . 1.5600000000000001 110.958 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.408 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 81.1 t80 -51.85 -52.21 51.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 2.4700000000000002 110.747 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 54.8 mt -62.53 -41.91 93.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.204 -0.453 . . . . 1.4399999999999999 111.312 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.74 -44.92 97.37 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.957 -0.639 . . . . 0.64000000000000001 113.347 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.408 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 8.0 ptp180 -61.18 -32.64 72.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.894 0.347 . . . . 3.0299999999999998 111.384 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -85.38 -15.94 41.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.654 0.264 . . . . 4.4299999999999997 111.144 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 15.8 mt -64.46 -81.66 0.03 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.848 0.356 . . . . 1.8100000000000001 110.965 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 4.4 t . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.149 -0.929 . . . . 3.6200000000000001 111.27 179.968 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.646 -0.181 . . . . 7.6200000000000001 112.646 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -112.41 -179.66 19.62 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.677 -0.773 . . . . 6.9500000000000002 112.451 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 48.6 mt -72.6 -68.92 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 8.1300000000000008 110.936 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -78.11 -81.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.086 -0.506 . . . . 7.2300000000000004 110.848 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' B' ' 159' ' ' ALA . 7.3 t 77.98 139.34 0.07 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.031 -0.531 . . . . 5.6299999999999999 110.797 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' B' ' 158' ' ' SER . . . 91.83 -67.69 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.68 -0.691 . . . . 4.6200000000000001 110.527 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.66 -42.86 99.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.612 -0.722 . . . . 5.7300000000000004 111.13 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -83.62 -35.71 24.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 4.0599999999999996 111.09 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.59 -47.08 87.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.269 -0.423 . . . . 3.73 110.869 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . 0.435 ' HG3' ' CG2' ' B' ' 164' ' ' VAL . 19.2 ptpt -57.4 -26.97 61.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 4.2599999999999998 110.772 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . 0.435 ' CG2' ' HG3' ' B' ' 163' ' ' LYS . 3.0 t -110.38 23.29 4.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.297 -0.411 . . . . 3.27 111.053 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -136.65 -52.26 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.77 0.319 . . . . 3.1899999999999999 111.046 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.466 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 64.4 mt -47.84 -57.36 10.29 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.42 . . . . 2.5299999999999998 111.508 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 25.0 Cg_endo -61.83 -23.93 76.66 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.156 1.904 . . . . 1.4199999999999999 112.456 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 35.4 t -65.41 -45.96 81.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.417 -0.356 . . . . 1.99 110.943 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 55.3 mt -54.86 -48.71 72.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 1.6899999999999999 110.786 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.6 mp -57.87 -50.33 73.7 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.199 -0.455 . . . . 1.3899999999999999 110.631 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 61.6 mt -59.05 -41.48 87.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.485 . . . . 1.24 110.651 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 172' ' ' SER . . . . . 0.416 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 73.5 m -51.93 -50.32 61.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.41999999999999998 110.889 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.482 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 60.6 m80 -61.18 -52.32 65.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.37 111.181 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 98.0 mt -60.91 -52.35 65.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.361 -0.381 . . . . 1.1899999999999999 111.002 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.28 -43.73 98.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 1.21 111.039 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.429 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -53.41 -52.35 59.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 1.1100000000000001 111.342 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 60.4 mt -60.95 -47.76 92.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.426 -0.352 . . . . 1.0900000000000001 110.918 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.28 -51.1 43.87 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.639 -0.791 . . . . 0.29999999999999999 112.164 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 97.3 mt -55.25 -46.86 76.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.973 0.416 . . . . 1.1799999999999999 110.796 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.96 -42.9 82.08 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.669 -0.777 . . . . 0.28000000000000003 112.545 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 58.2 mt -61.89 -51.1 76.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 1.6299999999999999 111.019 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -58.67 -49.85 76.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 2.4100000000000001 110.812 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 73.7 mt -61.93 -46.02 97.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 1.6100000000000001 111.101 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -58.88 -49.54 77.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.639 -0.791 . . . . 0.71999999999999997 112.415 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -60.01 -22.42 62.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.781 0.324 . . . . 2.4700000000000002 111.08 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -99.53 35.0 2.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.897 0.38 . . . . 4.25 110.591 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 77.4 mt -97.15 -85.43 0.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.98 -0.555 . . . . 2.1499999999999999 111.348 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.395 -0.812 . . . . 2.54 111.18 -179.672 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.593 -0.203 . . . . 7.8200000000000003 112.593 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 168.7 175.59 38.29 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.823 -0.703 . . . . 6.0599999999999996 112.511 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 17.4 mm -70.96 -56.34 10.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.976 0.417 . . . . 7.0599999999999996 111.023 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -76.27 -58.65 3.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.975 -0.557 . . . . 5.9500000000000002 111.093 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 87.8 p 53.22 108.41 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.127 -0.488 . . . . 5.5499999999999998 111.296 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' A' ' 158' ' ' SER . . . 95.86 -66.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.576 -0.738 . . . . 4.21 110.436 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.51 -29.69 66.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 5.3600000000000003 110.556 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -99.47 -45.11 5.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.953 -0.567 . . . . 3.6200000000000001 110.787 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 83.6 mt -62.1 -40.11 94.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 3.54 110.533 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 159' ' ' ALA . 40.0 ttmt -58.61 -38.36 77.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.969 -0.56 . . . . 3.5699999999999998 110.854 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 5.1 t -100.01 30.94 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 116.06 -0.518 . . . . 3.2000000000000002 111.209 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.405 ' CZ ' HD12 ' A' ' 169' ' ' LEU . 18.9 t80 -148.22 -56.59 0.22 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.861 0.362 . . . . 2.77 110.964 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.471 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 60.1 mt -49.86 -54.21 34.59 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 2.29 111.43 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 56.3 Cg_endo -68.94 -38.08 10.21 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.218 1.945 . . . . 1.3 112.406 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 65.9 m -51.14 -50.73 58.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.265 -0.425 . . . . 1.8700000000000001 110.839 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.405 HD12 ' CZ ' ' A' ' 165' ' ' PHE . 85.5 mt -61.78 -51.91 66.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.151 -0.477 . . . . 1.4099999999999999 111.005 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 83.7 mt -52.88 -51.45 61.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.27 -0.423 . . . . 1.3300000000000001 110.987 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 79.3 mt -58.28 -42.32 86.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.339 -0.391 . . . . 1.1399999999999999 111.011 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.4 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 65.2 m -59.7 -52.13 66.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.39000000000000001 111.002 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.434 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 74.8 m80 -60.44 -51.83 67.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.35999999999999999 111.02 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.3 mt -57.02 -52.25 66.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 1.1799999999999999 111.12 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 74.1 mt -58.12 -49.46 76.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 1.1499999999999999 111.137 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.439 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -51.34 -52.24 47.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.935 0.398 . . . . 1.0600000000000001 110.673 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 70.6 mt -59.2 -41.97 85.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 1.29 110.13 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.66 -46.05 89.64 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.666 -0.778 . . . . 0.29999999999999999 111.834 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 44.4 mt -55.71 -47.82 76.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.004 0.43 . . . . 1.1399999999999999 110.077 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.427 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -55.18 -43.75 83.87 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.792 -0.718 . . . . 0.31 112.339 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 49.4 mm -58.34 -52.28 61.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.837 0.351 . . . . 1.5600000000000001 111.068 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -53.95 -48.25 70.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 2.4700000000000002 110.784 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 68.7 mt -62.1 -42.62 95.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 1.4399999999999999 111.191 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.5 -47.14 91.59 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.867 -0.682 . . . . 0.64000000000000001 112.984 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.428 ' HG3' ' N ' ' A' ' 186' ' ' ARG . 13.5 ptp180 -62.18 -40.8 97.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.552 0.215 . . . . 3.0299999999999998 111.407 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.428 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 15.9 ptm180 -68.69 -8.77 45.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.654 -0.248 . . . . 4.4299999999999997 111.46 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.6 mt -55.93 -84.25 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.839 0.352 . . . . 1.8100000000000001 110.997 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.42 -0.8 . . . . 3.6200000000000001 111.325 -179.906 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.483 -0.247 . . . . 7.6200000000000001 112.483 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -168.37 -170.48 33.11 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.761 -0.733 . . . . 6.9500000000000002 112.432 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 45.0 mt -71.01 -60.74 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.856 0.36 . . . . 8.1300000000000008 111.025 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.445 ' O ' ' N ' ' B' ' 159' ' ' ALA . 68.8 m-85 -76.33 -41.58 47.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 7.2300000000000004 111.135 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 70.1 m 41.69 -89.25 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.986 -0.552 . . . . 5.6299999999999999 112.189 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -54.95 -63.24 1.21 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.765 0.317 . . . . 4.6200000000000001 111.4 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.4 -23.32 37.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 5.7300000000000004 111.276 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . 0.409 ' HB2' ' HB2' ' B' ' 157' ' ' PHE . 41.6 t80 -77.43 -54.81 5.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.415 -0.357 . . . . 4.0599999999999996 110.922 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 34.3 mt -63.13 -36.93 85.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 3.73 110.868 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . 0.446 ' HB3' ' NZ ' ' B' ' 163' ' ' LYS . 7.8 mtpm? -56.97 -19.52 18.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.499 . . . . 4.2599999999999998 111.486 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 26.4 m -133.75 34.93 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.728 0.299 . . . . 3.27 111.297 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -131.34 -60.47 0.95 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.333 -0.394 . . . . 3.1899999999999999 111.421 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.48 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 89.8 mt -63.72 -46.2 82.41 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.428 -0.351 . . . . 2.5299999999999998 111.883 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 99.7 Cg_exo -42.24 -53.59 3.52 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.358 2.039 . . . . 1.4199999999999999 112.564 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 42.5 t -57.86 -41.51 82.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.164 -0.471 . . . . 1.99 111.098 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.416 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 27.2 mt -59.24 -51.23 70.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.317 -0.401 . . . . 1.6899999999999999 111.364 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . 0.42 ' N ' HD13 ' B' ' 170' ' ' LEU . 7.7 mp -59.86 -49.01 79.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.738 0.304 . . . . 1.3899999999999999 110.972 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.99 -41.49 98.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 1.24 110.904 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 172' ' ' SER . . . . . 0.434 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 73.0 m -57.95 -52.35 65.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.41999999999999998 111.37 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 60.9 m80 -62.24 -52.45 63.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.333 -0.394 . . . . 0.37 111.358 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 97.5 mt -54.77 -53.07 59.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.921 0.391 . . . . 1.1899999999999999 110.703 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.37 -49.33 74.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.962 -0.563 . . . . 1.21 110.993 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.439 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -51.74 -52.58 47.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.0 -0.546 . . . . 1.1100000000000001 111.635 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.402 HG13 ' HB2' ' A' ' 176' ' ' ALA . 70.7 mt -62.04 -46.66 95.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.919 0.39 . . . . 1.0900000000000001 110.668 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.16 -46.46 91.56 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.598 -0.81 . . . . 0.29999999999999999 111.963 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 94.4 mt -55.24 -46.06 76.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.987 0.422 . . . . 1.1799999999999999 110.212 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.14 -42.18 80.85 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.644 -0.789 . . . . 0.28000000000000003 111.777 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.427 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 40.4 mm -58.0 -50.73 76.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.883 0.373 . . . . 1.6299999999999999 110.589 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -58.66 -49.76 76.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.008 -0.542 . . . . 2.4100000000000001 111.237 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 50.4 mt -59.59 -51.34 73.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.367 -0.379 . . . . 1.6100000000000001 111.335 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . 0.405 ' O ' ' HG ' ' B' ' 187' ' ' LEU . . . -62.37 -52.24 50.74 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.755 -0.736 . . . . 0.71999999999999997 112.866 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . 0.419 ' CG ' ' O ' ' B' ' 181' ' ' ILE . 0.0 OUTLIER -63.07 -13.68 38.97 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.667 0.247 . . . . 2.4700000000000002 111.667 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -94.48 21.73 6.88 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.65 0.262 . . . . 4.25 111.127 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' B' ' 184' ' ' GLY . 7.1 mt -121.71 -66.08 1.07 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.165 0.507 . . . . 2.1499999999999999 110.67 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.295 -0.859 . . . . 2.54 111.164 179.922 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.504 -0.238 . . . . 7.8200000000000003 112.504 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -68.13 179.61 18.99 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.882 -0.675 . . . . 6.0599999999999996 112.689 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.408 HG22 ' CE2' ' A' ' 157' ' ' PHE . 13.4 mm -69.5 -17.75 21.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.856 0.36 . . . . 7.0599999999999996 111.39 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 159' ' ' ALA . 92.6 m-85 -156.21 -69.3 0.11 Allowed 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.236 -0.438 . . . . 5.9500000000000002 110.745 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.405 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 80.0 p 44.39 -90.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.021 -0.536 . . . . 5.5499999999999998 111.569 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -53.78 -54.49 37.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 4.21 111.17 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -56.39 -45.52 80.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 5.3600000000000003 111.098 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -64.84 -54.83 24.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.394 -0.366 . . . . 3.6200000000000001 111.059 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 158' ' ' SER . 21.4 mt -63.19 -33.36 75.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.395 -0.366 . . . . 3.54 110.982 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -57.07 -34.76 68.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 3.5699999999999998 111.218 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.46 44.07 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 3.2000000000000002 111.332 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -127.09 -65.66 0.94 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 2.77 110.863 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.514 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 55.4 mt -61.36 -43.75 90.55 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 2.29 111.354 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 23.0 Cg_exo -65.19 -36.13 38.1 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.382 2.055 . . . . 1.3 112.048 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.2 t -59.29 -43.81 92.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 1.8700000000000001 110.904 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 65.3 mt -59.4 -50.15 75.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.514 . . . . 1.4099999999999999 110.877 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 97.3 mt -55.39 -49.12 73.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.426 . . . . 1.3300000000000001 110.734 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.9 mt -56.28 -41.97 76.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 1.1399999999999999 110.755 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.473 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 72.9 m -57.49 -52.04 67.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 0.39000000000000001 110.862 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.432 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 70.1 m80 -61.17 -50.55 72.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.35999999999999999 110.815 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 92.8 mt -61.42 -52.14 65.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 1.1799999999999999 111.119 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 66.6 mt -62.03 -43.62 98.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.332 -0.395 . . . . 1.1499999999999999 111.089 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.425 ' CB ' ' HB1' ' B' ' 176' ' ' ALA . . . -51.84 -52.47 49.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.9 0.381 . . . . 1.0600000000000001 110.623 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 66.4 mt -58.15 -41.95 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 1.29 110.246 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.64 -44.53 60.08 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.621 -0.799 . . . . 0.29999999999999999 111.893 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 72.1 mt -61.32 -48.44 81.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.987 0.423 . . . . 1.1399999999999999 110.322 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.66 -52.05 50.88 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.579 -0.82 . . . . 0.31 112.338 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 56.1 mt -53.66 -49.37 57.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.868 0.366 . . . . 1.5600000000000001 110.954 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.422 ' O ' ' CG ' ' A' ' 186' ' ' ARG . 92.1 t80 -51.95 -51.43 57.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.507 . . . . 2.4700000000000002 110.777 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 59.4 mt -62.7 -41.9 94.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.112 -0.494 . . . . 1.4399999999999999 111.165 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.19 -52.62 48.41 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.941 -0.647 . . . . 0.64000000000000001 113.265 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.07 -22.86 66.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.822 0.311 . . . . 3.0299999999999998 111.005 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.422 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 1.5 mmp_? -67.28 -41.23 85.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.392 . . . . 4.4299999999999997 110.935 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 187' ' ' LEU . 6.6 mt -52.21 -66.42 0.39 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.504 . . . . 1.8100000000000001 110.664 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 81.4 p . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.278 -0.867 . . . . 3.6200000000000001 111.088 179.921 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.45 -0.26 . . . . 7.6200000000000001 112.45 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 167.48 179.36 40.25 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.624 -0.798 . . . . 6.9500000000000002 112.511 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 48.7 mt -71.87 -66.21 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.9 0.381 . . . . 8.1300000000000008 110.892 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.432 ' O ' ' N ' ' B' ' 159' ' ' ALA . 29.8 m-85 -77.56 -44.16 29.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.042 -0.526 . . . . 7.2300000000000004 110.819 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 53.0 p 44.39 -89.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.849 -0.614 . . . . 5.6299999999999999 111.953 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -58.33 -54.75 43.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.836 0.351 . . . . 4.6200000000000001 111.469 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -54.99 -50.87 67.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.156 -0.475 . . . . 5.7300000000000004 111.112 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -64.12 -49.59 71.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 4.0599999999999996 111.217 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.33 -40.06 95.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 3.73 111.32 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -57.77 -32.96 68.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.282 -0.417 . . . . 4.2599999999999998 111.309 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 32.4 m -112.82 28.0 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.731 0.301 . . . . 3.27 111.297 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -122.56 -52.41 1.92 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.333 -0.394 . . . . 3.1899999999999999 110.806 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.481 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 85.9 mt -60.2 -45.6 97.75 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.12 -0.491 . . . . 2.5299999999999998 111.525 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 89.3 Cg_endo -82.18 -26.57 2.77 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.383 2.055 . . . . 1.4199999999999999 112.524 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 81.1 p -57.22 -48.56 78.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 1.99 110.929 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.424 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 84.0 mt -52.23 -49.4 64.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 1.6899999999999999 111.049 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . 0.412 HD11 ' N ' ' B' ' 170' ' ' LEU . 7.2 mp -61.88 -47.99 82.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.36 -0.382 . . . . 1.3899999999999999 111.082 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 90.2 mt -61.87 -44.74 96.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 1.24 111.141 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 172' ' ' SER . . . . . 0.432 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 71.0 m -53.04 -52.11 59.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.318 -0.401 . . . . 0.41999999999999998 110.979 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.473 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 61.6 m80 -60.48 -52.5 64.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.37 111.201 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 86.6 mt -60.29 -52.35 65.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.844 0.354 . . . . 1.1899999999999999 111.236 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.17 -45.3 94.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.43 . . . . 1.21 111.208 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.425 ' HB1' ' CB ' ' A' ' 176' ' ' ALA . . . -53.28 -52.53 58.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 1.1100000000000001 111.51 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 69.8 mt -59.14 -42.83 87.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.827 0.346 . . . . 1.0900000000000001 110.799 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.56 -51.11 50.4 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.508 -0.853 . . . . 0.29999999999999999 111.963 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 66.3 mt -56.38 -42.48 77.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.911 0.386 . . . . 1.1799999999999999 110.256 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.56 -47.35 70.45 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.673 -0.775 . . . . 0.28000000000000003 112.069 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 49.7 mt -57.4 -48.64 82.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.868 0.366 . . . . 1.6299999999999999 110.69 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -54.0 -47.07 71.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 2.4100000000000001 110.502 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 72.3 mt -62.4 -51.53 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.079 -0.51 . . . . 1.6100000000000001 110.934 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . 0.409 ' HA2' ' CD1' ' B' ' 187' ' ' LEU . . . -62.19 -52.51 49.18 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.808 -0.71 . . . . 0.71999999999999997 112.8 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -20.15 51.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.724 0.297 . . . . 2.4700000000000002 111.073 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -105.96 49.29 0.81 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.949 0.404 . . . . 4.25 110.509 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . 0.409 ' CD1' ' HA2' ' B' ' 184' ' ' GLY . 70.0 mt -113.93 -84.74 0.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 2.1499999999999999 111.315 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.108 -0.948 . . . . 2.54 111.09 -179.647 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.484 -0.247 . . . . 7.8200000000000003 112.484 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 178.53 175.93 46.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.813 -0.708 . . . . 6.0599999999999996 112.544 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 69.9 mt -70.6 -52.72 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 7.0599999999999996 111.006 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.433 ' CB ' ' HB2' ' A' ' 161' ' ' PHE . 37.8 m-85 -76.34 -63.39 1.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.039 -0.528 . . . . 5.9500000000000002 110.605 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.8 m 40.26 -91.11 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.073 -0.512 . . . . 5.5499999999999998 111.865 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -57.87 -54.54 45.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.806 0.336 . . . . 4.21 110.986 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -55.9 -36.19 67.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.424 . . . . 5.3600000000000003 110.702 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.433 ' HB2' ' CB ' ' A' ' 157' ' ' PHE . 55.1 t80 -72.23 -57.57 4.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.935 -0.575 . . . . 3.6200000000000001 110.792 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 68.2 mt -63.46 -26.22 68.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 3.54 111.052 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -57.33 -29.59 64.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 3.5699999999999998 110.802 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 4.9 t -113.99 39.34 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 116.232 -0.44 . . . . 3.2000000000000002 111.202 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.437 ' CE2' HD12 ' A' ' 169' ' ' LEU . 80.1 t80 -149.65 -54.74 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.474 -0.33 . . . . 2.77 111.624 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.481 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 76.1 mt -60.39 -45.0 97.43 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 112.281 0.474 . . . . 2.29 112.281 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 50.9 Cg_exo -53.5 -49.43 17.37 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.181 1.92 . . . . 1.3 112.391 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.8 t -57.34 -50.07 74.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 1.8700000000000001 110.88 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.437 HD12 ' CE2' ' A' ' 165' ' ' PHE . 40.8 mt -62.16 -48.97 77.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 1.4099999999999999 111.053 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 64.6 mt -52.26 -51.8 56.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.875 0.369 . . . . 1.3300000000000001 110.757 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.6 mt -56.43 -42.35 77.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 1.1399999999999999 110.856 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.426 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 74.8 m -58.38 -52.55 65.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.42 . . . . 0.39000000000000001 110.85 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.426 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 72.4 m80 -62.48 -51.97 65.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.35999999999999999 110.744 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.65 -51.78 68.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 1.1799999999999999 110.987 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.7 mt -60.19 -44.11 95.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 1.1499999999999999 110.98 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.419 ' CB ' ' HB1' ' B' ' 176' ' ' ALA . . . -53.75 -52.37 60.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 1.0600000000000001 110.788 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 68.5 mt -55.47 -45.42 78.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 1.29 110.162 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.91 -42.15 59.84 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.505 -0.855 . . . . 0.29999999999999999 111.825 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 68.2 mt -59.06 -48.09 82.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.979 0.419 . . . . 1.1399999999999999 110.105 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.421 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -58.64 -46.51 93.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.677 -0.773 . . . . 0.31 112.344 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 48.0 mm -59.73 -49.93 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.878 0.371 . . . . 1.5600000000000001 111.081 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -51.88 -49.93 62.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 2.4700000000000002 110.915 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 71.9 mt -62.56 -42.55 96.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 1.4399999999999999 111.186 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.2 -52.51 49.17 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.849 -0.691 . . . . 0.64000000000000001 112.951 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -24.17 67.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 3.0299999999999998 111.017 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -69.23 -37.55 78.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.445 . . . . 4.4299999999999997 111.044 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.432 HD21 ' N ' ' A' ' 187' ' ' LEU . 6.3 mt -52.13 -37.62 54.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.083 0.468 . . . . 1.8100000000000001 110.53 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 75.7 p . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.222 -0.894 . . . . 3.6200000000000001 111.356 179.939 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.557 -0.217 . . . . 7.6200000000000001 112.557 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -139.33 -153.83 6.2 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.743 -0.741 . . . . 6.9500000000000002 112.493 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 9.6 mm -70.14 -48.26 62.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.934 0.397 . . . . 8.1300000000000008 111.083 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.437 ' O ' ' N ' ' B' ' 159' ' ' ALA . 18.3 m-30 -77.04 -39.17 50.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.976 -0.556 . . . . 7.2300000000000004 111.37 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 69.0 m 44.41 -90.01 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.089 -0.505 . . . . 5.6299999999999999 111.761 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -56.14 -55.14 36.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.666 0.27 . . . . 4.6200000000000001 111.517 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -56.05 -46.78 78.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.462 -0.336 . . . . 5.7300000000000004 111.094 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -63.94 -53.52 49.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 4.0599999999999996 110.992 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.4 -32.07 72.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.487 . . . . 3.73 111.059 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -60.84 -25.99 67.03 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.178 -0.465 . . . . 4.2599999999999998 110.587 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.15 28.62 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.433 . . . . 3.27 111.307 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -129.82 -44.01 1.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 3.1899999999999999 110.853 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.5 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 87.3 mt -65.08 -43.33 66.53 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 2.5299999999999998 111.54 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 17.9 Cg_endo -90.23 24.56 0.61 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.868 2.378 . . . . 1.4199999999999999 112.405 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 55.0 m -114.07 -43.61 3.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.414 -0.357 . . . . 1.99 110.891 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.419 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 82.4 mt -61.5 -41.92 98.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 1.6899999999999999 110.944 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 6.3 mp -60.48 -47.25 86.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 1.3899999999999999 110.979 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 48.5 mt -61.02 -41.74 97.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.303 -0.408 . . . . 1.24 110.731 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 172' ' ' SER . . . . . 0.426 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 70.8 m -54.92 -51.36 66.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.41999999999999998 110.937 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.426 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 67.0 m80 -61.66 -52.41 64.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.229 -0.441 . . . . 0.37 111.131 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 90.6 mt -55.39 -52.93 61.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.445 -0.343 . . . . 1.1899999999999999 110.8 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.8 -45.04 94.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 1.21 110.979 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.419 ' HB1' ' CB ' ' A' ' 176' ' ' ALA . . . -54.67 -53.02 60.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 1.1100000000000001 111.268 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 56.9 mt -62.19 -42.62 95.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.359 -0.382 . . . . 1.0900000000000001 110.585 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.55 -46.51 81.11 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.61 -0.805 . . . . 0.29999999999999999 111.9 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 94.9 mt -57.44 -47.94 80.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.37 . . . . 1.1799999999999999 110.346 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.31 -43.53 64.95 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.572 -0.823 . . . . 0.28000000000000003 112.34 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.421 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 40.0 mm -60.29 -49.87 82.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.872 0.367 . . . . 1.6299999999999999 110.993 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -59.36 -47.97 83.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.54 . . . . 2.4100000000000001 110.986 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 65.6 mt -62.17 -44.52 99.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 1.6100000000000001 111.147 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.38 -46.83 93.05 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.831 -0.7 . . . . 0.71999999999999997 112.92 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -62.53 -13.86 35.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.923 0.342 . . . . 2.4700000000000002 111.923 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -106.5 29.84 6.54 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.814 0.34 . . . . 4.25 111.32 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 13.5 mt -118.57 -65.78 1.14 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.299 0.571 . . . . 2.1499999999999999 110.51 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.058 0 CA-C-N 115.281 -0.872 . . . . 2.54 111.269 -179.698 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.527 -0.229 . . . . 7.8200000000000003 112.527 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -112.3 179.86 19.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.697 -0.763 . . . . 6.0599999999999996 112.758 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.441 HG23 ' CE2' ' A' ' 157' ' ' PHE . 9.5 mt -70.29 -25.51 27.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.996 0.426 . . . . 7.0599999999999996 110.947 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 159' ' ' ALA . 70.4 m-85 -156.56 -43.33 0.07 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.853 -0.612 . . . . 5.9500000000000002 110.795 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 66.9 m 50.02 -86.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.09 -0.505 . . . . 5.5499999999999998 111.811 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -54.18 -57.06 12.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.578 0.227 . . . . 4.21 111.599 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.39 -59.93 4.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.728 0.299 . . . . 5.3600000000000003 110.775 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -55.61 -50.91 68.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.272 -0.422 . . . . 3.6200000000000001 111.009 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.1 mt -60.52 -39.7 88.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 3.54 111.124 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -58.66 -33.68 70.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 3.5699999999999998 111.136 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.8 m -115.6 24.41 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.443 -0.344 . . . . 3.2000000000000002 111.555 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -118.44 -55.56 2.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.766 0.317 . . . . 2.77 110.883 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.477 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 83.8 mt -56.25 -45.39 99.92 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 2.29 111.539 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 96.8 Cg_endo -80.8 -37.66 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.207 1.938 . . . . 1.3 112.339 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 80.8 p -51.34 -47.56 62.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 1.8700000000000001 110.89 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 96.7 mt -61.75 -47.66 84.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.419 . . . . 1.4099999999999999 110.766 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 88.4 mt -55.21 -50.52 69.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 1.3300000000000001 110.938 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.8 mt -57.29 -45.18 84.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 1.1399999999999999 110.881 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.423 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 75.8 m -55.43 -51.93 65.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.288 -0.414 . . . . 0.39000000000000001 110.703 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.431 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 77.2 m80 -61.95 -48.71 79.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.033 -0.53 . . . . 0.35999999999999999 110.844 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 88.8 mt -58.99 -49.8 76.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.314 -0.403 . . . . 1.1799999999999999 110.921 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 82.6 mt -59.92 -51.09 71.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 1.1499999999999999 111.086 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.441 ' CB ' ' HB2' ' B' ' 176' ' ' ALA . . . -52.03 -52.65 49.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 1.0600000000000001 110.933 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.28 -42.28 90.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.044 -0.525 . . . . 1.29 110.274 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.66 -44.64 60.22 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.579 -0.82 . . . . 0.29999999999999999 112.102 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 50.8 mt -62.61 -52.53 63.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.859 0.361 . . . . 1.1399999999999999 110.494 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.01 -52.14 45.28 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.732 -0.747 . . . . 0.31 112.545 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 59.3 mt -55.76 -41.56 66.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.813 0.339 . . . . 1.5600000000000001 110.582 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -55.39 -43.27 75.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.123 -0.49 . . . . 2.4700000000000002 110.596 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 4.7 mm -61.67 -48.71 87.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.938 0.399 . . . . 1.4399999999999999 110.843 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -58.79 -50.8 63.66 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.963 -0.637 . . . . 0.64000000000000001 112.933 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -55.43 -26.53 42.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.667 0.27 . . . . 3.0299999999999998 111.387 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 4.7 ptm85 -98.92 37.95 1.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.875 0.369 . . . . 4.4299999999999997 110.978 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 27.1 mt -115.81 -70.14 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.297 0.57 . . . . 1.8100000000000001 110.582 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 66.0 p . . . . . 0 C--O 1.249 1.064 0 CA-C-N 115.188 -0.914 . . . . 3.6200000000000001 111.072 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.511 -0.236 . . . . 7.6200000000000001 112.511 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -149.22 -169.68 16.03 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.634 -0.793 . . . . 6.9500000000000002 112.709 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . 0.476 HG23 ' CE2' ' B' ' 157' ' ' PHE . 9.4 mm -70.19 -20.41 22.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.75 0.309 . . . . 8.1300000000000008 111.347 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.476 ' CE2' HG23 ' B' ' 156' ' ' ILE . 96.1 m-85 -161.57 -58.65 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 7.2300000000000004 110.853 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 29.1 t 46.36 -88.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.995 -0.548 . . . . 5.6299999999999999 111.598 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -57.29 -55.88 29.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.872 0.367 . . . . 4.6200000000000001 111.492 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -54.69 -27.96 44.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.252 -0.431 . . . . 5.7300000000000004 111.609 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -88.62 -50.27 6.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.833 0.349 . . . . 4.0599999999999996 111.128 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.69 -37.62 87.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 3.73 111.24 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -55.94 -23.2 30.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 4.2599999999999998 111.041 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 31.4 m -131.17 45.5 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.335 -0.393 . . . . 3.27 111.072 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . 0.48 ' CZ ' HD13 ' B' ' 169' ' ' LEU . 34.5 t80 -139.96 -65.7 0.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 3.1899999999999999 110.925 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.472 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 81.0 mt -49.82 -58.82 8.19 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 2.5299999999999998 111.63 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 1.4 Cg_endo -42.83 -53.31 4.02 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.512 2.141 . . . . 1.4199999999999999 112.587 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 51.0 m -52.13 -42.93 63.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.865 0.364 . . . . 1.99 111.175 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.48 HD13 ' CZ ' ' B' ' 165' ' ' PHE . 49.8 mt -61.99 -49.93 74.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 1.6899999999999999 111.216 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.6 mp -61.68 -49.77 75.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.463 -0.335 . . . . 1.3899999999999999 110.885 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 88.8 mt -57.34 -41.82 80.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.379 -0.373 . . . . 1.24 110.775 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 172' ' ' SER . . . . . 0.431 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 67.5 m -57.21 -51.3 69.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.41999999999999998 110.976 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.423 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 69.0 m80 -61.17 -52.47 64.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.335 -0.393 . . . . 0.37 111.017 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 88.2 mt -60.49 -52.3 65.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.907 0.384 . . . . 1.1899999999999999 110.92 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.17 -42.61 99.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.065 -0.516 . . . . 1.21 110.948 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.441 ' HB2' ' CB ' ' A' ' 176' ' ' ALA . . . -53.6 -52.03 61.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.055 -0.52 . . . . 1.1100000000000001 111.333 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 59.8 mt -60.44 -44.41 96.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.75 0.31 . . . . 1.0900000000000001 110.853 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.58 -51.78 49.82 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.608 -0.806 . . . . 0.29999999999999999 112.263 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.8 -41.98 78.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.756 0.312 . . . . 1.1799999999999999 110.651 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.47 -49.32 74.2 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.712 -0.756 . . . . 0.28000000000000003 112.197 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 60.3 mt -54.83 -50.98 56.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 1.6299999999999999 110.756 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . 0.418 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 80.3 t80 -53.05 -52.31 58.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.077 -0.51 . . . . 2.4100000000000001 110.812 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 63.3 mt -62.26 -45.17 99.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 1.6100000000000001 110.974 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -58.81 -48.66 84.13 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.764 -0.731 . . . . 0.71999999999999997 112.688 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . 0.418 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 6.9 ptp180 -58.91 -18.54 34.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.576 0.227 . . . . 2.4700000000000002 111.376 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -108.19 49.35 0.81 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.914 0.388 . . . . 4.25 110.826 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 18.1 mt -111.39 -82.22 0.58 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 2.1499999999999999 111.141 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 28.3 p . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.154 -0.927 . . . . 2.54 111.188 -179.727 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.591 -0.203 . . . . 7.8200000000000003 112.591 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 154.45 166.7 15.39 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.836 -0.697 . . . . 6.0599999999999996 112.336 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 61.8 mt -70.28 -54.37 18.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.862 0.363 . . . . 7.0599999999999996 110.888 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 159' ' ' ALA . 87.5 m-85 -75.3 -61.08 2.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 5.9500000000000002 110.787 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.8 t 43.49 -90.83 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.942 -0.572 . . . . 5.5499999999999998 111.565 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.61 -52.8 63.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.736 0.303 . . . . 4.21 111.149 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.15 -37.06 71.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.342 -0.39 . . . . 5.3600000000000003 110.994 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -75.21 -55.76 5.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 3.6200000000000001 110.972 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 63.2 mt -62.39 -30.36 71.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 3.54 110.851 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -57.54 -35.02 69.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 3.5699999999999998 110.958 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 29.0 m -125.57 52.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 3.2000000000000002 111.279 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.482 ' CZ ' HD12 ' A' ' 169' ' ' LEU . 62.6 t80 -152.05 -47.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 2.77 111.085 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.481 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 89.4 mt -61.38 -56.97 28.62 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 2.29 111.797 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 11.3 Cg_endo -54.98 -48.38 21.5 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.224 1.949 . . . . 1.3 112.534 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.9 t -52.96 -52.74 57.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.445 -0.343 . . . . 1.8700000000000001 111.169 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.482 HD12 ' CZ ' ' A' ' 165' ' ' PHE . 42.0 mt -62.74 -51.4 67.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.324 -0.398 . . . . 1.4099999999999999 111.569 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 93.0 mt -51.49 -52.17 48.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.475 -0.329 . . . . 1.3300000000000001 111.153 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 83.5 mt -62.22 -42.78 99.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.395 -0.366 . . . . 1.1399999999999999 111.137 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.42 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 72.2 m -62.13 -53.0 61.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.436 -0.347 . . . . 0.39000000000000001 111.491 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.431 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 64.7 m80 -62.62 -53.11 59.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.496 -0.32 . . . . 0.35999999999999999 111.185 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 95.8 mt -57.0 -52.48 65.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.416 -0.356 . . . . 1.1799999999999999 111.098 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 74.3 mt -56.53 -41.44 76.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.404 -0.362 . . . . 1.1499999999999999 110.297 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.428 ' CB ' ' HB1' ' B' ' 176' ' ' ALA . . . -57.61 -48.58 79.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.151 -0.477 . . . . 1.0600000000000001 110.746 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 173' ' ' HIS . 18.2 mm -54.11 -46.35 66.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.934 0.397 . . . . 1.29 110.394 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.31 -42.02 81.47 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.673 -0.775 . . . . 0.29999999999999999 111.882 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 80.6 mt -57.45 -48.78 78.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.8 0.333 . . . . 1.1399999999999999 110.433 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -61.28 -51.78 55.9 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.827 -0.701 . . . . 0.31 112.551 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 56.1 mt -53.89 -48.73 62.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.788 0.328 . . . . 1.5600000000000001 111.136 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.404 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 52.8 t80 -53.74 -49.79 67.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 2.4700000000000002 110.876 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 70.5 mt -63.17 -42.23 95.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.151 -0.477 . . . . 1.4399999999999999 111.385 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.4 -53.11 44.41 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.8 -0.714 . . . . 0.64000000000000001 113.507 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -62.68 -17.26 60.29 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.712 0.264 . . . . 3.0299999999999998 111.712 -179.711 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -86.33 -25.29 25.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.592 0.234 . . . . 4.4299999999999997 111.525 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 14.9 mt -49.81 -61.04 2.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.326 0.584 . . . . 1.8100000000000001 110.788 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.235 -0.888 . . . . 3.6200000000000001 111.131 179.852 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.538 -0.225 . . . . 7.6200000000000001 112.538 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -117.46 174.2 15.12 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.81 -0.71 . . . . 6.9500000000000002 112.435 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 49.5 mt -71.98 -64.91 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 8.1300000000000008 111.088 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -76.93 -76.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 7.2300000000000004 110.762 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 64.3 m 62.49 -83.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 5.6299999999999999 111.462 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.67 80.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.434 -0.348 . . . . 4.6200000000000001 111.644 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -56.6 -30.05 62.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 5.7300000000000004 111.664 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -92.8 -48.99 6.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.79 0.328 . . . . 4.0599999999999996 111.1 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 69.9 mt -63.66 -31.82 73.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.196 -0.456 . . . . 3.73 111.406 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . 0.421 ' O ' ' CG ' ' B' ' 167' ' ' PRO . 16.2 ptpt -56.75 -23.12 40.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.506 -0.316 . . . . 4.2599999999999998 111.175 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 20.3 t -96.77 -18.11 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 3.27 111.465 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . 0.488 ' CE2' HD12 ' B' ' 169' ' ' LEU . 35.3 t80 -89.58 -42.7 11.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.514 -0.312 . . . . 3.1899999999999999 111.477 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.446 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 71.2 mt -57.31 -48.13 97.85 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.485 -0.325 . . . . 2.5299999999999998 111.739 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 78.2 Cg_exo -40.77 -54.73 2.27 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.347 2.031 . . . . 1.4199999999999999 112.638 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.6 m -56.35 -41.7 76.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.065 -0.516 . . . . 1.99 110.967 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.488 HD12 ' CE2' ' B' ' 165' ' ' PHE . 14.4 mt -62.1 -48.06 81.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.314 -0.403 . . . . 1.6899999999999999 111.192 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 8.1 mp -59.62 -49.66 76.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.743 0.306 . . . . 1.3899999999999999 110.761 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 97.8 mt -54.32 -41.74 69.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 1.24 110.663 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 172' ' ' SER . . . . . 0.431 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 59.8 m -59.95 -48.21 82.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.41999999999999998 111.249 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.42 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 68.2 m80 -60.4 -52.08 66.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.37 110.958 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 74.0 mt -61.03 -52.46 64.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.359 . . . . 1.1899999999999999 110.86 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.0 -44.12 97.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 1.21 110.901 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.428 ' HB1' ' CB ' ' A' ' 176' ' ' ALA . . . -52.81 -52.47 56.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.486 . . . . 1.1100000000000001 110.897 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 88.2 mt -55.38 -44.6 76.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.177 -0.465 . . . . 1.0900000000000001 110.285 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.77 -41.84 58.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.531 -0.842 . . . . 0.29999999999999999 111.479 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 80.0 mt -59.2 -48.13 82.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.02 0.438 . . . . 1.1799999999999999 110.288 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.51 -51.17 38.93 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.81 -0.709 . . . . 0.28000000000000003 112.565 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 58.3 mt -57.59 -52.15 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.735 0.302 . . . . 1.6299999999999999 110.946 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -52.6 -50.12 63.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 2.4100000000000001 111.182 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . 0.425 ' O ' ' CD2' ' B' ' 187' ' ' LEU . 57.2 mt -62.75 -52.31 61.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 1.6100000000000001 111.362 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.03 -50.72 64.82 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.983 -0.627 . . . . 0.71999999999999997 113.333 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -11.4 18.27 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.031 0.382 . . . . 2.4700000000000002 112.031 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -103.06 17.09 24.9 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 111.7 0.259 . . . . 4.25 111.7 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . 0.425 ' CD2' ' O ' ' B' ' 183' ' ' ILE . 3.5 mt -113.6 -67.05 1.03 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.242 0.544 . . . . 2.1499999999999999 110.719 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.199 -0.905 . . . . 2.54 111.275 -179.744 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 112.429 -0.268 . . . . 7.8200000000000003 112.429 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 158.68 176.39 30.69 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.794 -0.717 . . . . 6.0599999999999996 112.418 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.0 mp -73.05 -63.75 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 7.0599999999999996 110.532 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.439 ' O ' ' N ' ' A' ' 159' ' ' ALA . 26.7 m-85 -76.67 -55.19 5.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 5.9500000000000002 110.893 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.5 t 42.53 -89.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.992 -0.549 . . . . 5.5499999999999998 111.932 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -57.41 -54.61 44.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.825 0.345 . . . . 4.21 111.458 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -55.47 -49.22 73.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.409 . . . . 5.3600000000000003 110.973 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -66.16 -52.21 50.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.374 -0.376 . . . . 3.6200000000000001 110.964 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 82.8 mt -62.63 -29.89 70.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.013 -0.54 . . . . 3.54 111.087 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -57.53 -34.49 69.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.491 . . . . 3.5699999999999998 111.055 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 30.0 m -113.19 42.07 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.311 -0.404 . . . . 3.2000000000000002 111.149 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.426 ' CZ ' HD12 ' A' ' 169' ' ' LEU . 28.3 t80 -133.01 -55.16 0.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.056 -0.52 . . . . 2.77 110.794 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.505 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 61.2 mt -60.75 -44.66 95.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 2.29 111.484 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 87.5 Cg_exo -46.32 -44.41 20.25 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.422 2.082 . . . . 1.3 112.521 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 36.4 t -69.59 -41.96 75.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 1.8700000000000001 111.048 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.426 HD12 ' CZ ' ' A' ' 165' ' ' PHE . 53.1 mt -61.96 -44.22 97.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 1.4099999999999999 110.669 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 96.8 mt -53.67 -51.29 63.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 1.3300000000000001 110.651 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 83.9 mt -59.06 -45.24 91.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.126 -0.488 . . . . 1.1399999999999999 111.087 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.435 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 69.9 m -53.53 -53.11 56.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.39000000000000001 110.874 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.424 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 74.5 m80 -63.03 -52.12 64.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.35999999999999999 110.939 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.4 mt -54.62 -52.56 61.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 1.1799999999999999 110.932 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.55 -48.92 77.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.315 -0.402 . . . . 1.1499999999999999 111.027 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.429 ' CB ' ' HB2' ' B' ' 176' ' ' ALA . . . -51.92 -52.99 46.11 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.215 -0.448 . . . . 1.0600000000000001 111.165 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.431 HG21 ' CD1' ' A' ' 181' ' ' ILE . 62.8 mt -58.14 -46.85 88.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.411 . . . . 1.29 110.058 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.08 -41.89 53.88 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.671 -0.776 . . . . 0.29999999999999999 111.861 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 99.5 mt -58.94 -49.12 79.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.029 0.442 . . . . 1.1399999999999999 110.458 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.427 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -55.03 -50.69 58.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.764 -0.731 . . . . 0.31 112.876 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.437 HD13 ' CA ' ' B' ' 180' ' ' GLY . 4.0 mp -62.58 -46.01 97.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.802 0.334 . . . . 1.5600000000000001 110.628 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -51.82 -52.73 47.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 2.4700000000000002 110.975 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.76 -45.41 97.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.369 -0.378 . . . . 1.4399999999999999 111.405 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.7 -52.48 50.5 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.928 -0.653 . . . . 0.64000000000000001 113.263 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -19.53 61.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.76 0.314 . . . . 3.0299999999999998 110.98 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -91.86 19.6 6.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.397 -0.365 . . . . 4.4299999999999997 110.988 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 49.8 mt -99.04 -82.74 0.43 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.933 0.397 . . . . 1.8100000000000001 110.74 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.248 -0.882 . . . . 3.6200000000000001 111.087 179.642 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.537 -0.225 . . . . 7.6200000000000001 112.537 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -149.39 -165.35 12.3 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.779 -0.725 . . . . 6.9500000000000002 112.532 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 13.5 mm -69.79 -63.48 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.033 0.444 . . . . 8.1300000000000008 110.916 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.405 ' O ' ' HB3' ' B' ' 158' ' ' SER . 86.1 m-85 -76.85 -66.5 0.81 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.799 -0.637 . . . . 7.2300000000000004 110.689 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' B' ' 157' ' ' PHE . 9.0 t 79.79 -161.59 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.103 -0.498 . . . . 5.6299999999999999 111.067 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -55.32 -25.15 32.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.387 -0.369 . . . . 4.6200000000000001 111.258 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -52.21 -32.24 35.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.385 -0.37 . . . . 5.7300000000000004 110.861 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -85.15 -39.1 18.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.023 -0.535 . . . . 4.0599999999999996 110.559 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 90.7 mt -64.52 -32.88 74.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.936 -0.575 . . . . 3.73 111.169 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -57.22 -31.6 65.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.29 -0.414 . . . . 4.2599999999999998 111.231 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 35.7 m -118.15 41.23 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.427 -0.351 . . . . 3.27 111.495 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -151.68 -53.27 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 3.1899999999999999 111.352 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.465 ' HB2' ' CD ' ' B' ' 167' ' ' PRO . 69.2 mt -60.79 -60.36 10.91 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 112.267 0.469 . . . . 2.5299999999999998 112.267 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.465 ' CD ' ' HB2' ' B' ' 166' ' ' LEU . 5.7 Cg_exo -37.29 -54.16 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.085 2.523 . . . . 1.4199999999999999 113.172 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 45.0 t -54.11 -44.83 71.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.565 -0.289 . . . . 1.99 111.403 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.403 ' CD2' ' CD2' ' A' ' 169' ' ' LEU . 26.6 mt -62.81 -48.37 79.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.009 0.374 . . . . 1.6899999999999999 112.009 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 8.1 mp -54.22 -51.97 62.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.736 0.303 . . . . 1.3899999999999999 111.19 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.4 mt -62.34 -43.88 97.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.358 -0.383 . . . . 1.24 111.143 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 172' ' ' SER . . . . . 0.424 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 75.1 m -58.18 -52.55 65.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.282 -0.417 . . . . 0.41999999999999998 111.635 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.435 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 62.5 m80 -60.78 -52.55 64.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.446 -0.343 . . . . 0.37 111.378 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.5 mt -56.49 -51.4 68.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.408 -0.36 . . . . 1.1899999999999999 111.272 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.38 -46.24 89.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.291 -0.413 . . . . 1.21 111.49 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.429 ' HB2' ' CB ' ' A' ' 176' ' ' ALA . . . -59.62 -53.03 62.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.394 -0.366 . . . . 1.1100000000000001 111.606 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 40.5 mt -62.19 -42.89 96.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.813 0.34 . . . . 1.0900000000000001 110.726 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.34 -51.79 51.93 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.552 -0.832 . . . . 0.29999999999999999 112.194 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 95.5 mt -53.91 -51.23 64.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.787 0.327 . . . . 1.1799999999999999 110.487 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . 0.437 ' CA ' HD13 ' A' ' 181' ' ' ILE . . . -51.29 -42.49 49.77 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.58 -0.819 . . . . 0.28000000000000003 112.422 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.427 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 29.6 mm -59.81 -47.65 90.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.711 0.291 . . . . 1.6299999999999999 110.69 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . 0.408 ' OH ' ' NH1' ' B' ' 186' ' ' ARG . 67.5 t80 -57.19 -52.14 66.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 2.4100000000000001 110.912 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 13.1 mm -62.37 -44.69 99.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 1.6100000000000001 111.201 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.84 -52.21 53.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.833 -0.698 . . . . 0.71999999999999997 113.013 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . 0.428 ' HG3' ' N ' ' B' ' 186' ' ' ARG . 8.1 ptp180 -55.17 -33.44 62.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 2.4700000000000002 111.036 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . 0.428 ' N ' ' HG3' ' B' ' 185' ' ' ARG . 77.5 mtp180 -108.52 57.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.296 -0.411 . . . . 4.25 111.043 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 30.8 mt -98.86 -83.95 0.41 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 2.1499999999999999 111.124 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.185 -0.912 . . . . 2.54 111.229 -179.843 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.553 -0.219 . . . . 7.8200000000000003 112.553 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -93.33 177.79 38.07 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.719 -0.753 . . . . 6.0599999999999996 112.392 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 55.4 mt -70.58 -65.1 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.942 0.401 . . . . 7.0599999999999996 110.69 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -77.51 -70.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.973 -0.558 . . . . 5.9500000000000002 110.745 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.2 t 66.03 -77.47 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.963 -0.562 . . . . 5.5499999999999998 111.394 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.26 -51.8 66.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.107 -0.497 . . . . 4.21 111.572 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -57.5 -57.37 12.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.386 -0.37 . . . . 5.3600000000000003 111.102 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -62.5 -48.57 78.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 3.6200000000000001 111.106 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 77.1 mt -62.64 -33.27 74.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.197 -0.456 . . . . 3.54 111.216 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -58.08 -28.83 64.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.306 -0.406 . . . . 3.5699999999999998 111.253 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.81 37.83 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.445 -0.343 . . . . 3.2000000000000002 111.536 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.465 ' CZ ' HD11 ' A' ' 169' ' ' LEU . 90.5 t80 -139.2 -57.51 0.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.39 . . . . 2.77 111.108 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.495 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 60.8 mt -57.68 -44.8 99.72 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 2.29 111.728 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 63.2 Cg_exo -51.16 -54.06 6.08 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.285 1.99 . . . . 1.3 112.308 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 86.7 p -53.18 -48.78 67.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 1.8700000000000001 111.092 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.465 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 46.8 mt -62.08 -51.93 65.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 1.4099999999999999 110.986 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 88.2 mt -55.42 -50.37 69.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.11 -0.495 . . . . 1.3300000000000001 110.952 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.32 -45.43 84.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 1.1399999999999999 111.151 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.438 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 73.1 m -56.56 -53.23 60.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.872 0.368 . . . . 0.39000000000000001 110.986 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.425 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 77.7 m80 -63.02 -52.36 63.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.35999999999999999 110.949 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.6 mt -58.86 -52.14 67.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 1.1799999999999999 111.147 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 77.1 mt -59.44 -46.93 87.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.39 . . . . 1.1499999999999999 110.788 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.428 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -53.37 -52.24 59.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.262 -0.426 . . . . 1.0600000000000001 110.781 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 86.1 mt -58.69 -41.78 83.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.255 -0.43 . . . . 1.29 110.332 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.96 -45.98 55.8 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.672 -0.775 . . . . 0.29999999999999999 111.943 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 50.9 mt -62.14 -48.05 81.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.835 0.35 . . . . 1.1399999999999999 110.516 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.06 -52.42 47.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.551 -0.833 . . . . 0.31 112.306 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 47.7 mt -60.35 -43.34 93.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.811 0.339 . . . . 1.5600000000000001 111.091 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.412 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 78.5 t80 -53.72 -48.25 69.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.13 -0.486 . . . . 2.4700000000000002 110.659 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.54 -41.55 92.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 1.4399999999999999 111.106 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.09 -44.11 98.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.99 -0.624 . . . . 0.64000000000000001 113.208 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.412 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 10.9 ptp180 -62.44 -39.09 92.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.83 0.315 . . . . 3.0299999999999998 111.581 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.4 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 10.5 ptm180 -69.94 -17.16 63.31 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.656 0.243 . . . . 4.4299999999999997 111.656 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 57.2 mt -52.36 -83.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.887 0.375 . . . . 1.8100000000000001 110.852 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.141 -0.933 . . . . 3.6200000000000001 111.256 179.887 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 112.532 -0.227 . . . . 7.6200000000000001 112.532 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -90.55 -173.15 44.41 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.755 -0.736 . . . . 6.9500000000000002 112.455 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . 0.485 HG23 ' CE2' ' B' ' 157' ' ' PHE . 9.2 mm -69.75 -18.68 22.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.742 0.306 . . . . 8.1300000000000008 111.394 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.485 ' CE2' HG23 ' B' ' 156' ' ' ILE . 87.1 m-85 -160.06 -71.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.888 0.375 . . . . 7.2300000000000004 110.991 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 58.1 m 61.8 -91.91 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.114 -0.494 . . . . 5.6299999999999999 110.885 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.24 -58.35 8.35 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.868 0.366 . . . . 4.6200000000000001 110.953 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -58.03 -21.78 46.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.065 -0.516 . . . . 5.7300000000000004 111.095 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -86.52 -41.09 14.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.383 -0.371 . . . . 4.0599999999999996 111.549 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 20.5 mt -62.41 -36.85 83.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.64 0.257 . . . . 3.73 111.138 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . 0.4 ' HG3' HG22 ' B' ' 164' ' ' VAL . 18.1 ptpt -57.49 -20.7 32.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.517 -0.31 . . . . 4.2599999999999998 111.076 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . 0.4 HG22 ' HG3' ' B' ' 163' ' ' LYS . 66.0 t -108.76 -36.41 3.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.077 0.465 . . . . 3.27 110.568 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . 0.523 ' CZ ' ' CD2' ' B' ' 169' ' ' LEU . 80.5 t80 -56.06 -77.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.657 -0.701 . . . . 3.1899999999999999 111.26 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.485 ' HB2' ' CD ' ' B' ' 167' ' ' PRO . 81.9 mt -38.48 -63.46 0.57 Allowed Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 112.706 0.632 . . . . 2.5299999999999998 112.706 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.485 ' CD ' ' HB2' ' B' ' 166' ' ' LEU . 2.9 Cg_exo -38.17 -55.92 1.11 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.898 2.399 . . . . 1.4199999999999999 113.011 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 48.8 m -60.32 -44.8 95.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.238 -0.437 . . . . 1.99 111.615 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.523 ' CD2' ' CZ ' ' B' ' 165' ' ' PHE . 7.1 mp -62.9 -49.08 76.22 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.238 0.459 . . . . 1.6899999999999999 112.238 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . 0.433 ' CD1' ' O ' ' B' ' 166' ' ' LEU . 7.4 mp -52.01 -50.51 61.21 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.759 -0.377 . . . . 1.3899999999999999 110.661 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 89.9 mt -57.77 -41.57 82.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 1.24 110.462 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 172' ' ' SER . . . . . 0.425 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 63.6 m -54.29 -45.8 72.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.435 . . . . 0.41999999999999998 110.731 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.438 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 77.0 m80 -60.0 -52.29 66.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.454 . . . . 0.37 110.905 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 83.2 mt -57.81 -52.66 64.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.412 . . . . 1.1899999999999999 110.71 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 87.3 mt -62.69 -42.34 99.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.094 -0.503 . . . . 1.21 110.857 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.428 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -52.2 -52.37 52.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 1.1100000000000001 111.352 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 53.9 mt -61.85 -45.59 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.421 . . . . 1.0900000000000001 111.039 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.69 -51.24 53.95 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.565 -0.826 . . . . 0.29999999999999999 112.109 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 94.3 mt -54.46 -47.63 72.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.779 0.323 . . . . 1.1799999999999999 110.349 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.32 -43.41 51.45 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.602 -0.808 . . . . 0.28000000000000003 111.919 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 58.7 mt -58.57 -49.68 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.898 0.38 . . . . 1.6299999999999999 110.456 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . 0.423 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 55.7 t80 -54.88 -50.94 67.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.943 -0.572 . . . . 2.4100000000000001 111.078 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 16.0 mm -62.85 -44.82 99.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.968 0.413 . . . . 1.6100000000000001 111.328 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . 0.433 ' HA2' ' CD1' ' B' ' 187' ' ' LEU . . . -61.28 -50.84 62.64 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.114 -0.565 . . . . 0.71999999999999997 113.203 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . 0.423 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 5.6 ptp180 -51.52 -31.24 23.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.752 0.31 . . . . 2.4700000000000002 111.344 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -98.87 53.68 1.0 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.886 0.374 . . . . 4.25 110.871 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . 0.433 ' CD1' ' HA2' ' B' ' 184' ' ' GLY . 57.9 mt -111.38 -84.45 0.57 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.007 -0.542 . . . . 2.1499999999999999 111.247 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.189 -0.91 . . . . 2.54 111.184 -179.752 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 C--O 1.23 0.109 0 CA-C-O 120.829 0.262 . . . . 0.98 112.276 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.5 m -55.06 -47.79 74.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 1.47 110.895 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.19 -46.61 88.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.73 110.754 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 79.7 mt -52.48 -50.05 63.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.337 -0.392 . . . . 0.63 110.655 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 98.5 mt -57.91 -46.17 85.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.505 . . . . 0.4 110.783 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.441 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 73.0 m -55.11 -53.38 56.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.882 0.373 . . . . 0.23 111.261 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.428 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 77.2 m80 -63.21 -52.78 60.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.29 111.222 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 98.4 mt -59.85 -52.96 63.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.415 -0.357 . . . . 0.47 111.321 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 171' ' ' LEU . 67.6 mt -53.52 -41.81 66.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.035 0.445 . . . . 0.41 110.306 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.547 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -58.24 -44.56 88.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.885 -0.598 . . . . 0.27 110.369 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.423 HD13 ' O ' ' B' ' 176' ' ' ALA . 47.6 mm -55.79 -43.28 73.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.252 -0.431 . . . . 0.62 109.883 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.03 -45.37 92.46 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.718 -0.754 . . . . 0.28 111.823 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 47.8 mt -54.41 -51.36 65.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.852 0.358 . . . . 0.43 110.459 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.57 -43.06 67.61 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.631 -0.795 . . . . 0.29 112.291 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 50.2 mm -61.28 -46.98 95.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.361 . . . . 0.89 110.885 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -56.97 -45.68 82.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 1.56 110.615 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 56.5 mt -62.76 -48.48 87.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.077 -0.51 . . . . 0.83 110.956 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.25 -52.34 50.24 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.929 -0.653 . . . . 0.64 112.92 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -22.62 62.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.73 0.3 . . . . 2.54 111.188 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.356 -0.384 . . . . 3.95 111.205 179.701 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.466 -0.106 0 CA-C-O 120.827 0.261 . . . . 1.07 112.363 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 79.1 p -55.31 -41.99 73.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 1.59 111.198 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 83.2 mt -57.58 -50.74 72.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.367 -0.378 . . . . 1.09 111.331 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.462 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.5 mp -57.66 -44.94 86.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.477 -0.329 . . . . 0.72 111.126 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 93.0 mt -61.91 -41.61 98.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.354 -0.385 . . . . 0.5 110.857 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 172' ' ' SER . . . . . 0.428 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 58.8 m -57.64 -52.34 65.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.31 111.358 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.441 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 73.9 m80 -62.03 -52.72 62.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.332 -0.395 . . . . 0.3 111.1 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 55.4 mt -55.64 -51.47 67.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.43 -0.35 . . . . 0.44 110.976 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 94.2 mt -60.84 -42.02 96.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.362 -0.381 . . . . 0.46 110.772 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.547 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -59.74 -52.9 63.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.25 111.04 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 73.3 mt -53.79 -42.85 54.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.863 0.363 . . . . 0.31 110.059 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.0 -43.55 82.94 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.554 -0.832 . . . . 0.26 111.649 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 94.9 mt -56.5 -50.59 71.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.972 0.415 . . . . 0.47 110.363 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.44 -46.29 81.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.676 -0.774 . . . . 0.27 112.579 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 56.9 mt -55.32 -45.62 77.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.831 0.348 . . . . 0.93 111.05 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.425 ' O ' ' HG2' ' B' ' 185' ' ' ARG . 63.1 t80 -59.58 -51.54 69.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 1.52 110.892 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 61.6 mt -62.26 -44.08 98.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 1.1 111.201 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.31 -46.36 94.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.906 -0.664 . . . . 0.72 113.092 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' B' ' 182' ' ' TYR . 12.6 ptm180 . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.675 0.274 . . . . 2.16 111.403 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo . . . . . 0 C--O 1.231 0.167 0 CA-C-O 120.822 0.259 . . . . 0.98 112.396 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 70.1 m -58.86 -43.73 90.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.298 -0.41 . . . . 1.47 110.955 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 73.0 mt -59.7 -48.7 80.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.73 110.926 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 86.4 mt -52.28 -52.08 54.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.63 110.99 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.5 mt -55.13 -43.11 73.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.4 110.927 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.418 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 75.2 m -55.23 -52.16 64.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.352 -0.385 . . . . 0.23 111.016 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.421 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 73.7 m80 -62.37 -51.12 68.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.29 111.037 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.27 -52.06 66.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.47 111.089 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 84.9 mt -58.66 -44.06 90.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.41 110.952 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.576 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -51.9 -52.19 51.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.421 . . . . 0.27 110.625 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 65.9 mt -54.08 -46.24 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.076 -0.511 . . . . 0.62 110.205 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.58 -42.68 85.02 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.614 -0.803 . . . . 0.28 111.899 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 53.4 mt -55.26 -50.38 69.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.397 . . . . 0.43 110.298 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.521 ' HA2' HD13 ' B' ' 181' ' ' ILE . . . -56.21 -46.05 86.73 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.596 -0.812 . . . . 0.29 112.18 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 39.6 mm -60.58 -48.4 88.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.82 0.343 . . . . 0.89 110.95 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.422 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 52.1 t80 -53.31 -51.94 60.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 1.56 110.982 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.96 -48.81 86.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.295 -0.412 . . . . 0.83 111.471 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.27 -51.48 56.26 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 121.162 -0.542 . . . . 0.64 113.713 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.1 OUTLIER -51.62 -31.79 26.56 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.648 -0.325 . . . . 2.54 111.231 -179.15 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.42 ' NH2' ' OH ' ' A' ' 182' ' ' TYR . 83.3 mtt180 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.461 -0.336 . . . . 3.95 111.233 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.462 -0.348 0 CA-C-O 120.821 0.259 . . . . 1.07 112.654 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 59.0 m -63.18 -43.99 96.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 1.59 111.455 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.411 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 89.3 mt -59.19 -51.46 69.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 1.09 111.462 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.48 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.2 mp -61.89 -49.52 75.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.464 -0.334 . . . . 0.72 111.149 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.76 -41.61 82.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 0.5 110.913 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 172' ' ' SER . . . . . 0.421 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 74.8 m -56.5 -52.95 62.82 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.31 111.117 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.418 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 63.0 m80 -62.57 -52.23 64.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.345 -0.389 . . . . 0.3 110.806 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 97.4 mt -54.14 -52.11 62.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.44 111.095 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.23 -50.97 69.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.46 111.181 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.549 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.17 -52.78 57.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.424 -0.353 . . . . 0.25 111.225 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.576 HG13 ' HB1' ' A' ' 176' ' ' ALA . 62.3 mt -61.94 -41.77 92.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.836 0.35 . . . . 0.31 110.394 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.48 -50.23 48.81 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.585 -0.817 . . . . 0.26 111.836 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 83.8 mt -57.17 -44.84 83.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.901 0.382 . . . . 0.47 110.224 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.02 -46.26 85.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.615 -0.802 . . . . 0.27 112.209 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.521 HD13 ' HA2' ' A' ' 180' ' ' GLY . 34.1 mm -55.76 -50.99 64.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.882 0.372 . . . . 0.93 110.716 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.409 ' O ' ' HG2' ' B' ' 185' ' ' ARG . 50.8 t80 -52.71 -52.18 57.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 1.52 110.891 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 54.0 mt -62.18 -44.13 98.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.02 -0.537 . . . . 1.1 110.994 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.05 -50.39 65.92 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.767 -0.73 . . . . 0.72 112.692 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' B' ' 182' ' ' TYR . 13.7 ptp180 . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.789 0.328 . . . . 2.16 110.864 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 C--O 1.23 0.114 0 CA-C-O 120.756 0.232 . . . . 0.98 112.35 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.8 t -63.9 -49.44 72.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 1.47 110.825 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 45.9 mt -59.46 -45.7 90.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.226 -0.443 . . . . 0.73 110.874 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 86.9 mt -51.79 -50.24 61.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.337 -0.392 . . . . 0.63 110.58 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 93.9 mt -58.89 -41.45 87.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 0.4 110.591 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.479 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 68.9 m -56.45 -52.23 65.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.23 110.777 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.428 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 75.7 m80 -61.39 -51.86 67.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.29 110.723 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.3 mt -58.89 -52.0 67.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.47 110.88 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.0 mt -61.54 -43.35 99.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.41 110.901 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.5 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -52.81 -52.51 56.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.27 110.876 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 71.4 mt -56.91 -43.0 79.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.62 110.307 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.13 -42.03 80.27 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.524 -0.846 . . . . 0.28 111.927 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 45.2 mt -60.0 -51.59 69.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.927 0.394 . . . . 0.43 110.306 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.17 -42.98 56.24 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.602 -0.808 . . . . 0.29 112.395 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.423 HD13 ' O ' ' B' ' 180' ' ' GLY . 49.9 mm -62.06 -51.9 66.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.836 0.351 . . . . 0.89 111.102 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -56.59 -50.64 71.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 1.56 110.813 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.417 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 63.6 mt -60.3 -43.19 93.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.49 . . . . 0.83 111.047 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.2 -48.65 81.36 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.815 -0.707 . . . . 0.64 112.93 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -62.2 -38.1 87.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.593 0.235 . . . . 2.54 111.606 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 183' ' ' ILE . 37.7 ptt180 . . . . . 0 C--N 1.328 -0.34 0 N-CA-C 111.64 0.237 . . . . 3.95 111.64 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo . . . . . 0 C--O 1.231 0.138 0 CA-C-O 120.766 0.236 . . . . 1.07 112.398 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.1 t -46.87 -42.24 17.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.292 -0.413 . . . . 1.59 111.32 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 72.5 mt -62.4 -49.54 75.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 1.09 110.955 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.429 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.5 mp -57.71 -42.31 83.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.72 110.626 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 71.9 mt -59.48 -43.11 93.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.5 110.434 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 172' ' ' SER . . . . . 0.428 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 69.6 m -54.74 -52.09 63.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.31 110.709 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.479 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 60.1 m80 -58.77 -52.29 66.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.049 -0.523 . . . . 0.3 110.882 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 96.5 mt -57.78 -50.32 73.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.41 . . . . 0.44 111.056 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 78.0 mt -62.11 -47.28 85.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.46 110.991 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.5 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -55.15 -52.98 61.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.25 111.076 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.491 HG13 ' HB1' ' A' ' 176' ' ' ALA . 66.1 mt -62.13 -42.84 96.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.359 -0.382 . . . . 0.31 110.609 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.57 -49.86 50.93 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.616 -0.802 . . . . 0.26 111.97 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 89.0 mt -57.91 -46.17 85.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.898 0.38 . . . . 0.47 110.455 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.423 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -56.01 -50.38 61.83 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.547 -0.835 . . . . 0.27 112.191 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 67.4 mt -53.91 -46.93 64.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 0.93 110.849 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.414 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 47.3 t80 -54.45 -51.63 64.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 1.52 110.73 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 69.5 mt -63.27 -48.79 85.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.178 -0.465 . . . . 1.1 111.16 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.29 -52.74 47.37 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.957 -0.64 . . . . 0.72 113.4 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.757 0.278 . . . . 2.16 111.214 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo . . . . . 0 C--O 1.23 0.108 0 CA-C-O 120.806 0.253 . . . . 0.98 112.511 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.6 m -78.01 -51.97 9.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 1.47 111.334 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.08 -50.16 74.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.454 -0.339 . . . . 0.73 111.218 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.402 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 96.2 mt -52.13 -52.41 51.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.417 -0.356 . . . . 0.63 111.1 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.8 mt -62.44 -41.86 99.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.305 -0.407 . . . . 0.4 111.219 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.429 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 69.1 m -60.59 -53.28 59.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.42 -0.354 . . . . 0.23 111.352 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.446 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 66.2 m80 -62.92 -52.58 62.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.745 0.307 . . . . 0.29 110.889 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 170' ' ' LEU . 96.6 mt -57.72 -52.86 63.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.412 -0.358 . . . . 0.47 110.591 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 83.5 mt -62.88 -44.82 95.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.41 110.803 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.426 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -51.53 -52.32 47.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.428 . . . . 0.27 110.933 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.41 -45.03 97.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 0.62 110.477 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.4 -49.5 51.27 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.655 -0.783 . . . . 0.28 111.99 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 43.3 mt -55.58 -49.04 73.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 0.43 110.227 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.473 ' HA2' ' CG1' ' B' ' 181' ' ' ILE . . . -51.77 -46.16 54.64 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.524 -0.846 . . . . 0.29 112.45 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 41.7 mm -62.63 -48.24 89.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.748 0.308 . . . . 0.89 111.192 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.409 ' HA ' ' HG2' ' A' ' 185' ' ' ARG . 55.6 t80 -62.07 -52.21 64.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 1.56 111.242 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 94.6 mt -51.79 -51.1 29.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.286 -0.415 . . . . 0.83 110.986 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.01 -52.56 45.98 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.49 -0.862 . . . . 0.64 112.321 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.45 ' HG3' ' N ' ' A' ' 186' ' ' ARG . 10.9 ptp180 -62.93 -41.78 99.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.956 0.408 . . . . 2.54 110.721 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.45 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 3.95 111.21 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo . . . . . 0 C--O 1.231 0.148 0 CA-C-O 120.838 0.266 . . . . 1.07 112.374 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 74.2 p -54.53 -41.67 69.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 1.59 111.009 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.417 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 59.7 mt -60.8 -52.66 64.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.329 -0.396 . . . . 1.09 111.132 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.1 mp -62.89 -44.59 95.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.756 0.312 . . . . 0.72 110.918 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 94.7 mt -59.95 -43.89 94.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.329 -0.396 . . . . 0.5 110.824 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 172' ' ' SER . . . . . 0.446 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 61.4 m -60.6 -48.97 79.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.31 111.012 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 41.9 m80 -61.42 -52.08 66.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.3 110.917 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 64.7 mt -59.67 -51.54 69.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.39 -0.368 . . . . 0.44 110.845 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.51 -51.99 65.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.46 111.483 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.426 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -51.93 -53.94 35.28 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.758 0.313 . . . . 0.25 111.3 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.418 HG13 ' HB1' ' A' ' 176' ' ' ALA . 67.4 mt -62.97 -44.59 99.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.31 110.703 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.97 -48.01 82.57 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.631 -0.795 . . . . 0.26 112.062 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 88.9 mt -53.96 -48.79 69.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 0.47 110.457 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.17 -48.24 81.39 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.704 -0.76 . . . . 0.27 112.654 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.473 ' CG1' ' HA2' ' A' ' 180' ' ' GLY . 52.5 mt -62.06 -48.82 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.735 0.302 . . . . 0.93 111.521 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.406 ' HA ' ' HG2' ' B' ' 185' ' ' ARG . 88.5 t80 -51.59 -52.25 48.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.321 -0.399 . . . . 1.52 111.297 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 58.6 mt -62.05 -46.65 95.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.321 -0.399 . . . . 1.1 111.203 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.39 -45.51 95.78 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.782 -0.723 . . . . 0.72 113.024 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' B' ' 182' ' ' TYR . 10.0 ptp180 . . . . . 0 C--N 1.329 -0.29 0 N-CA-C 111.685 0.254 . . . . 2.16 111.685 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo . . . . . 0 N--CA 1.464 -0.259 0 CA-C-O 120.806 0.252 . . . . 0.98 112.528 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 53.8 m -48.14 -52.37 20.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 1.47 111.32 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 69.0 mt -61.3 -48.88 79.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.439 . . . . 0.73 111.008 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 89.2 mt -58.56 -49.77 76.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.63 111.077 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.31 -42.1 94.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.4 111.382 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.473 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 67.1 m -56.16 -53.39 57.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.739 0.304 . . . . 0.23 111.193 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.435 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 69.0 m80 -62.96 -51.69 65.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.351 -0.386 . . . . 0.29 110.765 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 95.7 mt -57.83 -51.88 67.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.47 111.241 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.69 -49.46 77.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.41 111.275 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.533 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -51.51 -52.92 42.83 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.854 0.359 . . . . 0.27 111.042 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 68.6 mt -57.45 -44.25 84.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.62 110.243 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.95 -44.01 82.42 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.719 -0.753 . . . . 0.28 111.916 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 75.6 mt -56.17 -52.54 64.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.958 0.409 . . . . 0.43 110.221 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.62 -45.11 68.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.566 -0.826 . . . . 0.29 112.07 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 48.0 mm -60.95 -42.44 92.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 0.89 110.806 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -55.14 -42.21 72.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 1.56 110.662 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.433 ' N ' HD13 ' A' ' 183' ' ' ILE . 3.7 mm -62.87 -52.99 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.83 110.864 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -63.43 -52.86 43.26 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.023 -0.608 . . . . 0.64 113.356 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.28 -26.44 12.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.701 0.286 . . . . 2.54 111.184 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.406 -0.361 . . . . 3.95 110.977 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo . . . . . 0 C--O 1.231 0.161 0 CA-C-O 120.772 0.238 . . . . 1.07 112.25 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 63.5 m -49.75 -44.92 48.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 1.59 110.973 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.42 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 26.0 mt -52.73 -49.45 65.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 1.09 110.673 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.467 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.3 mp -59.96 -44.45 94.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 0.72 110.452 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.17 -41.72 98.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.5 110.605 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 172' ' ' SER . . . . . 0.435 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 72.2 m -54.1 -49.73 68.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.31 110.637 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.473 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 66.9 m80 -60.26 -52.17 66.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.3 110.692 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.41 -52.41 65.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.44 110.994 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 76.6 mt -62.5 -43.83 97.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 0.46 110.937 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.511 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.41 -53.43 51.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.25 110.965 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.533 HG13 ' HB1' ' A' ' 176' ' ' ALA . 41.4 mt -62.64 -44.95 99.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.31 110.413 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.82 -51.15 46.82 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.674 -0.774 . . . . 0.26 111.892 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 97.0 mt -55.12 -42.95 73.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 0.47 110.092 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.23 -42.6 93.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.667 -0.777 . . . . 0.27 112.042 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 41.4 mm -58.18 -52.21 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.729 0.299 . . . . 0.93 110.601 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -51.71 -52.5 47.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 1.52 110.575 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 64.3 mt -62.89 -45.16 99.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.96 -0.564 . . . . 1.1 110.912 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.16 -52.36 50.28 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.979 -0.629 . . . . 0.72 112.999 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.82 0.343 . . . . 2.16 110.87 -179.699 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.464 -0.236 0 CA-C-O 120.775 0.24 . . . . 0.98 112.516 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 79.9 p -65.67 -42.41 91.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 1.47 110.922 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 80.1 mt -60.65 -49.87 75.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.73 110.846 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 95.2 mt -54.88 -51.1 67.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.297 -0.41 . . . . 0.63 110.769 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.5 -41.5 85.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.4 111.042 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.472 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 68.3 m -55.98 -52.88 62.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.76 0.314 . . . . 0.23 111.097 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.451 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 66.6 m80 -62.94 -52.57 62.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.29 110.905 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.0 mt -58.31 -52.23 66.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.47 110.841 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.4 -44.94 95.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.0 -0.546 . . . . 0.41 110.933 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.442 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -52.12 -52.37 52.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.27 110.822 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 68.9 mt -57.31 -42.64 80.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.268 -0.424 . . . . 0.62 110.128 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.3 -41.43 87.1 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.788 -0.72 . . . . 0.28 111.755 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 76.8 mt -59.45 -49.26 78.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.949 0.404 . . . . 0.43 110.199 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.8 -47.36 65.41 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.671 -0.776 . . . . 0.29 112.072 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.431 HD13 ' O ' ' B' ' 180' ' ' GLY . 32.6 mm -56.25 -46.45 81.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 0.89 110.841 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.409 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 88.8 t80 -57.59 -49.45 76.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 1.56 110.989 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 54.7 mt -62.78 -43.83 99.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.23 -0.441 . . . . 0.83 111.353 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.34 -52.21 51.02 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.039 -0.601 . . . . 0.64 113.469 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -61.34 -20.78 63.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.767 0.284 . . . . 2.54 111.395 -179.373 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 28.4 mmt180 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.576 -0.284 . . . . 3.95 111.676 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 N--CA 1.463 -0.278 0 CA-C-O 120.783 0.243 . . . . 1.07 112.383 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 91.5 p -54.36 -42.8 70.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 1.59 110.87 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.406 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 81.8 mt -58.78 -49.6 77.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 1.09 110.643 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.468 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.0 mp -62.17 -47.11 85.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.046 -0.525 . . . . 0.72 110.724 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 79.6 mt -59.65 -43.63 93.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.5 110.822 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 172' ' ' SER . . . . . 0.451 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 75.6 m -54.24 -50.2 67.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.269 -0.423 . . . . 0.31 110.607 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.472 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 56.6 m80 -62.26 -52.47 63.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.3 110.931 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 89.2 mt -58.62 -52.49 65.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.373 -0.376 . . . . 0.44 111.083 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 64.7 mt -62.3 -46.15 90.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.46 111.051 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.49 -53.02 57.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 0.25 110.907 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.434 HG13 ' HB1' ' A' ' 176' ' ' ALA . 72.6 mt -62.22 -42.02 93.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.188 -0.46 . . . . 0.31 110.533 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.06 -45.44 92.44 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.565 -0.826 . . . . 0.26 111.951 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.93 -46.0 85.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 0.47 110.236 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.431 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -54.62 -44.38 79.12 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.584 -0.817 . . . . 0.27 112.183 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 60.3 mt -60.91 -46.88 95.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.721 0.296 . . . . 0.93 111.034 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -55.58 -47.46 76.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 1.52 111.083 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 59.4 mt -61.25 -50.37 80.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 1.1 111.07 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -58.15 -51.29 59.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.83 -0.7 . . . . 0.72 112.712 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 . . . . . 0 C--N 1.33 -0.25 0 CA-C-O 120.701 0.286 . . . . 2.16 111.285 -179.617 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo . . . . . 0 C--O 1.23 0.119 0 CA-C-O 120.771 0.238 . . . . 0.98 112.329 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.5 t -74.21 -52.82 11.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 1.47 110.911 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 60.2 mt -62.61 -46.27 89.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.73 110.914 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.79 -52.36 49.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.27 -0.423 . . . . 0.63 110.635 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.4 mt -57.67 -43.66 85.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.243 -0.435 . . . . 0.4 110.745 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.426 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 75.6 m -57.51 -52.79 63.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.23 110.706 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.451 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 64.9 m80 -62.87 -51.89 65.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.29 110.746 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.49 -52.3 66.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 0.47 111.109 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 81.8 mt -53.71 -50.82 65.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.465 -0.334 . . . . 0.41 110.781 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.575 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -53.36 -52.28 59.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.27 110.697 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 81.4 mt -58.43 -42.86 85.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.62 110.232 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.0 -43.77 55.84 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.627 -0.797 . . . . 0.28 111.796 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.0 -43.27 99.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.007 0.432 . . . . 0.43 109.914 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -61.13 -45.59 96.25 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.657 -0.783 . . . . 0.29 112.137 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 48.7 mm -60.33 -46.04 95.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.891 0.377 . . . . 0.89 110.924 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.408 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 51.1 t80 -54.52 -50.2 68.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.063 -0.517 . . . . 1.56 110.844 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.79 -47.17 94.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.171 -0.468 . . . . 0.83 111.224 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.42 -52.69 47.41 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.818 -0.706 . . . . 0.64 112.969 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.1 OUTLIER -61.93 -15.48 43.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.563 0.221 . . . . 2.54 111.329 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.68 0.276 . . . . 3.95 110.984 179.645 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo . . . . . 0 C--O 1.231 0.129 0 N-CA-C 112.782 0.262 . . . . 1.07 112.782 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 67.3 m -50.45 -43.28 55.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.431 -0.35 . . . . 1.59 111.071 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.13 -44.07 97.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.301 -0.409 . . . . 1.09 111.249 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.434 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.7 mp -60.74 -50.11 74.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.72 110.776 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 89.2 mt -53.65 -42.69 68.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.5 110.903 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 172' ' ' SER . . . . . 0.451 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 74.7 m -58.44 -49.59 76.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.196 -0.456 . . . . 0.31 110.998 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.426 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 66.5 m80 -58.72 -52.61 64.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.3 111.101 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 82.5 mt -59.91 -52.46 65.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.369 -0.378 . . . . 0.44 111.13 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.58 -42.56 99.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 0.46 110.952 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.539 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -52.39 -52.76 51.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 0.25 111.338 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.575 HG13 ' HB1' ' A' ' 176' ' ' ALA . 31.6 mt -61.43 -42.64 94.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 0.31 110.628 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.46 -49.95 54.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.536 -0.84 . . . . 0.26 111.787 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 77.0 mt -55.86 -46.1 78.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 0.47 110.272 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.96 -41.89 69.18 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.639 -0.791 . . . . 0.27 112.019 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 41.9 mm -59.8 -52.13 64.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.866 0.365 . . . . 0.93 110.835 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.425 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 47.9 t80 -54.96 -50.82 67.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 1.52 110.803 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 57.1 mt -62.01 -45.98 97.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 1.1 111.322 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -56.01 -49.82 64.99 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.825 -0.703 . . . . 0.72 112.481 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.425 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 10.6 ptp180 . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 120.55 0.214 . . . . 2.16 111.255 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo . . . . . 0 N--CA 1.466 -0.138 0 CA-C-O 120.845 0.269 . . . . 0.98 112.435 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 49.6 m -60.78 -45.7 93.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 1.47 111.216 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 26.0 mt -58.99 -46.23 88.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.389 -0.369 . . . . 0.73 111.12 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 65.6 mt -54.36 -52.06 62.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.329 -0.396 . . . . 0.63 110.639 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 86.9 mt -57.76 -43.89 85.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.4 110.688 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.446 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 58.2 m -56.1 -52.54 63.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.23 110.811 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.427 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 80.8 m80 -62.6 -52.09 64.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.29 110.978 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.9 mt -58.02 -52.53 65.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.361 -0.382 . . . . 0.47 110.951 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.4 mt -56.69 -45.49 81.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.299 -0.41 . . . . 0.41 110.832 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.523 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -56.49 -52.32 65.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 0.27 110.904 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 75.7 mt -57.83 -42.98 83.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.62 110.648 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.51 -45.06 67.54 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.697 -0.763 . . . . 0.28 112.255 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 79.5 mt -61.98 -49.8 74.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.836 0.35 . . . . 0.43 110.525 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.449 ' CA ' HG13 ' B' ' 181' ' ' ILE . . . -55.96 -51.76 53.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.727 -0.749 . . . . 0.29 112.595 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.411 HG12 ' O ' ' B' ' 180' ' ' GLY . 47.7 mt -59.19 -43.62 89.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.786 0.327 . . . . 0.89 111.172 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.444 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 34.1 t80 -53.75 -47.88 70.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.026 0.441 . . . . 1.56 110.577 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 72.9 mt -62.78 -48.0 90.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.069 -0.514 . . . . 0.83 111.099 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.06 -46.35 94.73 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.93 -0.652 . . . . 0.64 112.967 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 11.2 ptm180 -61.8 -28.69 69.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.029 0.442 . . . . 2.54 110.851 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 115.6 -0.727 . . . . 3.95 111.583 -179.512 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 0 N--CA 1.466 -0.137 0 N-CA-C 112.727 0.241 . . . . 1.07 112.727 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 48.7 m -51.53 -42.41 61.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.901 0.381 . . . . 1.59 110.767 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 65.7 mt -62.31 -46.91 86.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 1.09 111.016 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.409 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.4 mp -59.52 -49.1 79.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.423 -0.353 . . . . 0.72 110.571 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 85.3 mt -52.56 -41.81 63.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.42 . . . . 0.5 110.387 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 172' ' ' SER . . . . . 0.427 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 58.5 m -60.51 -51.81 67.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.52 . . . . 0.31 110.597 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.446 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 54.8 m80 -61.52 -51.95 66.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.122 -0.49 . . . . 0.3 110.809 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 93.1 mt -59.77 -52.23 66.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.33 -0.396 . . . . 0.44 110.794 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.23 -43.91 97.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.46 110.976 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.523 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -51.95 -52.47 50.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.25 111.074 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.514 HG13 ' HB1' ' A' ' 176' ' ' ALA . 52.3 mt -61.99 -46.78 95.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.434 -0.348 . . . . 0.31 110.591 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.23 -47.15 76.25 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.624 -0.798 . . . . 0.26 111.858 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 93.4 mt -54.23 -49.49 69.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.47 110.491 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.411 ' O ' HG12 ' A' ' 181' ' ' ILE . . . -56.41 -44.43 89.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.554 -0.831 . . . . 0.27 112.142 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.449 HG13 ' CA ' ' A' ' 180' ' ' GLY . 66.3 mt -61.43 -52.44 61.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.809 0.338 . . . . 0.93 110.791 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.416 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 46.5 t80 -56.7 -51.99 66.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.023 -0.535 . . . . 1.52 110.964 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 62.6 mt -62.39 -48.58 87.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.397 -0.365 . . . . 1.1 110.832 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.68 -52.36 48.82 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.839 -0.696 . . . . 0.72 112.973 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.416 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 1.4 ptp180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.634 0.254 . . . . 2.16 111.521 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo . . . . . 0 C--O 1.231 0.135 0 CA-C-O 120.906 0.294 . . . . 0.98 112.505 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.6 t -51.03 -51.94 48.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.456 . . . . 1.47 111.118 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 39.8 mt -59.68 -51.35 70.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.365 -0.38 . . . . 0.73 110.912 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 91.7 mt -53.63 -49.59 67.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.63 110.75 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 97.2 mt -62.09 -43.0 99.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.4 110.921 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.429 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 69.3 m -57.3 -52.61 64.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.23 111.019 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.408 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 65.4 m80 -62.78 -52.52 62.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 0.29 111.242 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.8 mt -61.28 -52.1 66.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 0.47 111.354 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 171' ' ' LEU . 81.5 mt -57.49 -46.44 83.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.35 -0.386 . . . . 0.41 111.14 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.635 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -54.48 -52.57 61.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.927 0.394 . . . . 0.27 110.907 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.4 ' O ' HG12 ' A' ' 181' ' ' ILE . 68.9 mt -58.01 -43.87 85.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.244 -0.435 . . . . 0.62 110.336 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.68 -47.08 65.45 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.495 -0.86 . . . . 0.28 111.923 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 70.0 mt -55.82 -50.1 71.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.381 . . . . 0.43 110.398 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.446 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -54.74 -43.29 80.07 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.561 -0.828 . . . . 0.29 112.354 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 177' ' ' ILE . 40.7 mm -62.38 -49.2 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.912 0.387 . . . . 0.89 111.101 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.413 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 51.1 t80 -56.74 -50.4 72.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.952 -0.567 . . . . 1.56 111.343 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.414 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 58.3 mt -59.87 -46.36 93.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.83 111.305 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.19 -47.98 86.01 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.775 -0.726 . . . . 0.64 112.899 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 11.6 ptp180 -58.78 -28.88 66.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.661 0.267 . . . . 2.54 111.108 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 183' ' ' ILE . 34.4 ptt180 . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.372 . . . . 3.95 110.853 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.463 -0.281 0 N-CA-C 112.852 0.289 . . . . 1.07 112.852 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 48.1 t -79.91 -44.8 19.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.865 0.364 . . . . 1.59 111.258 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 59.6 mt -62.31 -45.77 91.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 1.09 111.396 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.48 -51.67 68.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.324 -0.398 . . . . 0.72 111.247 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 92.8 mt -58.56 -41.71 86.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.385 -0.37 . . . . 0.5 111.05 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 172' ' ' SER . . . . . 0.408 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 68.9 m -54.04 -52.32 61.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.31 111.382 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 62.9 m80 -61.55 -52.53 64.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.383 -0.371 . . . . 0.3 111.324 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 80.1 mt -55.74 -52.72 62.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.44 110.922 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.91 -47.41 83.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.114 -0.494 . . . . 0.46 111.362 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.576 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -55.09 -53.32 57.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.25 111.751 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.635 HG13 ' HB1' ' A' ' 176' ' ' ALA . 53.4 mt -62.58 -43.29 98.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 0.31 110.862 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.28 -47.99 83.68 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.611 -0.804 . . . . 0.26 112.126 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.413 ' O ' HD12 ' B' ' 183' ' ' ILE . 93.6 mt -55.14 -51.85 65.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.759 0.314 . . . . 0.47 110.583 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.47 -41.82 49.58 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.613 -0.803 . . . . 0.27 112.017 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.446 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 27.2 mm -59.43 -48.88 85.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.755 0.312 . . . . 0.93 110.624 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -51.68 -52.51 47.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 1.52 111.269 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 183' ' ' ILE . . . . . 0.542 ' H ' HD12 ' B' ' 183' ' ' ILE . 4.0 mp -63.57 -52.47 57.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.451 -0.341 . . . . 1.1 111.228 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.47 -52.57 48.11 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.905 -0.664 . . . . 0.72 113.469 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.437 ' CG ' ' O ' ' B' ' 181' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.546 0.213 . . . . 2.16 111.515 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo . . . . . 0 C--O 1.23 0.12 0 CA-C-O 120.78 0.242 . . . . 0.98 111.951 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.4 t -47.73 -47.47 30.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.28 -0.418 . . . . 1.47 110.992 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.415 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 29.3 mt -61.99 -51.32 68.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.73 110.724 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 87.6 mt -57.79 -51.94 67.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.63 110.634 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 95.2 mt -53.05 -47.13 68.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.4 110.484 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.42 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 70.3 m -51.96 -51.96 53.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.035 -0.529 . . . . 0.23 110.831 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.46 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 58.3 m80 -61.51 -52.33 64.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.29 110.749 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 84.9 mt -57.19 -50.67 72.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.47 111.003 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.9 mt -59.78 -44.8 93.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.41 110.811 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.469 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -57.34 -52.68 64.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.429 . . . . 0.27 110.716 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.408 ' O ' HG12 ' A' ' 181' ' ' ILE . 71.0 mt -58.99 -42.66 86.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.48 . . . . 0.62 110.332 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.7 -43.15 53.52 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.587 -0.816 . . . . 0.28 111.796 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.02 -47.7 83.59 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.736 -0.468 . . . . 0.43 109.736 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -58.44 -49.23 78.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 0.29 112.224 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 177' ' ' ILE . 35.2 mm -53.27 -45.95 56.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.763 0.316 . . . . 0.89 110.88 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -58.4 -44.3 88.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 1.56 110.993 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 72.4 mt -62.7 -48.92 85.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.395 -0.366 . . . . 0.83 111.199 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.15 -52.11 52.1 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.927 -0.654 . . . . 0.64 112.846 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.427 ' HD3' ' N ' ' A' ' 186' ' ' ARG . 0.0 OUTLIER -60.56 -28.1 68.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.789 0.328 . . . . 2.54 110.97 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.427 ' N ' ' HD3' ' A' ' 185' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 3.95 110.713 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 C--O 1.231 0.158 0 CA-C-O 120.703 0.21 . . . . 1.07 112.414 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 51.7 m -62.26 -41.57 98.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.333 -0.394 . . . . 1.59 110.787 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.411 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 78.2 mt -60.39 -45.06 94.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 1.09 110.927 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.493 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.1 mp -62.34 -50.95 69.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.72 110.836 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.6 mt -58.15 -41.54 83.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.5 110.599 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 172' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 73.0 m -55.02 -52.19 63.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.031 -0.531 . . . . 0.31 111.1 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.42 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 71.6 m80 -60.58 -52.53 64.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.3 111.139 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 87.8 mt -59.98 -52.49 65.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.339 -0.392 . . . . 0.44 111.019 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.69 -42.88 99.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.134 -0.485 . . . . 0.46 111.021 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.469 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.04 -52.57 58.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.25 111.478 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.465 HG13 ' HB1' ' A' ' 176' ' ' ALA . 53.1 mt -62.23 -41.86 93.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.358 . . . . 0.31 110.9 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.08 -49.9 68.36 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.71 -0.757 . . . . 0.26 112.387 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 83.1 mt -58.47 -42.38 87.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.47 110.668 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.405 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -55.7 -49.88 63.54 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.723 -0.751 . . . . 0.27 112.36 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 55.7 mt -57.97 -45.15 87.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.859 0.362 . . . . 0.93 110.959 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -53.32 -50.9 64.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 1.52 110.693 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 64.5 mt -62.3 -41.97 93.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.031 -0.531 . . . . 1.1 111.136 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.91 -49.07 79.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.904 -0.665 . . . . 0.72 112.842 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.706 0.289 . . . . 2.16 111.373 -179.594 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 N--CA 1.463 -0.274 0 CA-C-O 120.865 0.277 . . . . 0.98 112.298 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.1 t -56.77 -42.74 79.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 1.47 110.57 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.61 -51.49 68.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.962 -0.563 . . . . 0.73 110.782 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 85.9 mt -52.57 -48.7 66.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.985 -0.552 . . . . 0.63 110.823 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 97.9 mt -55.97 -42.87 76.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.322 -0.399 . . . . 0.4 110.764 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.479 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 67.9 m -57.21 -52.47 65.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.23 110.871 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.417 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 73.0 m80 -62.2 -52.27 64.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.29 110.87 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.8 mt -59.0 -51.64 69.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.066 -0.516 . . . . 0.47 111.005 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 171' ' ' LEU . 85.1 mt -60.56 -42.41 96.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.41 111.008 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.623 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -56.06 -52.36 64.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.995 0.426 . . . . 0.27 110.875 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.45 -41.52 81.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.551 . . . . 0.62 110.469 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.04 -44.58 83.27 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.772 -0.728 . . . . 0.28 112.129 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 70.8 mt -61.06 -47.11 87.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.949 0.404 . . . . 0.43 110.355 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.445 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -52.68 -52.42 38.36 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.676 -0.773 . . . . 0.29 112.587 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 39.3 mt -61.96 -42.88 96.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 0.89 111.032 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.425 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 83.5 t80 -51.9 -52.08 52.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.016 0.436 . . . . 1.56 110.695 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 65.8 mt -63.5 -48.03 88.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.133 -0.485 . . . . 0.83 111.203 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.78 -52.85 45.4 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.983 -0.627 . . . . 0.64 113.692 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -54.98 -24.41 23.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.866 0.333 . . . . 2.54 110.801 -179.292 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 18.7 mtp-105 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 3.95 110.865 179.485 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 N--CA 1.462 -0.326 0 CA-C-O 120.74 0.225 . . . . 1.07 112.633 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 66.3 m -53.22 -44.13 67.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 1.59 111.08 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.413 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 84.5 mt -54.6 -51.13 66.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.28 -0.418 . . . . 1.09 111.177 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.452 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.4 mp -62.17 -46.14 90.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.387 -0.37 . . . . 0.72 110.854 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.3 -42.65 91.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.336 -0.393 . . . . 0.5 110.847 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 172' ' ' SER . . . . . 0.417 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 68.3 m -56.87 -52.21 66.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.483 . . . . 0.31 111.005 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.479 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 66.8 m80 -62.54 -52.6 62.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.3 111.289 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.78 -52.56 64.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.359 . . . . 0.44 111.24 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 69.4 mt -62.46 -43.32 99.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.316 -0.402 . . . . 0.46 111.032 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.549 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -58.36 -52.7 64.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.25 111.142 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.623 HG13 ' HB1' ' A' ' 176' ' ' ALA . 82.7 mt -60.07 -42.34 89.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.428 -0.351 . . . . 0.31 110.418 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.57 -49.75 59.86 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.564 -0.827 . . . . 0.26 111.97 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 88.7 mt -56.25 -46.76 79.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.47 110.397 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.03 -42.98 55.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.526 -0.845 . . . . 0.27 111.812 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.445 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 17.7 mm -60.05 -51.87 67.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.836 0.35 . . . . 0.93 110.611 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.436 ' HA ' ' HG2' ' B' ' 185' ' ' ARG . 51.0 t80 -51.3 -49.48 61.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.792 -0.64 . . . . 1.52 111.224 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 61.1 mt -58.73 -52.45 59.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.212 -0.449 . . . . 1.1 111.324 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.0 -52.38 53.72 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.882 -0.675 . . . . 0.72 113.098 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' B' ' 182' ' ' TYR . 6.1 ptp180 . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.366 . . . . 2.16 111.141 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo . . . . . 0 C--O 1.231 0.175 0 CA-C-O 120.808 0.253 . . . . 0.98 111.515 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 60.3 m -50.23 -48.96 54.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 1.47 110.68 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 78.1 mt -54.71 -50.7 67.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.507 . . . . 0.73 110.173 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.31 -42.92 96.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.05 -0.523 . . . . 0.63 110.208 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 76.5 mt -62.17 -41.27 98.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.961 -0.563 . . . . 0.4 110.635 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.428 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 73.6 m -55.85 -52.72 63.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.359 -0.382 . . . . 0.23 110.855 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.437 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 73.3 m80 -62.6 -52.09 64.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.29 110.929 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.5 mt -59.88 -52.55 64.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.226 -0.443 . . . . 0.47 111.21 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 75.0 mt -56.2 -46.02 79.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.41 110.542 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.504 ' HB3' ' HB1' ' B' ' 176' ' ' ALA . . . -52.41 -52.01 56.08 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.142 -0.481 . . . . 0.27 110.15 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 69.1 mt -58.85 -42.56 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 115.975 -0.557 . . . . 0.62 109.81 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.23 -43.65 64.18 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.654 -0.784 . . . . 0.28 111.724 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 78.5 mt -60.21 -46.01 91.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.95 0.405 . . . . 0.43 110.115 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -58.59 -43.59 96.04 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.554 -0.832 . . . . 0.29 112.029 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 45.6 mm -58.31 -44.41 88.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.899 0.381 . . . . 0.89 110.749 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.4 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 76.8 t80 -60.03 -49.54 77.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 1.56 110.741 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 57.9 mt -62.23 -48.92 86.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.83 111.31 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.2 -52.67 51.35 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.768 -0.729 . . . . 0.64 113.046 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.12 -17.93 59.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.707 0.289 . . . . 2.54 111.224 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 28.5 mmt180 . . . . . 0 CA--C 1.532 0.258 0 CA-C-N 116.544 -0.298 . . . . 3.95 111.417 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.835 0.264 . . . . 1.07 112.176 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.5 t -50.87 -42.29 58.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 1.59 110.98 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.414 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 46.0 mt -54.13 -50.68 66.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.435 . . . . 1.09 110.68 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.48 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.0 mp -61.14 -44.12 97.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.72 110.386 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.05 -41.56 98.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.5 110.279 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 172' ' ' SER . . . . . 0.437 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 73.6 m -55.06 -44.24 74.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.081 -0.509 . . . . 0.31 110.502 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.428 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 68.7 m80 -61.74 -52.54 63.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.3 110.846 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 94.4 mt -58.44 -52.56 65.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.862 0.363 . . . . 0.44 110.723 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.8 -42.2 99.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.073 -0.512 . . . . 0.46 111.204 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' A' ' 176' ' ' ALA . . . -59.11 -52.46 65.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.426 . . . . 0.25 111.573 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.441 HG13 ' HB1' ' A' ' 176' ' ' ALA . 87.0 mt -56.97 -45.54 83.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 0.31 110.648 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.8 -45.89 77.85 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.511 -0.852 . . . . 0.26 111.855 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 95.8 mt -55.78 -46.26 78.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.942 0.401 . . . . 0.47 110.143 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.15 -41.62 79.1 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.744 -0.741 . . . . 0.27 112.051 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 53.4 mt -61.11 -46.86 95.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.878 0.371 . . . . 0.93 110.803 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.431 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 89.0 t80 -59.7 -46.92 87.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.05 -0.523 . . . . 1.52 110.963 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 47.8 mt -62.99 -47.71 91.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.326 -0.397 . . . . 1.1 111.511 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.09 -51.92 50.57 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 121.284 -0.484 . . . . 0.72 113.624 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.388 0 CA-C-O 120.788 0.328 . . . . 2.16 111.366 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo . . . . . 0 C--O 1.231 0.155 0 CA-C-O 120.803 0.251 . . . . 0.98 112.237 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 57.7 m -53.69 -42.26 67.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 1.47 110.841 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.41 -51.01 69.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.73 110.915 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 89.5 mt -55.33 -48.57 73.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.63 110.905 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.9 mt -59.07 -42.72 91.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.4 111.082 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.484 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 67.9 m -55.97 -53.1 60.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.311 -0.404 . . . . 0.23 111.025 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.411 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 70.8 m80 -62.77 -52.5 62.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.29 110.832 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 78.9 mt -57.83 -51.72 68.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.47 111.309 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 73.9 mt -60.77 -45.54 93.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.367 -0.379 . . . . 0.41 111.175 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.474 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -56.1 -52.7 63.36 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.017 0.437 . . . . 0.27 110.67 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.407 ' O ' HG12 ' A' ' 181' ' ' ILE . 63.2 mt -59.55 -42.49 88.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.128 -0.487 . . . . 0.62 109.861 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.78 -42.06 52.14 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.639 -0.791 . . . . 0.28 111.553 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 83.7 mt -61.35 -46.2 91.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.075 0.464 . . . . 0.43 109.751 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -61.55 -44.08 98.45 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.643 -0.789 . . . . 0.29 112.291 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 177' ' ' ILE . 47.5 mm -60.81 -51.32 74.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.331 . . . . 0.89 110.958 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.415 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 81.1 t80 -51.85 -52.21 51.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 1.56 110.747 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.413 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 54.8 mt -62.53 -41.91 93.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.204 -0.453 . . . . 0.83 111.312 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.74 -44.92 97.37 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.957 -0.639 . . . . 0.64 113.347 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 8.0 ptp180 -61.18 -32.64 72.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.894 0.347 . . . . 2.54 111.384 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 183' ' ' ILE . 36.8 ptt180 . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.654 0.264 . . . . 3.95 111.144 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.69 0.204 . . . . 1.07 112.456 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 35.4 t -65.41 -45.96 81.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.417 -0.356 . . . . 1.59 110.943 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 55.3 mt -54.86 -48.71 72.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 1.09 110.786 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.436 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.6 mp -57.87 -50.33 73.7 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.199 -0.455 . . . . 0.72 110.631 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 61.6 mt -59.05 -41.48 87.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.485 . . . . 0.5 110.651 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 172' ' ' SER . . . . . 0.411 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 73.5 m -51.93 -50.32 61.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.31 110.889 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.484 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 60.6 m80 -61.18 -52.32 65.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.3 111.181 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 98.0 mt -60.91 -52.35 65.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.361 -0.381 . . . . 0.44 111.002 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.28 -43.73 98.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.46 111.039 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.474 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.41 -52.35 59.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.25 111.342 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.43 HG13 ' HB1' ' A' ' 176' ' ' ALA . 60.4 mt -60.95 -47.76 92.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.426 -0.352 . . . . 0.31 110.918 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.28 -51.1 43.87 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.639 -0.791 . . . . 0.26 112.164 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 97.3 mt -55.25 -46.86 76.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.973 0.416 . . . . 0.47 110.796 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.96 -42.9 82.08 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.669 -0.777 . . . . 0.27 112.545 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 58.2 mt -61.89 -51.1 76.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 0.93 111.019 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.405 ' O ' ' HG2' ' B' ' 185' ' ' ARG . 29.1 t80 -58.67 -49.85 76.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 1.52 110.812 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 73.7 mt -61.93 -46.02 97.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 1.1 111.101 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -58.88 -49.54 77.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.639 -0.791 . . . . 0.72 112.415 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' B' ' 182' ' ' TYR . 12.2 ptm180 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.781 0.324 . . . . 2.16 111.08 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 C--O 1.23 0.121 0 CA-C-O 120.747 0.228 . . . . 0.98 112.406 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 65.9 m -51.14 -50.73 58.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.265 -0.425 . . . . 1.47 110.839 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 85.5 mt -61.78 -51.91 66.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.151 -0.477 . . . . 0.73 111.005 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 83.7 mt -52.88 -51.45 61.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.27 -0.423 . . . . 0.63 110.987 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 79.3 mt -58.28 -42.32 86.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.339 -0.391 . . . . 0.4 111.011 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 65.2 m -59.7 -52.13 66.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.23 111.002 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.425 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 74.8 m80 -60.44 -51.83 67.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.29 111.02 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.3 mt -57.02 -52.25 66.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 0.47 111.12 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 74.1 mt -58.12 -49.46 76.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.41 111.137 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.579 ' HB3' ' HB1' ' B' ' 176' ' ' ALA . . . -51.34 -52.24 47.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.935 0.398 . . . . 0.27 110.673 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 70.6 mt -59.2 -41.97 85.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 0.62 110.13 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.66 -46.05 89.64 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.666 -0.778 . . . . 0.28 111.834 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 44.4 mt -55.71 -47.82 76.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.004 0.43 . . . . 0.43 110.077 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.444 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -55.18 -43.75 83.87 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.792 -0.718 . . . . 0.29 112.339 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 49.4 mm -58.34 -52.28 61.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.837 0.351 . . . . 0.89 111.068 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -53.95 -48.25 70.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 1.56 110.784 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.412 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 68.7 mt -62.1 -42.62 95.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.83 111.191 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.5 -47.14 91.59 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.867 -0.682 . . . . 0.64 112.984 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.436 ' HG3' ' N ' ' A' ' 186' ' ' ARG . 13.5 ptp180 -62.18 -40.8 97.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.552 0.215 . . . . 2.54 111.407 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.436 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 15.9 ptm180 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.654 -0.248 . . . . 3.95 111.46 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo . . . . . 0 N--CA 1.466 -0.141 0 CA-C-O 120.881 0.284 . . . . 1.07 112.564 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 42.5 t -57.86 -41.51 82.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.164 -0.471 . . . . 1.59 111.098 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.416 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 27.2 mt -59.24 -51.23 70.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.317 -0.401 . . . . 1.09 111.364 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.423 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.7 mp -59.86 -49.01 79.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.738 0.304 . . . . 0.72 110.972 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.99 -41.49 98.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 0.5 110.904 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 172' ' ' SER . . . . . 0.425 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 73.0 m -57.95 -52.35 65.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.31 111.37 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 60.9 m80 -62.24 -52.45 63.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.333 -0.394 . . . . 0.3 111.358 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 97.5 mt -54.77 -53.07 59.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.921 0.391 . . . . 0.44 110.703 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.37 -49.33 74.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.962 -0.563 . . . . 0.46 110.993 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.579 ' HB1' ' HB3' ' A' ' 176' ' ' ALA . . . -51.74 -52.58 47.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.0 -0.546 . . . . 0.25 111.635 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.553 HG13 ' HB1' ' A' ' 176' ' ' ALA . 70.7 mt -62.04 -46.66 95.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.919 0.39 . . . . 0.31 110.668 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.16 -46.46 91.56 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.598 -0.81 . . . . 0.26 111.963 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 94.4 mt -55.24 -46.06 76.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.987 0.422 . . . . 0.47 110.212 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.14 -42.18 80.85 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.644 -0.789 . . . . 0.27 111.777 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.444 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 40.4 mm -58.0 -50.73 76.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.883 0.373 . . . . 0.93 110.589 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -58.66 -49.76 76.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.008 -0.542 . . . . 1.52 111.237 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 50.4 mt -59.59 -51.34 73.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.367 -0.379 . . . . 1.1 111.335 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.37 -52.24 50.74 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.755 -0.736 . . . . 0.72 112.866 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.419 ' CG ' ' O ' ' B' ' 181' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 N-CA-C 111.667 0.247 . . . . 2.16 111.667 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.809 0.254 . . . . 0.98 112.048 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.2 t -59.29 -43.81 92.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 1.47 110.904 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 65.3 mt -59.4 -50.15 75.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.514 . . . . 0.73 110.877 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 97.3 mt -55.39 -49.12 73.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.426 . . . . 0.63 110.734 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.9 mt -56.28 -41.97 76.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.4 110.755 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.472 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 72.9 m -57.49 -52.04 67.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 0.23 110.862 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.431 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 70.1 m80 -61.17 -50.55 72.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.29 110.815 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 92.8 mt -61.42 -52.14 65.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.47 111.119 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 66.6 mt -62.03 -43.62 98.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.332 -0.395 . . . . 0.41 111.089 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.462 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -51.84 -52.47 49.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.9 0.381 . . . . 0.27 110.623 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 66.4 mt -58.15 -41.95 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.62 110.246 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.64 -44.53 60.08 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.621 -0.799 . . . . 0.28 111.893 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 72.1 mt -61.32 -48.44 81.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.987 0.423 . . . . 0.43 110.322 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.66 -52.05 50.88 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.579 -0.82 . . . . 0.29 112.338 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 56.1 mt -53.66 -49.37 57.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.868 0.366 . . . . 0.89 110.954 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.422 ' O ' ' CG ' ' A' ' 186' ' ' ARG . 92.1 t80 -51.95 -51.43 57.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.507 . . . . 1.56 110.777 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 59.4 mt -62.7 -41.9 94.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.112 -0.494 . . . . 0.83 111.165 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.19 -52.62 48.41 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.941 -0.647 . . . . 0.64 113.265 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.07 -22.86 66.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.822 0.311 . . . . 2.54 111.005 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.422 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 1.5 mmp_? . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.392 . . . . 3.95 110.935 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo . . . . . 0 N--CA 1.464 -0.259 0 CA-C-O 120.782 0.243 . . . . 1.07 112.524 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 81.1 p -57.22 -48.56 78.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 1.59 110.929 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.424 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 84.0 mt -52.23 -49.4 64.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 1.09 111.049 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.474 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.2 mp -61.88 -47.99 82.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.36 -0.382 . . . . 0.72 111.082 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 90.2 mt -61.87 -44.74 96.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 0.5 111.141 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 172' ' ' SER . . . . . 0.431 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 71.0 m -53.04 -52.11 59.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.318 -0.401 . . . . 0.31 110.979 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.472 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 61.6 m80 -60.48 -52.5 64.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.3 111.201 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 86.6 mt -60.29 -52.35 65.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.844 0.354 . . . . 0.44 111.236 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.17 -45.3 94.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.43 . . . . 0.46 111.208 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.462 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.28 -52.53 58.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.25 111.51 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.461 HG13 ' HB1' ' A' ' 176' ' ' ALA . 69.8 mt -59.14 -42.83 87.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.827 0.346 . . . . 0.31 110.799 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.56 -51.11 50.4 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.508 -0.853 . . . . 0.26 111.963 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 66.3 mt -56.38 -42.48 77.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.911 0.386 . . . . 0.47 110.256 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.56 -47.35 70.45 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.673 -0.775 . . . . 0.27 112.069 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 49.7 mt -57.4 -48.64 82.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.868 0.366 . . . . 0.93 110.69 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -54.0 -47.07 71.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 1.52 110.502 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 72.3 mt -62.4 -51.53 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.079 -0.51 . . . . 1.1 110.934 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.19 -52.51 49.18 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.808 -0.71 . . . . 0.72 112.8 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.724 0.297 . . . . 2.16 111.073 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 C--O 1.232 0.206 0 CA-C-O 120.813 0.256 . . . . 0.98 112.391 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.8 t -57.34 -50.07 74.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 1.47 110.88 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 40.8 mt -62.16 -48.97 77.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 0.73 111.053 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 64.6 mt -52.26 -51.8 56.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.875 0.369 . . . . 0.63 110.757 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.6 mt -56.43 -42.35 77.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 0.4 110.856 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.421 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 74.8 m -58.38 -52.55 65.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.42 . . . . 0.23 110.85 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.423 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 72.4 m80 -62.48 -51.97 65.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.29 110.744 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.65 -51.78 68.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.47 110.987 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.7 mt -60.19 -44.11 95.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.41 110.98 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.544 ' HB3' ' HB1' ' B' ' 176' ' ' ALA . . . -53.75 -52.37 60.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.27 110.788 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.402 ' O ' HG12 ' A' ' 181' ' ' ILE . 68.5 mt -55.47 -45.42 78.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 0.62 110.162 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.91 -42.15 59.84 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.505 -0.855 . . . . 0.28 111.825 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 68.2 mt -59.06 -48.09 82.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.979 0.419 . . . . 0.43 110.105 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.435 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -58.64 -46.51 93.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.677 -0.773 . . . . 0.29 112.344 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 177' ' ' ILE . 48.0 mm -59.73 -49.93 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.878 0.371 . . . . 0.89 111.081 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -51.88 -49.93 62.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 1.56 110.915 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.449 HD12 HD11 ' B' ' 181' ' ' ILE . 71.9 mt -62.56 -42.55 96.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.83 111.186 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.2 -52.51 49.17 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.849 -0.691 . . . . 0.64 112.951 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -24.17 67.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 2.54 111.017 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.445 . . . . 3.95 111.044 179.772 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo . . . . . 0 N--CA 1.455 -0.786 0 CA-C-O 120.708 0.211 . . . . 1.07 112.405 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 55.0 m -114.07 -43.61 3.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.414 -0.357 . . . . 1.59 110.891 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.419 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 82.4 mt -61.5 -41.92 98.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 1.09 110.944 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.465 ' N ' HD12 ' B' ' 170' ' ' LEU . 6.3 mp -60.48 -47.25 86.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.72 110.979 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 48.5 mt -61.02 -41.74 97.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.303 -0.408 . . . . 0.5 110.731 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 172' ' ' SER . . . . . 0.423 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 70.8 m -54.92 -51.36 66.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.31 110.937 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.421 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 67.0 m80 -61.66 -52.41 64.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.229 -0.441 . . . . 0.3 111.131 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 90.6 mt -55.39 -52.93 61.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.445 -0.343 . . . . 0.44 110.8 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.8 -45.04 94.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.46 110.979 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.544 ' HB1' ' HB3' ' A' ' 176' ' ' ALA . . . -54.67 -53.02 60.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.25 111.268 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 56.9 mt -62.19 -42.62 95.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.359 -0.382 . . . . 0.31 110.585 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.55 -46.51 81.11 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.61 -0.805 . . . . 0.26 111.9 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 94.9 mt -57.44 -47.94 80.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.37 . . . . 0.47 110.346 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.31 -43.53 64.95 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.572 -0.823 . . . . 0.27 112.34 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.449 HD11 HD12 ' A' ' 183' ' ' ILE . 40.0 mm -60.29 -49.87 82.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.872 0.367 . . . . 0.93 110.993 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -59.36 -47.97 83.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.54 . . . . 1.52 110.986 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 65.6 mt -62.17 -44.52 99.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 1.1 111.147 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.38 -46.83 93.05 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.831 -0.7 . . . . 0.72 112.92 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 . . . . . 0 C--N 1.328 -0.339 0 N-CA-C 111.923 0.342 . . . . 2.16 111.923 -179.518 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo . . . . . 0 N--CA 1.463 -0.299 0 CA-C-O 120.783 0.243 . . . . 0.98 112.339 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 80.8 p -51.34 -47.56 62.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 1.47 110.89 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 96.7 mt -61.75 -47.66 84.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.419 . . . . 0.73 110.766 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 88.4 mt -55.21 -50.52 69.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 0.63 110.938 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.8 mt -57.29 -45.18 84.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.4 110.881 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.419 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 75.8 m -55.43 -51.93 65.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.288 -0.414 . . . . 0.23 110.703 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.424 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 77.2 m80 -61.95 -48.71 79.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.033 -0.53 . . . . 0.29 110.844 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 88.8 mt -58.99 -49.8 76.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.314 -0.403 . . . . 0.47 110.921 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 82.6 mt -59.92 -51.09 71.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.41 111.086 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.543 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -52.03 -52.65 49.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 0.27 110.933 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.28 -42.28 90.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.044 -0.525 . . . . 0.62 110.274 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.66 -44.64 60.22 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.579 -0.82 . . . . 0.28 112.102 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 50.8 mt -62.61 -52.53 63.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.859 0.361 . . . . 0.43 110.494 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.01 -52.14 45.28 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.732 -0.747 . . . . 0.29 112.545 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 59.3 mt -55.76 -41.56 66.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.813 0.339 . . . . 0.89 110.582 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -55.39 -43.27 75.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.123 -0.49 . . . . 1.56 110.596 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.402 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 4.7 mm -61.67 -48.71 87.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.938 0.399 . . . . 0.83 110.843 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -58.79 -50.8 63.66 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.963 -0.637 . . . . 0.64 112.933 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -55.43 -26.53 42.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.667 0.27 . . . . 2.54 111.387 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 183' ' ' ILE . 4.7 ptm85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.875 0.369 . . . . 3.95 110.978 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo . . . . . 0 N--CA 1.465 -0.168 0 CA-C-O 120.739 0.225 . . . . 1.07 112.587 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 51.0 m -52.13 -42.93 63.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.865 0.364 . . . . 1.59 111.175 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 49.8 mt -61.99 -49.93 74.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 1.09 111.216 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.443 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.6 mp -61.68 -49.77 75.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.463 -0.335 . . . . 0.72 110.885 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 88.8 mt -57.34 -41.82 80.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.379 -0.373 . . . . 0.5 110.775 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 172' ' ' SER . . . . . 0.424 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 67.5 m -57.21 -51.3 69.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.31 110.976 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.419 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 69.0 m80 -61.17 -52.47 64.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.335 -0.393 . . . . 0.3 111.017 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 88.2 mt -60.49 -52.3 65.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.907 0.384 . . . . 0.44 110.92 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.17 -42.61 99.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.065 -0.516 . . . . 0.46 110.948 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.6 -52.03 61.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.055 -0.52 . . . . 0.25 111.333 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.528 HG13 ' HB1' ' A' ' 176' ' ' ALA . 59.8 mt -60.44 -44.41 96.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.75 0.31 . . . . 0.31 110.853 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.58 -51.78 49.82 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.608 -0.806 . . . . 0.26 112.263 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.8 -41.98 78.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.756 0.312 . . . . 0.47 110.651 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.47 -49.32 74.2 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.712 -0.756 . . . . 0.27 112.197 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 60.3 mt -54.83 -50.98 56.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.93 110.756 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.418 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 80.3 t80 -53.05 -52.31 58.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.077 -0.51 . . . . 1.52 110.812 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 63.3 mt -62.26 -45.17 99.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 1.1 110.974 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -58.81 -48.66 84.13 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.764 -0.731 . . . . 0.72 112.688 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.418 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 6.9 ptp180 . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.576 0.227 . . . . 2.16 111.376 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.71 0.213 . . . . 0.98 112.534 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.9 t -52.96 -52.74 57.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.445 -0.343 . . . . 1.47 111.169 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 42.0 mt -62.74 -51.4 67.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.324 -0.398 . . . . 0.73 111.569 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 93.0 mt -51.49 -52.17 48.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.475 -0.329 . . . . 0.63 111.153 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 83.5 mt -62.22 -42.78 99.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.395 -0.366 . . . . 0.4 111.137 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.414 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 72.2 m -62.13 -53.0 61.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.436 -0.347 . . . . 0.23 111.491 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.428 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 64.7 m80 -62.62 -53.11 59.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.496 -0.32 . . . . 0.29 111.185 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 95.8 mt -57.0 -52.48 65.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.416 -0.356 . . . . 0.47 111.098 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 171' ' ' LEU . 74.3 mt -56.53 -41.44 76.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.404 -0.362 . . . . 0.41 110.297 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.502 ' HB3' ' HB1' ' B' ' 176' ' ' ALA . . . -57.61 -48.58 79.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.151 -0.477 . . . . 0.27 110.746 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.418 HD12 ' HB2' ' B' ' 179' ' ' LEU . 18.2 mm -54.11 -46.35 66.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.934 0.397 . . . . 0.62 110.394 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.31 -42.02 81.47 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.673 -0.775 . . . . 0.28 111.882 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 80.6 mt -57.45 -48.78 78.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.8 0.333 . . . . 0.43 110.433 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -61.28 -51.78 55.9 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.827 -0.701 . . . . 0.29 112.551 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 56.1 mt -53.89 -48.73 62.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.788 0.328 . . . . 0.89 111.136 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.423 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 52.8 t80 -53.74 -49.79 67.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 1.56 110.876 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 70.5 mt -63.17 -42.23 95.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.151 -0.477 . . . . 0.83 111.385 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.4 -53.11 44.41 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.8 -0.714 . . . . 0.64 113.507 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -62.68 -17.26 60.29 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.712 0.264 . . . . 2.54 111.712 -179.711 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.592 0.234 . . . . 3.95 111.525 -179.79 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo . . . . . 0 N--CA 1.464 -0.213 0 CA-C-O 120.855 0.273 . . . . 1.07 112.638 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.6 m -56.35 -41.7 76.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.065 -0.516 . . . . 1.59 110.967 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 14.4 mt -62.1 -48.06 81.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.314 -0.403 . . . . 1.09 111.192 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.404 ' N ' HD12 ' B' ' 170' ' ' LEU . 8.1 mp -59.62 -49.66 76.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.743 0.306 . . . . 0.72 110.761 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 97.8 mt -54.32 -41.74 69.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.5 110.663 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 172' ' ' SER . . . . . 0.428 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 59.8 m -59.95 -48.21 82.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.31 111.249 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.414 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 68.2 m80 -60.4 -52.08 66.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.3 110.958 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 74.0 mt -61.03 -52.46 64.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.359 . . . . 0.44 110.86 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.0 -44.12 97.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.46 110.901 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.502 ' HB1' ' HB3' ' A' ' 176' ' ' ALA . . . -52.81 -52.47 56.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.486 . . . . 0.25 110.897 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 88.2 mt -55.38 -44.6 76.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.177 -0.465 . . . . 0.31 110.285 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.77 -41.84 58.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.531 -0.842 . . . . 0.26 111.479 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.418 ' HB2' HD12 ' A' ' 177' ' ' ILE . 80.0 mt -59.2 -48.13 82.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.02 0.438 . . . . 0.47 110.288 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.51 -51.17 38.93 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.81 -0.709 . . . . 0.27 112.565 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.408 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 58.3 mt -57.59 -52.15 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.735 0.302 . . . . 0.93 110.946 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.405 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 60.4 t80 -52.6 -50.12 63.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 1.52 111.182 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 57.2 mt -62.75 -52.31 61.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 1.1 111.362 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.03 -50.72 64.82 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.983 -0.627 . . . . 0.72 113.333 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' B' ' 181' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 N-CA-C 112.031 0.382 . . . . 2.16 112.031 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo . . . . . 0 C--O 1.231 0.171 0 CA-C-O 120.828 0.262 . . . . 0.98 112.521 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 36.4 t -69.59 -41.96 75.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 1.47 111.048 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.403 ' CD2' ' CD2' ' B' ' 169' ' ' LEU . 53.1 mt -61.96 -44.22 97.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.73 110.669 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 96.8 mt -53.67 -51.29 63.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.63 110.651 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 83.9 mt -59.06 -45.24 91.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.126 -0.488 . . . . 0.4 111.087 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.423 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 69.9 m -53.53 -53.11 56.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.23 110.874 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.415 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 74.5 m80 -63.03 -52.12 64.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.29 110.939 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.4 mt -54.62 -52.56 61.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.47 110.932 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.55 -48.92 77.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.315 -0.402 . . . . 0.41 111.027 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.534 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -51.92 -52.99 46.11 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.215 -0.448 . . . . 0.27 111.165 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.508 ' O ' HD12 ' A' ' 181' ' ' ILE . 62.8 mt -58.14 -46.85 88.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.411 . . . . 0.62 110.058 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.08 -41.89 53.88 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.671 -0.776 . . . . 0.28 111.861 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 99.5 mt -58.94 -49.12 79.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.029 0.442 . . . . 0.43 110.458 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.439 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -55.03 -50.69 58.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.764 -0.731 . . . . 0.29 112.876 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.508 HD12 ' O ' ' A' ' 177' ' ' ILE . 4.0 mp -62.58 -46.01 97.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.802 0.334 . . . . 0.89 110.628 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.401 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 51.4 t80 -51.82 -52.73 47.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 1.56 110.975 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.76 -45.41 97.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.369 -0.378 . . . . 0.83 111.405 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.7 -52.48 50.5 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.928 -0.653 . . . . 0.64 113.263 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -61.06 -19.53 61.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.76 0.314 . . . . 2.54 110.98 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 116.397 -0.365 . . . . 3.95 110.988 179.313 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 N--CA 1.464 -0.248 0 N-CA-C 113.172 0.412 . . . . 1.07 113.172 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 45.0 t -54.11 -44.83 71.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.565 -0.289 . . . . 1.59 111.403 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.403 ' CD2' ' CD2' ' A' ' 169' ' ' LEU . 26.6 mt -62.81 -48.37 79.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.009 0.374 . . . . 1.09 112.009 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.413 ' N ' HD12 ' B' ' 170' ' ' LEU . 8.1 mp -54.22 -51.97 62.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.736 0.303 . . . . 0.72 111.19 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.4 mt -62.34 -43.88 97.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.358 -0.383 . . . . 0.5 111.143 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 172' ' ' SER . . . . . 0.415 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 75.1 m -58.18 -52.55 65.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.282 -0.417 . . . . 0.31 111.635 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.423 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 62.5 m80 -60.78 -52.55 64.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.446 -0.343 . . . . 0.3 111.378 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.5 mt -56.49 -51.4 68.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.408 -0.36 . . . . 0.44 111.272 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.38 -46.24 89.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.291 -0.413 . . . . 0.46 111.49 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -59.62 -53.03 62.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.394 -0.366 . . . . 0.25 111.606 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.532 HG13 ' HB1' ' A' ' 176' ' ' ALA . 40.5 mt -62.19 -42.89 96.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.813 0.34 . . . . 0.31 110.726 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.34 -51.79 51.93 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.552 -0.832 . . . . 0.26 112.194 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.408 ' O ' HG12 ' B' ' 183' ' ' ILE . 95.5 mt -53.91 -51.23 64.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.787 0.327 . . . . 0.47 110.487 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.29 -42.49 49.77 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.58 -0.819 . . . . 0.27 112.422 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.439 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 29.6 mm -59.81 -47.65 90.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.711 0.291 . . . . 0.93 110.69 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -57.19 -52.14 66.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 1.52 110.912 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 183' ' ' ILE . . . . . 0.408 HG12 ' O ' ' B' ' 179' ' ' LEU . 13.1 mm -62.37 -44.69 99.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 1.1 111.201 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.84 -52.21 53.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.833 -0.698 . . . . 0.72 113.013 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 2.16 111.036 -179.714 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo . . . . . 0 C--O 1.232 0.201 0 CA-C-O 120.785 0.244 . . . . 0.98 112.308 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 86.7 p -53.18 -48.78 67.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 1.47 111.092 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 46.8 mt -62.08 -51.93 65.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.73 110.986 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 88.2 mt -55.42 -50.37 69.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.11 -0.495 . . . . 0.63 110.952 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 94.4 mt -57.32 -45.43 84.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.4 111.151 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.44 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 73.1 m -56.56 -53.23 60.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.872 0.368 . . . . 0.23 110.986 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.432 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 77.7 m80 -63.02 -52.36 63.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.29 110.949 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.6 mt -58.86 -52.14 67.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.47 111.147 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 171' ' ' LEU . 77.1 mt -59.44 -46.93 87.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.39 . . . . 0.41 110.788 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.464 ' HB3' ' HB1' ' B' ' 176' ' ' ALA . . . -53.37 -52.24 59.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.262 -0.426 . . . . 0.27 110.781 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 86.1 mt -58.69 -41.78 83.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.255 -0.43 . . . . 0.62 110.332 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.96 -45.98 55.8 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.672 -0.775 . . . . 0.28 111.943 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 50.9 mt -62.14 -48.05 81.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.835 0.35 . . . . 0.43 110.516 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.06 -52.42 47.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.551 -0.833 . . . . 0.29 112.306 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' B' ' 180' ' ' GLY . 47.7 mt -60.35 -43.34 93.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.811 0.339 . . . . 0.89 111.091 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.419 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 78.5 t80 -53.72 -48.25 69.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.13 -0.486 . . . . 1.56 110.659 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.409 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 76.5 mt -62.54 -41.55 92.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.83 111.106 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.09 -44.11 98.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.99 -0.624 . . . . 0.64 113.208 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 10.9 ptp180 -62.44 -39.09 92.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.83 0.315 . . . . 2.54 111.581 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 183' ' ' ILE . 10.5 ptm180 . . . . . 0 C--N 1.329 -0.285 0 N-CA-C 111.656 0.243 . . . . 3.95 111.656 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.462 -0.345 0 N-CA-C 113.011 0.35 . . . . 1.07 113.011 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 48.8 m -60.32 -44.8 95.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.238 -0.437 . . . . 1.59 111.615 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.412 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 7.1 mp -62.9 -49.08 76.22 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.238 0.459 . . . . 1.09 112.238 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 mp -52.01 -50.51 61.21 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.759 -0.377 . . . . 0.72 110.661 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 89.9 mt -57.77 -41.57 82.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 0.5 110.462 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 172' ' ' SER . . . . . 0.432 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 63.6 m -54.29 -45.8 72.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.435 . . . . 0.31 110.731 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.44 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 77.0 m80 -60.0 -52.29 66.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.454 . . . . 0.3 110.905 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 83.2 mt -57.81 -52.66 64.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.412 . . . . 0.44 110.71 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 87.3 mt -62.69 -42.34 99.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.094 -0.503 . . . . 0.46 110.857 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.464 ' HB1' ' HB3' ' A' ' 176' ' ' ALA . . . -52.2 -52.37 52.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.25 111.352 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 53.9 mt -61.85 -45.59 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.421 . . . . 0.31 111.039 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.69 -51.24 53.95 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.565 -0.826 . . . . 0.26 112.109 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.4 ' O ' HG12 ' B' ' 183' ' ' ILE . 94.3 mt -54.46 -47.63 72.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.779 0.323 . . . . 0.47 110.349 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 181' ' ' ILE . . . -51.32 -43.41 51.45 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.602 -0.808 . . . . 0.27 111.919 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 58.7 mt -58.57 -49.68 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.898 0.38 . . . . 0.93 110.456 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.423 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 55.7 t80 -54.88 -50.94 67.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.943 -0.572 . . . . 1.52 111.078 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 183' ' ' ILE . . . . . 0.4 HG12 ' O ' ' B' ' 179' ' ' LEU . 16.0 mm -62.85 -44.82 99.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.968 0.413 . . . . 1.1 111.328 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.28 -50.84 62.64 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.114 -0.565 . . . . 0.72 113.203 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.423 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 5.6 ptp180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.752 0.31 . . . . 2.16 111.344 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.126 0 N-CA-C 112.507 -0.237 . . . . 7.39 112.507 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -89.5 175.81 42.7 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.839 -0.696 . . . . 6.02 112.408 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 65.2 mt -70.63 -62.89 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.884 0.373 . . . . 6.75 111.074 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' A' ' 159' ' ' ALA . 73.8 m-85 -76.75 -39.19 52.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 5.45 110.893 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 71.4 m 42.41 -89.66 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.779 -0.646 . . . . 5.17 112.089 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.89 -53.6 56.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.715 0.293 . . . . 3.89 111.634 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -55.76 -57.63 11.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.811 0.339 . . . . 5.36 111.078 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.424 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 89.5 t80 -59.85 -49.87 76.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 3.21 111.08 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.3 mt -62.31 -36.7 82.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.349 -0.387 . . . . 3.31 110.886 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -56.91 -29.46 63.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 3.11 111.045 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 35.5 m -119.37 31.09 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 2.66 111.315 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -135.89 -44.98 0.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 2.06 110.754 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.497 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 81.1 mt -62.69 -49.41 82.82 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 1.88 111.442 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 61.5 Cg_endo -74.05 -35.0 4.52 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.065 1.843 . . . . 0.98 112.276 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.5 m -55.06 -47.79 74.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 1.47 110.895 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.19 -46.61 88.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.73 110.754 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 79.7 mt -52.48 -50.05 63.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.337 -0.392 . . . . 0.63 110.655 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 98.5 mt -57.91 -46.17 85.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.505 . . . . 0.4 110.783 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.441 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 73.0 m -55.11 -53.38 56.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.882 0.373 . . . . 0.23 111.261 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.428 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 77.2 m80 -63.21 -52.78 60.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.29 111.222 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 98.4 mt -59.85 -52.96 63.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.415 -0.357 . . . . 0.47 111.321 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 171' ' ' LEU . 67.6 mt -53.52 -41.81 66.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.035 0.445 . . . . 0.41 110.306 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.547 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -58.24 -44.56 88.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.885 -0.598 . . . . 0.27 110.369 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.423 HD13 ' O ' ' B' ' 176' ' ' ALA . 47.6 mm -55.79 -43.28 73.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.252 -0.431 . . . . 0.62 109.883 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.03 -45.37 92.46 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.718 -0.754 . . . . 0.28 111.823 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 47.8 mt -54.41 -51.36 65.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.852 0.358 . . . . 0.43 110.459 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.57 -43.06 67.61 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.631 -0.795 . . . . 0.29 112.291 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 50.2 mm -61.28 -46.98 95.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.361 . . . . 0.89 110.885 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -56.97 -45.68 82.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 1.56 110.615 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 56.5 mt -62.76 -48.48 87.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.077 -0.51 . . . . 0.83 110.956 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.25 -52.34 50.24 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.929 -0.653 . . . . 0.64 112.92 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.451 ' HB3' ' CD1' ' B' ' 187' ' ' LEU . 0.0 OUTLIER -59.66 -22.62 62.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.73 0.3 . . . . 2.54 111.188 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -80.63 -22.04 40.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.356 -0.384 . . . . 3.95 111.205 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 31.1 mt -57.79 -85.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.443 -0.344 . . . . 1.52 111.183 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.401 ' OXT' HG23 ' A' ' 188' ' ' THR . 1.7 t . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.202 -0.904 . . . . 3.05 111.275 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.559 -0.216 . . . . 7.46 112.559 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -141.79 -172.06 13.23 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.718 -0.753 . . . . 6.55 112.517 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 24.3 mm -70.35 -66.54 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.075 0.464 . . . . 7.86 110.874 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.45 ' CB ' ' HB2' ' B' ' 161' ' ' PHE . 91.9 m-85 -77.44 -65.39 0.97 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.6 -0.727 . . . . 6.6 111.011 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 32.3 t 45.69 -89.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.098 -0.501 . . . . 5.34 111.42 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -54.17 -60.95 2.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.806 0.336 . . . . 4.29 110.79 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 160' ' ' GLU . . . . . 0.413 ' HA ' ' CE ' ' B' ' 163' ' ' LYS . 37.4 tt0 -58.21 -24.55 59.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 5.73 110.841 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.45 ' HB2' ' CB ' ' B' ' 157' ' ' PHE . 92.0 t80 -77.61 -48.92 15.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.297 -0.411 . . . . 3.56 111.059 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.411 ' HA ' ' HB3' ' B' ' 165' ' ' PHE . 33.6 mt -62.67 -37.25 85.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.213 -0.448 . . . . 3.37 111.08 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.413 ' CE ' ' HA ' ' B' ' 160' ' ' GLU . 49.2 mtmt -56.86 -22.86 40.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.388 -0.369 . . . . 3.86 111.102 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 28.2 m -129.6 29.17 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.446 -0.343 . . . . 2.87 111.287 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 165' ' ' PHE . . . . . 0.411 ' HB3' ' HA ' ' B' ' 162' ' ' LEU . 71.7 t80 -126.71 -44.66 1.65 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 2.48 110.913 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.495 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 73.3 mt -67.34 -44.35 46.57 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 2.14 111.522 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 6.1 Cg_exo -74.67 -34.9 3.87 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.614 2.209 . . . . 1.07 112.363 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 79.1 p -55.31 -41.99 73.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 1.59 111.198 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 83.2 mt -57.58 -50.74 72.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.367 -0.378 . . . . 1.09 111.331 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.462 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.5 mp -57.66 -44.94 86.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.477 -0.329 . . . . 0.72 111.126 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 93.0 mt -61.91 -41.61 98.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.354 -0.385 . . . . 0.5 110.857 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 172' ' ' SER . . . . . 0.428 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 58.8 m -57.64 -52.34 65.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.31 111.358 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.441 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 73.9 m80 -62.03 -52.72 62.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.332 -0.395 . . . . 0.3 111.1 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 55.4 mt -55.64 -51.47 67.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.43 -0.35 . . . . 0.44 110.976 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 94.2 mt -60.84 -42.02 96.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.362 -0.381 . . . . 0.46 110.772 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.547 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -59.74 -52.9 63.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.25 111.04 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 73.3 mt -53.79 -42.85 54.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.863 0.363 . . . . 0.31 110.059 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.0 -43.55 82.94 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.554 -0.832 . . . . 0.26 111.649 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 94.9 mt -56.5 -50.59 71.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.972 0.415 . . . . 0.47 110.363 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.44 -46.29 81.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.676 -0.774 . . . . 0.27 112.579 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 56.9 mt -55.32 -45.62 77.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.831 0.348 . . . . 0.93 111.05 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.425 ' O ' ' HG2' ' B' ' 185' ' ' ARG . 63.1 t80 -59.58 -51.54 69.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 1.52 110.892 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 183' ' ' ILE . . . . . 0.402 ' O ' ' HG2' ' B' ' 186' ' ' ARG . 61.6 mt -62.26 -44.08 98.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 1.1 111.201 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.31 -46.36 94.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.906 -0.664 . . . . 0.72 113.092 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' B' ' 182' ' ' TYR . 12.6 ptm180 -58.07 -21.91 47.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.675 0.274 . . . . 2.16 111.403 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' B' ' 183' ' ' ILE . 38.7 ptt180 -103.79 36.88 2.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.956 0.408 . . . . 3.82 110.684 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 187' ' ' LEU . . . . . 0.451 ' CD1' ' HB3' ' A' ' 185' ' ' ARG . 24.1 mt -89.68 -82.83 0.25 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.973 -0.558 . . . . 1.63 111.191 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 30.7 p . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.186 -0.912 . . . . 2.31 111.239 -179.632 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.151 0 N-CA-C 112.443 -0.263 . . . . 7.39 112.443 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -94.35 161.46 24.2 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.743 -0.742 . . . . 6.02 112.622 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 41.5 mt -71.16 -56.75 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.372 . . . . 6.75 111.112 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.439 ' O ' ' N ' ' A' ' 159' ' ' ALA . 46.2 m-85 -76.69 -70.34 0.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.08 -0.509 . . . . 5.45 111.154 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 74.6 m 44.23 -90.73 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.297 -0.41 . . . . 5.17 111.369 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -57.78 -49.33 76.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.897 0.38 . . . . 3.89 110.942 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.25 -56.41 22.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.516 . . . . 5.36 110.873 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -59.03 -48.67 80.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 3.21 111.209 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 97.5 mt -62.35 -31.04 71.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.368 -0.378 . . . . 3.31 111.094 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.1 -38.12 75.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.937 0.398 . . . . 3.11 110.797 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 164' ' ' VAL . 10.6 t -98.05 22.7 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.101 -0.499 . . . . 2.66 111.315 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.501 ' CE2' HD11 ' A' ' 169' ' ' LEU . 89.0 t80 -125.2 -41.89 2.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.372 -0.377 . . . . 2.06 110.761 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.485 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 94.5 mt -52.03 -56.9 17.56 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.986 -0.552 . . . . 1.88 111.545 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 30.1 Cg_endo -63.0 -31.65 76.62 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.212 1.941 . . . . 0.98 112.396 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 70.1 m -58.86 -43.73 90.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.298 -0.41 . . . . 1.47 110.955 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.501 HD11 ' CE2' ' A' ' 165' ' ' PHE . 73.0 mt -59.7 -48.7 80.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.73 110.926 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 86.4 mt -52.28 -52.08 54.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.63 110.99 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.5 mt -55.13 -43.11 73.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.4 110.927 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.418 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 75.2 m -55.23 -52.16 64.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.352 -0.385 . . . . 0.23 111.016 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.421 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 73.7 m80 -62.37 -51.12 68.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.29 111.037 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.27 -52.06 66.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.47 111.089 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 84.9 mt -58.66 -44.06 90.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.41 110.952 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.576 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -51.9 -52.19 51.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.421 . . . . 0.27 110.625 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 65.9 mt -54.08 -46.24 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.076 -0.511 . . . . 0.62 110.205 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.58 -42.68 85.02 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.614 -0.803 . . . . 0.28 111.899 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 53.4 mt -55.26 -50.38 69.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.397 . . . . 0.43 110.298 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.521 ' HA2' HD13 ' B' ' 181' ' ' ILE . . . -56.21 -46.05 86.73 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.596 -0.812 . . . . 0.29 112.18 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 39.6 mm -60.58 -48.4 88.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.82 0.343 . . . . 0.89 110.95 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.422 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 52.1 t80 -53.31 -51.94 60.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 1.56 110.982 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.96 -48.81 86.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.295 -0.412 . . . . 0.83 111.471 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.27 -51.48 56.26 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 121.162 -0.542 . . . . 0.64 113.713 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.1 OUTLIER -51.62 -31.79 26.56 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.648 -0.325 . . . . 2.54 111.231 -179.15 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.42 ' NH2' ' OH ' ' A' ' 182' ' ' TYR . 83.3 mtt180 -84.23 -22.93 30.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.461 -0.336 . . . . 3.95 111.233 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.06 -81.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 1.52 110.777 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.185 -0.912 . . . . 3.05 111.763 179.83 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 112.42 -0.272 . . . . 7.46 112.42 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -154.62 157.2 27.39 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.715 -0.755 . . . . 6.55 112.448 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 53.1 mt -70.58 -60.38 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.77 0.319 . . . . 7.86 111.093 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' B' ' 159' ' ' ALA . 97.3 m-85 -76.66 -54.14 7.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 6.6 111.045 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 80.3 p 41.65 -91.62 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.233 -0.44 . . . . 5.34 111.457 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -60.02 -52.26 66.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.118 0.485 . . . . 4.29 110.84 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -56.25 -27.84 56.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.855 -0.612 . . . . 5.73 111.032 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.411 ' HB2' ' CB ' ' B' ' 157' ' ' PHE . 56.3 t80 -87.53 -53.93 4.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 3.56 111.193 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.28 -38.48 89.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 3.37 111.026 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -56.09 -25.64 46.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 3.86 111.024 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.72 35.78 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 2.87 111.143 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -129.16 -45.98 1.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 2.48 110.949 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.487 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 88.0 mt -70.53 -45.59 18.51 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 2.14 111.426 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 71.6 Cg_endo -84.44 -22.81 3.05 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.465 2.11 . . . . 1.07 112.654 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 59.0 m -63.18 -43.99 96.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 1.59 111.455 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.411 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 89.3 mt -59.19 -51.46 69.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 1.09 111.462 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.48 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.2 mp -61.89 -49.52 75.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.464 -0.334 . . . . 0.72 111.149 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.76 -41.61 82.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 0.5 110.913 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 172' ' ' SER . . . . . 0.421 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 74.8 m -56.5 -52.95 62.82 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.31 111.117 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.418 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 63.0 m80 -62.57 -52.23 64.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.345 -0.389 . . . . 0.3 110.806 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 97.4 mt -54.14 -52.11 62.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.44 111.095 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.23 -50.97 69.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.46 111.181 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.549 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.17 -52.78 57.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.424 -0.353 . . . . 0.25 111.225 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.576 HG13 ' HB1' ' A' ' 176' ' ' ALA . 62.3 mt -61.94 -41.77 92.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.836 0.35 . . . . 0.31 110.394 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.48 -50.23 48.81 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.585 -0.817 . . . . 0.26 111.836 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 83.8 mt -57.17 -44.84 83.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.901 0.382 . . . . 0.47 110.224 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.02 -46.26 85.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.615 -0.802 . . . . 0.27 112.209 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.521 HD13 ' HA2' ' A' ' 180' ' ' GLY . 34.1 mm -55.76 -50.99 64.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.882 0.372 . . . . 0.93 110.716 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.409 ' O ' ' HG2' ' B' ' 185' ' ' ARG . 50.8 t80 -52.71 -52.18 57.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 1.52 110.891 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 54.0 mt -62.18 -44.13 98.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.02 -0.537 . . . . 1.1 110.994 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.05 -50.39 65.92 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.767 -0.73 . . . . 0.72 112.692 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.435 ' HG3' ' N ' ' B' ' 186' ' ' ARG . 13.7 ptp180 -58.13 -38.91 77.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.789 0.328 . . . . 2.16 110.864 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.435 ' N ' ' HG3' ' B' ' 185' ' ' ARG . 66.3 mtt180 -100.97 50.54 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 3.82 111.151 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 187' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 185' ' ' ARG . 12.0 mt -91.03 -80.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 1.63 110.862 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 32.9 p . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.255 -0.879 . . . . 2.31 111.171 -179.922 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.427 -0.269 . . . . 7.39 112.427 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -136.85 163.71 25.26 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.819 -0.705 . . . . 6.02 112.401 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 21.2 mm -71.3 -61.93 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.056 0.455 . . . . 6.75 110.906 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.436 ' O ' ' N ' ' A' ' 159' ' ' ALA . 88.8 m-85 -76.25 -73.2 0.29 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.772 -0.649 . . . . 5.45 110.995 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.405 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 75.1 m 47.62 -88.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.987 -0.552 . . . . 5.17 111.498 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.0 -50.58 70.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.76 0.314 . . . . 3.89 111.189 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -57.13 -64.99 0.7 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.273 -0.422 . . . . 5.36 110.939 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -50.79 -50.06 56.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 3.21 110.826 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 158' ' ' SER . 97.7 mt -62.58 -40.89 98.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 3.31 110.944 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -56.68 -35.38 68.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.457 . . . . 3.11 111.014 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 31.0 m -96.07 30.98 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.991 0.424 . . . . 2.66 110.859 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.547 ' CZ ' HD11 ' A' ' 169' ' ' LEU . 93.6 t80 -147.07 -44.57 0.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.002 -0.545 . . . . 2.06 110.914 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.489 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 93.8 mt -57.66 -51.96 77.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 1.88 111.593 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 56.1 Cg_endo -70.03 -27.38 25.23 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.078 1.852 . . . . 0.98 112.35 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.8 t -63.9 -49.44 72.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 1.47 110.825 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.547 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 45.9 mt -59.46 -45.7 90.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.226 -0.443 . . . . 0.73 110.874 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 86.9 mt -51.79 -50.24 61.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.337 -0.392 . . . . 0.63 110.58 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 93.9 mt -58.89 -41.45 87.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 0.4 110.591 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.479 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 68.9 m -56.45 -52.23 65.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.23 110.777 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.428 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 75.7 m80 -61.39 -51.86 67.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.29 110.723 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.3 mt -58.89 -52.0 67.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.47 110.88 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.0 mt -61.54 -43.35 99.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.41 110.901 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.5 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -52.81 -52.51 56.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.27 110.876 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 71.4 mt -56.91 -43.0 79.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.62 110.307 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.13 -42.03 80.27 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.524 -0.846 . . . . 0.28 111.927 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 45.2 mt -60.0 -51.59 69.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.927 0.394 . . . . 0.43 110.306 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.17 -42.98 56.24 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.602 -0.808 . . . . 0.29 112.395 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.423 HD13 ' O ' ' B' ' 180' ' ' GLY . 49.9 mm -62.06 -51.9 66.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.836 0.351 . . . . 0.89 111.102 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -56.59 -50.64 71.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 1.56 110.813 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.417 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 63.6 mt -60.3 -43.19 93.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.49 . . . . 0.83 111.047 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.2 -48.65 81.36 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.815 -0.707 . . . . 0.64 112.93 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -62.2 -38.1 87.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.593 0.235 . . . . 2.54 111.606 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 183' ' ' ILE . 37.7 ptt180 -74.82 -9.41 58.52 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.64 0.237 . . . . 3.95 111.64 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 183' ' ' ILE . 24.8 mt -56.8 -80.88 0.02 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.106 0.479 . . . . 1.52 110.695 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 70.3 p . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.272 -0.871 . . . . 3.05 111.173 179.946 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.581 -0.208 . . . . 7.46 112.581 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.23 174.96 11.94 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.847 -0.692 . . . . 6.55 112.665 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 33.2 mm -69.81 -64.99 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.239 0.542 . . . . 7.86 111.228 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' B' ' 159' ' ' ALA . 84.8 m-85 -74.62 -69.86 0.44 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.321 -0.854 . . . . 6.6 111.049 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 28.9 t 51.72 -88.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.489 . . . . 5.34 111.164 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -57.54 -52.58 64.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.884 0.374 . . . . 4.29 111.307 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 160' ' ' GLU . . . . . 0.457 ' HA ' ' CD ' ' B' ' 163' ' ' LYS . 45.5 mt-10 -57.27 -23.07 45.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 5.73 111.561 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -93.95 -50.22 5.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.886 0.374 . . . . 3.56 111.312 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 60.5 mt -63.0 -37.03 85.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.057 -0.519 . . . . 3.37 111.282 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.457 ' CD ' ' HA ' ' B' ' 160' ' ' GLU . 14.6 ptmm? -57.15 -36.42 70.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.453 -0.34 . . . . 3.86 110.925 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 6.4 m -117.11 41.76 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.415 . . . . 2.87 111.071 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -144.99 -47.06 0.23 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 2.48 110.728 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.497 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 84.5 mt -65.43 -55.12 26.7 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.029 -0.532 . . . . 2.14 111.589 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 32.9 Cg_endo -63.96 -40.37 28.0 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.124 1.883 . . . . 1.07 112.398 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.1 t -46.87 -42.24 17.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.292 -0.413 . . . . 1.59 111.32 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 72.5 mt -62.4 -49.54 75.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 1.09 110.955 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.429 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.5 mp -57.71 -42.31 83.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.72 110.626 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 71.9 mt -59.48 -43.11 93.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.5 110.434 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 172' ' ' SER . . . . . 0.428 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 69.6 m -54.74 -52.09 63.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.31 110.709 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.479 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 60.1 m80 -58.77 -52.29 66.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.049 -0.523 . . . . 0.3 110.882 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 96.5 mt -57.78 -50.32 73.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.41 . . . . 0.44 111.056 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 78.0 mt -62.11 -47.28 85.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.46 110.991 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.5 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -55.15 -52.98 61.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.25 111.076 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.491 HG13 ' HB1' ' A' ' 176' ' ' ALA . 66.1 mt -62.13 -42.84 96.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.359 -0.382 . . . . 0.31 110.609 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.57 -49.86 50.93 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.616 -0.802 . . . . 0.26 111.97 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 89.0 mt -57.91 -46.17 85.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.898 0.38 . . . . 0.47 110.455 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.423 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -56.01 -50.38 61.83 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.547 -0.835 . . . . 0.27 112.191 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 67.4 mt -53.91 -46.93 64.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 0.93 110.849 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.414 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 47.3 t80 -54.45 -51.63 64.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 1.52 110.73 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 69.5 mt -63.27 -48.79 85.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.178 -0.465 . . . . 1.1 111.16 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.29 -52.74 47.37 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.957 -0.64 . . . . 0.72 113.4 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.8 OUTLIER -57.68 -20.31 32.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.757 0.278 . . . . 2.16 111.214 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.436 ' NE ' ' HA ' ' B' ' 186' ' ' ARG . 3.9 mmp_? -94.17 40.25 1.08 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.846 0.355 . . . . 3.82 110.572 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 41.2 mt -101.08 -85.39 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.039 -0.528 . . . . 1.63 111.218 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.256 -0.878 . . . . 2.31 111.221 -179.843 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.457 -0.257 . . . . 7.39 112.457 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 161.02 173.25 29.41 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.758 -0.734 . . . . 6.02 112.31 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 55.7 mt -70.72 -57.54 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.672 0.272 . . . . 6.75 111.078 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.454 ' O ' ' N ' ' A' ' 159' ' ' ALA . 96.6 m-85 -75.97 -42.44 48.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.384 . . . . 5.45 110.674 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 33.6 t 42.84 -87.58 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.844 -0.616 . . . . 5.17 112.346 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -54.57 -53.05 59.68 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.791 0.293 . . . . 3.89 111.791 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.413 ' HB3' ' HB3' ' A' ' 157' ' ' PHE . 0.3 OUTLIER -56.23 -55.61 31.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.765 0.317 . . . . 5.36 111.144 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -64.18 -48.43 75.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.351 -0.386 . . . . 3.21 111.322 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 47.1 mt -61.42 -29.02 69.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.273 -0.421 . . . . 3.31 110.906 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -57.0 -49.21 76.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 3.11 110.778 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.6 m -105.48 42.81 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.491 . . . . 2.66 111.348 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.623 ' CZ ' HD11 ' A' ' 169' ' ' LEU . 7.5 t80 -145.17 -51.75 0.27 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.337 -0.392 . . . . 2.06 110.975 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.494 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 81.1 mt -55.48 -44.66 99.76 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.49 -0.323 . . . . 1.88 111.414 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 68.8 Cg_exo -50.48 -37.74 52.43 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.239 1.959 . . . . 0.98 112.511 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.6 m -78.01 -51.97 9.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 1.47 111.334 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.623 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 19.5 mt -61.08 -50.16 74.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.454 -0.339 . . . . 0.73 111.218 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.402 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 96.2 mt -52.13 -52.41 51.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.417 -0.356 . . . . 0.63 111.1 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.8 mt -62.44 -41.86 99.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.305 -0.407 . . . . 0.4 111.219 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.429 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 69.1 m -60.59 -53.28 59.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.42 -0.354 . . . . 0.23 111.352 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.446 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 66.2 m80 -62.92 -52.58 62.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.745 0.307 . . . . 0.29 110.889 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 170' ' ' LEU . 96.6 mt -57.72 -52.86 63.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.412 -0.358 . . . . 0.47 110.591 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 83.5 mt -62.88 -44.82 95.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.41 110.803 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.426 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -51.53 -52.32 47.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.428 . . . . 0.27 110.933 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.41 -45.03 97.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 0.62 110.477 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.4 -49.5 51.27 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.655 -0.783 . . . . 0.28 111.99 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 43.3 mt -55.58 -49.04 73.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 0.43 110.227 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.473 ' HA2' ' CG1' ' B' ' 181' ' ' ILE . . . -51.77 -46.16 54.64 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.524 -0.846 . . . . 0.29 112.45 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 41.7 mm -62.63 -48.24 89.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.748 0.308 . . . . 0.89 111.192 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.409 ' HA ' ' HG2' ' A' ' 185' ' ' ARG . 55.6 t80 -62.07 -52.21 64.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 1.56 111.242 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 94.6 mt -51.79 -51.1 29.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.286 -0.415 . . . . 0.83 110.986 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.01 -52.56 45.98 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.49 -0.862 . . . . 0.64 112.321 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.45 ' HG3' ' N ' ' A' ' 186' ' ' ARG . 10.9 ptp180 -62.93 -41.78 99.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.956 0.408 . . . . 2.54 110.721 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.45 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -64.38 -14.26 55.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 3.95 111.21 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 41.7 mt -50.92 -83.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.907 0.384 . . . . 1.52 111.031 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 188' ' ' THR . 1.7 t . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.354 -0.831 . . . . 3.05 111.27 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.427 -0.269 . . . . 7.46 112.427 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -166.97 -144.83 4.25 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.782 -0.723 . . . . 6.55 112.467 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 52.1 mt -68.38 -54.21 23.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.804 0.335 . . . . 7.86 110.627 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.424 ' HB3' ' HB2' ' B' ' 161' ' ' PHE . 58.8 m-85 -76.39 -39.61 53.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 6.6 110.414 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' B' ' 157' ' ' PHE . 10.2 t 80.71 -164.51 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.76 -0.655 . . . . 5.34 111.39 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.436 ' HA ' HD12 ' B' ' 162' ' ' LEU . . . -56.37 -25.2 48.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 4.29 111.531 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -51.38 -61.0 2.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.415 -0.357 . . . . 5.73 110.822 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.558 ' CZ ' ' CD1' ' B' ' 165' ' ' PHE . 32.1 t80 -56.59 -35.92 68.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.313 -0.403 . . . . 3.56 110.443 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' B' ' 159' ' ' ALA . 60.4 mt -63.72 -31.91 73.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 3.37 111.19 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -56.74 -36.88 70.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.346 . . . . 3.86 110.85 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 34.8 m -118.26 26.78 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 2.87 111.431 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 165' ' ' PHE . . . . . 0.558 ' CD1' ' CZ ' ' B' ' 161' ' ' PHE . 50.4 t80 -101.8 -65.84 0.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.416 -0.357 . . . . 2.48 111.027 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.492 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 60.4 mt -55.08 -44.91 99.87 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.304 -0.407 . . . . 2.14 111.446 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 55.9 Cg_exo -51.45 -54.09 5.96 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.258 1.972 . . . . 1.07 112.374 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 74.2 p -54.53 -41.67 69.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 1.59 111.009 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.417 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 59.7 mt -60.8 -52.66 64.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.329 -0.396 . . . . 1.09 111.132 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.416 ' CD1' ' O ' ' B' ' 166' ' ' LEU . 7.1 mp -62.89 -44.59 95.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.756 0.312 . . . . 0.72 110.918 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 94.7 mt -59.95 -43.89 94.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.329 -0.396 . . . . 0.5 110.824 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 172' ' ' SER . . . . . 0.446 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 61.4 m -60.6 -48.97 79.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.31 111.012 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 41.9 m80 -61.42 -52.08 66.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.3 110.917 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 64.7 mt -59.67 -51.54 69.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.39 -0.368 . . . . 0.44 110.845 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.51 -51.99 65.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.46 111.483 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.426 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -51.93 -53.94 35.28 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.758 0.313 . . . . 0.25 111.3 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.418 HG13 ' HB1' ' A' ' 176' ' ' ALA . 67.4 mt -62.97 -44.59 99.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.31 110.703 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.97 -48.01 82.57 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.631 -0.795 . . . . 0.26 112.062 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 88.9 mt -53.96 -48.79 69.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 0.47 110.457 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.17 -48.24 81.39 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.704 -0.76 . . . . 0.27 112.654 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.473 ' CG1' ' HA2' ' A' ' 180' ' ' GLY . 52.5 mt -62.06 -48.82 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.735 0.302 . . . . 0.93 111.521 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.406 ' HA ' ' HG2' ' B' ' 185' ' ' ARG . 88.5 t80 -51.59 -52.25 48.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.321 -0.399 . . . . 1.52 111.297 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 58.6 mt -62.05 -46.65 95.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.321 -0.399 . . . . 1.1 111.203 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.39 -45.51 95.78 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.782 -0.723 . . . . 0.72 113.024 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' B' ' 182' ' ' TYR . 10.0 ptp180 -60.95 -17.76 53.21 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.685 0.254 . . . . 2.16 111.685 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -109.2 45.56 1.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.851 0.358 . . . . 3.82 110.859 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 62.4 mt -137.84 -85.2 0.3 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.059 -0.519 . . . . 1.63 111.214 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.277 -0.868 . . . . 2.31 111.217 -179.813 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.535 -0.226 . . . . 7.39 112.535 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -130.08 -178.69 15.55 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.864 -0.684 . . . . 6.02 112.483 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 57.3 mt -69.18 -59.3 3.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.897 0.38 . . . . 6.75 110.834 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -77.15 -62.41 1.66 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 5.45 110.727 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.434 ' O ' ' CG ' ' A' ' 162' ' ' LEU . 40.0 t 69.08 -77.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.964 -0.562 . . . . 5.17 111.17 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.35 -58.18 9.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.37 -0.377 . . . . 3.89 111.192 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 163' ' ' LYS . 14.3 mm-40 -57.23 -59.8 4.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.437 -0.347 . . . . 5.36 110.853 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.46 ' CZ ' ' CD1' ' A' ' 165' ' ' PHE . 91.5 t80 -51.95 -51.63 55.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.894 0.378 . . . . 3.21 110.549 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.434 ' CG ' ' O ' ' A' ' 158' ' ' SER . 53.6 mt -61.98 -26.47 68.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 3.31 110.35 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 160' ' ' GLU . 10.8 tppt? -56.39 -41.15 75.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.954 -0.566 . . . . 3.11 110.446 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 26.2 m -125.22 55.51 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.792 -0.64 . . . . 2.66 111.184 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.46 ' CD1' ' CZ ' ' A' ' 161' ' ' PHE . 83.7 t80 -144.25 -51.21 0.3 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.274 -0.421 . . . . 2.06 111.051 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.474 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 95.9 mt -52.75 -46.23 96.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 1.88 111.48 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 91.5 Cg_endo -81.64 -37.77 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.338 2.025 . . . . 0.98 112.528 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 53.8 m -48.14 -52.37 20.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 1.47 111.32 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.445 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 69.0 mt -61.3 -48.88 79.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.439 . . . . 0.73 111.008 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 89.2 mt -58.56 -49.77 76.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.63 111.077 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.31 -42.1 94.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.4 111.382 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.473 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 67.1 m -56.16 -53.39 57.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.739 0.304 . . . . 0.23 111.193 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.435 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 69.0 m80 -62.96 -51.69 65.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.351 -0.386 . . . . 0.29 110.765 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 95.7 mt -57.83 -51.88 67.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.47 111.241 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.69 -49.46 77.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.41 111.275 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.533 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -51.51 -52.92 42.83 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.854 0.359 . . . . 0.27 111.042 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 68.6 mt -57.45 -44.25 84.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.62 110.243 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.95 -44.01 82.42 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.719 -0.753 . . . . 0.28 111.916 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 75.6 mt -56.17 -52.54 64.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.958 0.409 . . . . 0.43 110.221 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.62 -45.11 68.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.566 -0.826 . . . . 0.29 112.07 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 48.0 mm -60.95 -42.44 92.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 0.89 110.806 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -55.14 -42.21 72.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 1.56 110.662 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.433 ' N ' HD13 ' A' ' 183' ' ' ILE . 3.7 mm -62.87 -52.99 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.83 110.864 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -63.43 -52.86 43.26 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.023 -0.608 . . . . 0.64 113.356 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.28 -26.44 12.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.701 0.286 . . . . 2.54 111.184 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.76 -22.11 65.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.406 -0.361 . . . . 3.95 110.977 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 187' ' ' LEU . 35.7 mt -55.25 -84.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.414 -0.357 . . . . 1.52 110.717 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.166 -0.921 . . . . 3.05 111.769 179.638 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.172 0 N-CA-C 112.498 -0.241 . . . . 7.46 112.498 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.65 165.46 28.73 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 6.55 112.52 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 52.0 mt -71.81 -65.9 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.921 0.391 . . . . 7.86 110.86 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.441 ' O ' ' N ' ' B' ' 159' ' ' ALA . 82.8 m-85 -77.73 -70.57 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.016 -0.538 . . . . 6.6 110.909 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 73.5 m 40.08 -90.04 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.106 -0.497 . . . . 5.34 112.137 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -56.31 -55.11 37.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.825 0.345 . . . . 4.29 111.101 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 160' ' ' GLU . . . . . 0.404 ' O ' HG22 ' B' ' 164' ' ' VAL . 36.8 tt0 -54.69 -43.63 72.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 5.73 111.004 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -59.5 -57.73 11.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 3.56 110.997 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 45.0 mt -63.29 -37.31 86.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 3.37 110.952 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -56.42 -37.81 70.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.462 . . . . 3.86 110.885 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.404 HG22 ' O ' ' B' ' 160' ' ' GLU . 21.8 m -101.36 30.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 2.87 111.014 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -128.4 -52.2 1.28 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.121 -0.491 . . . . 2.48 110.908 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.507 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 64.8 mt -57.83 -43.72 98.86 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 2.14 111.684 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 22.8 Cg_exo -64.77 -40.0 23.86 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.277 1.985 . . . . 1.07 112.25 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 63.5 m -49.75 -44.92 48.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 1.59 110.973 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.42 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 26.0 mt -52.73 -49.45 65.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 1.09 110.673 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.467 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.3 mp -59.96 -44.45 94.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 0.72 110.452 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.17 -41.72 98.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.5 110.605 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 172' ' ' SER . . . . . 0.435 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 72.2 m -54.1 -49.73 68.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.31 110.637 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.473 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 66.9 m80 -60.26 -52.17 66.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.3 110.692 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.41 -52.41 65.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.44 110.994 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 76.6 mt -62.5 -43.83 97.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 0.46 110.937 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.511 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.41 -53.43 51.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.25 110.965 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.533 HG13 ' HB1' ' A' ' 176' ' ' ALA . 41.4 mt -62.64 -44.95 99.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.31 110.413 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.82 -51.15 46.82 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.674 -0.774 . . . . 0.26 111.892 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 97.0 mt -55.12 -42.95 73.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 0.47 110.092 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.23 -42.6 93.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.667 -0.777 . . . . 0.27 112.042 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 41.4 mm -58.18 -52.21 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.729 0.299 . . . . 0.93 110.601 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -51.71 -52.5 47.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 1.52 110.575 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 64.3 mt -62.89 -45.16 99.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.96 -0.564 . . . . 1.1 110.912 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.16 -52.36 50.28 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.979 -0.629 . . . . 0.72 112.999 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -53.37 -27.4 23.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.82 0.343 . . . . 2.16 110.87 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -111.24 58.11 0.62 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 3.82 111.124 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 16.7 mt -105.02 -83.17 0.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.124 -0.489 . . . . 1.63 110.874 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.302 -0.856 . . . . 2.31 111.192 179.941 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.62 -0.192 . . . . 7.39 112.62 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -131.74 172.08 21.05 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.736 -0.745 . . . . 6.02 112.637 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 56.7 mt -70.9 -60.51 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.911 0.386 . . . . 6.75 110.963 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.442 ' HB2' ' HB2' ' A' ' 161' ' ' PHE . 89.7 m-85 -76.75 -56.16 4.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.979 -0.555 . . . . 5.45 110.927 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.432 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 74.7 m 47.89 -90.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.994 -0.548 . . . . 5.17 111.545 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -52.77 -57.01 11.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.599 0.238 . . . . 3.89 111.528 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.546 ' O ' HG12 ' A' ' 164' ' ' VAL . 0.2 OUTLIER -57.36 -54.2 49.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.77 0.319 . . . . 5.36 110.71 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.442 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 20.9 t80 -46.22 -58.57 3.54 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.165 -0.47 . . . . 3.21 111.228 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 158' ' ' SER . 32.6 mt -60.27 -47.81 84.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 3.31 110.143 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -58.66 -21.01 53.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.904 -0.589 . . . . 3.11 110.814 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 160' ' ' GLU . 9.9 p -118.42 25.68 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.406 -0.361 . . . . 2.66 111.152 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -131.84 -61.27 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.374 -0.376 . . . . 2.06 111.365 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.501 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 85.3 mt -63.25 -47.09 85.52 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.441 -0.345 . . . . 1.88 111.786 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 72.7 Cg_endo -76.53 -24.69 10.26 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.185 1.923 . . . . 0.98 112.516 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 79.9 p -65.67 -42.41 91.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 1.47 110.922 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 80.1 mt -60.65 -49.87 75.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.73 110.846 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 95.2 mt -54.88 -51.1 67.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.297 -0.41 . . . . 0.63 110.769 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.5 -41.5 85.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.4 111.042 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.472 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 68.3 m -55.98 -52.88 62.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.76 0.314 . . . . 0.23 111.097 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.451 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 66.6 m80 -62.94 -52.57 62.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.29 110.905 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.0 mt -58.31 -52.23 66.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.47 110.841 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.4 -44.94 95.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.0 -0.546 . . . . 0.41 110.933 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.442 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -52.12 -52.37 52.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.27 110.822 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 68.9 mt -57.31 -42.64 80.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.268 -0.424 . . . . 0.62 110.128 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.3 -41.43 87.1 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.788 -0.72 . . . . 0.28 111.755 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 76.8 mt -59.45 -49.26 78.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.949 0.404 . . . . 0.43 110.199 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.8 -47.36 65.41 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.671 -0.776 . . . . 0.29 112.072 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.431 HD13 ' O ' ' B' ' 180' ' ' GLY . 32.6 mm -56.25 -46.45 81.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 0.89 110.841 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.409 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 88.8 t80 -57.59 -49.45 76.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 1.56 110.989 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 54.7 mt -62.78 -43.83 99.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.23 -0.441 . . . . 0.83 111.353 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.4 ' O ' ' HG ' ' A' ' 187' ' ' LEU . . . -62.34 -52.21 51.02 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.039 -0.601 . . . . 0.64 113.469 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -61.34 -20.78 63.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.767 0.284 . . . . 2.54 111.395 -179.373 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 28.4 mmt180 -74.35 -5.68 43.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.576 -0.284 . . . . 3.95 111.676 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 184' ' ' GLY . 22.6 mt -57.57 -83.44 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.902 0.382 . . . . 1.52 111.085 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 81.5 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.188 -0.91 . . . . 3.05 111.136 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.53 -0.228 . . . . 7.46 112.53 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -157.21 -174.74 27.31 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.653 -0.784 . . . . 6.55 112.694 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 26.5 mm -70.66 -66.05 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.265 0.555 . . . . 7.86 111.057 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.429 ' O ' ' N ' ' B' ' 159' ' ' ALA . 65.4 m-85 -75.84 -59.61 2.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.341 -0.845 . . . . 6.6 111.13 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.405 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 31.3 t 43.97 -91.29 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.134 -0.484 . . . . 5.34 111.351 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -60.03 -48.85 80.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.928 0.394 . . . . 4.29 110.992 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -57.98 -34.15 69.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.925 -0.579 . . . . 5.73 111.368 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -86.14 -44.43 12.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.711 0.291 . . . . 3.56 111.309 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' B' ' 158' ' ' SER . 92.7 mt -62.5 -43.69 98.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.408 -0.36 . . . . 3.37 111.105 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.455 ' HG3' HG23 ' B' ' 164' ' ' VAL . 17.9 ptpt -57.26 -28.45 62.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.374 -0.375 . . . . 3.86 110.633 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.615 ' O ' HG12 ' B' ' 164' ' ' VAL . 21.4 t -98.91 25.49 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 2.87 110.725 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -126.41 -47.54 1.58 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 2.48 110.858 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.487 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 85.9 mt -61.24 -45.55 95.39 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 2.14 111.272 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 94.2 Cg_endo -81.02 -27.26 3.07 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.31 2.007 . . . . 1.07 112.383 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 91.5 p -54.36 -42.8 70.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 1.59 110.87 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.406 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 81.8 mt -58.78 -49.6 77.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 1.09 110.643 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.468 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.0 mp -62.17 -47.11 85.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.046 -0.525 . . . . 0.72 110.724 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 79.6 mt -59.65 -43.63 93.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.5 110.822 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 172' ' ' SER . . . . . 0.451 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 75.6 m -54.24 -50.2 67.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.269 -0.423 . . . . 0.31 110.607 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.472 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 56.6 m80 -62.26 -52.47 63.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.3 110.931 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 89.2 mt -58.62 -52.49 65.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.373 -0.376 . . . . 0.44 111.083 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 64.7 mt -62.3 -46.15 90.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.46 111.051 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.49 -53.02 57.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 0.25 110.907 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.434 HG13 ' HB1' ' A' ' 176' ' ' ALA . 72.6 mt -62.22 -42.02 93.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.188 -0.46 . . . . 0.31 110.533 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.06 -45.44 92.44 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.565 -0.826 . . . . 0.26 111.951 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.93 -46.0 85.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 0.47 110.236 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.431 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -54.62 -44.38 79.12 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.584 -0.817 . . . . 0.27 112.183 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 60.3 mt -60.91 -46.88 95.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.721 0.296 . . . . 0.93 111.034 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -55.58 -47.46 76.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 1.52 111.083 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 59.4 mt -61.25 -50.37 80.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 1.1 111.07 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -58.15 -51.29 59.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.83 -0.7 . . . . 0.72 112.712 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -62.07 -22.87 66.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.701 0.286 . . . . 2.16 111.285 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -93.55 43.08 1.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.935 0.397 . . . . 3.82 110.764 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 56.5 mt -138.03 -85.68 0.28 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 1.63 111.293 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 30.3 p . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.226 -0.892 . . . . 2.31 111.207 -179.59 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.368 -0.293 . . . . 7.39 112.368 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.04 179.62 38.47 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.656 -0.783 . . . . 6.02 112.604 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.408 ' O ' ' CD2' ' A' ' 157' ' ' PHE . 13.6 mm -69.04 -19.24 23.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.793 0.33 . . . . 6.75 111.158 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.438 ' O ' ' N ' ' A' ' 159' ' ' ALA . 30.1 m-85 -159.5 -67.66 0.08 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.18 -0.464 . . . . 5.45 110.53 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.417 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 74.9 m 40.19 -90.83 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.034 -0.53 . . . . 5.17 112.067 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.7 -52.45 64.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.752 0.31 . . . . 3.89 111.435 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.414 ' OE1' ' CE1' ' A' ' 157' ' ' PHE . 40.2 tt0 -55.94 -65.61 0.57 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.419 -0.355 . . . . 5.36 110.876 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.422 ' CB ' ' HB3' ' A' ' 157' ' ' PHE . 77.5 t80 -51.73 -51.11 58.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 3.21 110.856 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 158' ' ' SER . 87.7 mt -62.75 -33.28 74.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 3.31 111.297 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -57.16 -35.15 69.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.453 -0.34 . . . . 3.11 110.863 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 34.5 m -106.9 28.89 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.265 -0.425 . . . . 2.66 110.992 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.52 ' CZ ' HD11 ' A' ' 169' ' ' LEU . 61.8 t80 -133.06 -63.0 0.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 2.06 110.838 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.483 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 73.8 mt -49.12 -57.79 10.55 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 1.88 111.407 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 26.0 Cg_endo -61.8 -21.71 72.79 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.291 1.994 . . . . 0.98 112.329 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.5 t -74.21 -52.82 11.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 1.47 110.911 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.52 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 60.2 mt -62.61 -46.27 89.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.73 110.914 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.79 -52.36 49.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.27 -0.423 . . . . 0.63 110.635 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.4 mt -57.67 -43.66 85.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.243 -0.435 . . . . 0.4 110.745 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.426 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 75.6 m -57.51 -52.79 63.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.23 110.706 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.451 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 64.9 m80 -62.87 -51.89 65.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.29 110.746 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.49 -52.3 66.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 0.47 111.109 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 81.8 mt -53.71 -50.82 65.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.465 -0.334 . . . . 0.41 110.781 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.575 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -53.36 -52.28 59.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.27 110.697 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 81.4 mt -58.43 -42.86 85.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.62 110.232 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.0 -43.77 55.84 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.627 -0.797 . . . . 0.28 111.796 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.0 -43.27 99.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.007 0.432 . . . . 0.43 109.914 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -61.13 -45.59 96.25 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.657 -0.783 . . . . 0.29 112.137 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 48.7 mm -60.33 -46.04 95.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.891 0.377 . . . . 0.89 110.924 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.408 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 51.1 t80 -54.52 -50.2 68.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.063 -0.517 . . . . 1.56 110.844 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.79 -47.17 94.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.171 -0.468 . . . . 0.83 111.224 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.42 -52.69 47.41 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.818 -0.706 . . . . 0.64 112.969 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.1 OUTLIER -61.93 -15.48 43.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.563 0.221 . . . . 2.54 111.329 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -92.25 20.94 5.54 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.68 0.276 . . . . 3.95 110.984 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 49.0 mt -99.92 -83.64 0.43 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.914 0.387 . . . . 1.52 110.836 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.361 -0.828 . . . . 3.05 111.128 179.816 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.522 -0.231 . . . . 7.46 112.522 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 155.87 -159.63 29.43 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.7 -0.762 . . . . 6.55 112.536 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 53.3 mt -70.7 -49.97 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.916 0.389 . . . . 7.86 111.246 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' B' ' 159' ' ' ALA . 29.9 m-85 -75.85 -65.05 0.95 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.086 -0.507 . . . . 6.6 111.24 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.415 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 31.2 t 54.2 -87.53 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.107 -0.497 . . . . 5.34 110.905 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -56.55 -54.71 42.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.825 0.345 . . . . 4.29 111.023 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -55.79 -34.19 65.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 5.73 111.117 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -76.55 -55.23 5.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.353 -0.385 . . . . 3.56 111.018 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' B' ' 158' ' ' SER . 72.8 mt -62.96 -29.64 70.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 3.37 111.152 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -56.41 -36.7 69.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.411 . . . . 3.86 111.066 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 33.0 m -98.84 28.55 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 2.87 111.15 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -142.81 -46.78 0.32 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.319 -0.4 . . . . 2.48 111.147 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.489 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 82.8 mt -55.83 -59.03 12.69 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.168 -0.469 . . . . 2.14 111.823 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 10.5 Cg_endo -54.02 -44.41 49.55 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.418 2.079 . . . . 1.07 112.782 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 67.3 m -50.45 -43.28 55.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.431 -0.35 . . . . 1.59 111.071 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.13 -44.07 97.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.301 -0.409 . . . . 1.09 111.249 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.434 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.7 mp -60.74 -50.11 74.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.72 110.776 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 89.2 mt -53.65 -42.69 68.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.5 110.903 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 172' ' ' SER . . . . . 0.451 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 74.7 m -58.44 -49.59 76.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.196 -0.456 . . . . 0.31 110.998 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.426 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 66.5 m80 -58.72 -52.61 64.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.3 111.101 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 82.5 mt -59.91 -52.46 65.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.369 -0.378 . . . . 0.44 111.13 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.58 -42.56 99.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 0.46 110.952 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.539 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -52.39 -52.76 51.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 0.25 111.338 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.575 HG13 ' HB1' ' A' ' 176' ' ' ALA . 31.6 mt -61.43 -42.64 94.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 0.31 110.628 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.46 -49.95 54.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.536 -0.84 . . . . 0.26 111.787 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 77.0 mt -55.86 -46.1 78.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 0.47 110.272 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.96 -41.89 69.18 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.639 -0.791 . . . . 0.27 112.019 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 41.9 mm -59.8 -52.13 64.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.866 0.365 . . . . 0.93 110.835 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.425 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 47.9 t80 -54.96 -50.82 67.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 1.52 110.803 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 183' ' ' ILE . . . . . 0.422 ' HA ' ' HG2' ' B' ' 186' ' ' ARG . 57.1 mt -62.01 -45.98 97.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 1.1 111.322 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -56.01 -49.82 64.99 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.825 -0.703 . . . . 0.72 112.481 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.425 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 10.6 ptp180 -61.0 -18.73 59.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.55 0.214 . . . . 2.16 111.255 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.422 ' HG2' ' HA ' ' B' ' 183' ' ' ILE . 13.3 ptm180 -113.6 42.14 2.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.884 0.374 . . . . 3.82 110.675 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 28.9 mt -91.77 -85.05 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 1.63 111.267 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.259 -0.877 . . . . 2.31 111.281 -179.906 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.403 -0.279 . . . . 7.39 112.403 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -82.27 158.22 37.72 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.678 -0.772 . . . . 6.02 112.577 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.526 HD12 ' N ' ' A' ' 156' ' ' ILE . 3.7 mp -74.28 -68.23 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.949 0.404 . . . . 6.75 110.562 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' A' ' 159' ' ' ALA . 85.9 m-85 -76.74 -56.06 4.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.963 -0.562 . . . . 5.45 110.776 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.418 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 74.2 m 41.16 -91.36 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.983 -0.553 . . . . 5.17 111.766 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -57.05 -51.86 67.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.771 0.319 . . . . 3.89 111.285 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -56.46 -48.89 76.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.442 . . . . 5.36 110.972 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.538 ' CZ ' ' CD1' ' A' ' 165' ' ' PHE . 76.5 t80 -61.57 -56.7 17.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 3.21 110.957 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 158' ' ' SER . 61.0 mt -61.01 -35.54 77.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 3.31 111.082 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -57.49 -27.25 62.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 3.11 111.384 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 34.8 m -134.26 25.97 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.76 0.314 . . . . 2.66 111.615 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.538 ' CD1' ' CZ ' ' A' ' 161' ' ' PHE . 81.7 t80 -120.68 -52.16 2.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.058 0.456 . . . . 2.06 110.16 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.505 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 84.5 mt -60.1 -43.97 95.35 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.834 -0.621 . . . . 1.88 111.421 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 88.2 Cg_exo -44.92 -53.1 5.53 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.23 1.953 . . . . 0.98 112.435 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 49.6 m -60.78 -45.7 93.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 1.47 111.216 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.512 HD11 ' CE2' ' A' ' 165' ' ' PHE . 26.0 mt -58.99 -46.23 88.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.389 -0.369 . . . . 0.73 111.12 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 65.6 mt -54.36 -52.06 62.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.329 -0.396 . . . . 0.63 110.639 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 86.9 mt -57.76 -43.89 85.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.4 110.688 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.446 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 58.2 m -56.1 -52.54 63.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.23 110.811 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.427 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 80.8 m80 -62.6 -52.09 64.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.29 110.978 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.9 mt -58.02 -52.53 65.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.361 -0.382 . . . . 0.47 110.951 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.4 mt -56.69 -45.49 81.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.299 -0.41 . . . . 0.41 110.832 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.523 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -56.49 -52.32 65.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 0.27 110.904 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 75.7 mt -57.83 -42.98 83.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.62 110.648 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.51 -45.06 67.54 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.697 -0.763 . . . . 0.28 112.255 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 79.5 mt -61.98 -49.8 74.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.836 0.35 . . . . 0.43 110.525 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.449 ' CA ' HG13 ' B' ' 181' ' ' ILE . . . -55.96 -51.76 53.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.727 -0.749 . . . . 0.29 112.595 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.411 HG12 ' O ' ' B' ' 180' ' ' GLY . 47.7 mt -59.19 -43.62 89.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.786 0.327 . . . . 0.89 111.172 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.444 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 34.1 t80 -53.75 -47.88 70.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.026 0.441 . . . . 1.56 110.577 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 72.9 mt -62.78 -48.0 90.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.069 -0.514 . . . . 0.83 111.099 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.402 ' HA2' ' HG ' ' A' ' 187' ' ' LEU . . . -61.06 -46.35 94.73 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.93 -0.652 . . . . 0.64 112.967 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 11.2 ptm180 -61.8 -28.69 69.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.029 0.442 . . . . 2.54 110.851 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -84.64 11.68 8.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.6 -0.727 . . . . 3.95 111.583 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.402 ' HG ' ' HA2' ' A' ' 184' ' ' GLY . 68.6 mt -79.15 -77.07 0.18 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.153 0.501 . . . . 1.52 110.818 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 68.0 p . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.261 -0.876 . . . . 3.05 111.109 179.924 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.557 -0.217 . . . . 7.46 112.557 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 159.55 -153.95 25.0 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.869 -0.681 . . . . 6.55 112.363 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 42.1 mt -70.15 -58.37 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.893 0.378 . . . . 7.86 110.823 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' B' ' 159' ' ' ALA . 49.4 m-85 -77.66 -75.32 0.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.05 -0.523 . . . . 6.6 110.918 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 28.7 t 39.91 -92.36 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.234 -0.439 . . . . 5.34 111.542 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -60.07 -46.34 89.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.939 0.4 . . . . 4.29 110.925 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 160' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' B' ' 163' ' ' LYS . 13.2 mm-40 -58.04 -34.68 70.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.84 -0.618 . . . . 5.73 111.54 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.404 ' HB2' ' HB3' ' B' ' 157' ' ' PHE . 46.0 t80 -87.64 -44.75 10.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.803 0.335 . . . . 3.56 111.496 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 69.8 mt -62.35 -35.97 80.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.305 -0.407 . . . . 3.37 111.457 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.436 ' HG3' HG23 ' B' ' 164' ' ' VAL . 17.7 ptpt -57.75 -22.38 46.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.707 0.289 . . . . 3.86 111.17 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.448 ' O ' HG12 ' B' ' 164' ' ' VAL . 3.8 t -106.16 26.34 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.902 0.382 . . . . 2.87 110.932 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -142.34 -45.48 0.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 2.48 111.009 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.502 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 76.1 mt -59.64 -47.29 97.95 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 2.14 111.922 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 68.2 Cg_endo -75.67 -32.46 4.65 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.141 1.894 . . . . 1.07 112.727 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 48.7 m -51.53 -42.41 61.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.901 0.381 . . . . 1.59 110.767 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 65.7 mt -62.31 -46.91 86.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 1.09 111.016 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.409 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.4 mp -59.52 -49.1 79.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.423 -0.353 . . . . 0.72 110.571 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 85.3 mt -52.56 -41.81 63.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.42 . . . . 0.5 110.387 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 172' ' ' SER . . . . . 0.427 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 58.5 m -60.51 -51.81 67.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.52 . . . . 0.31 110.597 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.446 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 54.8 m80 -61.52 -51.95 66.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.122 -0.49 . . . . 0.3 110.809 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 93.1 mt -59.77 -52.23 66.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.33 -0.396 . . . . 0.44 110.794 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.23 -43.91 97.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.46 110.976 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.523 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -51.95 -52.47 50.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.25 111.074 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.514 HG13 ' HB1' ' A' ' 176' ' ' ALA . 52.3 mt -61.99 -46.78 95.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.434 -0.348 . . . . 0.31 110.591 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.23 -47.15 76.25 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.624 -0.798 . . . . 0.26 111.858 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 93.4 mt -54.23 -49.49 69.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.47 110.491 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.411 ' O ' HG12 ' A' ' 181' ' ' ILE . . . -56.41 -44.43 89.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.554 -0.831 . . . . 0.27 112.142 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.449 HG13 ' CA ' ' A' ' 180' ' ' GLY . 66.3 mt -61.43 -52.44 61.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.809 0.338 . . . . 0.93 110.791 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.518 ' CE2' ' NH2' ' B' ' 186' ' ' ARG . 46.5 t80 -56.7 -51.99 66.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.023 -0.535 . . . . 1.52 110.964 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 62.6 mt -62.39 -48.58 87.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.397 -0.365 . . . . 1.1 110.832 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.68 -52.36 48.82 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.839 -0.696 . . . . 0.72 112.973 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.416 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 1.4 ptp180 -53.68 -26.62 23.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.634 0.254 . . . . 2.16 111.521 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.518 ' NH2' ' CE2' ' B' ' 182' ' ' TYR . 68.9 mtm180 -104.62 57.0 0.7 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.901 0.381 . . . . 3.82 110.921 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 75.9 mt -150.37 -85.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.556 . . . . 1.63 111.375 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 29.8 p . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.365 -0.826 . . . . 2.31 111.222 -179.712 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.525 -0.23 . . . . 7.39 112.525 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -125.85 -176.6 14.57 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.838 -0.696 . . . . 6.02 112.425 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 28.6 mt -67.76 -59.65 3.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.82 0.343 . . . . 6.75 110.255 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.436 ' HB3' ' HB2' ' A' ' 161' ' ' PHE . 95.7 m-85 -78.14 -48.34 16.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.494 . . . . 5.45 110.361 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' ' 157' ' ' PHE . 14.6 t 76.2 -157.91 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.991 -0.549 . . . . 5.17 111.178 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -53.05 -22.59 6.11 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.552 -0.294 . . . . 3.89 111.406 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -56.05 -48.16 76.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.427 -0.351 . . . . 5.36 110.76 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' A' ' 157' ' ' PHE . 23.3 t80 -73.48 -45.43 54.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 3.21 110.777 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.43 -31.66 72.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.412 -0.358 . . . . 3.31 110.705 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -56.92 -23.93 48.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 3.11 110.936 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 32.7 m -121.22 27.4 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 2.66 110.837 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.483 ' CZ ' HD11 ' A' ' 169' ' ' LEU . 88.8 t80 -135.4 -51.03 0.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 2.06 111.115 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.502 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 84.3 mt -62.08 -44.38 89.21 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.386 . . . . 1.88 111.614 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 57.3 Cg_exo -51.76 -57.88 1.91 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.156 1.904 . . . . 0.98 112.505 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.6 t -51.03 -51.94 48.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.456 . . . . 1.47 111.118 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.483 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 39.8 mt -59.68 -51.35 70.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.365 -0.38 . . . . 0.73 110.912 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 91.7 mt -53.63 -49.59 67.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.63 110.75 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 97.2 mt -62.09 -43.0 99.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.4 110.921 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.429 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 69.3 m -57.3 -52.61 64.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.23 111.019 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.408 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 65.4 m80 -62.78 -52.52 62.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 0.29 111.242 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.8 mt -61.28 -52.1 66.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 0.47 111.354 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 171' ' ' LEU . 81.5 mt -57.49 -46.44 83.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.35 -0.386 . . . . 0.41 111.14 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.635 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -54.48 -52.57 61.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.927 0.394 . . . . 0.27 110.907 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.4 ' O ' HG12 ' A' ' 181' ' ' ILE . 68.9 mt -58.01 -43.87 85.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.244 -0.435 . . . . 0.62 110.336 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.68 -47.08 65.45 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.495 -0.86 . . . . 0.28 111.923 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 70.0 mt -55.82 -50.1 71.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.381 . . . . 0.43 110.398 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.446 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -54.74 -43.29 80.07 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.561 -0.828 . . . . 0.29 112.354 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 177' ' ' ILE . 40.7 mm -62.38 -49.2 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.912 0.387 . . . . 0.89 111.101 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.413 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 51.1 t80 -56.74 -50.4 72.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.952 -0.567 . . . . 1.56 111.343 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.414 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 58.3 mt -59.87 -46.36 93.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.83 111.305 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.19 -47.98 86.01 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.775 -0.726 . . . . 0.64 112.899 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 11.6 ptp180 -58.78 -28.88 66.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.661 0.267 . . . . 2.54 111.108 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 183' ' ' ILE . 34.4 ptt180 -93.99 37.49 1.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.372 . . . . 3.95 110.853 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 27.4 mt -112.73 -73.87 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.164 0.507 . . . . 1.52 110.668 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.318 -0.849 . . . . 3.05 111.768 179.886 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 112.535 -0.226 . . . . 7.46 112.535 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -161.47 -151.36 6.24 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.804 -0.712 . . . . 6.55 112.457 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 57.9 mt -69.95 -57.46 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.848 0.356 . . . . 7.86 110.905 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.424 ' O ' ' HB3' ' B' ' 158' ' ' SER . 53.3 m-85 -77.87 -71.58 0.41 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 6.6 110.75 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' B' ' 157' ' ' PHE . 21.7 t 72.17 -160.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.388 -0.369 . . . . 5.34 110.974 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.24 -23.71 15.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.371 -0.377 . . . . 4.29 110.997 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.66 -61.23 2.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.964 0.411 . . . . 5.73 110.511 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.414 ' CB ' ' HB3' ' B' ' 157' ' ' PHE . 25.8 t80 -56.99 -35.35 69.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.094 -0.503 . . . . 3.56 110.465 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 74.5 mt -64.69 -30.72 71.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 3.37 111.283 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -56.08 -29.05 60.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.76 0.314 . . . . 3.86 110.897 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 34.0 m -126.88 44.3 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 2.87 111.214 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -141.51 -67.62 0.4 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.327 -0.397 . . . . 2.48 111.154 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.484 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 74.0 mt -60.41 -59.4 13.96 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.112 -0.494 . . . . 2.14 111.816 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 6.1 Cg_exo -39.06 -31.84 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.791 2.327 . . . . 1.07 112.852 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 48.1 t -79.91 -44.8 19.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.865 0.364 . . . . 1.59 111.258 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 59.6 mt -62.31 -45.77 91.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 1.09 111.396 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.48 -51.67 68.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.324 -0.398 . . . . 0.72 111.247 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 92.8 mt -58.56 -41.71 86.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.385 -0.37 . . . . 0.5 111.05 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 172' ' ' SER . . . . . 0.408 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 68.9 m -54.04 -52.32 61.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.31 111.382 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 62.9 m80 -61.55 -52.53 64.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.383 -0.371 . . . . 0.3 111.324 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 80.1 mt -55.74 -52.72 62.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.44 110.922 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.91 -47.41 83.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.114 -0.494 . . . . 0.46 111.362 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.576 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -55.09 -53.32 57.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.25 111.751 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.635 HG13 ' HB1' ' A' ' 176' ' ' ALA . 53.4 mt -62.58 -43.29 98.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 0.31 110.862 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.28 -47.99 83.68 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.611 -0.804 . . . . 0.26 112.126 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.413 ' O ' HD12 ' B' ' 183' ' ' ILE . 93.6 mt -55.14 -51.85 65.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.759 0.314 . . . . 0.47 110.583 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.47 -41.82 49.58 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.613 -0.803 . . . . 0.27 112.017 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.446 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 27.2 mm -59.43 -48.88 85.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.755 0.312 . . . . 0.93 110.624 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -51.68 -52.51 47.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 1.52 111.269 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 183' ' ' ILE . . . . . 0.542 HD12 ' H ' ' B' ' 183' ' ' ILE . 4.0 mp -63.57 -52.47 57.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.451 -0.341 . . . . 1.1 111.228 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.47 -52.57 48.11 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.905 -0.664 . . . . 0.72 113.469 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.464 ' CD ' ' HG3' ' B' ' 186' ' ' ARG . 0.7 OUTLIER -55.19 -20.21 9.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.546 0.213 . . . . 2.16 111.515 -179.353 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.464 ' HG3' ' CD ' ' B' ' 185' ' ' ARG . 49.9 mtp180 -108.07 37.03 2.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.817 0.341 . . . . 3.82 110.838 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 19.7 mt -89.78 -84.0 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 1.63 111.174 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 188' ' ' THR . . . . . 0.403 HG23 ' OXT' ' B' ' 188' ' ' THR . 1.5 t . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.203 -0.903 . . . . 2.31 111.218 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 112.505 -0.238 . . . . 7.39 112.505 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -98.48 162.2 20.61 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 6.02 112.504 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 50.2 mt -71.33 -63.08 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.826 0.346 . . . . 6.75 111.114 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 159' ' ' ALA . 91.7 m-85 -76.49 -44.38 35.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 5.45 110.724 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.4 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 79.8 p 43.24 -88.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.849 -0.614 . . . . 5.17 112.129 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.56 -56.25 23.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.753 0.311 . . . . 3.89 111.454 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -55.69 -52.45 63.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.305 -0.407 . . . . 5.36 110.972 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.428 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 84.1 t80 -62.4 -50.84 69.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.883 0.373 . . . . 3.21 110.793 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 158' ' ' SER . 88.3 mt -62.47 -28.16 69.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.063 -0.517 . . . . 3.31 110.807 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -57.39 -38.85 74.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 3.11 110.87 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 34.5 m -112.06 20.03 6.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 2.66 111.569 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -97.72 -49.32 4.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.757 0.313 . . . . 2.06 110.637 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.499 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 75.6 mt -62.44 -44.25 87.08 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 1.88 111.173 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 31.5 Cg_exo -59.07 -47.56 17.32 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.121 1.881 . . . . 0.98 111.951 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.4 t -47.73 -47.47 30.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.28 -0.418 . . . . 1.47 110.992 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.415 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 29.3 mt -61.99 -51.32 68.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.73 110.724 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 87.6 mt -57.79 -51.94 67.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.63 110.634 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 95.2 mt -53.05 -47.13 68.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.4 110.484 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.42 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 70.3 m -51.96 -51.96 53.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.035 -0.529 . . . . 0.23 110.831 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.46 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 58.3 m80 -61.51 -52.33 64.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.29 110.749 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 84.9 mt -57.19 -50.67 72.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.47 111.003 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.9 mt -59.78 -44.8 93.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.41 110.811 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.469 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -57.34 -52.68 64.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.429 . . . . 0.27 110.716 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.408 ' O ' HG12 ' A' ' 181' ' ' ILE . 71.0 mt -58.99 -42.66 86.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.48 . . . . 0.62 110.332 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.7 -43.15 53.52 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.587 -0.816 . . . . 0.28 111.796 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.02 -47.7 83.59 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.736 -0.468 . . . . 0.43 109.736 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -58.44 -49.23 78.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 0.29 112.224 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 177' ' ' ILE . 35.2 mm -53.27 -45.95 56.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.763 0.316 . . . . 0.89 110.88 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -58.4 -44.3 88.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 1.56 110.993 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 72.4 mt -62.7 -48.92 85.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.395 -0.366 . . . . 0.83 111.199 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.15 -52.11 52.1 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.927 -0.654 . . . . 0.64 112.846 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.427 ' HD3' ' N ' ' A' ' 186' ' ' ARG . 0.0 OUTLIER -60.56 -28.1 68.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.789 0.328 . . . . 2.54 110.97 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.427 ' N ' ' HD3' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -61.79 -31.87 72.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 3.95 110.713 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.435 HD23 ' N ' ' A' ' 187' ' ' LEU . 3.8 mt -72.1 -59.14 2.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.036 -0.529 . . . . 1.52 110.64 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.398 -0.81 . . . . 3.05 111.665 -179.958 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.087 0 N-CA-C 112.484 -0.246 . . . . 7.46 112.484 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 149.99 175.39 22.12 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.73 -0.748 . . . . 6.55 112.58 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 15.9 mm -69.93 -63.25 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.948 0.404 . . . . 7.86 111.082 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -76.53 -69.53 0.51 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.864 -0.607 . . . . 6.6 110.781 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.434 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 43.4 t 43.86 -97.19 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.215 -0.448 . . . . 5.34 110.899 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.88 -36.77 70.49 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.961 0.41 . . . . 4.29 110.492 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 160' ' ' GLU . . . . . 0.426 ' HA ' ' HE2' ' B' ' 163' ' ' LYS . 34.3 tt0 -59.89 -35.15 74.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.0 -0.546 . . . . 5.73 110.497 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -77.7 -38.97 46.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.807 -0.633 . . . . 3.56 110.793 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' B' ' 158' ' ' SER . 14.6 mt -63.01 -33.34 75.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 3.37 110.87 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.426 ' HE2' ' HA ' ' B' ' 160' ' ' GLU . 46.8 mtmt -56.31 -26.83 53.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.874 0.369 . . . . 3.86 110.966 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.48 47.25 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 2.87 111.055 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -142.03 -54.47 0.44 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 2.48 110.993 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.476 HD22 ' N ' ' B' ' 166' ' ' LEU . 3.1 mm? -71.46 -59.22 3.28 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 2.14 111.563 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 19.2 Cg_endo -59.43 -26.75 83.02 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.286 1.991 . . . . 1.07 112.414 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 51.7 m -62.26 -41.57 98.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.333 -0.394 . . . . 1.59 110.787 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.411 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 78.2 mt -60.39 -45.06 94.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 1.09 110.927 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.493 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.1 mp -62.34 -50.95 69.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.72 110.836 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.6 mt -58.15 -41.54 83.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.5 110.599 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 172' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 73.0 m -55.02 -52.19 63.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.031 -0.531 . . . . 0.31 111.1 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.42 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 71.6 m80 -60.58 -52.53 64.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.3 111.139 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 87.8 mt -59.98 -52.49 65.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.339 -0.392 . . . . 0.44 111.019 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.69 -42.88 99.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.134 -0.485 . . . . 0.46 111.021 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.469 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.04 -52.57 58.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.25 111.478 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.465 HG13 ' HB1' ' A' ' 176' ' ' ALA . 53.1 mt -62.23 -41.86 93.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.358 . . . . 0.31 110.9 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.08 -49.9 68.36 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.71 -0.757 . . . . 0.26 112.387 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 83.1 mt -58.47 -42.38 87.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.47 110.668 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.405 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -55.7 -49.88 63.54 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.723 -0.751 . . . . 0.27 112.36 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 55.7 mt -57.97 -45.15 87.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.859 0.362 . . . . 0.93 110.959 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -53.32 -50.9 64.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 1.52 110.693 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 183' ' ' ILE . . . . . 0.409 ' HA ' ' HG2' ' B' ' 186' ' ' ARG . 64.5 mt -62.3 -41.97 93.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.031 -0.531 . . . . 1.1 111.136 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.91 -49.07 79.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.904 -0.665 . . . . 0.72 112.842 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -61.14 -28.77 69.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.706 0.289 . . . . 2.16 111.373 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.409 ' HG2' ' HA ' ' B' ' 183' ' ' ILE . 8.0 ptm180 -95.36 28.86 2.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.881 0.372 . . . . 3.82 110.832 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 35.9 mt -84.61 -84.29 0.15 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 1.63 111.269 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 31.0 p . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.167 -0.921 . . . . 2.31 111.161 -179.62 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.475 -0.25 . . . . 7.39 112.475 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -143.15 164.89 27.14 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.681 -0.771 . . . . 6.02 112.355 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 61.8 mt -72.56 -66.35 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.797 0.332 . . . . 6.75 110.814 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.43 ' O ' ' N ' ' A' ' 159' ' ' ALA . 63.0 m-85 -78.09 -43.43 29.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.097 -0.501 . . . . 5.45 110.892 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.41 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 40.3 t 42.55 -90.66 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.95 -0.568 . . . . 5.17 111.923 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -57.35 -51.62 68.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.754 0.312 . . . . 3.89 111.371 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -56.2 -56.02 26.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 5.36 110.93 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.41 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 86.3 t80 -61.39 -50.62 72.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.147 -0.479 . . . . 3.21 111.022 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 158' ' ' SER . 87.1 mt -62.15 -32.42 73.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 3.31 111.144 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -56.49 -21.93 29.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 3.11 111.221 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 31.9 m -139.31 40.45 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.493 -0.321 . . . . 2.66 111.319 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -133.42 -61.8 0.8 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.32 -0.4 . . . . 2.06 111.025 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.498 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 91.7 mt -52.01 -46.37 92.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 1.88 111.628 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 74.1 Cg_endo -77.38 -32.16 3.12 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.059 1.839 . . . . 0.98 112.298 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.1 t -56.77 -42.74 79.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 1.47 110.57 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.61 -51.49 68.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.962 -0.563 . . . . 0.73 110.782 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 85.9 mt -52.57 -48.7 66.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.985 -0.552 . . . . 0.63 110.823 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 97.9 mt -55.97 -42.87 76.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.322 -0.399 . . . . 0.4 110.764 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.479 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 67.9 m -57.21 -52.47 65.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.23 110.871 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.417 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 73.0 m80 -62.2 -52.27 64.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.29 110.87 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.8 mt -59.0 -51.64 69.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.066 -0.516 . . . . 0.47 111.005 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 171' ' ' LEU . 85.1 mt -60.56 -42.41 96.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.41 111.008 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.623 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -56.06 -52.36 64.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.995 0.426 . . . . 0.27 110.875 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.45 -41.52 81.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.551 . . . . 0.62 110.469 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.04 -44.58 83.27 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.772 -0.728 . . . . 0.28 112.129 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 70.8 mt -61.06 -47.11 87.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.949 0.404 . . . . 0.43 110.355 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.445 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -52.68 -52.42 38.36 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.676 -0.773 . . . . 0.29 112.587 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 39.3 mt -61.96 -42.88 96.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 0.89 111.032 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.425 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 83.5 t80 -51.9 -52.08 52.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.016 0.436 . . . . 1.56 110.695 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 65.8 mt -63.5 -48.03 88.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.133 -0.485 . . . . 0.83 111.203 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.78 -52.85 45.4 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.983 -0.627 . . . . 0.64 113.692 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -54.98 -24.41 23.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.866 0.333 . . . . 2.54 110.801 -179.292 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 18.7 mtp-105 -81.98 -24.9 35.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 3.95 110.865 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 60.3 mt -65.68 -85.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.492 . . . . 1.52 111.015 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.357 -0.83 . . . . 3.05 111.206 -179.983 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.427 -0.269 . . . . 7.46 112.427 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -105.16 -144.17 12.52 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.835 -0.697 . . . . 6.55 112.594 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 44.8 mt -68.67 -39.74 80.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.889 0.376 . . . . 7.86 110.832 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.545 ' CD1' ' N ' ' B' ' 158' ' ' SER . 8.4 p90 -159.41 -48.63 0.05 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.998 -0.546 . . . . 6.6 110.724 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.545 ' N ' ' CD1' ' B' ' 157' ' ' PHE . 90.4 p 44.92 -172.56 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.01 -0.541 . . . . 5.34 112.024 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' B' ' 162' ' ' LEU . . . -51.37 -24.12 4.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.931 0.396 . . . . 4.29 110.933 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -53.67 -43.06 68.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.241 0.543 . . . . 5.73 110.735 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.565 ' CZ ' ' CD1' ' B' ' 165' ' ' PHE . 42.8 t80 -86.15 -33.2 20.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.524 -0.762 . . . . 3.56 110.753 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' B' ' 159' ' ' ALA . 84.0 mt -63.24 -42.32 99.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 3.37 111.122 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -57.4 -24.55 56.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.429 -0.351 . . . . 3.86 111.249 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 22.7 m -123.67 32.77 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 2.87 111.323 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 165' ' ' PHE . . . . . 0.565 ' CD1' ' CZ ' ' B' ' 161' ' ' PHE . 85.8 t80 -137.93 -61.95 0.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 2.48 111.336 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.481 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 73.6 mt -52.18 -46.03 93.85 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.366 -0.379 . . . . 2.14 111.809 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 87.0 Cg_endo -79.59 -35.48 0.79 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.257 1.972 . . . . 1.07 112.633 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 66.3 m -53.22 -44.13 67.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 1.59 111.08 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.413 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 84.5 mt -54.6 -51.13 66.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.28 -0.418 . . . . 1.09 111.177 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.452 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.4 mp -62.17 -46.14 90.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.387 -0.37 . . . . 0.72 110.854 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.3 -42.65 91.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.336 -0.393 . . . . 0.5 110.847 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 172' ' ' SER . . . . . 0.417 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 68.3 m -56.87 -52.21 66.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.483 . . . . 0.31 111.005 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.479 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 66.8 m80 -62.54 -52.6 62.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.3 111.289 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.78 -52.56 64.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.359 . . . . 0.44 111.24 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 69.4 mt -62.46 -43.32 99.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.316 -0.402 . . . . 0.46 111.032 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.549 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -58.36 -52.7 64.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.25 111.142 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.623 HG13 ' HB1' ' A' ' 176' ' ' ALA . 82.7 mt -60.07 -42.34 89.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.428 -0.351 . . . . 0.31 110.418 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.57 -49.75 59.86 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.564 -0.827 . . . . 0.26 111.97 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 88.7 mt -56.25 -46.76 79.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.47 110.397 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.03 -42.98 55.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.526 -0.845 . . . . 0.27 111.812 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.445 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 17.7 mm -60.05 -51.87 67.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.836 0.35 . . . . 0.93 110.611 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.436 ' HA ' ' HG2' ' B' ' 185' ' ' ARG . 51.0 t80 -51.3 -49.48 61.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.792 -0.64 . . . . 1.52 111.224 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 61.1 mt -58.73 -52.45 59.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.212 -0.449 . . . . 1.1 111.324 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 184' ' ' GLY . . . . . 0.435 ' HA2' ' CD1' ' B' ' 187' ' ' LEU . . . -59.0 -52.38 53.72 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.882 -0.675 . . . . 0.72 113.098 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' B' ' 182' ' ' TYR . 6.1 ptp180 -55.37 -31.25 61.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.366 . . . . 2.16 111.141 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.429 ' N ' ' HG3' ' B' ' 185' ' ' ARG . 72.6 mtp85 -102.54 56.2 0.78 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.041 -0.527 . . . . 3.82 110.846 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 187' ' ' LEU . . . . . 0.435 ' CD1' ' HA2' ' B' ' 184' ' ' GLY . 50.1 mt -113.03 -84.55 0.59 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.944 -0.571 . . . . 1.63 111.266 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 27.7 p . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.258 -0.877 . . . . 2.31 111.327 -179.499 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.454 -0.258 . . . . 7.39 112.454 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -161.93 175.54 38.44 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.813 -0.708 . . . . 6.02 112.479 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 23.4 mm -69.82 -52.73 28.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.94 0.4 . . . . 6.75 111.07 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.465 ' HB2' ' CB ' ' A' ' 161' ' ' PHE . 63.1 m-85 -76.22 -29.83 57.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.88 -0.6 . . . . 5.45 111.056 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.8 p 81.26 -158.94 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.055 -0.521 . . . . 5.17 111.43 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 162' ' ' LEU . . . -51.78 -25.19 7.09 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.461 -0.336 . . . . 3.89 111.262 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -56.79 -44.84 82.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.368 -0.378 . . . . 5.36 110.425 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.539 ' CZ ' ' CD1' ' A' ' 165' ' ' PHE . 85.3 t80 -86.17 -40.2 15.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 3.21 110.685 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 159' ' ' ALA . 75.2 mt -61.72 -32.94 73.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.298 -0.41 . . . . 3.31 110.507 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -58.37 -24.9 61.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 3.11 110.898 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.9 m -131.68 43.56 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.194 -0.457 . . . . 2.66 111.116 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.539 ' CD1' ' CZ ' ' A' ' 161' ' ' PHE . 88.6 t80 -127.59 -53.86 1.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 2.06 110.692 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.489 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 87.3 mt -48.59 -55.69 18.28 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.182 -0.463 . . . . 1.88 111.175 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 32.7 Cg_endo -63.99 -37.66 42.17 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 121.895 1.73 . . . . 0.98 111.515 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 60.3 m -50.23 -48.96 54.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 1.47 110.68 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 78.1 mt -54.71 -50.7 67.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.507 . . . . 0.73 110.173 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.31 -42.92 96.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.05 -0.523 . . . . 0.63 110.208 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 76.5 mt -62.17 -41.27 98.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.961 -0.563 . . . . 0.4 110.635 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.428 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 73.6 m -55.85 -52.72 63.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.359 -0.382 . . . . 0.23 110.855 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.437 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 73.3 m80 -62.6 -52.09 64.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.29 110.929 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.5 mt -59.88 -52.55 64.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.226 -0.443 . . . . 0.47 111.21 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 75.0 mt -56.2 -46.02 79.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.41 110.542 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.504 ' HB3' ' HB1' ' B' ' 176' ' ' ALA . . . -52.41 -52.01 56.08 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.142 -0.481 . . . . 0.27 110.15 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 69.1 mt -58.85 -42.56 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 115.975 -0.557 . . . . 0.62 109.81 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.23 -43.65 64.18 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.654 -0.784 . . . . 0.28 111.724 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 78.5 mt -60.21 -46.01 91.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.95 0.405 . . . . 0.43 110.115 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -58.59 -43.59 96.04 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.554 -0.832 . . . . 0.29 112.029 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 45.6 mm -58.31 -44.41 88.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.899 0.381 . . . . 0.89 110.749 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.4 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 76.8 t80 -60.03 -49.54 77.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 1.56 110.741 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 57.9 mt -62.23 -48.92 86.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.83 111.31 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.2 -52.67 51.35 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.768 -0.729 . . . . 0.64 113.046 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.12 -17.93 59.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.707 0.289 . . . . 2.54 111.224 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 28.5 mmt180 -82.05 4.94 21.01 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.544 -0.298 . . . . 3.95 111.417 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 51.1 mt -75.8 -84.66 0.05 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.912 0.387 . . . . 1.52 111.063 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 188' ' ' THR . 2.2 t . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.336 -0.84 . . . . 3.05 111.227 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 112.482 -0.247 . . . . 7.46 112.482 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -142.96 169.35 25.69 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.665 -0.779 . . . . 6.55 112.409 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 51.9 mt -70.77 -55.55 13.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.949 0.404 . . . . 7.86 110.907 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -76.14 -41.34 50.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 6.6 110.686 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.42 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 67.9 m 40.13 -94.1 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.944 -0.571 . . . . 5.34 111.578 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.423 ' O ' ' CD ' ' B' ' 163' ' ' LYS . . . -58.96 -54.84 42.61 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.679 0.276 . . . . 4.29 111.195 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 160' ' ' GLU . . . . . 0.422 ' HA ' ' HG2' ' B' ' 163' ' ' LYS . 38.8 tt0 -53.95 -26.09 23.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.175 -0.466 . . . . 5.73 111.361 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -80.16 -42.6 23.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.818 0.342 . . . . 3.56 110.792 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' B' ' 158' ' ' SER . 22.4 mt -63.88 -26.1 68.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.421 . . . . 3.37 111.096 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.423 ' CD ' ' O ' ' B' ' 159' ' ' ALA . 20.5 mmmt -56.98 -36.87 70.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.017 0.437 . . . . 3.86 110.578 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 31.7 m -114.18 30.17 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.937 -0.574 . . . . 2.87 111.239 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 165' ' ' PHE . . . . . 0.42 ' HB3' ' HA ' ' B' ' 162' ' ' LEU . 52.9 t80 -120.06 -46.55 2.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.425 -0.352 . . . . 2.48 110.903 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.488 ' HB2' ' HD3' ' B' ' 167' ' ' PRO . 91.0 mt -50.32 -54.37 35.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 2.14 111.267 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.488 ' HD3' ' HB2' ' B' ' 166' ' ' LEU . 53.3 Cg_endo -68.6 -35.77 16.28 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.136 1.891 . . . . 1.07 112.176 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.5 t -50.87 -42.29 58.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 1.59 110.98 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.414 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 46.0 mt -54.13 -50.68 66.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.435 . . . . 1.09 110.68 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.48 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.0 mp -61.14 -44.12 97.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.72 110.386 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.05 -41.56 98.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.5 110.279 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 172' ' ' SER . . . . . 0.437 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 73.6 m -55.06 -44.24 74.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.081 -0.509 . . . . 0.31 110.502 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.428 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 68.7 m80 -61.74 -52.54 63.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.3 110.846 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 94.4 mt -58.44 -52.56 65.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.862 0.363 . . . . 0.44 110.723 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.8 -42.2 99.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.073 -0.512 . . . . 0.46 111.204 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' A' ' 176' ' ' ALA . . . -59.11 -52.46 65.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.426 . . . . 0.25 111.573 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.441 HG13 ' HB1' ' A' ' 176' ' ' ALA . 87.0 mt -56.97 -45.54 83.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 0.31 110.648 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.8 -45.89 77.85 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.511 -0.852 . . . . 0.26 111.855 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 95.8 mt -55.78 -46.26 78.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.942 0.401 . . . . 0.47 110.143 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.15 -41.62 79.1 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.744 -0.741 . . . . 0.27 112.051 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 53.4 mt -61.11 -46.86 95.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.878 0.371 . . . . 0.93 110.803 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.431 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 89.0 t80 -59.7 -46.92 87.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.05 -0.523 . . . . 1.52 110.963 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 183' ' ' ILE . . . . . 0.4 ' O ' ' HG ' ' B' ' 187' ' ' LEU . 47.8 mt -62.99 -47.71 91.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.326 -0.397 . . . . 1.1 111.511 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 184' ' ' GLY . . . . . 0.432 ' HA2' ' CD1' ' B' ' 187' ' ' LEU . . . -55.09 -51.92 50.57 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 121.284 -0.484 . . . . 0.72 113.624 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.8 OUTLIER -60.07 -22.42 62.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.788 0.328 . . . . 2.16 111.366 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.45 ' O ' HD23 ' B' ' 187' ' ' LEU . 12.2 mmm180 -96.28 38.41 1.2 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.38 -0.373 . . . . 3.82 111.441 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 187' ' ' LEU . . . . . 0.45 HD23 ' O ' ' B' ' 186' ' ' ARG . 23.3 mt -127.0 -65.09 0.97 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.486 0.66 . . . . 1.63 110.426 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 34.7 p . . . . . 0 C--O 1.249 1.049 0 CA-C-N 114.882 -1.054 . . . . 2.31 111.325 -179.83 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.516 -0.234 . . . . 7.39 112.516 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -113.82 160.04 13.37 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.743 -0.741 . . . . 6.02 112.486 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 56.8 mt -71.4 -65.16 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 6.75 110.992 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.43 ' O ' ' N ' ' A' ' 159' ' ' ALA . 34.1 m-85 -77.69 -63.63 1.34 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.013 -0.54 . . . . 5.45 111.087 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.412 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 33.7 t 44.12 -90.55 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.095 -0.502 . . . . 5.17 111.569 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.7 -52.63 64.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.744 0.307 . . . . 3.89 110.932 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -57.28 -44.76 84.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 5.36 111.018 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -68.23 -51.61 43.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 3.21 111.102 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 158' ' ' SER . 92.5 mt -62.83 -29.74 70.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 3.31 111.192 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -57.91 -41.92 83.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.389 -0.369 . . . . 3.11 110.568 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 164' ' ' VAL . 5.2 t -98.99 40.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.049 -0.523 . . . . 2.66 110.756 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -131.3 -67.04 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 2.06 110.849 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.468 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 70.7 mt -50.66 -58.21 10.8 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.109 -0.496 . . . . 1.88 111.532 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 23.7 Cg_endo -61.67 -38.54 60.45 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.187 1.925 . . . . 0.98 112.237 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 57.7 m -53.69 -42.26 67.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 1.47 110.841 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.41 -51.01 69.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.73 110.915 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 89.5 mt -55.33 -48.57 73.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.63 110.905 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.9 mt -59.07 -42.72 91.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.4 111.082 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.484 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 67.9 m -55.97 -53.1 60.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.311 -0.404 . . . . 0.23 111.025 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.411 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 70.8 m80 -62.77 -52.5 62.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.29 110.832 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 78.9 mt -57.83 -51.72 68.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.47 111.309 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 73.9 mt -60.77 -45.54 93.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.367 -0.379 . . . . 0.41 111.175 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.474 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -56.1 -52.7 63.36 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.017 0.437 . . . . 0.27 110.67 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.407 ' O ' HG12 ' A' ' 181' ' ' ILE . 63.2 mt -59.55 -42.49 88.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.128 -0.487 . . . . 0.62 109.861 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.78 -42.06 52.14 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.639 -0.791 . . . . 0.28 111.553 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 83.7 mt -61.35 -46.2 91.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.075 0.464 . . . . 0.43 109.751 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -61.55 -44.08 98.45 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.643 -0.789 . . . . 0.29 112.291 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 177' ' ' ILE . 47.5 mm -60.81 -51.32 74.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.331 . . . . 0.89 110.958 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.415 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 81.1 t80 -51.85 -52.21 51.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 1.56 110.747 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.413 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 54.8 mt -62.53 -41.91 93.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.204 -0.453 . . . . 0.83 111.312 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.74 -44.92 97.37 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.957 -0.639 . . . . 0.64 113.347 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 8.0 ptp180 -61.18 -32.64 72.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.894 0.347 . . . . 2.54 111.384 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 183' ' ' ILE . 36.8 ptt180 -85.38 -15.94 41.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.654 0.264 . . . . 3.95 111.144 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.428 ' HA ' HD23 ' A' ' 187' ' ' LEU . 15.8 mt -64.46 -81.66 0.03 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.848 0.356 . . . . 1.52 110.965 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.569 ' OXT' HG23 ' A' ' 188' ' ' THR . 4.4 t . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.149 -0.929 . . . . 3.05 111.27 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.646 -0.181 . . . . 7.46 112.646 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -112.41 -179.66 19.62 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.677 -0.773 . . . . 6.55 112.451 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 48.6 mt -72.6 -68.92 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 7.86 110.936 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -78.11 -81.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.086 -0.506 . . . . 6.6 110.848 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.575 ' O ' ' HB3' ' B' ' 159' ' ' ALA . 7.3 t 77.98 139.34 0.07 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.031 -0.531 . . . . 5.34 110.797 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' B' ' 158' ' ' SER . . . 91.83 -67.69 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.68 -0.691 . . . . 4.29 110.527 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.66 -42.86 99.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.612 -0.722 . . . . 5.73 111.13 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -83.62 -35.71 24.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 3.56 111.09 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.59 -47.08 87.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.269 -0.423 . . . . 3.37 110.869 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.631 ' HG3' HG23 ' B' ' 164' ' ' VAL . 19.2 ptpt -57.4 -26.97 61.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 3.86 110.772 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.631 HG23 ' HG3' ' B' ' 163' ' ' LYS . 3.0 t -110.38 23.29 4.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.297 -0.411 . . . . 2.87 111.053 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 165' ' ' PHE . . . . . 0.4 ' O ' ' HB3' ' B' ' 168' ' ' SER . 85.3 t80 -136.65 -52.26 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.77 0.319 . . . . 2.48 111.046 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.478 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 64.4 mt -47.84 -57.36 10.29 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.42 . . . . 2.14 111.508 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 25.0 Cg_endo -61.83 -23.93 76.66 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.156 1.904 . . . . 1.07 112.456 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 168' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' B' ' 165' ' ' PHE . 35.4 t -65.41 -45.96 81.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.417 -0.356 . . . . 1.59 110.943 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 55.3 mt -54.86 -48.71 72.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 1.09 110.786 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.436 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.6 mp -57.87 -50.33 73.7 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.199 -0.455 . . . . 0.72 110.631 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 61.6 mt -59.05 -41.48 87.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.485 . . . . 0.5 110.651 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 172' ' ' SER . . . . . 0.411 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 73.5 m -51.93 -50.32 61.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.31 110.889 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.484 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 60.6 m80 -61.18 -52.32 65.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.3 111.181 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 98.0 mt -60.91 -52.35 65.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.361 -0.381 . . . . 0.44 111.002 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.28 -43.73 98.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.46 111.039 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.474 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.41 -52.35 59.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.25 111.342 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.43 HG13 ' HB1' ' A' ' 176' ' ' ALA . 60.4 mt -60.95 -47.76 92.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.426 -0.352 . . . . 0.31 110.918 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.28 -51.1 43.87 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.639 -0.791 . . . . 0.26 112.164 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 97.3 mt -55.25 -46.86 76.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.973 0.416 . . . . 0.47 110.796 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.96 -42.9 82.08 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.669 -0.777 . . . . 0.27 112.545 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 58.2 mt -61.89 -51.1 76.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 0.93 111.019 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.405 ' O ' ' HG2' ' B' ' 185' ' ' ARG . 29.1 t80 -58.67 -49.85 76.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 1.52 110.812 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 73.7 mt -61.93 -46.02 97.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 1.1 111.101 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 184' ' ' GLY . . . . . 0.405 ' HA2' ' CD1' ' B' ' 187' ' ' LEU . . . -58.88 -49.54 77.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.639 -0.791 . . . . 0.72 112.415 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' B' ' 182' ' ' TYR . 12.2 ptm180 -60.01 -22.42 62.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.781 0.324 . . . . 2.16 111.08 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -99.53 35.0 2.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.897 0.38 . . . . 3.82 110.591 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 187' ' ' LEU . . . . . 0.405 ' CD1' ' HA2' ' B' ' 184' ' ' GLY . 77.4 mt -97.15 -85.43 0.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.98 -0.555 . . . . 1.63 111.348 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 188' ' ' THR . . . . . 0.402 ' O ' HG23 ' B' ' 188' ' ' THR . 1.5 t . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.395 -0.812 . . . . 2.31 111.18 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.593 -0.203 . . . . 7.39 112.593 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 168.7 175.59 38.29 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.823 -0.703 . . . . 6.02 112.511 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 17.4 mm -70.96 -56.34 10.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.976 0.417 . . . . 6.75 111.023 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -76.27 -58.65 3.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.975 -0.557 . . . . 5.45 111.093 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.574 ' O ' ' HB3' ' A' ' 159' ' ' ALA . 87.8 p 53.22 108.41 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.127 -0.488 . . . . 5.17 111.296 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 158' ' ' SER . . . 95.86 -66.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.576 -0.738 . . . . 3.89 110.436 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.51 -29.69 66.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 5.36 110.556 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -99.47 -45.11 5.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.953 -0.567 . . . . 3.21 110.787 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 83.6 mt -62.1 -40.11 94.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 3.31 110.533 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 159' ' ' ALA . 40.0 ttmt -58.61 -38.36 77.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.969 -0.56 . . . . 3.11 110.854 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 164' ' ' VAL . 5.1 t -100.01 30.94 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 116.06 -0.518 . . . . 2.66 111.209 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.406 ' CZ ' HD11 ' A' ' 169' ' ' LEU . 18.9 t80 -148.22 -56.59 0.22 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.861 0.362 . . . . 2.06 110.964 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.489 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 60.1 mt -49.86 -54.21 34.59 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 1.88 111.43 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 56.3 Cg_endo -68.94 -38.08 10.21 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.218 1.945 . . . . 0.98 112.406 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 65.9 m -51.14 -50.73 58.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.265 -0.425 . . . . 1.47 110.839 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.406 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 85.5 mt -61.78 -51.91 66.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.151 -0.477 . . . . 0.73 111.005 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 83.7 mt -52.88 -51.45 61.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.27 -0.423 . . . . 0.63 110.987 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 79.3 mt -58.28 -42.32 86.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.339 -0.391 . . . . 0.4 111.011 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 65.2 m -59.7 -52.13 66.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.23 111.002 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.425 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 74.8 m80 -60.44 -51.83 67.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.29 111.02 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.3 mt -57.02 -52.25 66.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 0.47 111.12 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 74.1 mt -58.12 -49.46 76.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.41 111.137 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.579 ' HB3' ' HB1' ' B' ' 176' ' ' ALA . . . -51.34 -52.24 47.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.935 0.398 . . . . 0.27 110.673 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 70.6 mt -59.2 -41.97 85.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 0.62 110.13 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.66 -46.05 89.64 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.666 -0.778 . . . . 0.28 111.834 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 44.4 mt -55.71 -47.82 76.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.004 0.43 . . . . 0.43 110.077 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.444 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -55.18 -43.75 83.87 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.792 -0.718 . . . . 0.29 112.339 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 49.4 mm -58.34 -52.28 61.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.837 0.351 . . . . 0.89 111.068 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -53.95 -48.25 70.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 1.56 110.784 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.412 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 68.7 mt -62.1 -42.62 95.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.83 111.191 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.5 -47.14 91.59 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.867 -0.682 . . . . 0.64 112.984 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.436 ' HG3' ' N ' ' A' ' 186' ' ' ARG . 13.5 ptp180 -62.18 -40.8 97.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.552 0.215 . . . . 2.54 111.407 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.436 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 15.9 ptm180 -68.69 -8.77 45.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.654 -0.248 . . . . 3.95 111.46 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.6 mt -55.93 -84.25 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.839 0.352 . . . . 1.52 110.997 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 188' ' ' THR . 4.3 t . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.42 -0.8 . . . . 3.05 111.325 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.483 -0.247 . . . . 7.46 112.483 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -168.37 -170.48 33.11 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.761 -0.733 . . . . 6.55 112.432 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 45.0 mt -71.01 -60.74 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.856 0.36 . . . . 7.86 111.025 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.446 ' HB2' ' HB2' ' B' ' 161' ' ' PHE . 68.8 m-85 -76.33 -41.58 47.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 6.6 111.135 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 70.1 m 41.69 -89.25 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.986 -0.552 . . . . 5.34 112.189 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -54.95 -63.24 1.21 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.765 0.317 . . . . 4.29 111.4 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.4 -23.32 37.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 5.73 111.276 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.446 ' HB2' ' HB2' ' B' ' 157' ' ' PHE . 41.6 t80 -77.43 -54.81 5.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.415 -0.357 . . . . 3.56 110.922 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 34.3 mt -63.13 -36.93 85.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 3.37 110.868 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.452 ' NZ ' ' HB3' ' B' ' 163' ' ' LYS . 7.8 mtpm? -56.97 -19.52 18.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.499 . . . . 3.86 111.486 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 26.4 m -133.75 34.93 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.728 0.299 . . . . 2.87 111.297 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -131.34 -60.47 0.95 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.333 -0.394 . . . . 2.48 111.421 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.48 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 89.8 mt -63.72 -46.2 82.41 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.428 -0.351 . . . . 2.14 111.883 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 99.7 Cg_exo -42.24 -53.59 3.52 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.358 2.039 . . . . 1.07 112.564 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 42.5 t -57.86 -41.51 82.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.164 -0.471 . . . . 1.59 111.098 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.416 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 27.2 mt -59.24 -51.23 70.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.317 -0.401 . . . . 1.09 111.364 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.423 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.7 mp -59.86 -49.01 79.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.738 0.304 . . . . 0.72 110.972 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.99 -41.49 98.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 0.5 110.904 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 172' ' ' SER . . . . . 0.425 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 73.0 m -57.95 -52.35 65.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.31 111.37 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 60.9 m80 -62.24 -52.45 63.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.333 -0.394 . . . . 0.3 111.358 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 97.5 mt -54.77 -53.07 59.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.921 0.391 . . . . 0.44 110.703 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.37 -49.33 74.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.962 -0.563 . . . . 0.46 110.993 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.579 ' HB1' ' HB3' ' A' ' 176' ' ' ALA . . . -51.74 -52.58 47.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.0 -0.546 . . . . 0.25 111.635 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.553 HG13 ' HB1' ' A' ' 176' ' ' ALA . 70.7 mt -62.04 -46.66 95.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.919 0.39 . . . . 0.31 110.668 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.16 -46.46 91.56 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.598 -0.81 . . . . 0.26 111.963 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 94.4 mt -55.24 -46.06 76.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.987 0.422 . . . . 0.47 110.212 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.14 -42.18 80.85 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.644 -0.789 . . . . 0.27 111.777 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.444 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 40.4 mm -58.0 -50.73 76.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.883 0.373 . . . . 0.93 110.589 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.404 ' O ' ' HG2' ' B' ' 186' ' ' ARG . 88.6 t80 -58.66 -49.76 76.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.008 -0.542 . . . . 1.52 111.237 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 50.4 mt -59.59 -51.34 73.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.367 -0.379 . . . . 1.1 111.335 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 184' ' ' GLY . . . . . 0.423 ' O ' ' HG ' ' B' ' 187' ' ' LEU . . . -62.37 -52.24 50.74 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.755 -0.736 . . . . 0.72 112.866 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.419 ' CG ' ' O ' ' B' ' 181' ' ' ILE . 0.0 OUTLIER -63.07 -13.68 38.97 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.667 0.247 . . . . 2.16 111.667 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' B' ' 182' ' ' TYR . 12.5 mmm180 -94.48 21.73 6.88 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.65 0.262 . . . . 3.82 111.127 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 187' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' B' ' 184' ' ' GLY . 7.1 mt -121.71 -66.08 1.07 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.165 0.507 . . . . 1.63 110.67 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.295 -0.859 . . . . 2.31 111.164 179.922 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.504 -0.238 . . . . 7.39 112.504 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -68.13 179.61 18.99 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.882 -0.675 . . . . 6.02 112.689 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.431 HG22 ' CE2' ' A' ' 157' ' ' PHE . 13.4 mm -69.5 -17.75 21.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.856 0.36 . . . . 6.75 111.39 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 159' ' ' ALA . 92.6 m-85 -156.21 -69.3 0.11 Allowed 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.236 -0.438 . . . . 5.45 110.745 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.422 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 80.0 p 44.39 -90.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.021 -0.536 . . . . 5.17 111.569 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -53.78 -54.49 37.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 3.89 111.17 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -56.39 -45.52 80.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 5.36 111.098 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.43 ' HB2' ' HB3' ' A' ' 157' ' ' PHE . 69.5 t80 -64.84 -54.83 24.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.394 -0.366 . . . . 3.21 111.059 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 158' ' ' SER . 21.4 mt -63.19 -33.36 75.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.395 -0.366 . . . . 3.31 110.982 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -57.07 -34.76 68.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 3.11 111.218 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.46 44.07 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 2.66 111.332 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' A' ' 161' ' ' PHE . 81.2 t80 -127.09 -65.66 0.94 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 2.06 110.863 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.514 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 55.4 mt -61.36 -43.75 90.55 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 1.88 111.354 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 23.0 Cg_exo -65.19 -36.13 38.1 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.382 2.055 . . . . 0.98 112.048 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.2 t -59.29 -43.81 92.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 1.47 110.904 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 65.3 mt -59.4 -50.15 75.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.514 . . . . 0.73 110.877 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 97.3 mt -55.39 -49.12 73.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.426 . . . . 0.63 110.734 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.9 mt -56.28 -41.97 76.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.4 110.755 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.472 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 72.9 m -57.49 -52.04 67.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 0.23 110.862 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.431 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 70.1 m80 -61.17 -50.55 72.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.29 110.815 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 92.8 mt -61.42 -52.14 65.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.47 111.119 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 66.6 mt -62.03 -43.62 98.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.332 -0.395 . . . . 0.41 111.089 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.462 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -51.84 -52.47 49.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.9 0.381 . . . . 0.27 110.623 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 66.4 mt -58.15 -41.95 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.62 110.246 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.64 -44.53 60.08 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.621 -0.799 . . . . 0.28 111.893 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 72.1 mt -61.32 -48.44 81.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.987 0.423 . . . . 0.43 110.322 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.66 -52.05 50.88 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.579 -0.82 . . . . 0.29 112.338 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 56.1 mt -53.66 -49.37 57.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.868 0.366 . . . . 0.89 110.954 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.422 ' O ' ' CG ' ' A' ' 186' ' ' ARG . 92.1 t80 -51.95 -51.43 57.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.507 . . . . 1.56 110.777 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 59.4 mt -62.7 -41.9 94.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.112 -0.494 . . . . 0.83 111.165 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.19 -52.62 48.41 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.941 -0.647 . . . . 0.64 113.265 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.07 -22.86 66.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.822 0.311 . . . . 2.54 111.005 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.422 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 1.5 mmp_? -67.28 -41.23 85.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.392 . . . . 3.95 110.935 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.402 ' N ' HD23 ' A' ' 187' ' ' LEU . 6.6 mt -52.21 -66.42 0.39 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.504 . . . . 1.52 110.664 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 81.4 p . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.278 -0.867 . . . . 3.05 111.088 179.921 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.45 -0.26 . . . . 7.46 112.45 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 167.48 179.36 40.25 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.624 -0.798 . . . . 6.55 112.511 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 48.7 mt -71.87 -66.21 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.9 0.381 . . . . 7.86 110.892 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.432 ' O ' ' N ' ' B' ' 159' ' ' ALA . 29.8 m-85 -77.56 -44.16 29.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.042 -0.526 . . . . 6.6 110.819 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 53.0 p 44.39 -89.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.849 -0.614 . . . . 5.34 111.953 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -58.33 -54.75 43.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.836 0.351 . . . . 4.29 111.469 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -54.99 -50.87 67.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.156 -0.475 . . . . 5.73 111.112 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.409 ' HB2' ' HB2' ' B' ' 157' ' ' PHE . 88.0 t80 -64.12 -49.59 71.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 3.56 111.217 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.33 -40.06 95.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 3.37 111.32 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -57.77 -32.96 68.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.282 -0.417 . . . . 3.86 111.309 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 32.4 m -112.82 28.0 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.731 0.301 . . . . 2.87 111.297 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -122.56 -52.41 1.92 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.333 -0.394 . . . . 2.48 110.806 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.481 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 85.9 mt -60.2 -45.6 97.75 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.12 -0.491 . . . . 2.14 111.525 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 89.3 Cg_endo -82.18 -26.57 2.77 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.383 2.055 . . . . 1.07 112.524 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 81.1 p -57.22 -48.56 78.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 1.59 110.929 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.424 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 84.0 mt -52.23 -49.4 64.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 1.09 111.049 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.474 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.2 mp -61.88 -47.99 82.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.36 -0.382 . . . . 0.72 111.082 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 90.2 mt -61.87 -44.74 96.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 0.5 111.141 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 172' ' ' SER . . . . . 0.431 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 71.0 m -53.04 -52.11 59.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.318 -0.401 . . . . 0.31 110.979 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.472 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 61.6 m80 -60.48 -52.5 64.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.3 111.201 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 86.6 mt -60.29 -52.35 65.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.844 0.354 . . . . 0.44 111.236 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.17 -45.3 94.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.43 . . . . 0.46 111.208 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.462 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.28 -52.53 58.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.25 111.51 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.461 HG13 ' HB1' ' A' ' 176' ' ' ALA . 69.8 mt -59.14 -42.83 87.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.827 0.346 . . . . 0.31 110.799 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.56 -51.11 50.4 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.508 -0.853 . . . . 0.26 111.963 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 66.3 mt -56.38 -42.48 77.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.911 0.386 . . . . 0.47 110.256 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.56 -47.35 70.45 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.673 -0.775 . . . . 0.27 112.069 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 49.7 mt -57.4 -48.64 82.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.868 0.366 . . . . 0.93 110.69 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -54.0 -47.07 71.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 1.52 110.502 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 72.3 mt -62.4 -51.53 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.079 -0.51 . . . . 1.1 110.934 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 184' ' ' GLY . . . . . 0.417 ' HA2' ' CD1' ' B' ' 187' ' ' LEU . . . -62.19 -52.51 49.18 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.808 -0.71 . . . . 0.72 112.8 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -20.15 51.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.724 0.297 . . . . 2.16 111.073 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -105.96 49.29 0.81 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.949 0.404 . . . . 3.82 110.509 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 187' ' ' LEU . . . . . 0.417 ' CD1' ' HA2' ' B' ' 184' ' ' GLY . 70.0 mt -113.93 -84.74 0.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 1.63 111.315 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.108 -0.948 . . . . 2.31 111.09 -179.647 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.484 -0.247 . . . . 7.39 112.484 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 178.53 175.93 46.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.813 -0.708 . . . . 6.02 112.544 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 69.9 mt -70.6 -52.72 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 6.75 111.006 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.45 ' CB ' ' HB2' ' A' ' 161' ' ' PHE . 37.8 m-85 -76.34 -63.39 1.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.039 -0.528 . . . . 5.45 110.605 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.402 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 72.8 m 40.26 -91.11 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.073 -0.512 . . . . 5.17 111.865 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -57.87 -54.54 45.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.806 0.336 . . . . 3.89 110.986 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -55.9 -36.19 67.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.424 . . . . 5.36 110.702 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.45 ' HB2' ' CB ' ' A' ' 157' ' ' PHE . 55.1 t80 -72.23 -57.57 4.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.935 -0.575 . . . . 3.21 110.792 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 158' ' ' SER . 68.2 mt -63.46 -26.22 68.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 3.31 111.052 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 167' ' ' PRO . 40.0 ttmt -57.33 -29.59 64.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 3.11 110.802 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 164' ' ' VAL . 4.9 t -113.99 39.34 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 116.232 -0.44 . . . . 2.66 111.202 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.437 ' CE2' HD11 ' A' ' 169' ' ' LEU . 80.1 t80 -149.65 -54.74 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.474 -0.33 . . . . 2.06 111.624 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.481 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 76.1 mt -60.39 -45.0 97.43 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 112.281 0.474 . . . . 1.88 112.281 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 50.9 Cg_exo -53.5 -49.43 17.37 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.181 1.92 . . . . 0.98 112.391 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.8 t -57.34 -50.07 74.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 1.47 110.88 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.437 HD11 ' CE2' ' A' ' 165' ' ' PHE . 40.8 mt -62.16 -48.97 77.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 0.73 111.053 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 166' ' ' LEU . 64.6 mt -52.26 -51.8 56.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.875 0.369 . . . . 0.63 110.757 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.6 mt -56.43 -42.35 77.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 0.4 110.856 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.421 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 74.8 m -58.38 -52.55 65.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.42 . . . . 0.23 110.85 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.423 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 72.4 m80 -62.48 -51.97 65.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.29 110.744 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.65 -51.78 68.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.47 110.987 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.7 mt -60.19 -44.11 95.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.41 110.98 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.544 ' HB3' ' HB1' ' B' ' 176' ' ' ALA . . . -53.75 -52.37 60.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.27 110.788 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.402 ' O ' HG12 ' A' ' 181' ' ' ILE . 68.5 mt -55.47 -45.42 78.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 0.62 110.162 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.91 -42.15 59.84 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.505 -0.855 . . . . 0.28 111.825 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 68.2 mt -59.06 -48.09 82.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.979 0.419 . . . . 0.43 110.105 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.435 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -58.64 -46.51 93.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.677 -0.773 . . . . 0.29 112.344 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 177' ' ' ILE . 48.0 mm -59.73 -49.93 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.878 0.371 . . . . 0.89 111.081 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -51.88 -49.93 62.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 1.56 110.915 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.449 HD12 HD11 ' B' ' 181' ' ' ILE . 71.9 mt -62.56 -42.55 96.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.83 111.186 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.4 ' O ' ' HG ' ' A' ' 187' ' ' LEU . . . -62.2 -52.51 49.17 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.849 -0.691 . . . . 0.64 112.951 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -24.17 67.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 2.54 111.017 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -69.23 -37.55 78.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.445 . . . . 3.95 111.044 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.425 HD23 ' N ' ' A' ' 187' ' ' LEU . 6.3 mt -52.13 -37.62 54.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.083 0.468 . . . . 1.52 110.53 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 75.7 p . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.222 -0.894 . . . . 3.05 111.356 179.939 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.557 -0.217 . . . . 7.46 112.557 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -139.33 -153.83 6.2 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.743 -0.741 . . . . 6.55 112.493 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 9.6 mm -70.14 -48.26 62.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.934 0.397 . . . . 7.86 111.083 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.437 ' HB2' ' HB2' ' B' ' 161' ' ' PHE . 18.3 m-30 -77.04 -39.17 50.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.976 -0.556 . . . . 6.6 111.37 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.406 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 69.0 m 44.41 -90.01 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.089 -0.505 . . . . 5.34 111.761 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -56.14 -55.14 36.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.666 0.27 . . . . 4.29 111.517 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -56.05 -46.78 78.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.462 -0.336 . . . . 5.73 111.094 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.437 ' HB2' ' HB2' ' B' ' 157' ' ' PHE . 56.1 t80 -63.94 -53.52 49.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 3.56 110.992 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 158' ' ' SER . 89.2 mt -62.4 -32.07 72.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.487 . . . . 3.37 111.059 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -60.84 -25.99 67.03 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.178 -0.465 . . . . 3.86 110.587 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.15 28.62 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.433 . . . . 2.87 111.307 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -129.82 -44.01 1.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 2.48 110.853 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.5 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 87.3 mt -65.08 -43.33 66.53 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 2.14 111.54 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 17.9 Cg_endo -90.23 24.56 0.61 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.868 2.378 . . . . 1.07 112.405 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 55.0 m -114.07 -43.61 3.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.414 -0.357 . . . . 1.59 110.891 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.419 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 82.4 mt -61.5 -41.92 98.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 1.09 110.944 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.465 HD12 ' N ' ' B' ' 170' ' ' LEU . 6.3 mp -60.48 -47.25 86.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.72 110.979 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 48.5 mt -61.02 -41.74 97.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.303 -0.408 . . . . 0.5 110.731 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 172' ' ' SER . . . . . 0.423 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 70.8 m -54.92 -51.36 66.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.31 110.937 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.421 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 67.0 m80 -61.66 -52.41 64.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.229 -0.441 . . . . 0.3 111.131 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 90.6 mt -55.39 -52.93 61.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.445 -0.343 . . . . 0.44 110.8 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.8 -45.04 94.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.46 110.979 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.544 ' HB1' ' HB3' ' A' ' 176' ' ' ALA . . . -54.67 -53.02 60.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.25 111.268 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 56.9 mt -62.19 -42.62 95.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.359 -0.382 . . . . 0.31 110.585 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.55 -46.51 81.11 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.61 -0.805 . . . . 0.26 111.9 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 94.9 mt -57.44 -47.94 80.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.37 . . . . 0.47 110.346 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.31 -43.53 64.95 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.572 -0.823 . . . . 0.27 112.34 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.449 HD11 HD12 ' A' ' 183' ' ' ILE . 40.0 mm -60.29 -49.87 82.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.872 0.367 . . . . 0.93 110.993 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -59.36 -47.97 83.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.54 . . . . 1.52 110.986 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 183' ' ' ILE . . . . . 0.409 ' O ' ' HG2' ' B' ' 186' ' ' ARG . 65.6 mt -62.17 -44.52 99.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 1.1 111.147 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.38 -46.83 93.05 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.831 -0.7 . . . . 0.72 112.92 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -62.53 -13.86 35.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.923 0.342 . . . . 2.16 111.923 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' B' ' 183' ' ' ILE . 33.5 ptt180 -106.5 29.84 6.54 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.814 0.34 . . . . 3.82 111.32 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 13.5 mt -118.57 -65.78 1.14 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.299 0.571 . . . . 1.63 110.51 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 188' ' ' THR . . . . . 0.408 HG23 ' OXT' ' B' ' 188' ' ' THR . 1.5 t . . . . . 0 C--O 1.249 1.058 0 CA-C-N 115.281 -0.872 . . . . 2.31 111.269 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.527 -0.229 . . . . 7.39 112.527 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -112.3 179.86 19.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.697 -0.763 . . . . 6.02 112.758 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.428 HG22 ' CE2' ' A' ' 157' ' ' PHE . 9.5 mt -70.29 -25.51 27.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.996 0.426 . . . . 6.75 110.947 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 159' ' ' ALA . 70.4 m-85 -156.56 -43.33 0.07 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.853 -0.612 . . . . 5.45 110.795 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.411 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 66.9 m 50.02 -86.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.09 -0.505 . . . . 5.17 111.811 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -54.18 -57.06 12.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.578 0.227 . . . . 3.89 111.599 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -56.39 -59.93 4.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.728 0.299 . . . . 5.36 110.775 -179.659 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 165' ' ' PHE . 70.0 t80 -55.61 -50.91 68.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.272 -0.422 . . . . 3.21 111.009 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 158' ' ' SER . 88.1 mt -60.52 -39.7 88.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 3.31 111.124 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -58.66 -33.68 70.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 3.11 111.136 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.8 m -115.6 24.41 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.443 -0.344 . . . . 2.66 111.555 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 161' ' ' PHE . 90.2 t80 -118.44 -55.56 2.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.766 0.317 . . . . 2.06 110.883 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.48 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 83.8 mt -56.25 -45.39 99.92 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 1.88 111.539 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 96.8 Cg_endo -80.8 -37.66 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.207 1.938 . . . . 0.98 112.339 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 80.8 p -51.34 -47.56 62.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 1.47 110.89 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 96.7 mt -61.75 -47.66 84.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.419 . . . . 0.73 110.766 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 88.4 mt -55.21 -50.52 69.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 0.63 110.938 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.8 mt -57.29 -45.18 84.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.4 110.881 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.419 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 75.8 m -55.43 -51.93 65.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.288 -0.414 . . . . 0.23 110.703 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.424 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 77.2 m80 -61.95 -48.71 79.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.033 -0.53 . . . . 0.29 110.844 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 88.8 mt -58.99 -49.8 76.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.314 -0.403 . . . . 0.47 110.921 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 82.6 mt -59.92 -51.09 71.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.41 111.086 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.543 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -52.03 -52.65 49.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 0.27 110.933 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.28 -42.28 90.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.044 -0.525 . . . . 0.62 110.274 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.66 -44.64 60.22 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.579 -0.82 . . . . 0.28 112.102 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 50.8 mt -62.61 -52.53 63.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.859 0.361 . . . . 0.43 110.494 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.01 -52.14 45.28 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.732 -0.747 . . . . 0.29 112.545 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 59.3 mt -55.76 -41.56 66.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.813 0.339 . . . . 0.89 110.582 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -55.39 -43.27 75.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.123 -0.49 . . . . 1.56 110.596 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.402 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 4.7 mm -61.67 -48.71 87.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.938 0.399 . . . . 0.83 110.843 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -58.79 -50.8 63.66 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.963 -0.637 . . . . 0.64 112.933 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -55.43 -26.53 42.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.667 0.27 . . . . 2.54 111.387 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 183' ' ' ILE . 4.7 ptm85 -98.92 37.95 1.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.875 0.369 . . . . 3.95 110.978 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 27.1 mt -115.81 -70.14 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.297 0.57 . . . . 1.52 110.582 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 66.0 p . . . . . 0 C--O 1.249 1.064 0 CA-C-N 115.188 -0.914 . . . . 3.05 111.072 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.511 -0.236 . . . . 7.46 112.511 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -149.22 -169.68 16.03 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.634 -0.793 . . . . 6.55 112.709 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 156' ' ' ILE . . . . . 0.503 HG22 ' CE2' ' B' ' 157' ' ' PHE . 9.4 mm -70.19 -20.41 22.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.75 0.309 . . . . 7.86 111.347 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.503 ' CE2' HG22 ' B' ' 156' ' ' ILE . 96.1 m-85 -161.57 -58.65 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 6.6 110.853 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 29.1 t 46.36 -88.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.995 -0.548 . . . . 5.34 111.598 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -57.29 -55.88 29.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.872 0.367 . . . . 4.29 111.492 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -54.69 -27.96 44.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.252 -0.431 . . . . 5.73 111.609 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -88.62 -50.27 6.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.833 0.349 . . . . 3.56 111.128 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.69 -37.62 87.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 3.37 111.24 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -55.94 -23.2 30.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 3.86 111.041 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 31.4 m -131.17 45.5 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.335 -0.393 . . . . 2.87 111.072 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 165' ' ' PHE . . . . . 0.492 ' CZ ' HD11 ' B' ' 169' ' ' LEU . 34.5 t80 -139.96 -65.7 0.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 2.48 110.925 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.486 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 81.0 mt -49.82 -58.82 8.19 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 2.14 111.63 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 1.4 Cg_endo -42.83 -53.31 4.02 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.512 2.141 . . . . 1.07 112.587 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 51.0 m -52.13 -42.93 63.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.865 0.364 . . . . 1.59 111.175 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.492 HD11 ' CZ ' ' B' ' 165' ' ' PHE . 49.8 mt -61.99 -49.93 74.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 1.09 111.216 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.443 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.6 mp -61.68 -49.77 75.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.463 -0.335 . . . . 0.72 110.885 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 88.8 mt -57.34 -41.82 80.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.379 -0.373 . . . . 0.5 110.775 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 172' ' ' SER . . . . . 0.424 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 67.5 m -57.21 -51.3 69.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.31 110.976 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.419 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 69.0 m80 -61.17 -52.47 64.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.335 -0.393 . . . . 0.3 111.017 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 88.2 mt -60.49 -52.3 65.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.907 0.384 . . . . 0.44 110.92 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.17 -42.61 99.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.065 -0.516 . . . . 0.46 110.948 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.6 -52.03 61.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.055 -0.52 . . . . 0.25 111.333 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.528 HG13 ' HB1' ' A' ' 176' ' ' ALA . 59.8 mt -60.44 -44.41 96.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.75 0.31 . . . . 0.31 110.853 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.58 -51.78 49.82 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.608 -0.806 . . . . 0.26 112.263 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.8 -41.98 78.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.756 0.312 . . . . 0.47 110.651 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.47 -49.32 74.2 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.712 -0.756 . . . . 0.27 112.197 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 60.3 mt -54.83 -50.98 56.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.93 110.756 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.418 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 80.3 t80 -53.05 -52.31 58.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.077 -0.51 . . . . 1.52 110.812 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 63.3 mt -62.26 -45.17 99.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 1.1 110.974 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -58.81 -48.66 84.13 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.764 -0.731 . . . . 0.72 112.688 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.418 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 6.9 ptp180 -58.91 -18.54 34.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.576 0.227 . . . . 2.16 111.376 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -108.19 49.35 0.81 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.914 0.388 . . . . 3.82 110.826 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 18.1 mt -111.39 -82.22 0.58 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 1.63 111.141 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 28.3 p . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.154 -0.927 . . . . 2.31 111.188 -179.727 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.591 -0.203 . . . . 7.39 112.591 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 154.45 166.7 15.39 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.836 -0.697 . . . . 6.02 112.336 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 61.8 mt -70.28 -54.37 18.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.862 0.363 . . . . 6.75 110.888 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 159' ' ' ALA . 87.5 m-85 -75.3 -61.08 2.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 5.45 110.787 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.409 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 39.8 t 43.49 -90.83 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.942 -0.572 . . . . 5.17 111.565 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.61 -52.8 63.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.736 0.303 . . . . 3.89 111.149 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.15 -37.06 71.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.342 -0.39 . . . . 5.36 110.994 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -75.21 -55.76 5.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 3.21 110.972 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 158' ' ' SER . 63.2 mt -62.39 -30.36 71.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 3.31 110.851 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -57.54 -35.02 69.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 3.11 110.958 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 29.0 m -125.57 52.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 2.66 111.279 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.576 ' CZ ' HD11 ' A' ' 169' ' ' LEU . 62.6 t80 -152.05 -47.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 2.06 111.085 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.499 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 89.4 mt -61.38 -56.97 28.62 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 1.88 111.797 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 11.3 Cg_endo -54.98 -48.38 21.5 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.224 1.949 . . . . 0.98 112.534 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.9 t -52.96 -52.74 57.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.445 -0.343 . . . . 1.47 111.169 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.576 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 42.0 mt -62.74 -51.4 67.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.324 -0.398 . . . . 0.73 111.569 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 93.0 mt -51.49 -52.17 48.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.475 -0.329 . . . . 0.63 111.153 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 83.5 mt -62.22 -42.78 99.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.395 -0.366 . . . . 0.4 111.137 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.414 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 72.2 m -62.13 -53.0 61.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.436 -0.347 . . . . 0.23 111.491 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.428 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 64.7 m80 -62.62 -53.11 59.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.496 -0.32 . . . . 0.29 111.185 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 95.8 mt -57.0 -52.48 65.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.416 -0.356 . . . . 0.47 111.098 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 171' ' ' LEU . 74.3 mt -56.53 -41.44 76.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.404 -0.362 . . . . 0.41 110.297 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.502 ' HB3' ' HB1' ' B' ' 176' ' ' ALA . . . -57.61 -48.58 79.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.151 -0.477 . . . . 0.27 110.746 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.418 HD12 ' HB2' ' B' ' 179' ' ' LEU . 18.2 mm -54.11 -46.35 66.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.934 0.397 . . . . 0.62 110.394 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.31 -42.02 81.47 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.673 -0.775 . . . . 0.28 111.882 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 80.6 mt -57.45 -48.78 78.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.8 0.333 . . . . 0.43 110.433 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -61.28 -51.78 55.9 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.827 -0.701 . . . . 0.29 112.551 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 56.1 mt -53.89 -48.73 62.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.788 0.328 . . . . 0.89 111.136 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.423 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 52.8 t80 -53.74 -49.79 67.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 1.56 110.876 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 70.5 mt -63.17 -42.23 95.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.151 -0.477 . . . . 0.83 111.385 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.4 -53.11 44.41 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.8 -0.714 . . . . 0.64 113.507 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -62.68 -17.26 60.29 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.712 0.264 . . . . 2.54 111.712 -179.711 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -86.33 -25.29 25.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.592 0.234 . . . . 3.95 111.525 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 14.9 mt -49.81 -61.04 2.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.326 0.584 . . . . 1.52 110.788 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.435 HG21 ' O ' ' B' ' 188' ' ' THR . 1.6 t . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.235 -0.888 . . . . 3.05 111.131 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.538 -0.225 . . . . 7.46 112.538 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -117.46 174.2 15.12 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.81 -0.71 . . . . 6.55 112.435 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 49.5 mt -71.98 -64.91 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 7.86 111.088 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -76.93 -76.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 6.6 110.762 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 64.3 m 62.49 -83.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 5.34 111.462 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.67 80.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.434 -0.348 . . . . 4.29 111.644 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 160' ' ' GLU . . . . . 0.401 ' HA ' ' HE3' ' B' ' 163' ' ' LYS . 17.7 mm-40 -56.6 -30.05 62.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 5.73 111.664 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -92.8 -48.99 6.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.79 0.328 . . . . 3.56 111.1 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 69.9 mt -63.66 -31.82 73.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.196 -0.456 . . . . 3.37 111.406 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.421 ' O ' ' CG ' ' B' ' 167' ' ' PRO . 16.2 ptpt -56.75 -23.12 40.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.506 -0.316 . . . . 3.86 111.175 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 20.3 t -96.77 -18.11 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 2.87 111.465 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 165' ' ' PHE . . . . . 0.519 ' CE2' HD11 ' B' ' 169' ' ' LEU . 35.3 t80 -89.58 -42.7 11.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.514 -0.312 . . . . 2.48 111.477 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.464 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 71.2 mt -57.31 -48.13 97.85 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.485 -0.325 . . . . 2.14 111.739 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 78.2 Cg_exo -40.77 -54.73 2.27 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.347 2.031 . . . . 1.07 112.638 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.6 m -56.35 -41.7 76.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.065 -0.516 . . . . 1.59 110.967 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.519 HD11 ' CE2' ' B' ' 165' ' ' PHE . 14.4 mt -62.1 -48.06 81.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.314 -0.403 . . . . 1.09 111.192 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.404 HD12 ' N ' ' B' ' 170' ' ' LEU . 8.1 mp -59.62 -49.66 76.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.743 0.306 . . . . 0.72 110.761 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 97.8 mt -54.32 -41.74 69.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.5 110.663 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 172' ' ' SER . . . . . 0.428 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 59.8 m -59.95 -48.21 82.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.31 111.249 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.414 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 68.2 m80 -60.4 -52.08 66.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.3 110.958 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 74.0 mt -61.03 -52.46 64.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.359 . . . . 0.44 110.86 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.0 -44.12 97.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.46 110.901 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.502 ' HB1' ' HB3' ' A' ' 176' ' ' ALA . . . -52.81 -52.47 56.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.486 . . . . 0.25 110.897 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 88.2 mt -55.38 -44.6 76.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.177 -0.465 . . . . 0.31 110.285 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.77 -41.84 58.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.531 -0.842 . . . . 0.26 111.479 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.418 ' HB2' HD12 ' A' ' 177' ' ' ILE . 80.0 mt -59.2 -48.13 82.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.02 0.438 . . . . 0.47 110.288 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.51 -51.17 38.93 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.81 -0.709 . . . . 0.27 112.565 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.408 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 58.3 mt -57.59 -52.15 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.735 0.302 . . . . 0.93 110.946 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.405 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 60.4 t80 -52.6 -50.12 63.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 1.52 111.182 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 183' ' ' ILE . . . . . 0.425 ' O ' ' CD2' ' B' ' 187' ' ' LEU . 57.2 mt -62.75 -52.31 61.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 1.1 111.362 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.03 -50.72 64.82 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.983 -0.627 . . . . 0.72 113.333 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' B' ' 181' ' ' ILE . 0.0 OUTLIER -62.91 -11.4 18.27 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.031 0.382 . . . . 2.16 112.031 -179.578 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -103.06 17.09 24.9 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 111.7 0.259 . . . . 3.82 111.7 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 187' ' ' LEU . . . . . 0.425 ' CD2' ' O ' ' B' ' 183' ' ' ILE . 3.5 mt -113.6 -67.05 1.03 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.242 0.544 . . . . 1.63 110.719 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 188' ' ' THR . . . . . 0.435 ' O ' HG21 ' A' ' 188' ' ' THR . 1.6 t . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.199 -0.905 . . . . 2.31 111.275 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 112.429 -0.268 . . . . 7.39 112.429 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 158.68 176.39 30.69 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.794 -0.717 . . . . 6.02 112.418 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.478 HD12 ' N ' ' A' ' 156' ' ' ILE . 4.0 mp -73.05 -63.75 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 6.75 110.532 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.439 ' O ' ' N ' ' A' ' 159' ' ' ALA . 26.7 m-85 -76.67 -55.19 5.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 5.45 110.893 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.401 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 29.5 t 42.53 -89.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.992 -0.549 . . . . 5.17 111.932 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -57.41 -54.61 44.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.825 0.345 . . . . 3.89 111.458 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.419 ' HA ' ' HE2' ' A' ' 163' ' ' LYS . 40.1 tt0 -55.47 -49.22 73.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.409 . . . . 5.36 110.973 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -66.16 -52.21 50.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.374 -0.376 . . . . 3.21 110.964 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 158' ' ' SER . 82.8 mt -62.63 -29.89 70.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.013 -0.54 . . . . 3.31 111.087 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.419 ' HE2' ' HA ' ' A' ' 160' ' ' GLU . 34.8 ttpt -57.53 -34.49 69.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.491 . . . . 3.11 111.055 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 30.0 m -113.19 42.07 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.311 -0.404 . . . . 2.66 111.149 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.439 ' CZ ' HD11 ' A' ' 169' ' ' LEU . 28.3 t80 -133.01 -55.16 0.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.056 -0.52 . . . . 2.06 110.794 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.505 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 61.2 mt -60.75 -44.66 95.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 1.88 111.484 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 87.5 Cg_exo -46.32 -44.41 20.25 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.422 2.082 . . . . 0.98 112.521 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 36.4 t -69.59 -41.96 75.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 1.47 111.048 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.439 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 53.1 mt -61.96 -44.22 97.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.73 110.669 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 96.8 mt -53.67 -51.29 63.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.63 110.651 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 83.9 mt -59.06 -45.24 91.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.126 -0.488 . . . . 0.4 111.087 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.423 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 69.9 m -53.53 -53.11 56.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.23 110.874 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.415 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 74.5 m80 -63.03 -52.12 64.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.29 110.939 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.4 mt -54.62 -52.56 61.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.47 110.932 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.55 -48.92 77.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.315 -0.402 . . . . 0.41 111.027 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.534 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -51.92 -52.99 46.11 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.215 -0.448 . . . . 0.27 111.165 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.508 ' O ' HD12 ' A' ' 181' ' ' ILE . 62.8 mt -58.14 -46.85 88.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.411 . . . . 0.62 110.058 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.08 -41.89 53.88 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.671 -0.776 . . . . 0.28 111.861 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 99.5 mt -58.94 -49.12 79.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.029 0.442 . . . . 0.43 110.458 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.439 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -55.03 -50.69 58.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.764 -0.731 . . . . 0.29 112.876 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.508 HD12 ' O ' ' A' ' 177' ' ' ILE . 4.0 mp -62.58 -46.01 97.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.802 0.334 . . . . 0.89 110.628 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.401 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 51.4 t80 -51.82 -52.73 47.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 1.56 110.975 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.76 -45.41 97.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.369 -0.378 . . . . 0.83 111.405 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.7 -52.48 50.5 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.928 -0.653 . . . . 0.64 113.263 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -61.06 -19.53 61.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.76 0.314 . . . . 2.54 110.98 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -91.86 19.6 6.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.397 -0.365 . . . . 3.95 110.988 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 49.8 mt -99.04 -82.74 0.43 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.933 0.397 . . . . 1.52 110.74 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.248 -0.882 . . . . 3.05 111.087 179.642 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.537 -0.225 . . . . 7.46 112.537 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -149.39 -165.35 12.3 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.779 -0.725 . . . . 6.55 112.532 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 13.5 mm -69.79 -63.48 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.033 0.444 . . . . 7.86 110.916 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.425 ' O ' ' HB3' ' B' ' 158' ' ' SER . 86.1 m-85 -76.85 -66.5 0.81 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.799 -0.637 . . . . 6.6 110.689 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' B' ' 157' ' ' PHE . 9.0 t 79.79 -161.59 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.103 -0.498 . . . . 5.34 111.067 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -55.32 -25.15 32.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.387 -0.369 . . . . 4.29 111.258 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 160' ' ' GLU . . . . . 0.426 ' HA ' ' HE2' ' B' ' 163' ' ' LYS . 41.6 mt-10 -52.21 -32.24 35.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.385 -0.37 . . . . 5.73 110.861 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -85.15 -39.1 18.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.023 -0.535 . . . . 3.56 110.559 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 90.7 mt -64.52 -32.88 74.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.936 -0.575 . . . . 3.37 111.169 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.426 ' HE2' ' HA ' ' B' ' 160' ' ' GLU . 48.4 mtmt -57.22 -31.6 65.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.29 -0.414 . . . . 3.86 111.231 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 35.7 m -118.15 41.23 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.427 -0.351 . . . . 2.87 111.495 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -151.68 -53.27 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 2.48 111.352 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.475 ' HB2' ' CD ' ' B' ' 167' ' ' PRO . 69.2 mt -60.79 -60.36 10.91 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 112.267 0.469 . . . . 2.14 112.267 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.475 ' CD ' ' HB2' ' B' ' 166' ' ' LEU . 5.7 Cg_exo -37.29 -54.16 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.085 2.523 . . . . 1.07 113.172 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 45.0 t -54.11 -44.83 71.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.565 -0.289 . . . . 1.59 111.403 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.403 ' CD2' ' CD2' ' A' ' 169' ' ' LEU . 26.6 mt -62.81 -48.37 79.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.009 0.374 . . . . 1.09 112.009 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.413 ' N ' HD12 ' B' ' 170' ' ' LEU . 8.1 mp -54.22 -51.97 62.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.736 0.303 . . . . 0.72 111.19 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.4 mt -62.34 -43.88 97.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.358 -0.383 . . . . 0.5 111.143 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 172' ' ' SER . . . . . 0.415 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 75.1 m -58.18 -52.55 65.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.282 -0.417 . . . . 0.31 111.635 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.423 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 62.5 m80 -60.78 -52.55 64.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.446 -0.343 . . . . 0.3 111.378 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.5 mt -56.49 -51.4 68.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.408 -0.36 . . . . 0.44 111.272 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.38 -46.24 89.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.291 -0.413 . . . . 0.46 111.49 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -59.62 -53.03 62.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.394 -0.366 . . . . 0.25 111.606 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.532 HG13 ' HB1' ' A' ' 176' ' ' ALA . 40.5 mt -62.19 -42.89 96.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.813 0.34 . . . . 0.31 110.726 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.34 -51.79 51.93 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.552 -0.832 . . . . 0.26 112.194 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.408 ' O ' HG12 ' B' ' 183' ' ' ILE . 95.5 mt -53.91 -51.23 64.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.787 0.327 . . . . 0.47 110.487 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.29 -42.49 49.77 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.58 -0.819 . . . . 0.27 112.422 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.439 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 29.6 mm -59.81 -47.65 90.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.711 0.291 . . . . 0.93 110.69 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.408 ' OH ' ' NH1' ' B' ' 186' ' ' ARG . 67.5 t80 -57.19 -52.14 66.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 1.52 110.912 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 183' ' ' ILE . . . . . 0.408 HG12 ' O ' ' B' ' 179' ' ' LEU . 13.1 mm -62.37 -44.69 99.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 1.1 111.201 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.84 -52.21 53.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.833 -0.698 . . . . 0.72 113.013 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.435 ' HG3' ' N ' ' B' ' 186' ' ' ARG . 8.1 ptp180 -55.17 -33.44 62.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 2.16 111.036 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.435 ' N ' ' HG3' ' B' ' 185' ' ' ARG . 77.5 mtp180 -108.52 57.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.296 -0.411 . . . . 3.82 111.043 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 30.8 mt -98.86 -83.95 0.41 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 1.63 111.124 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.185 -0.912 . . . . 2.31 111.229 -179.843 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.553 -0.219 . . . . 7.39 112.553 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -93.33 177.79 38.07 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.719 -0.753 . . . . 6.02 112.392 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 55.4 mt -70.58 -65.1 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.942 0.401 . . . . 6.75 110.69 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.4 ' HB3' ' HB2' ' A' ' 160' ' ' GLU . 59.2 m-85 -77.51 -70.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.973 -0.558 . . . . 5.45 110.745 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.2 t 66.03 -77.47 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.963 -0.562 . . . . 5.17 111.394 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.26 -51.8 66.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.107 -0.497 . . . . 3.89 111.572 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.4 ' HB2' ' HB3' ' A' ' 157' ' ' PHE . 1.2 mp0 -57.5 -57.37 12.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.386 -0.37 . . . . 5.36 111.102 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -62.5 -48.57 78.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 3.21 111.106 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 77.1 mt -62.64 -33.27 74.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.197 -0.456 . . . . 3.31 111.216 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -58.08 -28.83 64.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.306 -0.406 . . . . 3.11 111.253 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.81 37.83 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.445 -0.343 . . . . 2.66 111.536 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.492 ' CZ ' HD11 ' A' ' 169' ' ' LEU . 90.5 t80 -139.2 -57.51 0.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.39 . . . . 2.06 111.108 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.495 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 60.8 mt -57.68 -44.8 99.72 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 1.88 111.728 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 63.2 Cg_exo -51.16 -54.06 6.08 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.285 1.99 . . . . 0.98 112.308 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 86.7 p -53.18 -48.78 67.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 1.47 111.092 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.492 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 46.8 mt -62.08 -51.93 65.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.73 110.986 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 88.2 mt -55.42 -50.37 69.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.11 -0.495 . . . . 0.63 110.952 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 94.4 mt -57.32 -45.43 84.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.4 111.151 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.44 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 73.1 m -56.56 -53.23 60.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.872 0.368 . . . . 0.23 110.986 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.432 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 77.7 m80 -63.02 -52.36 63.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.29 110.949 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.6 mt -58.86 -52.14 67.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.47 111.147 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 171' ' ' LEU . 77.1 mt -59.44 -46.93 87.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.39 . . . . 0.41 110.788 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.464 ' HB3' ' HB1' ' B' ' 176' ' ' ALA . . . -53.37 -52.24 59.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.262 -0.426 . . . . 0.27 110.781 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 86.1 mt -58.69 -41.78 83.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.255 -0.43 . . . . 0.62 110.332 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.96 -45.98 55.8 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.672 -0.775 . . . . 0.28 111.943 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 50.9 mt -62.14 -48.05 81.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.835 0.35 . . . . 0.43 110.516 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.06 -52.42 47.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.551 -0.833 . . . . 0.29 112.306 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' B' ' 180' ' ' GLY . 47.7 mt -60.35 -43.34 93.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.811 0.339 . . . . 0.89 111.091 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.419 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 78.5 t80 -53.72 -48.25 69.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.13 -0.486 . . . . 1.56 110.659 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.409 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 76.5 mt -62.54 -41.55 92.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.83 111.106 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.09 -44.11 98.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.99 -0.624 . . . . 0.64 113.208 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 10.9 ptp180 -62.44 -39.09 92.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.83 0.315 . . . . 2.54 111.581 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 183' ' ' ILE . 10.5 ptm180 -69.94 -17.16 63.31 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.656 0.243 . . . . 3.95 111.656 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 57.2 mt -52.36 -83.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.887 0.375 . . . . 1.52 110.852 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.141 -0.933 . . . . 3.05 111.256 179.887 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 112.532 -0.227 . . . . 7.46 112.532 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -90.55 -173.15 44.41 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.755 -0.736 . . . . 6.55 112.455 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 156' ' ' ILE . . . . . 0.598 HG22 ' CE2' ' B' ' 157' ' ' PHE . 9.2 mm -69.75 -18.68 22.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.742 0.306 . . . . 7.86 111.394 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.598 ' CE2' HG22 ' B' ' 156' ' ' ILE . 87.1 m-85 -160.06 -71.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.888 0.375 . . . . 6.6 110.991 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.411 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 58.1 m 61.8 -91.91 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.114 -0.494 . . . . 5.34 110.885 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.24 -58.35 8.35 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.868 0.366 . . . . 4.29 110.953 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 160' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' B' ' 163' ' ' LYS . 41.5 tt0 -58.03 -21.78 46.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.065 -0.516 . . . . 5.73 111.095 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -86.52 -41.09 14.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.383 -0.371 . . . . 3.56 111.549 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.421 ' HA ' ' HB3' ' B' ' 165' ' ' PHE . 20.5 mt -62.41 -36.85 83.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.64 0.257 . . . . 3.37 111.138 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.498 ' HG3' HG23 ' B' ' 164' ' ' VAL . 18.1 ptpt -57.49 -20.7 32.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.517 -0.31 . . . . 3.86 111.076 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.498 HG23 ' HG3' ' B' ' 163' ' ' LYS . 66.0 t -108.76 -36.41 3.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.077 0.465 . . . . 2.87 110.568 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 165' ' ' PHE . . . . . 0.563 ' CZ ' HD21 ' B' ' 169' ' ' LEU . 80.5 t80 -56.06 -77.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.657 -0.701 . . . . 2.48 111.26 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.501 ' HB2' ' CD ' ' B' ' 167' ' ' PRO . 81.9 mt -38.48 -63.46 0.57 Allowed Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 112.706 0.632 . . . . 2.14 112.706 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.501 ' CD ' ' HB2' ' B' ' 166' ' ' LEU . 2.9 Cg_exo -38.17 -55.92 1.11 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.898 2.399 . . . . 1.07 113.011 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 48.8 m -60.32 -44.8 95.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.238 -0.437 . . . . 1.59 111.615 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.563 HD21 ' CZ ' ' B' ' 165' ' ' PHE . 7.1 mp -62.9 -49.08 76.22 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.238 0.459 . . . . 1.09 112.238 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.433 ' CD1' ' O ' ' B' ' 166' ' ' LEU . 7.4 mp -52.01 -50.51 61.21 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.759 -0.377 . . . . 0.72 110.661 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 89.9 mt -57.77 -41.57 82.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 0.5 110.462 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 172' ' ' SER . . . . . 0.432 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 63.6 m -54.29 -45.8 72.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.435 . . . . 0.31 110.731 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.44 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 77.0 m80 -60.0 -52.29 66.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.454 . . . . 0.3 110.905 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 83.2 mt -57.81 -52.66 64.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.412 . . . . 0.44 110.71 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 87.3 mt -62.69 -42.34 99.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.094 -0.503 . . . . 0.46 110.857 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.464 ' HB1' ' HB3' ' A' ' 176' ' ' ALA . . . -52.2 -52.37 52.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.25 111.352 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 53.9 mt -61.85 -45.59 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.421 . . . . 0.31 111.039 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.69 -51.24 53.95 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.565 -0.826 . . . . 0.26 112.109 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.4 ' O ' HG12 ' B' ' 183' ' ' ILE . 94.3 mt -54.46 -47.63 72.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.779 0.323 . . . . 0.47 110.349 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 181' ' ' ILE . . . -51.32 -43.41 51.45 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.602 -0.808 . . . . 0.27 111.919 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 58.7 mt -58.57 -49.68 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.898 0.38 . . . . 0.93 110.456 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.423 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 55.7 t80 -54.88 -50.94 67.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.943 -0.572 . . . . 1.52 111.078 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 183' ' ' ILE . . . . . 0.4 HG12 ' O ' ' B' ' 179' ' ' LEU . 16.0 mm -62.85 -44.82 99.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.968 0.413 . . . . 1.1 111.328 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 184' ' ' GLY . . . . . 0.445 ' HA2' ' CD1' ' B' ' 187' ' ' LEU . . . -61.28 -50.84 62.64 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.114 -0.565 . . . . 0.72 113.203 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.423 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 5.6 ptp180 -51.52 -31.24 23.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.752 0.31 . . . . 2.16 111.344 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -98.87 53.68 1.0 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.886 0.374 . . . . 3.82 110.871 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 187' ' ' LEU . . . . . 0.445 ' CD1' ' HA2' ' B' ' 184' ' ' GLY . 57.9 mt -111.38 -84.45 0.57 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.007 -0.542 . . . . 1.63 111.247 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.189 -0.91 . . . . 2.31 111.184 -179.752 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 C--O 1.23 0.109 0 CA-C-O 120.829 0.262 . . . . 0.98 112.276 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.5 m -55.06 -47.79 74.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 1.47 110.895 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.19 -46.61 88.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.73 110.754 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 79.7 mt -52.48 -50.05 63.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.337 -0.392 . . . . 0.63 110.655 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 98.5 mt -57.91 -46.17 85.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.505 . . . . 0.4 110.783 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.441 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 73.0 m -55.11 -53.38 56.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.882 0.373 . . . . 0.23 111.261 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.428 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 77.2 m80 -63.21 -52.78 60.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.29 111.222 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 98.4 mt -59.85 -52.96 63.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.415 -0.357 . . . . 0.47 111.321 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 171' ' ' LEU . 67.6 mt -53.52 -41.81 66.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.035 0.445 . . . . 0.41 110.306 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.547 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -58.24 -44.56 88.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.885 -0.598 . . . . 0.27 110.369 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.423 HD13 ' O ' ' B' ' 176' ' ' ALA . 47.6 mm -55.79 -43.28 73.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.252 -0.431 . . . . 0.62 109.883 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.03 -45.37 92.46 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.718 -0.754 . . . . 0.28 111.823 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 47.8 mt -54.41 -51.36 65.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.852 0.358 . . . . 0.43 110.459 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.57 -43.06 67.61 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.631 -0.795 . . . . 0.29 112.291 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 50.2 mm -61.28 -46.98 95.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.361 . . . . 0.89 110.885 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -56.97 -45.68 82.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 1.56 110.615 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 56.5 mt -62.76 -48.48 87.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.077 -0.51 . . . . 0.83 110.956 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.25 -52.34 50.24 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.929 -0.653 . . . . 0.64 112.92 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -22.62 62.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.73 0.3 . . . . 2.54 111.188 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.356 -0.384 . . . . 3.95 111.205 179.701 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.466 -0.106 0 CA-C-O 120.827 0.261 . . . . 1.07 112.363 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 79.1 p -55.31 -41.99 73.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 1.59 111.198 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 83.2 mt -57.58 -50.74 72.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.367 -0.378 . . . . 1.09 111.331 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.462 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.5 mp -57.66 -44.94 86.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.477 -0.329 . . . . 0.72 111.126 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 93.0 mt -61.91 -41.61 98.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.354 -0.385 . . . . 0.5 110.857 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . 0.428 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 58.8 m -57.64 -52.34 65.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.31 111.358 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.441 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 73.9 m80 -62.03 -52.72 62.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.332 -0.395 . . . . 0.3 111.1 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 55.4 mt -55.64 -51.47 67.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.43 -0.35 . . . . 0.44 110.976 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 94.2 mt -60.84 -42.02 96.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.362 -0.381 . . . . 0.46 110.772 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.547 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -59.74 -52.9 63.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.25 111.04 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 73.3 mt -53.79 -42.85 54.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.863 0.363 . . . . 0.31 110.059 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.0 -43.55 82.94 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.554 -0.832 . . . . 0.26 111.649 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 94.9 mt -56.5 -50.59 71.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.972 0.415 . . . . 0.47 110.363 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.44 -46.29 81.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.676 -0.774 . . . . 0.27 112.579 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 56.9 mt -55.32 -45.62 77.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.831 0.348 . . . . 0.93 111.05 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.425 ' O ' ' HG2' ' B' ' 185' ' ' ARG . 63.1 t80 -59.58 -51.54 69.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 1.52 110.892 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 61.6 mt -62.26 -44.08 98.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 1.1 111.201 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.31 -46.36 94.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.906 -0.664 . . . . 0.72 113.092 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' B' ' 182' ' ' TYR . 12.6 ptm180 . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.675 0.274 . . . . 2.16 111.403 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo . . . . . 0 C--O 1.231 0.167 0 CA-C-O 120.822 0.259 . . . . 0.98 112.396 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 70.1 m -58.86 -43.73 90.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.298 -0.41 . . . . 1.47 110.955 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 73.0 mt -59.7 -48.7 80.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.73 110.926 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 86.4 mt -52.28 -52.08 54.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.63 110.99 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.5 mt -55.13 -43.11 73.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.4 110.927 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.418 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 75.2 m -55.23 -52.16 64.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.352 -0.385 . . . . 0.23 111.016 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.421 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 73.7 m80 -62.37 -51.12 68.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.29 111.037 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.27 -52.06 66.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.47 111.089 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 84.9 mt -58.66 -44.06 90.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.41 110.952 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.576 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -51.9 -52.19 51.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.421 . . . . 0.27 110.625 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 65.9 mt -54.08 -46.24 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.076 -0.511 . . . . 0.62 110.205 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.58 -42.68 85.02 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.614 -0.803 . . . . 0.28 111.899 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 53.4 mt -55.26 -50.38 69.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.397 . . . . 0.43 110.298 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.521 ' HA2' HD13 ' B' ' 181' ' ' ILE . . . -56.21 -46.05 86.73 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.596 -0.812 . . . . 0.29 112.18 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 39.6 mm -60.58 -48.4 88.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.82 0.343 . . . . 0.89 110.95 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.422 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 52.1 t80 -53.31 -51.94 60.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 1.56 110.982 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.96 -48.81 86.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.295 -0.412 . . . . 0.83 111.471 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.27 -51.48 56.26 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 121.162 -0.542 . . . . 0.64 113.713 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.1 OUTLIER -51.62 -31.79 26.56 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.648 -0.325 . . . . 2.54 111.231 -179.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.42 ' NH2' ' OH ' ' A' ' 182' ' ' TYR . 83.3 mtt180 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.461 -0.336 . . . . 3.95 111.233 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.462 -0.348 0 CA-C-O 120.821 0.259 . . . . 1.07 112.654 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 59.0 m -63.18 -43.99 96.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 1.59 111.455 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.411 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 89.3 mt -59.19 -51.46 69.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 1.09 111.462 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.48 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.2 mp -61.89 -49.52 75.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.464 -0.334 . . . . 0.72 111.149 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.76 -41.61 82.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 0.5 110.913 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . 0.421 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 74.8 m -56.5 -52.95 62.82 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.31 111.117 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.418 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 63.0 m80 -62.57 -52.23 64.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.345 -0.389 . . . . 0.3 110.806 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 97.4 mt -54.14 -52.11 62.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.44 111.095 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.23 -50.97 69.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.46 111.181 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.549 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.17 -52.78 57.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.424 -0.353 . . . . 0.25 111.225 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.576 HG13 ' HB1' ' A' ' 176' ' ' ALA . 62.3 mt -61.94 -41.77 92.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.836 0.35 . . . . 0.31 110.394 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.48 -50.23 48.81 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.585 -0.817 . . . . 0.26 111.836 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 83.8 mt -57.17 -44.84 83.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.901 0.382 . . . . 0.47 110.224 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.02 -46.26 85.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.615 -0.802 . . . . 0.27 112.209 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.521 HD13 ' HA2' ' A' ' 180' ' ' GLY . 34.1 mm -55.76 -50.99 64.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.882 0.372 . . . . 0.93 110.716 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.409 ' O ' ' HG2' ' B' ' 185' ' ' ARG . 50.8 t80 -52.71 -52.18 57.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 1.52 110.891 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 54.0 mt -62.18 -44.13 98.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.02 -0.537 . . . . 1.1 110.994 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.05 -50.39 65.92 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.767 -0.73 . . . . 0.72 112.692 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' B' ' 182' ' ' TYR . 13.7 ptp180 . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.789 0.328 . . . . 2.16 110.864 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 C--O 1.23 0.114 0 CA-C-O 120.756 0.232 . . . . 0.98 112.35 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.8 t -63.9 -49.44 72.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 1.47 110.825 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 45.9 mt -59.46 -45.7 90.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.226 -0.443 . . . . 0.73 110.874 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 86.9 mt -51.79 -50.24 61.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.337 -0.392 . . . . 0.63 110.58 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 93.9 mt -58.89 -41.45 87.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 0.4 110.591 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.479 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 68.9 m -56.45 -52.23 65.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.23 110.777 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.428 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 75.7 m80 -61.39 -51.86 67.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.29 110.723 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.3 mt -58.89 -52.0 67.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.47 110.88 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.0 mt -61.54 -43.35 99.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.41 110.901 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.5 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -52.81 -52.51 56.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.27 110.876 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 71.4 mt -56.91 -43.0 79.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.62 110.307 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.13 -42.03 80.27 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.524 -0.846 . . . . 0.28 111.927 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 45.2 mt -60.0 -51.59 69.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.927 0.394 . . . . 0.43 110.306 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.17 -42.98 56.24 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.602 -0.808 . . . . 0.29 112.395 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.423 HD13 ' O ' ' B' ' 180' ' ' GLY . 49.9 mm -62.06 -51.9 66.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.836 0.351 . . . . 0.89 111.102 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -56.59 -50.64 71.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 1.56 110.813 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.417 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 63.6 mt -60.3 -43.19 93.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.49 . . . . 0.83 111.047 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.2 -48.65 81.36 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.815 -0.707 . . . . 0.64 112.93 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -62.2 -38.1 87.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.593 0.235 . . . . 2.54 111.606 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 183' ' ' ILE . 37.7 ptt180 . . . . . 0 C--N 1.328 -0.34 0 N-CA-C 111.64 0.237 . . . . 3.95 111.64 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo . . . . . 0 C--O 1.231 0.138 0 CA-C-O 120.766 0.236 . . . . 1.07 112.398 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.1 t -46.87 -42.24 17.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.292 -0.413 . . . . 1.59 111.32 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 72.5 mt -62.4 -49.54 75.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 1.09 110.955 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.429 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.5 mp -57.71 -42.31 83.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.72 110.626 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 71.9 mt -59.48 -43.11 93.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.5 110.434 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . 0.428 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 69.6 m -54.74 -52.09 63.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.31 110.709 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.479 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 60.1 m80 -58.77 -52.29 66.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.049 -0.523 . . . . 0.3 110.882 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 96.5 mt -57.78 -50.32 73.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.41 . . . . 0.44 111.056 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 78.0 mt -62.11 -47.28 85.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.46 110.991 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.5 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -55.15 -52.98 61.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.25 111.076 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.491 HG13 ' HB1' ' A' ' 176' ' ' ALA . 66.1 mt -62.13 -42.84 96.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.359 -0.382 . . . . 0.31 110.609 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.57 -49.86 50.93 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.616 -0.802 . . . . 0.26 111.97 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 89.0 mt -57.91 -46.17 85.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.898 0.38 . . . . 0.47 110.455 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.423 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -56.01 -50.38 61.83 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.547 -0.835 . . . . 0.27 112.191 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 67.4 mt -53.91 -46.93 64.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 0.93 110.849 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.414 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 47.3 t80 -54.45 -51.63 64.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 1.52 110.73 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 69.5 mt -63.27 -48.79 85.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.178 -0.465 . . . . 1.1 111.16 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.29 -52.74 47.37 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.957 -0.64 . . . . 0.72 113.4 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.757 0.278 . . . . 2.16 111.214 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo . . . . . 0 C--O 1.23 0.108 0 CA-C-O 120.806 0.253 . . . . 0.98 112.511 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.6 m -78.01 -51.97 9.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 1.47 111.334 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.08 -50.16 74.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.454 -0.339 . . . . 0.73 111.218 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.402 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 96.2 mt -52.13 -52.41 51.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.417 -0.356 . . . . 0.63 111.1 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.8 mt -62.44 -41.86 99.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.305 -0.407 . . . . 0.4 111.219 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.429 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 69.1 m -60.59 -53.28 59.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.42 -0.354 . . . . 0.23 111.352 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.446 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 66.2 m80 -62.92 -52.58 62.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.745 0.307 . . . . 0.29 110.889 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 170' ' ' LEU . 96.6 mt -57.72 -52.86 63.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.412 -0.358 . . . . 0.47 110.591 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 83.5 mt -62.88 -44.82 95.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.41 110.803 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.426 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -51.53 -52.32 47.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.428 . . . . 0.27 110.933 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.41 -45.03 97.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 0.62 110.477 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.4 -49.5 51.27 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.655 -0.783 . . . . 0.28 111.99 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 43.3 mt -55.58 -49.04 73.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 0.43 110.227 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.473 ' HA2' ' CG1' ' B' ' 181' ' ' ILE . . . -51.77 -46.16 54.64 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.524 -0.846 . . . . 0.29 112.45 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 41.7 mm -62.63 -48.24 89.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.748 0.308 . . . . 0.89 111.192 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.409 ' HA ' ' HG2' ' A' ' 185' ' ' ARG . 55.6 t80 -62.07 -52.21 64.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 1.56 111.242 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 94.6 mt -51.79 -51.1 29.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.286 -0.415 . . . . 0.83 110.986 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.01 -52.56 45.98 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.49 -0.862 . . . . 0.64 112.321 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.45 ' HG3' ' N ' ' A' ' 186' ' ' ARG . 10.9 ptp180 -62.93 -41.78 99.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.956 0.408 . . . . 2.54 110.721 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.45 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 3.95 111.21 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo . . . . . 0 C--O 1.231 0.148 0 CA-C-O 120.838 0.266 . . . . 1.07 112.374 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 74.2 p -54.53 -41.67 69.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 1.59 111.009 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.417 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 59.7 mt -60.8 -52.66 64.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.329 -0.396 . . . . 1.09 111.132 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.1 mp -62.89 -44.59 95.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.756 0.312 . . . . 0.72 110.918 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 94.7 mt -59.95 -43.89 94.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.329 -0.396 . . . . 0.5 110.824 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . 0.446 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 61.4 m -60.6 -48.97 79.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.31 111.012 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 41.9 m80 -61.42 -52.08 66.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.3 110.917 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 64.7 mt -59.67 -51.54 69.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.39 -0.368 . . . . 0.44 110.845 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.51 -51.99 65.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.46 111.483 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.426 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -51.93 -53.94 35.28 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.758 0.313 . . . . 0.25 111.3 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.418 HG13 ' HB1' ' A' ' 176' ' ' ALA . 67.4 mt -62.97 -44.59 99.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.31 110.703 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.97 -48.01 82.57 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.631 -0.795 . . . . 0.26 112.062 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 88.9 mt -53.96 -48.79 69.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 0.47 110.457 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.17 -48.24 81.39 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.704 -0.76 . . . . 0.27 112.654 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.473 ' CG1' ' HA2' ' A' ' 180' ' ' GLY . 52.5 mt -62.06 -48.82 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.735 0.302 . . . . 0.93 111.521 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.406 ' HA ' ' HG2' ' B' ' 185' ' ' ARG . 88.5 t80 -51.59 -52.25 48.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.321 -0.399 . . . . 1.52 111.297 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 58.6 mt -62.05 -46.65 95.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.321 -0.399 . . . . 1.1 111.203 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.39 -45.51 95.78 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.782 -0.723 . . . . 0.72 113.024 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' B' ' 182' ' ' TYR . 10.0 ptp180 . . . . . 0 C--N 1.329 -0.29 0 N-CA-C 111.685 0.254 . . . . 2.16 111.685 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo . . . . . 0 N--CA 1.464 -0.259 0 CA-C-O 120.806 0.252 . . . . 0.98 112.528 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 53.8 m -48.14 -52.37 20.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 1.47 111.32 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 69.0 mt -61.3 -48.88 79.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.439 . . . . 0.73 111.008 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 89.2 mt -58.56 -49.77 76.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.63 111.077 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.31 -42.1 94.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.4 111.382 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.473 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 67.1 m -56.16 -53.39 57.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.739 0.304 . . . . 0.23 111.193 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.435 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 69.0 m80 -62.96 -51.69 65.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.351 -0.386 . . . . 0.29 110.765 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 95.7 mt -57.83 -51.88 67.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.47 111.241 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.69 -49.46 77.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.41 111.275 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.533 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -51.51 -52.92 42.83 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.854 0.359 . . . . 0.27 111.042 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 68.6 mt -57.45 -44.25 84.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.62 110.243 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.95 -44.01 82.42 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.719 -0.753 . . . . 0.28 111.916 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 75.6 mt -56.17 -52.54 64.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.958 0.409 . . . . 0.43 110.221 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.62 -45.11 68.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.566 -0.826 . . . . 0.29 112.07 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 48.0 mm -60.95 -42.44 92.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 0.89 110.806 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -55.14 -42.21 72.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 1.56 110.662 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.433 ' N ' HD13 ' A' ' 183' ' ' ILE . 3.7 mm -62.87 -52.99 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.83 110.864 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -63.43 -52.86 43.26 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.023 -0.608 . . . . 0.64 113.356 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.28 -26.44 12.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.701 0.286 . . . . 2.54 111.184 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.406 -0.361 . . . . 3.95 110.977 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo . . . . . 0 C--O 1.231 0.161 0 CA-C-O 120.772 0.238 . . . . 1.07 112.25 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 63.5 m -49.75 -44.92 48.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 1.59 110.973 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.42 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 26.0 mt -52.73 -49.45 65.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 1.09 110.673 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.467 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.3 mp -59.96 -44.45 94.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 0.72 110.452 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.17 -41.72 98.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.5 110.605 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . 0.435 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 72.2 m -54.1 -49.73 68.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.31 110.637 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.473 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 66.9 m80 -60.26 -52.17 66.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.3 110.692 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.41 -52.41 65.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.44 110.994 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 76.6 mt -62.5 -43.83 97.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 0.46 110.937 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.511 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.41 -53.43 51.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.25 110.965 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.533 HG13 ' HB1' ' A' ' 176' ' ' ALA . 41.4 mt -62.64 -44.95 99.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.31 110.413 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.82 -51.15 46.82 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.674 -0.774 . . . . 0.26 111.892 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 97.0 mt -55.12 -42.95 73.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 0.47 110.092 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.23 -42.6 93.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.667 -0.777 . . . . 0.27 112.042 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 41.4 mm -58.18 -52.21 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.729 0.299 . . . . 0.93 110.601 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -51.71 -52.5 47.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 1.52 110.575 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 64.3 mt -62.89 -45.16 99.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.96 -0.564 . . . . 1.1 110.912 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.16 -52.36 50.28 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.979 -0.629 . . . . 0.72 112.999 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.82 0.343 . . . . 2.16 110.87 -179.699 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.464 -0.236 0 CA-C-O 120.775 0.24 . . . . 0.98 112.516 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 79.9 p -65.67 -42.41 91.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 1.47 110.922 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 80.1 mt -60.65 -49.87 75.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.73 110.846 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 95.2 mt -54.88 -51.1 67.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.297 -0.41 . . . . 0.63 110.769 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.5 -41.5 85.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.4 111.042 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.472 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 68.3 m -55.98 -52.88 62.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.76 0.314 . . . . 0.23 111.097 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.451 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 66.6 m80 -62.94 -52.57 62.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.29 110.905 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.0 mt -58.31 -52.23 66.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.47 110.841 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.4 -44.94 95.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.0 -0.546 . . . . 0.41 110.933 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.442 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -52.12 -52.37 52.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.27 110.822 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 68.9 mt -57.31 -42.64 80.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.268 -0.424 . . . . 0.62 110.128 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.3 -41.43 87.1 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.788 -0.72 . . . . 0.28 111.755 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 76.8 mt -59.45 -49.26 78.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.949 0.404 . . . . 0.43 110.199 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.8 -47.36 65.41 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.671 -0.776 . . . . 0.29 112.072 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.431 HD13 ' O ' ' B' ' 180' ' ' GLY . 32.6 mm -56.25 -46.45 81.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 0.89 110.841 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.409 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 88.8 t80 -57.59 -49.45 76.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 1.56 110.989 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 54.7 mt -62.78 -43.83 99.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.23 -0.441 . . . . 0.83 111.353 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.34 -52.21 51.02 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.039 -0.601 . . . . 0.64 113.469 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -61.34 -20.78 63.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.767 0.284 . . . . 2.54 111.395 -179.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 28.4 mmt180 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.576 -0.284 . . . . 3.95 111.676 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 N--CA 1.463 -0.278 0 CA-C-O 120.783 0.243 . . . . 1.07 112.383 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 91.5 p -54.36 -42.8 70.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 1.59 110.87 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.406 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 81.8 mt -58.78 -49.6 77.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 1.09 110.643 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.468 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.0 mp -62.17 -47.11 85.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.046 -0.525 . . . . 0.72 110.724 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 79.6 mt -59.65 -43.63 93.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.5 110.822 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . 0.451 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 75.6 m -54.24 -50.2 67.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.269 -0.423 . . . . 0.31 110.607 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.472 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 56.6 m80 -62.26 -52.47 63.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.3 110.931 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 89.2 mt -58.62 -52.49 65.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.373 -0.376 . . . . 0.44 111.083 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 64.7 mt -62.3 -46.15 90.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.46 111.051 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.49 -53.02 57.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 0.25 110.907 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.434 HG13 ' HB1' ' A' ' 176' ' ' ALA . 72.6 mt -62.22 -42.02 93.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.188 -0.46 . . . . 0.31 110.533 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.06 -45.44 92.44 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.565 -0.826 . . . . 0.26 111.951 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.93 -46.0 85.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 0.47 110.236 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.431 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -54.62 -44.38 79.12 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.584 -0.817 . . . . 0.27 112.183 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 60.3 mt -60.91 -46.88 95.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.721 0.296 . . . . 0.93 111.034 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -55.58 -47.46 76.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 1.52 111.083 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 59.4 mt -61.25 -50.37 80.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 1.1 111.07 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -58.15 -51.29 59.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.83 -0.7 . . . . 0.72 112.712 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 . . . . . 0 C--N 1.33 -0.25 0 CA-C-O 120.701 0.286 . . . . 2.16 111.285 -179.617 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo . . . . . 0 C--O 1.23 0.119 0 CA-C-O 120.771 0.238 . . . . 0.98 112.329 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.5 t -74.21 -52.82 11.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 1.47 110.911 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 60.2 mt -62.61 -46.27 89.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.73 110.914 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.79 -52.36 49.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.27 -0.423 . . . . 0.63 110.635 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.4 mt -57.67 -43.66 85.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.243 -0.435 . . . . 0.4 110.745 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.426 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 75.6 m -57.51 -52.79 63.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.23 110.706 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.451 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 64.9 m80 -62.87 -51.89 65.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.29 110.746 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.49 -52.3 66.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 0.47 111.109 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 81.8 mt -53.71 -50.82 65.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.465 -0.334 . . . . 0.41 110.781 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.575 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -53.36 -52.28 59.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.27 110.697 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 81.4 mt -58.43 -42.86 85.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.62 110.232 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.0 -43.77 55.84 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.627 -0.797 . . . . 0.28 111.796 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.0 -43.27 99.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.007 0.432 . . . . 0.43 109.914 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -61.13 -45.59 96.25 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.657 -0.783 . . . . 0.29 112.137 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 48.7 mm -60.33 -46.04 95.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.891 0.377 . . . . 0.89 110.924 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.408 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 51.1 t80 -54.52 -50.2 68.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.063 -0.517 . . . . 1.56 110.844 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.79 -47.17 94.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.171 -0.468 . . . . 0.83 111.224 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.42 -52.69 47.41 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.818 -0.706 . . . . 0.64 112.969 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.1 OUTLIER -61.93 -15.48 43.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.563 0.221 . . . . 2.54 111.329 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.68 0.276 . . . . 3.95 110.984 179.645 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo . . . . . 0 C--O 1.231 0.129 0 N-CA-C 112.782 0.262 . . . . 1.07 112.782 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 67.3 m -50.45 -43.28 55.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.431 -0.35 . . . . 1.59 111.071 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.13 -44.07 97.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.301 -0.409 . . . . 1.09 111.249 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.434 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.7 mp -60.74 -50.11 74.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.72 110.776 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 89.2 mt -53.65 -42.69 68.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.5 110.903 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . 0.451 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 74.7 m -58.44 -49.59 76.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.196 -0.456 . . . . 0.31 110.998 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.426 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 66.5 m80 -58.72 -52.61 64.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.3 111.101 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 82.5 mt -59.91 -52.46 65.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.369 -0.378 . . . . 0.44 111.13 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.58 -42.56 99.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 0.46 110.952 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.539 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -52.39 -52.76 51.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 0.25 111.338 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.575 HG13 ' HB1' ' A' ' 176' ' ' ALA . 31.6 mt -61.43 -42.64 94.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 0.31 110.628 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.46 -49.95 54.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.536 -0.84 . . . . 0.26 111.787 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 77.0 mt -55.86 -46.1 78.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 0.47 110.272 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.96 -41.89 69.18 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.639 -0.791 . . . . 0.27 112.019 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 41.9 mm -59.8 -52.13 64.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.866 0.365 . . . . 0.93 110.835 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.425 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 47.9 t80 -54.96 -50.82 67.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 1.52 110.803 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 57.1 mt -62.01 -45.98 97.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 1.1 111.322 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -56.01 -49.82 64.99 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.825 -0.703 . . . . 0.72 112.481 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.425 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 10.6 ptp180 . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 120.55 0.214 . . . . 2.16 111.255 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo . . . . . 0 N--CA 1.466 -0.138 0 CA-C-O 120.845 0.269 . . . . 0.98 112.435 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 49.6 m -60.78 -45.7 93.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 1.47 111.216 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 26.0 mt -58.99 -46.23 88.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.389 -0.369 . . . . 0.73 111.12 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 65.6 mt -54.36 -52.06 62.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.329 -0.396 . . . . 0.63 110.639 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 86.9 mt -57.76 -43.89 85.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.4 110.688 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.446 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 58.2 m -56.1 -52.54 63.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.23 110.811 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.427 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 80.8 m80 -62.6 -52.09 64.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.29 110.978 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.9 mt -58.02 -52.53 65.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.361 -0.382 . . . . 0.47 110.951 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.4 mt -56.69 -45.49 81.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.299 -0.41 . . . . 0.41 110.832 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.523 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -56.49 -52.32 65.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 0.27 110.904 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 75.7 mt -57.83 -42.98 83.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.62 110.648 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.51 -45.06 67.54 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.697 -0.763 . . . . 0.28 112.255 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 79.5 mt -61.98 -49.8 74.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.836 0.35 . . . . 0.43 110.525 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.449 ' CA ' HG13 ' B' ' 181' ' ' ILE . . . -55.96 -51.76 53.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.727 -0.749 . . . . 0.29 112.595 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.411 HG12 ' O ' ' B' ' 180' ' ' GLY . 47.7 mt -59.19 -43.62 89.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.786 0.327 . . . . 0.89 111.172 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.444 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 34.1 t80 -53.75 -47.88 70.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.026 0.441 . . . . 1.56 110.577 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 72.9 mt -62.78 -48.0 90.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.069 -0.514 . . . . 0.83 111.099 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.06 -46.35 94.73 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.93 -0.652 . . . . 0.64 112.967 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 11.2 ptm180 -61.8 -28.69 69.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.029 0.442 . . . . 2.54 110.851 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 115.6 -0.727 . . . . 3.95 111.583 -179.512 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 0 N--CA 1.466 -0.137 0 N-CA-C 112.727 0.241 . . . . 1.07 112.727 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 48.7 m -51.53 -42.41 61.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.901 0.381 . . . . 1.59 110.767 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 65.7 mt -62.31 -46.91 86.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 1.09 111.016 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.409 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.4 mp -59.52 -49.1 79.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.423 -0.353 . . . . 0.72 110.571 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 85.3 mt -52.56 -41.81 63.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.42 . . . . 0.5 110.387 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . 0.427 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 58.5 m -60.51 -51.81 67.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.52 . . . . 0.31 110.597 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.446 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 54.8 m80 -61.52 -51.95 66.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.122 -0.49 . . . . 0.3 110.809 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 93.1 mt -59.77 -52.23 66.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.33 -0.396 . . . . 0.44 110.794 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.23 -43.91 97.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.46 110.976 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.523 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -51.95 -52.47 50.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.25 111.074 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.514 HG13 ' HB1' ' A' ' 176' ' ' ALA . 52.3 mt -61.99 -46.78 95.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.434 -0.348 . . . . 0.31 110.591 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.23 -47.15 76.25 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.624 -0.798 . . . . 0.26 111.858 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 93.4 mt -54.23 -49.49 69.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.47 110.491 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.411 ' O ' HG12 ' A' ' 181' ' ' ILE . . . -56.41 -44.43 89.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.554 -0.831 . . . . 0.27 112.142 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.449 HG13 ' CA ' ' A' ' 180' ' ' GLY . 66.3 mt -61.43 -52.44 61.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.809 0.338 . . . . 0.93 110.791 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.416 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 46.5 t80 -56.7 -51.99 66.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.023 -0.535 . . . . 1.52 110.964 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 62.6 mt -62.39 -48.58 87.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.397 -0.365 . . . . 1.1 110.832 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.68 -52.36 48.82 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.839 -0.696 . . . . 0.72 112.973 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.416 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 1.4 ptp180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.634 0.254 . . . . 2.16 111.521 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo . . . . . 0 C--O 1.231 0.135 0 CA-C-O 120.906 0.294 . . . . 0.98 112.505 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.6 t -51.03 -51.94 48.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.456 . . . . 1.47 111.118 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 39.8 mt -59.68 -51.35 70.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.365 -0.38 . . . . 0.73 110.912 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 91.7 mt -53.63 -49.59 67.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.63 110.75 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 97.2 mt -62.09 -43.0 99.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.4 110.921 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.429 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 69.3 m -57.3 -52.61 64.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.23 111.019 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.408 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 65.4 m80 -62.78 -52.52 62.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 0.29 111.242 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.8 mt -61.28 -52.1 66.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 0.47 111.354 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 171' ' ' LEU . 81.5 mt -57.49 -46.44 83.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.35 -0.386 . . . . 0.41 111.14 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.635 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -54.48 -52.57 61.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.927 0.394 . . . . 0.27 110.907 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.4 ' O ' HG12 ' A' ' 181' ' ' ILE . 68.9 mt -58.01 -43.87 85.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.244 -0.435 . . . . 0.62 110.336 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.68 -47.08 65.45 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.495 -0.86 . . . . 0.28 111.923 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 70.0 mt -55.82 -50.1 71.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.381 . . . . 0.43 110.398 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.446 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -54.74 -43.29 80.07 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.561 -0.828 . . . . 0.29 112.354 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 177' ' ' ILE . 40.7 mm -62.38 -49.2 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.912 0.387 . . . . 0.89 111.101 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.413 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 51.1 t80 -56.74 -50.4 72.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.952 -0.567 . . . . 1.56 111.343 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.414 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 58.3 mt -59.87 -46.36 93.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.83 111.305 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.19 -47.98 86.01 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.775 -0.726 . . . . 0.64 112.899 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 11.6 ptp180 -58.78 -28.88 66.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.661 0.267 . . . . 2.54 111.108 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 183' ' ' ILE . 34.4 ptt180 . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.372 . . . . 3.95 110.853 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.463 -0.281 0 N-CA-C 112.852 0.289 . . . . 1.07 112.852 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 48.1 t -79.91 -44.8 19.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.865 0.364 . . . . 1.59 111.258 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 59.6 mt -62.31 -45.77 91.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 1.09 111.396 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.48 -51.67 68.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.324 -0.398 . . . . 0.72 111.247 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 92.8 mt -58.56 -41.71 86.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.385 -0.37 . . . . 0.5 111.05 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . 0.408 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 68.9 m -54.04 -52.32 61.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.31 111.382 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 62.9 m80 -61.55 -52.53 64.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.383 -0.371 . . . . 0.3 111.324 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 80.1 mt -55.74 -52.72 62.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.44 110.922 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.91 -47.41 83.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.114 -0.494 . . . . 0.46 111.362 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.576 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -55.09 -53.32 57.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.25 111.751 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.635 HG13 ' HB1' ' A' ' 176' ' ' ALA . 53.4 mt -62.58 -43.29 98.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 0.31 110.862 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.28 -47.99 83.68 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.611 -0.804 . . . . 0.26 112.126 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.413 ' O ' HD12 ' B' ' 183' ' ' ILE . 93.6 mt -55.14 -51.85 65.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.759 0.314 . . . . 0.47 110.583 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.47 -41.82 49.58 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.613 -0.803 . . . . 0.27 112.017 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.446 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 27.2 mm -59.43 -48.88 85.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.755 0.312 . . . . 0.93 110.624 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -51.68 -52.51 47.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 1.52 111.269 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . 0.542 ' H ' HD12 ' B' ' 183' ' ' ILE . 4.0 mp -63.57 -52.47 57.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.451 -0.341 . . . . 1.1 111.228 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.47 -52.57 48.11 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.905 -0.664 . . . . 0.72 113.469 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.437 ' CG ' ' O ' ' B' ' 181' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.546 0.213 . . . . 2.16 111.515 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo . . . . . 0 C--O 1.23 0.12 0 CA-C-O 120.78 0.242 . . . . 0.98 111.951 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.4 t -47.73 -47.47 30.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.28 -0.418 . . . . 1.47 110.992 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.415 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 29.3 mt -61.99 -51.32 68.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.73 110.724 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 87.6 mt -57.79 -51.94 67.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.63 110.634 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 95.2 mt -53.05 -47.13 68.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.4 110.484 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.42 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 70.3 m -51.96 -51.96 53.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.035 -0.529 . . . . 0.23 110.831 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.46 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 58.3 m80 -61.51 -52.33 64.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.29 110.749 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 84.9 mt -57.19 -50.67 72.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.47 111.003 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.9 mt -59.78 -44.8 93.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.41 110.811 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.469 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -57.34 -52.68 64.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.429 . . . . 0.27 110.716 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.408 ' O ' HG12 ' A' ' 181' ' ' ILE . 71.0 mt -58.99 -42.66 86.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.48 . . . . 0.62 110.332 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.7 -43.15 53.52 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.587 -0.816 . . . . 0.28 111.796 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.02 -47.7 83.59 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.736 -0.468 . . . . 0.43 109.736 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -58.44 -49.23 78.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 0.29 112.224 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 177' ' ' ILE . 35.2 mm -53.27 -45.95 56.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.763 0.316 . . . . 0.89 110.88 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -58.4 -44.3 88.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 1.56 110.993 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 72.4 mt -62.7 -48.92 85.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.395 -0.366 . . . . 0.83 111.199 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.15 -52.11 52.1 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.927 -0.654 . . . . 0.64 112.846 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.427 ' HD3' ' N ' ' A' ' 186' ' ' ARG . 0.0 OUTLIER -60.56 -28.1 68.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.789 0.328 . . . . 2.54 110.97 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.427 ' N ' ' HD3' ' A' ' 185' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 3.95 110.713 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 C--O 1.231 0.158 0 CA-C-O 120.703 0.21 . . . . 1.07 112.414 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 51.7 m -62.26 -41.57 98.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.333 -0.394 . . . . 1.59 110.787 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.411 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 78.2 mt -60.39 -45.06 94.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 1.09 110.927 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.493 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.1 mp -62.34 -50.95 69.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.72 110.836 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.6 mt -58.15 -41.54 83.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.5 110.599 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 73.0 m -55.02 -52.19 63.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.031 -0.531 . . . . 0.31 111.1 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.42 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 71.6 m80 -60.58 -52.53 64.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.3 111.139 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 87.8 mt -59.98 -52.49 65.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.339 -0.392 . . . . 0.44 111.019 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.69 -42.88 99.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.134 -0.485 . . . . 0.46 111.021 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.469 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.04 -52.57 58.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.25 111.478 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.465 HG13 ' HB1' ' A' ' 176' ' ' ALA . 53.1 mt -62.23 -41.86 93.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.358 . . . . 0.31 110.9 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.08 -49.9 68.36 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.71 -0.757 . . . . 0.26 112.387 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 83.1 mt -58.47 -42.38 87.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.47 110.668 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.405 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -55.7 -49.88 63.54 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.723 -0.751 . . . . 0.27 112.36 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 55.7 mt -57.97 -45.15 87.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.859 0.362 . . . . 0.93 110.959 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -53.32 -50.9 64.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 1.52 110.693 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 64.5 mt -62.3 -41.97 93.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.031 -0.531 . . . . 1.1 111.136 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.91 -49.07 79.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.904 -0.665 . . . . 0.72 112.842 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.706 0.289 . . . . 2.16 111.373 -179.594 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 N--CA 1.463 -0.274 0 CA-C-O 120.865 0.277 . . . . 0.98 112.298 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.1 t -56.77 -42.74 79.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 1.47 110.57 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.61 -51.49 68.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.962 -0.563 . . . . 0.73 110.782 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 85.9 mt -52.57 -48.7 66.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.985 -0.552 . . . . 0.63 110.823 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 97.9 mt -55.97 -42.87 76.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.322 -0.399 . . . . 0.4 110.764 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.479 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 67.9 m -57.21 -52.47 65.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.23 110.871 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.417 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 73.0 m80 -62.2 -52.27 64.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.29 110.87 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.8 mt -59.0 -51.64 69.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.066 -0.516 . . . . 0.47 111.005 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 171' ' ' LEU . 85.1 mt -60.56 -42.41 96.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.41 111.008 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.623 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -56.06 -52.36 64.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.995 0.426 . . . . 0.27 110.875 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.45 -41.52 81.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.551 . . . . 0.62 110.469 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.04 -44.58 83.27 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.772 -0.728 . . . . 0.28 112.129 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 70.8 mt -61.06 -47.11 87.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.949 0.404 . . . . 0.43 110.355 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.445 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -52.68 -52.42 38.36 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.676 -0.773 . . . . 0.29 112.587 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 39.3 mt -61.96 -42.88 96.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 0.89 111.032 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.425 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 83.5 t80 -51.9 -52.08 52.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.016 0.436 . . . . 1.56 110.695 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 65.8 mt -63.5 -48.03 88.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.133 -0.485 . . . . 0.83 111.203 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.78 -52.85 45.4 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.983 -0.627 . . . . 0.64 113.692 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -54.98 -24.41 23.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.866 0.333 . . . . 2.54 110.801 -179.292 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 18.7 mtp-105 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 3.95 110.865 179.485 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 N--CA 1.462 -0.326 0 CA-C-O 120.74 0.225 . . . . 1.07 112.633 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 66.3 m -53.22 -44.13 67.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 1.59 111.08 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.413 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 84.5 mt -54.6 -51.13 66.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.28 -0.418 . . . . 1.09 111.177 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.452 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.4 mp -62.17 -46.14 90.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.387 -0.37 . . . . 0.72 110.854 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.3 -42.65 91.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.336 -0.393 . . . . 0.5 110.847 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . 0.417 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 68.3 m -56.87 -52.21 66.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.483 . . . . 0.31 111.005 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.479 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 66.8 m80 -62.54 -52.6 62.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.3 111.289 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.78 -52.56 64.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.359 . . . . 0.44 111.24 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 69.4 mt -62.46 -43.32 99.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.316 -0.402 . . . . 0.46 111.032 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.549 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -58.36 -52.7 64.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.25 111.142 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.623 HG13 ' HB1' ' A' ' 176' ' ' ALA . 82.7 mt -60.07 -42.34 89.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.428 -0.351 . . . . 0.31 110.418 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.57 -49.75 59.86 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.564 -0.827 . . . . 0.26 111.97 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 88.7 mt -56.25 -46.76 79.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.47 110.397 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.03 -42.98 55.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.526 -0.845 . . . . 0.27 111.812 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.445 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 17.7 mm -60.05 -51.87 67.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.836 0.35 . . . . 0.93 110.611 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.436 ' HA ' ' HG2' ' B' ' 185' ' ' ARG . 51.0 t80 -51.3 -49.48 61.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.792 -0.64 . . . . 1.52 111.224 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 61.1 mt -58.73 -52.45 59.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.212 -0.449 . . . . 1.1 111.324 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.0 -52.38 53.72 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.882 -0.675 . . . . 0.72 113.098 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' B' ' 182' ' ' TYR . 6.1 ptp180 . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.366 . . . . 2.16 111.141 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo . . . . . 0 C--O 1.231 0.175 0 CA-C-O 120.808 0.253 . . . . 0.98 111.515 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 60.3 m -50.23 -48.96 54.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 1.47 110.68 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 78.1 mt -54.71 -50.7 67.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.507 . . . . 0.73 110.173 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.31 -42.92 96.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.05 -0.523 . . . . 0.63 110.208 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 76.5 mt -62.17 -41.27 98.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.961 -0.563 . . . . 0.4 110.635 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.428 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 73.6 m -55.85 -52.72 63.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.359 -0.382 . . . . 0.23 110.855 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.437 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 73.3 m80 -62.6 -52.09 64.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.29 110.929 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.5 mt -59.88 -52.55 64.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.226 -0.443 . . . . 0.47 111.21 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 75.0 mt -56.2 -46.02 79.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.41 110.542 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.504 ' HB3' ' HB1' ' B' ' 176' ' ' ALA . . . -52.41 -52.01 56.08 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.142 -0.481 . . . . 0.27 110.15 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 69.1 mt -58.85 -42.56 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 115.975 -0.557 . . . . 0.62 109.81 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.23 -43.65 64.18 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.654 -0.784 . . . . 0.28 111.724 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 78.5 mt -60.21 -46.01 91.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.95 0.405 . . . . 0.43 110.115 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -58.59 -43.59 96.04 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.554 -0.832 . . . . 0.29 112.029 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 45.6 mm -58.31 -44.41 88.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.899 0.381 . . . . 0.89 110.749 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.4 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 76.8 t80 -60.03 -49.54 77.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 1.56 110.741 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 57.9 mt -62.23 -48.92 86.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.83 111.31 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.2 -52.67 51.35 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.768 -0.729 . . . . 0.64 113.046 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.12 -17.93 59.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.707 0.289 . . . . 2.54 111.224 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 28.5 mmt180 . . . . . 0 CA--C 1.532 0.258 0 CA-C-N 116.544 -0.298 . . . . 3.95 111.417 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.835 0.264 . . . . 1.07 112.176 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.5 t -50.87 -42.29 58.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 1.59 110.98 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.414 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 46.0 mt -54.13 -50.68 66.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.435 . . . . 1.09 110.68 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.48 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.0 mp -61.14 -44.12 97.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.72 110.386 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.05 -41.56 98.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.5 110.279 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . 0.437 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 73.6 m -55.06 -44.24 74.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.081 -0.509 . . . . 0.31 110.502 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.428 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 68.7 m80 -61.74 -52.54 63.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.3 110.846 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 94.4 mt -58.44 -52.56 65.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.862 0.363 . . . . 0.44 110.723 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.8 -42.2 99.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.073 -0.512 . . . . 0.46 111.204 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' A' ' 176' ' ' ALA . . . -59.11 -52.46 65.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.426 . . . . 0.25 111.573 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.441 HG13 ' HB1' ' A' ' 176' ' ' ALA . 87.0 mt -56.97 -45.54 83.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 0.31 110.648 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.8 -45.89 77.85 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.511 -0.852 . . . . 0.26 111.855 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 95.8 mt -55.78 -46.26 78.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.942 0.401 . . . . 0.47 110.143 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.15 -41.62 79.1 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.744 -0.741 . . . . 0.27 112.051 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 53.4 mt -61.11 -46.86 95.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.878 0.371 . . . . 0.93 110.803 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.431 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 89.0 t80 -59.7 -46.92 87.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.05 -0.523 . . . . 1.52 110.963 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 47.8 mt -62.99 -47.71 91.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.326 -0.397 . . . . 1.1 111.511 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.09 -51.92 50.57 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 121.284 -0.484 . . . . 0.72 113.624 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.388 0 CA-C-O 120.788 0.328 . . . . 2.16 111.366 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo . . . . . 0 C--O 1.231 0.155 0 CA-C-O 120.803 0.251 . . . . 0.98 112.237 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 57.7 m -53.69 -42.26 67.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 1.47 110.841 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.41 -51.01 69.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.73 110.915 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 89.5 mt -55.33 -48.57 73.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.63 110.905 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.9 mt -59.07 -42.72 91.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.4 111.082 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.484 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 67.9 m -55.97 -53.1 60.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.311 -0.404 . . . . 0.23 111.025 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.411 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 70.8 m80 -62.77 -52.5 62.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.29 110.832 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 78.9 mt -57.83 -51.72 68.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.47 111.309 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 73.9 mt -60.77 -45.54 93.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.367 -0.379 . . . . 0.41 111.175 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.474 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -56.1 -52.7 63.36 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.017 0.437 . . . . 0.27 110.67 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.407 ' O ' HG12 ' A' ' 181' ' ' ILE . 63.2 mt -59.55 -42.49 88.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.128 -0.487 . . . . 0.62 109.861 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.78 -42.06 52.14 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.639 -0.791 . . . . 0.28 111.553 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 83.7 mt -61.35 -46.2 91.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.075 0.464 . . . . 0.43 109.751 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -61.55 -44.08 98.45 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.643 -0.789 . . . . 0.29 112.291 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 177' ' ' ILE . 47.5 mm -60.81 -51.32 74.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.331 . . . . 0.89 110.958 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.415 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 81.1 t80 -51.85 -52.21 51.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 1.56 110.747 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.413 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 54.8 mt -62.53 -41.91 93.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.204 -0.453 . . . . 0.83 111.312 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.74 -44.92 97.37 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.957 -0.639 . . . . 0.64 113.347 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 8.0 ptp180 -61.18 -32.64 72.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.894 0.347 . . . . 2.54 111.384 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 183' ' ' ILE . 36.8 ptt180 . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.654 0.264 . . . . 3.95 111.144 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.69 0.204 . . . . 1.07 112.456 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 35.4 t -65.41 -45.96 81.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.417 -0.356 . . . . 1.59 110.943 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 55.3 mt -54.86 -48.71 72.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 1.09 110.786 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.436 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.6 mp -57.87 -50.33 73.7 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.199 -0.455 . . . . 0.72 110.631 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 61.6 mt -59.05 -41.48 87.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.485 . . . . 0.5 110.651 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . 0.411 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 73.5 m -51.93 -50.32 61.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.31 110.889 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.484 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 60.6 m80 -61.18 -52.32 65.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.3 111.181 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 98.0 mt -60.91 -52.35 65.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.361 -0.381 . . . . 0.44 111.002 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.28 -43.73 98.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.46 111.039 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.474 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.41 -52.35 59.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.25 111.342 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.43 HG13 ' HB1' ' A' ' 176' ' ' ALA . 60.4 mt -60.95 -47.76 92.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.426 -0.352 . . . . 0.31 110.918 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.28 -51.1 43.87 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.639 -0.791 . . . . 0.26 112.164 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 97.3 mt -55.25 -46.86 76.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.973 0.416 . . . . 0.47 110.796 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.96 -42.9 82.08 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.669 -0.777 . . . . 0.27 112.545 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 58.2 mt -61.89 -51.1 76.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 0.93 111.019 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.405 ' O ' ' HG2' ' B' ' 185' ' ' ARG . 29.1 t80 -58.67 -49.85 76.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 1.52 110.812 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 73.7 mt -61.93 -46.02 97.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 1.1 111.101 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -58.88 -49.54 77.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.639 -0.791 . . . . 0.72 112.415 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' B' ' 182' ' ' TYR . 12.2 ptm180 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.781 0.324 . . . . 2.16 111.08 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 C--O 1.23 0.121 0 CA-C-O 120.747 0.228 . . . . 0.98 112.406 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 65.9 m -51.14 -50.73 58.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.265 -0.425 . . . . 1.47 110.839 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 85.5 mt -61.78 -51.91 66.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.151 -0.477 . . . . 0.73 111.005 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 83.7 mt -52.88 -51.45 61.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.27 -0.423 . . . . 0.63 110.987 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 79.3 mt -58.28 -42.32 86.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.339 -0.391 . . . . 0.4 111.011 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 65.2 m -59.7 -52.13 66.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.23 111.002 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.425 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 74.8 m80 -60.44 -51.83 67.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.29 111.02 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.3 mt -57.02 -52.25 66.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 0.47 111.12 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 74.1 mt -58.12 -49.46 76.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.41 111.137 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.579 ' HB3' ' HB1' ' B' ' 176' ' ' ALA . . . -51.34 -52.24 47.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.935 0.398 . . . . 0.27 110.673 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 70.6 mt -59.2 -41.97 85.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 0.62 110.13 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.66 -46.05 89.64 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.666 -0.778 . . . . 0.28 111.834 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 44.4 mt -55.71 -47.82 76.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.004 0.43 . . . . 0.43 110.077 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.444 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -55.18 -43.75 83.87 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.792 -0.718 . . . . 0.29 112.339 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 49.4 mm -58.34 -52.28 61.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.837 0.351 . . . . 0.89 111.068 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -53.95 -48.25 70.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 1.56 110.784 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.412 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 68.7 mt -62.1 -42.62 95.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.83 111.191 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.5 -47.14 91.59 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.867 -0.682 . . . . 0.64 112.984 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.436 ' HG3' ' N ' ' A' ' 186' ' ' ARG . 13.5 ptp180 -62.18 -40.8 97.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.552 0.215 . . . . 2.54 111.407 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.436 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 15.9 ptm180 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.654 -0.248 . . . . 3.95 111.46 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo . . . . . 0 N--CA 1.466 -0.141 0 CA-C-O 120.881 0.284 . . . . 1.07 112.564 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 42.5 t -57.86 -41.51 82.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.164 -0.471 . . . . 1.59 111.098 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.416 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 27.2 mt -59.24 -51.23 70.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.317 -0.401 . . . . 1.09 111.364 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.423 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.7 mp -59.86 -49.01 79.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.738 0.304 . . . . 0.72 110.972 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.99 -41.49 98.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 0.5 110.904 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . 0.425 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 73.0 m -57.95 -52.35 65.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.31 111.37 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 60.9 m80 -62.24 -52.45 63.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.333 -0.394 . . . . 0.3 111.358 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 97.5 mt -54.77 -53.07 59.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.921 0.391 . . . . 0.44 110.703 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.37 -49.33 74.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.962 -0.563 . . . . 0.46 110.993 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.579 ' HB1' ' HB3' ' A' ' 176' ' ' ALA . . . -51.74 -52.58 47.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.0 -0.546 . . . . 0.25 111.635 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.553 HG13 ' HB1' ' A' ' 176' ' ' ALA . 70.7 mt -62.04 -46.66 95.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.919 0.39 . . . . 0.31 110.668 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.16 -46.46 91.56 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.598 -0.81 . . . . 0.26 111.963 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 94.4 mt -55.24 -46.06 76.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.987 0.422 . . . . 0.47 110.212 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.14 -42.18 80.85 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.644 -0.789 . . . . 0.27 111.777 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.444 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 40.4 mm -58.0 -50.73 76.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.883 0.373 . . . . 0.93 110.589 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -58.66 -49.76 76.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.008 -0.542 . . . . 1.52 111.237 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 50.4 mt -59.59 -51.34 73.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.367 -0.379 . . . . 1.1 111.335 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.37 -52.24 50.74 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.755 -0.736 . . . . 0.72 112.866 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.419 ' CG ' ' O ' ' B' ' 181' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 N-CA-C 111.667 0.247 . . . . 2.16 111.667 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.809 0.254 . . . . 0.98 112.048 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.2 t -59.29 -43.81 92.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 1.47 110.904 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 65.3 mt -59.4 -50.15 75.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.514 . . . . 0.73 110.877 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 97.3 mt -55.39 -49.12 73.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.426 . . . . 0.63 110.734 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.9 mt -56.28 -41.97 76.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.4 110.755 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.472 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 72.9 m -57.49 -52.04 67.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 0.23 110.862 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.431 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 70.1 m80 -61.17 -50.55 72.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.29 110.815 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 92.8 mt -61.42 -52.14 65.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.47 111.119 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 66.6 mt -62.03 -43.62 98.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.332 -0.395 . . . . 0.41 111.089 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.462 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -51.84 -52.47 49.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.9 0.381 . . . . 0.27 110.623 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 66.4 mt -58.15 -41.95 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.62 110.246 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.64 -44.53 60.08 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.621 -0.799 . . . . 0.28 111.893 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 72.1 mt -61.32 -48.44 81.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.987 0.423 . . . . 0.43 110.322 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.66 -52.05 50.88 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.579 -0.82 . . . . 0.29 112.338 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 56.1 mt -53.66 -49.37 57.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.868 0.366 . . . . 0.89 110.954 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.422 ' O ' ' CG ' ' A' ' 186' ' ' ARG . 92.1 t80 -51.95 -51.43 57.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.507 . . . . 1.56 110.777 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 59.4 mt -62.7 -41.9 94.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.112 -0.494 . . . . 0.83 111.165 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.19 -52.62 48.41 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.941 -0.647 . . . . 0.64 113.265 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.07 -22.86 66.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.822 0.311 . . . . 2.54 111.005 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.422 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 1.5 mmp_? . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.392 . . . . 3.95 110.935 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo . . . . . 0 N--CA 1.464 -0.259 0 CA-C-O 120.782 0.243 . . . . 1.07 112.524 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 81.1 p -57.22 -48.56 78.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 1.59 110.929 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.424 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 84.0 mt -52.23 -49.4 64.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 1.09 111.049 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.474 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.2 mp -61.88 -47.99 82.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.36 -0.382 . . . . 0.72 111.082 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 90.2 mt -61.87 -44.74 96.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 0.5 111.141 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . 0.431 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 71.0 m -53.04 -52.11 59.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.318 -0.401 . . . . 0.31 110.979 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.472 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 61.6 m80 -60.48 -52.5 64.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.3 111.201 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 86.6 mt -60.29 -52.35 65.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.844 0.354 . . . . 0.44 111.236 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.17 -45.3 94.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.43 . . . . 0.46 111.208 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.462 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.28 -52.53 58.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.25 111.51 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.461 HG13 ' HB1' ' A' ' 176' ' ' ALA . 69.8 mt -59.14 -42.83 87.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.827 0.346 . . . . 0.31 110.799 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.56 -51.11 50.4 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.508 -0.853 . . . . 0.26 111.963 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 66.3 mt -56.38 -42.48 77.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.911 0.386 . . . . 0.47 110.256 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.56 -47.35 70.45 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.673 -0.775 . . . . 0.27 112.069 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 49.7 mt -57.4 -48.64 82.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.868 0.366 . . . . 0.93 110.69 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -54.0 -47.07 71.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 1.52 110.502 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 72.3 mt -62.4 -51.53 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.079 -0.51 . . . . 1.1 110.934 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.19 -52.51 49.18 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.808 -0.71 . . . . 0.72 112.8 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.724 0.297 . . . . 2.16 111.073 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 C--O 1.232 0.206 0 CA-C-O 120.813 0.256 . . . . 0.98 112.391 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.8 t -57.34 -50.07 74.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 1.47 110.88 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 40.8 mt -62.16 -48.97 77.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 0.73 111.053 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 64.6 mt -52.26 -51.8 56.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.875 0.369 . . . . 0.63 110.757 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.6 mt -56.43 -42.35 77.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 0.4 110.856 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.421 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 74.8 m -58.38 -52.55 65.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.42 . . . . 0.23 110.85 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.423 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 72.4 m80 -62.48 -51.97 65.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.29 110.744 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.65 -51.78 68.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.47 110.987 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.7 mt -60.19 -44.11 95.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.41 110.98 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.544 ' HB3' ' HB1' ' B' ' 176' ' ' ALA . . . -53.75 -52.37 60.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.27 110.788 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.402 ' O ' HG12 ' A' ' 181' ' ' ILE . 68.5 mt -55.47 -45.42 78.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 0.62 110.162 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.91 -42.15 59.84 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.505 -0.855 . . . . 0.28 111.825 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 68.2 mt -59.06 -48.09 82.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.979 0.419 . . . . 0.43 110.105 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.435 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -58.64 -46.51 93.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.677 -0.773 . . . . 0.29 112.344 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 177' ' ' ILE . 48.0 mm -59.73 -49.93 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.878 0.371 . . . . 0.89 111.081 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -51.88 -49.93 62.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 1.56 110.915 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.449 HD12 HD11 ' B' ' 181' ' ' ILE . 71.9 mt -62.56 -42.55 96.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.83 111.186 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.2 -52.51 49.17 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.849 -0.691 . . . . 0.64 112.951 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -24.17 67.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 2.54 111.017 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.445 . . . . 3.95 111.044 179.772 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo . . . . . 0 N--CA 1.455 -0.786 0 CA-C-O 120.708 0.211 . . . . 1.07 112.405 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 55.0 m -114.07 -43.61 3.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.414 -0.357 . . . . 1.59 110.891 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.419 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 82.4 mt -61.5 -41.92 98.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 1.09 110.944 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.465 ' N ' HD12 ' B' ' 170' ' ' LEU . 6.3 mp -60.48 -47.25 86.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.72 110.979 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 48.5 mt -61.02 -41.74 97.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.303 -0.408 . . . . 0.5 110.731 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . 0.423 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 70.8 m -54.92 -51.36 66.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.31 110.937 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.421 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 67.0 m80 -61.66 -52.41 64.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.229 -0.441 . . . . 0.3 111.131 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 90.6 mt -55.39 -52.93 61.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.445 -0.343 . . . . 0.44 110.8 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.8 -45.04 94.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.46 110.979 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.544 ' HB1' ' HB3' ' A' ' 176' ' ' ALA . . . -54.67 -53.02 60.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.25 111.268 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 56.9 mt -62.19 -42.62 95.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.359 -0.382 . . . . 0.31 110.585 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.55 -46.51 81.11 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.61 -0.805 . . . . 0.26 111.9 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 94.9 mt -57.44 -47.94 80.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.37 . . . . 0.47 110.346 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.31 -43.53 64.95 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.572 -0.823 . . . . 0.27 112.34 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.449 HD11 HD12 ' A' ' 183' ' ' ILE . 40.0 mm -60.29 -49.87 82.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.872 0.367 . . . . 0.93 110.993 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -59.36 -47.97 83.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.54 . . . . 1.52 110.986 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 65.6 mt -62.17 -44.52 99.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 1.1 111.147 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.38 -46.83 93.05 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.831 -0.7 . . . . 0.72 112.92 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 . . . . . 0 C--N 1.328 -0.339 0 N-CA-C 111.923 0.342 . . . . 2.16 111.923 -179.518 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo . . . . . 0 N--CA 1.463 -0.299 0 CA-C-O 120.783 0.243 . . . . 0.98 112.339 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 80.8 p -51.34 -47.56 62.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 1.47 110.89 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 96.7 mt -61.75 -47.66 84.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.419 . . . . 0.73 110.766 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 88.4 mt -55.21 -50.52 69.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 0.63 110.938 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.8 mt -57.29 -45.18 84.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.4 110.881 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.419 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 75.8 m -55.43 -51.93 65.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.288 -0.414 . . . . 0.23 110.703 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.424 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 77.2 m80 -61.95 -48.71 79.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.033 -0.53 . . . . 0.29 110.844 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 88.8 mt -58.99 -49.8 76.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.314 -0.403 . . . . 0.47 110.921 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 82.6 mt -59.92 -51.09 71.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.41 111.086 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.543 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -52.03 -52.65 49.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 0.27 110.933 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.28 -42.28 90.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.044 -0.525 . . . . 0.62 110.274 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.66 -44.64 60.22 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.579 -0.82 . . . . 0.28 112.102 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 50.8 mt -62.61 -52.53 63.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.859 0.361 . . . . 0.43 110.494 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.01 -52.14 45.28 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.732 -0.747 . . . . 0.29 112.545 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 59.3 mt -55.76 -41.56 66.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.813 0.339 . . . . 0.89 110.582 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -55.39 -43.27 75.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.123 -0.49 . . . . 1.56 110.596 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.402 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 4.7 mm -61.67 -48.71 87.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.938 0.399 . . . . 0.83 110.843 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -58.79 -50.8 63.66 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.963 -0.637 . . . . 0.64 112.933 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -55.43 -26.53 42.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.667 0.27 . . . . 2.54 111.387 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 183' ' ' ILE . 4.7 ptm85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.875 0.369 . . . . 3.95 110.978 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo . . . . . 0 N--CA 1.465 -0.168 0 CA-C-O 120.739 0.225 . . . . 1.07 112.587 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 51.0 m -52.13 -42.93 63.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.865 0.364 . . . . 1.59 111.175 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 49.8 mt -61.99 -49.93 74.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 1.09 111.216 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.443 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.6 mp -61.68 -49.77 75.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.463 -0.335 . . . . 0.72 110.885 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 88.8 mt -57.34 -41.82 80.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.379 -0.373 . . . . 0.5 110.775 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . 0.424 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 67.5 m -57.21 -51.3 69.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.31 110.976 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.419 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 69.0 m80 -61.17 -52.47 64.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.335 -0.393 . . . . 0.3 111.017 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 88.2 mt -60.49 -52.3 65.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.907 0.384 . . . . 0.44 110.92 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.17 -42.61 99.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.065 -0.516 . . . . 0.46 110.948 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.6 -52.03 61.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.055 -0.52 . . . . 0.25 111.333 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.528 HG13 ' HB1' ' A' ' 176' ' ' ALA . 59.8 mt -60.44 -44.41 96.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.75 0.31 . . . . 0.31 110.853 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.58 -51.78 49.82 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.608 -0.806 . . . . 0.26 112.263 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.8 -41.98 78.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.756 0.312 . . . . 0.47 110.651 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.47 -49.32 74.2 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.712 -0.756 . . . . 0.27 112.197 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 60.3 mt -54.83 -50.98 56.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.93 110.756 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.418 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 80.3 t80 -53.05 -52.31 58.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.077 -0.51 . . . . 1.52 110.812 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 63.3 mt -62.26 -45.17 99.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 1.1 110.974 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -58.81 -48.66 84.13 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.764 -0.731 . . . . 0.72 112.688 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.418 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 6.9 ptp180 . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.576 0.227 . . . . 2.16 111.376 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.71 0.213 . . . . 0.98 112.534 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.9 t -52.96 -52.74 57.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.445 -0.343 . . . . 1.47 111.169 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 42.0 mt -62.74 -51.4 67.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.324 -0.398 . . . . 0.73 111.569 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 93.0 mt -51.49 -52.17 48.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.475 -0.329 . . . . 0.63 111.153 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 83.5 mt -62.22 -42.78 99.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.395 -0.366 . . . . 0.4 111.137 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.414 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 72.2 m -62.13 -53.0 61.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.436 -0.347 . . . . 0.23 111.491 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.428 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 64.7 m80 -62.62 -53.11 59.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.496 -0.32 . . . . 0.29 111.185 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 95.8 mt -57.0 -52.48 65.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.416 -0.356 . . . . 0.47 111.098 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 171' ' ' LEU . 74.3 mt -56.53 -41.44 76.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.404 -0.362 . . . . 0.41 110.297 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.502 ' HB3' ' HB1' ' B' ' 176' ' ' ALA . . . -57.61 -48.58 79.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.151 -0.477 . . . . 0.27 110.746 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.418 HD12 ' HB2' ' B' ' 179' ' ' LEU . 18.2 mm -54.11 -46.35 66.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.934 0.397 . . . . 0.62 110.394 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.31 -42.02 81.47 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.673 -0.775 . . . . 0.28 111.882 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 80.6 mt -57.45 -48.78 78.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.8 0.333 . . . . 0.43 110.433 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -61.28 -51.78 55.9 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.827 -0.701 . . . . 0.29 112.551 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 56.1 mt -53.89 -48.73 62.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.788 0.328 . . . . 0.89 111.136 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.423 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 52.8 t80 -53.74 -49.79 67.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 1.56 110.876 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 70.5 mt -63.17 -42.23 95.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.151 -0.477 . . . . 0.83 111.385 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.4 -53.11 44.41 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.8 -0.714 . . . . 0.64 113.507 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -62.68 -17.26 60.29 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.712 0.264 . . . . 2.54 111.712 -179.711 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.592 0.234 . . . . 3.95 111.525 -179.79 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo . . . . . 0 N--CA 1.464 -0.213 0 CA-C-O 120.855 0.273 . . . . 1.07 112.638 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.6 m -56.35 -41.7 76.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.065 -0.516 . . . . 1.59 110.967 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 14.4 mt -62.1 -48.06 81.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.314 -0.403 . . . . 1.09 111.192 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.404 ' N ' HD12 ' B' ' 170' ' ' LEU . 8.1 mp -59.62 -49.66 76.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.743 0.306 . . . . 0.72 110.761 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 97.8 mt -54.32 -41.74 69.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.5 110.663 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . 0.428 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 59.8 m -59.95 -48.21 82.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.31 111.249 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.414 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 68.2 m80 -60.4 -52.08 66.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.3 110.958 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 74.0 mt -61.03 -52.46 64.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.359 . . . . 0.44 110.86 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.0 -44.12 97.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.46 110.901 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.502 ' HB1' ' HB3' ' A' ' 176' ' ' ALA . . . -52.81 -52.47 56.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.486 . . . . 0.25 110.897 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 88.2 mt -55.38 -44.6 76.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.177 -0.465 . . . . 0.31 110.285 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.77 -41.84 58.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.531 -0.842 . . . . 0.26 111.479 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.418 ' HB2' HD12 ' A' ' 177' ' ' ILE . 80.0 mt -59.2 -48.13 82.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.02 0.438 . . . . 0.47 110.288 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.51 -51.17 38.93 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.81 -0.709 . . . . 0.27 112.565 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.408 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 58.3 mt -57.59 -52.15 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.735 0.302 . . . . 0.93 110.946 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.405 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 60.4 t80 -52.6 -50.12 63.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 1.52 111.182 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 57.2 mt -62.75 -52.31 61.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 1.1 111.362 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.03 -50.72 64.82 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.983 -0.627 . . . . 0.72 113.333 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' B' ' 181' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 N-CA-C 112.031 0.382 . . . . 2.16 112.031 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo . . . . . 0 C--O 1.231 0.171 0 CA-C-O 120.828 0.262 . . . . 0.98 112.521 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 36.4 t -69.59 -41.96 75.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 1.47 111.048 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.403 ' CD2' ' CD2' ' B' ' 169' ' ' LEU . 53.1 mt -61.96 -44.22 97.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.73 110.669 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 96.8 mt -53.67 -51.29 63.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.63 110.651 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 83.9 mt -59.06 -45.24 91.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.126 -0.488 . . . . 0.4 111.087 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.423 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 69.9 m -53.53 -53.11 56.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.23 110.874 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.415 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 74.5 m80 -63.03 -52.12 64.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.29 110.939 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.4 mt -54.62 -52.56 61.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.47 110.932 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.55 -48.92 77.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.315 -0.402 . . . . 0.41 111.027 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.534 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -51.92 -52.99 46.11 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.215 -0.448 . . . . 0.27 111.165 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.508 ' O ' HD12 ' A' ' 181' ' ' ILE . 62.8 mt -58.14 -46.85 88.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.411 . . . . 0.62 110.058 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.08 -41.89 53.88 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.671 -0.776 . . . . 0.28 111.861 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 99.5 mt -58.94 -49.12 79.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.029 0.442 . . . . 0.43 110.458 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.439 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -55.03 -50.69 58.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.764 -0.731 . . . . 0.29 112.876 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.508 HD12 ' O ' ' A' ' 177' ' ' ILE . 4.0 mp -62.58 -46.01 97.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.802 0.334 . . . . 0.89 110.628 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.401 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 51.4 t80 -51.82 -52.73 47.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 1.56 110.975 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.76 -45.41 97.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.369 -0.378 . . . . 0.83 111.405 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.7 -52.48 50.5 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.928 -0.653 . . . . 0.64 113.263 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -61.06 -19.53 61.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.76 0.314 . . . . 2.54 110.98 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 116.397 -0.365 . . . . 3.95 110.988 179.313 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 N--CA 1.464 -0.248 0 N-CA-C 113.172 0.412 . . . . 1.07 113.172 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 45.0 t -54.11 -44.83 71.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.565 -0.289 . . . . 1.59 111.403 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.403 ' CD2' ' CD2' ' A' ' 169' ' ' LEU . 26.6 mt -62.81 -48.37 79.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.009 0.374 . . . . 1.09 112.009 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.413 ' N ' HD12 ' B' ' 170' ' ' LEU . 8.1 mp -54.22 -51.97 62.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.736 0.303 . . . . 0.72 111.19 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.4 mt -62.34 -43.88 97.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.358 -0.383 . . . . 0.5 111.143 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . 0.415 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 75.1 m -58.18 -52.55 65.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.282 -0.417 . . . . 0.31 111.635 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.423 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 62.5 m80 -60.78 -52.55 64.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.446 -0.343 . . . . 0.3 111.378 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.5 mt -56.49 -51.4 68.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.408 -0.36 . . . . 0.44 111.272 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.38 -46.24 89.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.291 -0.413 . . . . 0.46 111.49 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -59.62 -53.03 62.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.394 -0.366 . . . . 0.25 111.606 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.532 HG13 ' HB1' ' A' ' 176' ' ' ALA . 40.5 mt -62.19 -42.89 96.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.813 0.34 . . . . 0.31 110.726 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.34 -51.79 51.93 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.552 -0.832 . . . . 0.26 112.194 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.408 ' O ' HG12 ' B' ' 183' ' ' ILE . 95.5 mt -53.91 -51.23 64.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.787 0.327 . . . . 0.47 110.487 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.29 -42.49 49.77 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.58 -0.819 . . . . 0.27 112.422 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.439 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 29.6 mm -59.81 -47.65 90.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.711 0.291 . . . . 0.93 110.69 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -57.19 -52.14 66.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 1.52 110.912 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . 0.408 HG12 ' O ' ' B' ' 179' ' ' LEU . 13.1 mm -62.37 -44.69 99.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 1.1 111.201 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.84 -52.21 53.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.833 -0.698 . . . . 0.72 113.013 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 2.16 111.036 -179.714 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo . . . . . 0 C--O 1.232 0.201 0 CA-C-O 120.785 0.244 . . . . 0.98 112.308 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 86.7 p -53.18 -48.78 67.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 1.47 111.092 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 46.8 mt -62.08 -51.93 65.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.73 110.986 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 88.2 mt -55.42 -50.37 69.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.11 -0.495 . . . . 0.63 110.952 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 94.4 mt -57.32 -45.43 84.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.4 111.151 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.44 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 73.1 m -56.56 -53.23 60.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.872 0.368 . . . . 0.23 110.986 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.432 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 77.7 m80 -63.02 -52.36 63.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.29 110.949 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.6 mt -58.86 -52.14 67.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.47 111.147 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 171' ' ' LEU . 77.1 mt -59.44 -46.93 87.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.39 . . . . 0.41 110.788 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.464 ' HB3' ' HB1' ' B' ' 176' ' ' ALA . . . -53.37 -52.24 59.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.262 -0.426 . . . . 0.27 110.781 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 86.1 mt -58.69 -41.78 83.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.255 -0.43 . . . . 0.62 110.332 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.96 -45.98 55.8 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.672 -0.775 . . . . 0.28 111.943 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 50.9 mt -62.14 -48.05 81.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.835 0.35 . . . . 0.43 110.516 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.06 -52.42 47.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.551 -0.833 . . . . 0.29 112.306 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' B' ' 180' ' ' GLY . 47.7 mt -60.35 -43.34 93.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.811 0.339 . . . . 0.89 111.091 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.419 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 78.5 t80 -53.72 -48.25 69.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.13 -0.486 . . . . 1.56 110.659 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.409 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 76.5 mt -62.54 -41.55 92.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.83 111.106 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.09 -44.11 98.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.99 -0.624 . . . . 0.64 113.208 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 10.9 ptp180 -62.44 -39.09 92.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.83 0.315 . . . . 2.54 111.581 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 183' ' ' ILE . 10.5 ptm180 . . . . . 0 C--N 1.329 -0.285 0 N-CA-C 111.656 0.243 . . . . 3.95 111.656 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.462 -0.345 0 N-CA-C 113.011 0.35 . . . . 1.07 113.011 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 48.8 m -60.32 -44.8 95.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.238 -0.437 . . . . 1.59 111.615 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.412 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 7.1 mp -62.9 -49.08 76.22 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.238 0.459 . . . . 1.09 112.238 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 mp -52.01 -50.51 61.21 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.759 -0.377 . . . . 0.72 110.661 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 89.9 mt -57.77 -41.57 82.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 0.5 110.462 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . 0.432 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 63.6 m -54.29 -45.8 72.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.435 . . . . 0.31 110.731 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.44 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 77.0 m80 -60.0 -52.29 66.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.454 . . . . 0.3 110.905 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 83.2 mt -57.81 -52.66 64.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.412 . . . . 0.44 110.71 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 87.3 mt -62.69 -42.34 99.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.094 -0.503 . . . . 0.46 110.857 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.464 ' HB1' ' HB3' ' A' ' 176' ' ' ALA . . . -52.2 -52.37 52.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.25 111.352 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 53.9 mt -61.85 -45.59 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.421 . . . . 0.31 111.039 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.69 -51.24 53.95 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.565 -0.826 . . . . 0.26 112.109 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.4 ' O ' HG12 ' B' ' 183' ' ' ILE . 94.3 mt -54.46 -47.63 72.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.779 0.323 . . . . 0.47 110.349 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 181' ' ' ILE . . . -51.32 -43.41 51.45 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.602 -0.808 . . . . 0.27 111.919 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 58.7 mt -58.57 -49.68 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.898 0.38 . . . . 0.93 110.456 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.423 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 55.7 t80 -54.88 -50.94 67.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.943 -0.572 . . . . 1.52 111.078 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . 0.4 HG12 ' O ' ' B' ' 179' ' ' LEU . 16.0 mm -62.85 -44.82 99.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.968 0.413 . . . . 1.1 111.328 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.28 -50.84 62.64 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.114 -0.565 . . . . 0.72 113.203 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.423 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 5.6 ptp180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.752 0.31 . . . . 2.16 111.344 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.126 0 N-CA-C 112.507 -0.237 . . . . 7.39 112.507 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -89.5 175.81 42.7 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.839 -0.696 . . . . 6.02 112.408 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 65.2 mt -70.63 -62.89 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.884 0.373 . . . . 6.75 111.074 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' A' ' 159' ' ' ALA . 73.8 m-85 -76.75 -39.19 52.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 5.45 110.893 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 71.4 m 42.41 -89.66 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.779 -0.646 . . . . 5.17 112.089 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.89 -53.6 56.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.715 0.293 . . . . 3.89 111.634 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -55.76 -57.63 11.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.811 0.339 . . . . 5.36 111.078 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.424 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 89.5 t80 -59.85 -49.87 76.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 3.21 111.08 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.3 mt -62.31 -36.7 82.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.349 -0.387 . . . . 3.31 110.886 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -56.91 -29.46 63.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 3.11 111.045 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 35.5 m -119.37 31.09 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 2.66 111.315 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -135.89 -44.98 0.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 2.06 110.754 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.497 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 81.1 mt -62.69 -49.41 82.82 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 1.88 111.442 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 61.5 Cg_endo -74.05 -35.0 4.52 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.065 1.843 . . . . 0.98 112.276 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.5 m -55.06 -47.79 74.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 1.47 110.895 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.19 -46.61 88.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.73 110.754 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 79.7 mt -52.48 -50.05 63.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.337 -0.392 . . . . 0.63 110.655 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 98.5 mt -57.91 -46.17 85.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.505 . . . . 0.4 110.783 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.441 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 73.0 m -55.11 -53.38 56.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.882 0.373 . . . . 0.23 111.261 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.428 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 77.2 m80 -63.21 -52.78 60.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.29 111.222 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 98.4 mt -59.85 -52.96 63.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.415 -0.357 . . . . 0.47 111.321 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 171' ' ' LEU . 67.6 mt -53.52 -41.81 66.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.035 0.445 . . . . 0.41 110.306 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.547 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -58.24 -44.56 88.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.885 -0.598 . . . . 0.27 110.369 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.423 HD13 ' O ' ' B' ' 176' ' ' ALA . 47.6 mm -55.79 -43.28 73.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.252 -0.431 . . . . 0.62 109.883 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.03 -45.37 92.46 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.718 -0.754 . . . . 0.28 111.823 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 47.8 mt -54.41 -51.36 65.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.852 0.358 . . . . 0.43 110.459 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.57 -43.06 67.61 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.631 -0.795 . . . . 0.29 112.291 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 50.2 mm -61.28 -46.98 95.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.361 . . . . 0.89 110.885 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -56.97 -45.68 82.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 1.56 110.615 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 56.5 mt -62.76 -48.48 87.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.077 -0.51 . . . . 0.83 110.956 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.25 -52.34 50.24 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.929 -0.653 . . . . 0.64 112.92 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.451 ' HB3' ' CD1' ' B' ' 187' ' ' LEU . 0.0 OUTLIER -59.66 -22.62 62.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.73 0.3 . . . . 2.54 111.188 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -80.63 -22.04 40.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.356 -0.384 . . . . 3.95 111.205 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 31.1 mt -57.79 -85.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.443 -0.344 . . . . 1.52 111.183 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.401 ' OXT' HG23 ' A' ' 188' ' ' THR . 1.7 t . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.202 -0.904 . . . . 3.05 111.275 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.559 -0.216 . . . . 7.46 112.559 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -141.79 -172.06 13.23 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.718 -0.753 . . . . 6.55 112.517 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 24.3 mm -70.35 -66.54 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.075 0.464 . . . . 7.86 110.874 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.45 ' CB ' ' HB2' ' B' ' 161' ' ' PHE . 91.9 m-85 -77.44 -65.39 0.97 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.6 -0.727 . . . . 6.6 111.011 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 32.3 t 45.69 -89.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.098 -0.501 . . . . 5.34 111.42 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -54.17 -60.95 2.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.806 0.336 . . . . 4.29 110.79 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . 0.413 ' HA ' ' CE ' ' B' ' 163' ' ' LYS . 37.4 tt0 -58.21 -24.55 59.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 5.73 110.841 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.45 ' HB2' ' CB ' ' B' ' 157' ' ' PHE . 92.0 t80 -77.61 -48.92 15.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.297 -0.411 . . . . 3.56 111.059 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.411 ' HA ' ' HB3' ' B' ' 165' ' ' PHE . 33.6 mt -62.67 -37.25 85.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.213 -0.448 . . . . 3.37 111.08 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.413 ' CE ' ' HA ' ' B' ' 160' ' ' GLU . 49.2 mtmt -56.86 -22.86 40.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.388 -0.369 . . . . 3.86 111.102 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 28.2 m -129.6 29.17 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.446 -0.343 . . . . 2.87 111.287 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . 0.411 ' HB3' ' HA ' ' B' ' 162' ' ' LEU . 71.7 t80 -126.71 -44.66 1.65 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 2.48 110.913 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.495 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 73.3 mt -67.34 -44.35 46.57 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 2.14 111.522 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 6.1 Cg_exo -74.67 -34.9 3.87 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.614 2.209 . . . . 1.07 112.363 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 79.1 p -55.31 -41.99 73.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 1.59 111.198 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 83.2 mt -57.58 -50.74 72.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.367 -0.378 . . . . 1.09 111.331 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.462 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.5 mp -57.66 -44.94 86.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.477 -0.329 . . . . 0.72 111.126 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 93.0 mt -61.91 -41.61 98.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.354 -0.385 . . . . 0.5 110.857 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . 0.428 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 58.8 m -57.64 -52.34 65.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.31 111.358 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.441 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 73.9 m80 -62.03 -52.72 62.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.332 -0.395 . . . . 0.3 111.1 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 55.4 mt -55.64 -51.47 67.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.43 -0.35 . . . . 0.44 110.976 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 94.2 mt -60.84 -42.02 96.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.362 -0.381 . . . . 0.46 110.772 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.547 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -59.74 -52.9 63.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.25 111.04 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 73.3 mt -53.79 -42.85 54.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.863 0.363 . . . . 0.31 110.059 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.0 -43.55 82.94 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.554 -0.832 . . . . 0.26 111.649 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 94.9 mt -56.5 -50.59 71.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.972 0.415 . . . . 0.47 110.363 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.44 -46.29 81.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.676 -0.774 . . . . 0.27 112.579 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 56.9 mt -55.32 -45.62 77.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.831 0.348 . . . . 0.93 111.05 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.425 ' O ' ' HG2' ' B' ' 185' ' ' ARG . 63.1 t80 -59.58 -51.54 69.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 1.52 110.892 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . 0.402 ' O ' ' HG2' ' B' ' 186' ' ' ARG . 61.6 mt -62.26 -44.08 98.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 1.1 111.201 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.31 -46.36 94.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.906 -0.664 . . . . 0.72 113.092 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' B' ' 182' ' ' TYR . 12.6 ptm180 -58.07 -21.91 47.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.675 0.274 . . . . 2.16 111.403 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' B' ' 183' ' ' ILE . 38.7 ptt180 -103.79 36.88 2.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.956 0.408 . . . . 3.82 110.684 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . 0.451 ' CD1' ' HB3' ' A' ' 185' ' ' ARG . 24.1 mt -89.68 -82.83 0.25 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.973 -0.558 . . . . 1.63 111.191 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 30.7 p . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.186 -0.912 . . . . 2.31 111.239 -179.632 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.151 0 N-CA-C 112.443 -0.263 . . . . 7.39 112.443 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -94.35 161.46 24.2 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.743 -0.742 . . . . 6.02 112.622 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 41.5 mt -71.16 -56.75 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.372 . . . . 6.75 111.112 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.439 ' O ' ' N ' ' A' ' 159' ' ' ALA . 46.2 m-85 -76.69 -70.34 0.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.08 -0.509 . . . . 5.45 111.154 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 74.6 m 44.23 -90.73 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.297 -0.41 . . . . 5.17 111.369 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -57.78 -49.33 76.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.897 0.38 . . . . 3.89 110.942 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.25 -56.41 22.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.516 . . . . 5.36 110.873 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -59.03 -48.67 80.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 3.21 111.209 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 97.5 mt -62.35 -31.04 71.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.368 -0.378 . . . . 3.31 111.094 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.1 -38.12 75.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.937 0.398 . . . . 3.11 110.797 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 164' ' ' VAL . 10.6 t -98.05 22.7 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.101 -0.499 . . . . 2.66 111.315 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.501 ' CE2' HD11 ' A' ' 169' ' ' LEU . 89.0 t80 -125.2 -41.89 2.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.372 -0.377 . . . . 2.06 110.761 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.485 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 94.5 mt -52.03 -56.9 17.56 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.986 -0.552 . . . . 1.88 111.545 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 30.1 Cg_endo -63.0 -31.65 76.62 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.212 1.941 . . . . 0.98 112.396 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 70.1 m -58.86 -43.73 90.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.298 -0.41 . . . . 1.47 110.955 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.501 HD11 ' CE2' ' A' ' 165' ' ' PHE . 73.0 mt -59.7 -48.7 80.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.73 110.926 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 86.4 mt -52.28 -52.08 54.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.63 110.99 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.5 mt -55.13 -43.11 73.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.4 110.927 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.418 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 75.2 m -55.23 -52.16 64.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.352 -0.385 . . . . 0.23 111.016 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.421 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 73.7 m80 -62.37 -51.12 68.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.29 111.037 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.27 -52.06 66.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.47 111.089 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 84.9 mt -58.66 -44.06 90.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.41 110.952 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.576 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -51.9 -52.19 51.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.421 . . . . 0.27 110.625 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 65.9 mt -54.08 -46.24 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.076 -0.511 . . . . 0.62 110.205 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.58 -42.68 85.02 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.614 -0.803 . . . . 0.28 111.899 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 53.4 mt -55.26 -50.38 69.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.397 . . . . 0.43 110.298 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.521 ' HA2' HD13 ' B' ' 181' ' ' ILE . . . -56.21 -46.05 86.73 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.596 -0.812 . . . . 0.29 112.18 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 39.6 mm -60.58 -48.4 88.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.82 0.343 . . . . 0.89 110.95 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.422 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 52.1 t80 -53.31 -51.94 60.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 1.56 110.982 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.96 -48.81 86.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.295 -0.412 . . . . 0.83 111.471 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.27 -51.48 56.26 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 121.162 -0.542 . . . . 0.64 113.713 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.1 OUTLIER -51.62 -31.79 26.56 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.648 -0.325 . . . . 2.54 111.231 -179.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.42 ' NH2' ' OH ' ' A' ' 182' ' ' TYR . 83.3 mtt180 -84.23 -22.93 30.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.461 -0.336 . . . . 3.95 111.233 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.06 -81.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 1.52 110.777 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.185 -0.912 . . . . 3.05 111.763 179.83 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 112.42 -0.272 . . . . 7.46 112.42 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -154.62 157.2 27.39 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.715 -0.755 . . . . 6.55 112.448 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 53.1 mt -70.58 -60.38 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.77 0.319 . . . . 7.86 111.093 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' B' ' 159' ' ' ALA . 97.3 m-85 -76.66 -54.14 7.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 6.6 111.045 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 80.3 p 41.65 -91.62 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.233 -0.44 . . . . 5.34 111.457 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -60.02 -52.26 66.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.118 0.485 . . . . 4.29 110.84 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -56.25 -27.84 56.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.855 -0.612 . . . . 5.73 111.032 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.411 ' HB2' ' CB ' ' B' ' 157' ' ' PHE . 56.3 t80 -87.53 -53.93 4.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 3.56 111.193 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.28 -38.48 89.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 3.37 111.026 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -56.09 -25.64 46.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 3.86 111.024 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.72 35.78 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 2.87 111.143 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -129.16 -45.98 1.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 2.48 110.949 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.487 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 88.0 mt -70.53 -45.59 18.51 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 2.14 111.426 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 71.6 Cg_endo -84.44 -22.81 3.05 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.465 2.11 . . . . 1.07 112.654 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 59.0 m -63.18 -43.99 96.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 1.59 111.455 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.411 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 89.3 mt -59.19 -51.46 69.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 1.09 111.462 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.48 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.2 mp -61.89 -49.52 75.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.464 -0.334 . . . . 0.72 111.149 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.76 -41.61 82.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 0.5 110.913 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . 0.421 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 74.8 m -56.5 -52.95 62.82 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.31 111.117 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.418 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 63.0 m80 -62.57 -52.23 64.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.345 -0.389 . . . . 0.3 110.806 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 97.4 mt -54.14 -52.11 62.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.44 111.095 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.23 -50.97 69.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.46 111.181 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.549 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.17 -52.78 57.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.424 -0.353 . . . . 0.25 111.225 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.576 HG13 ' HB1' ' A' ' 176' ' ' ALA . 62.3 mt -61.94 -41.77 92.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.836 0.35 . . . . 0.31 110.394 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.48 -50.23 48.81 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.585 -0.817 . . . . 0.26 111.836 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 83.8 mt -57.17 -44.84 83.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.901 0.382 . . . . 0.47 110.224 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.02 -46.26 85.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.615 -0.802 . . . . 0.27 112.209 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.521 HD13 ' HA2' ' A' ' 180' ' ' GLY . 34.1 mm -55.76 -50.99 64.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.882 0.372 . . . . 0.93 110.716 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.409 ' O ' ' HG2' ' B' ' 185' ' ' ARG . 50.8 t80 -52.71 -52.18 57.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 1.52 110.891 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 54.0 mt -62.18 -44.13 98.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.02 -0.537 . . . . 1.1 110.994 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.05 -50.39 65.92 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.767 -0.73 . . . . 0.72 112.692 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.435 ' HG3' ' N ' ' B' ' 186' ' ' ARG . 13.7 ptp180 -58.13 -38.91 77.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.789 0.328 . . . . 2.16 110.864 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.435 ' N ' ' HG3' ' B' ' 185' ' ' ARG . 66.3 mtt180 -100.97 50.54 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 3.82 111.151 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 185' ' ' ARG . 12.0 mt -91.03 -80.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 1.63 110.862 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 32.9 p . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.255 -0.879 . . . . 2.31 111.171 -179.922 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.427 -0.269 . . . . 7.39 112.427 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -136.85 163.71 25.26 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.819 -0.705 . . . . 6.02 112.401 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 21.2 mm -71.3 -61.93 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.056 0.455 . . . . 6.75 110.906 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.436 ' O ' ' N ' ' A' ' 159' ' ' ALA . 88.8 m-85 -76.25 -73.2 0.29 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.772 -0.649 . . . . 5.45 110.995 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.405 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 75.1 m 47.62 -88.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.987 -0.552 . . . . 5.17 111.498 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.0 -50.58 70.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.76 0.314 . . . . 3.89 111.189 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -57.13 -64.99 0.7 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.273 -0.422 . . . . 5.36 110.939 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -50.79 -50.06 56.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 3.21 110.826 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 158' ' ' SER . 97.7 mt -62.58 -40.89 98.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 3.31 110.944 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -56.68 -35.38 68.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.457 . . . . 3.11 111.014 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 31.0 m -96.07 30.98 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.991 0.424 . . . . 2.66 110.859 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.547 ' CZ ' HD11 ' A' ' 169' ' ' LEU . 93.6 t80 -147.07 -44.57 0.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.002 -0.545 . . . . 2.06 110.914 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.489 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 93.8 mt -57.66 -51.96 77.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 1.88 111.593 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 56.1 Cg_endo -70.03 -27.38 25.23 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.078 1.852 . . . . 0.98 112.35 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.8 t -63.9 -49.44 72.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 1.47 110.825 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.547 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 45.9 mt -59.46 -45.7 90.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.226 -0.443 . . . . 0.73 110.874 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 86.9 mt -51.79 -50.24 61.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.337 -0.392 . . . . 0.63 110.58 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 93.9 mt -58.89 -41.45 87.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 0.4 110.591 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.479 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 68.9 m -56.45 -52.23 65.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.23 110.777 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.428 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 75.7 m80 -61.39 -51.86 67.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.29 110.723 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.3 mt -58.89 -52.0 67.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.47 110.88 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.0 mt -61.54 -43.35 99.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.41 110.901 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.5 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -52.81 -52.51 56.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.27 110.876 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 71.4 mt -56.91 -43.0 79.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.62 110.307 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.13 -42.03 80.27 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.524 -0.846 . . . . 0.28 111.927 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 45.2 mt -60.0 -51.59 69.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.927 0.394 . . . . 0.43 110.306 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.17 -42.98 56.24 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.602 -0.808 . . . . 0.29 112.395 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.423 HD13 ' O ' ' B' ' 180' ' ' GLY . 49.9 mm -62.06 -51.9 66.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.836 0.351 . . . . 0.89 111.102 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -56.59 -50.64 71.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 1.56 110.813 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.417 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 63.6 mt -60.3 -43.19 93.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.49 . . . . 0.83 111.047 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.2 -48.65 81.36 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.815 -0.707 . . . . 0.64 112.93 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -62.2 -38.1 87.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.593 0.235 . . . . 2.54 111.606 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 183' ' ' ILE . 37.7 ptt180 -74.82 -9.41 58.52 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.64 0.237 . . . . 3.95 111.64 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 183' ' ' ILE . 24.8 mt -56.8 -80.88 0.02 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.106 0.479 . . . . 1.52 110.695 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 70.3 p . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.272 -0.871 . . . . 3.05 111.173 179.946 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.581 -0.208 . . . . 7.46 112.581 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.23 174.96 11.94 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.847 -0.692 . . . . 6.55 112.665 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 33.2 mm -69.81 -64.99 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.239 0.542 . . . . 7.86 111.228 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' B' ' 159' ' ' ALA . 84.8 m-85 -74.62 -69.86 0.44 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.321 -0.854 . . . . 6.6 111.049 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 28.9 t 51.72 -88.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.489 . . . . 5.34 111.164 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -57.54 -52.58 64.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.884 0.374 . . . . 4.29 111.307 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . 0.457 ' HA ' ' CD ' ' B' ' 163' ' ' LYS . 45.5 mt-10 -57.27 -23.07 45.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 5.73 111.561 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -93.95 -50.22 5.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.886 0.374 . . . . 3.56 111.312 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 60.5 mt -63.0 -37.03 85.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.057 -0.519 . . . . 3.37 111.282 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.457 ' CD ' ' HA ' ' B' ' 160' ' ' GLU . 14.6 ptmm? -57.15 -36.42 70.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.453 -0.34 . . . . 3.86 110.925 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 6.4 m -117.11 41.76 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.415 . . . . 2.87 111.071 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -144.99 -47.06 0.23 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 2.48 110.728 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.497 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 84.5 mt -65.43 -55.12 26.7 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.029 -0.532 . . . . 2.14 111.589 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 32.9 Cg_endo -63.96 -40.37 28.0 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.124 1.883 . . . . 1.07 112.398 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.1 t -46.87 -42.24 17.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.292 -0.413 . . . . 1.59 111.32 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 72.5 mt -62.4 -49.54 75.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 1.09 110.955 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.429 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.5 mp -57.71 -42.31 83.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.72 110.626 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 71.9 mt -59.48 -43.11 93.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.5 110.434 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . 0.428 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 69.6 m -54.74 -52.09 63.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.31 110.709 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.479 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 60.1 m80 -58.77 -52.29 66.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.049 -0.523 . . . . 0.3 110.882 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 96.5 mt -57.78 -50.32 73.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.41 . . . . 0.44 111.056 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 78.0 mt -62.11 -47.28 85.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.46 110.991 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.5 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -55.15 -52.98 61.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.25 111.076 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.491 HG13 ' HB1' ' A' ' 176' ' ' ALA . 66.1 mt -62.13 -42.84 96.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.359 -0.382 . . . . 0.31 110.609 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.57 -49.86 50.93 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.616 -0.802 . . . . 0.26 111.97 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 89.0 mt -57.91 -46.17 85.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.898 0.38 . . . . 0.47 110.455 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.423 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -56.01 -50.38 61.83 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.547 -0.835 . . . . 0.27 112.191 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 67.4 mt -53.91 -46.93 64.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 0.93 110.849 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.414 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 47.3 t80 -54.45 -51.63 64.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 1.52 110.73 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 69.5 mt -63.27 -48.79 85.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.178 -0.465 . . . . 1.1 111.16 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.29 -52.74 47.37 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.957 -0.64 . . . . 0.72 113.4 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.8 OUTLIER -57.68 -20.31 32.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.757 0.278 . . . . 2.16 111.214 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.436 ' NE ' ' HA ' ' B' ' 186' ' ' ARG . 3.9 mmp_? -94.17 40.25 1.08 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.846 0.355 . . . . 3.82 110.572 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 41.2 mt -101.08 -85.39 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.039 -0.528 . . . . 1.63 111.218 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.256 -0.878 . . . . 2.31 111.221 -179.843 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.457 -0.257 . . . . 7.39 112.457 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 161.02 173.25 29.41 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.758 -0.734 . . . . 6.02 112.31 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 55.7 mt -70.72 -57.54 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.672 0.272 . . . . 6.75 111.078 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.454 ' O ' ' N ' ' A' ' 159' ' ' ALA . 96.6 m-85 -75.97 -42.44 48.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.384 . . . . 5.45 110.674 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 33.6 t 42.84 -87.58 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.844 -0.616 . . . . 5.17 112.346 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -54.57 -53.05 59.68 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.791 0.293 . . . . 3.89 111.791 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.413 ' HB3' ' HB3' ' A' ' 157' ' ' PHE . 0.3 OUTLIER -56.23 -55.61 31.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.765 0.317 . . . . 5.36 111.144 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -64.18 -48.43 75.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.351 -0.386 . . . . 3.21 111.322 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 47.1 mt -61.42 -29.02 69.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.273 -0.421 . . . . 3.31 110.906 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -57.0 -49.21 76.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 3.11 110.778 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.6 m -105.48 42.81 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.491 . . . . 2.66 111.348 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.623 ' CZ ' HD11 ' A' ' 169' ' ' LEU . 7.5 t80 -145.17 -51.75 0.27 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.337 -0.392 . . . . 2.06 110.975 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.494 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 81.1 mt -55.48 -44.66 99.76 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.49 -0.323 . . . . 1.88 111.414 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 68.8 Cg_exo -50.48 -37.74 52.43 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.239 1.959 . . . . 0.98 112.511 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.6 m -78.01 -51.97 9.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 1.47 111.334 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.623 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 19.5 mt -61.08 -50.16 74.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.454 -0.339 . . . . 0.73 111.218 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.402 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 96.2 mt -52.13 -52.41 51.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.417 -0.356 . . . . 0.63 111.1 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.8 mt -62.44 -41.86 99.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.305 -0.407 . . . . 0.4 111.219 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.429 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 69.1 m -60.59 -53.28 59.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.42 -0.354 . . . . 0.23 111.352 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.446 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 66.2 m80 -62.92 -52.58 62.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.745 0.307 . . . . 0.29 110.889 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 170' ' ' LEU . 96.6 mt -57.72 -52.86 63.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.412 -0.358 . . . . 0.47 110.591 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 83.5 mt -62.88 -44.82 95.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.41 110.803 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.426 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -51.53 -52.32 47.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.428 . . . . 0.27 110.933 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.41 -45.03 97.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 0.62 110.477 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.4 -49.5 51.27 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.655 -0.783 . . . . 0.28 111.99 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 43.3 mt -55.58 -49.04 73.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 0.43 110.227 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.473 ' HA2' ' CG1' ' B' ' 181' ' ' ILE . . . -51.77 -46.16 54.64 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.524 -0.846 . . . . 0.29 112.45 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 41.7 mm -62.63 -48.24 89.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.748 0.308 . . . . 0.89 111.192 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.409 ' HA ' ' HG2' ' A' ' 185' ' ' ARG . 55.6 t80 -62.07 -52.21 64.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 1.56 111.242 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 94.6 mt -51.79 -51.1 29.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.286 -0.415 . . . . 0.83 110.986 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.01 -52.56 45.98 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.49 -0.862 . . . . 0.64 112.321 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.45 ' HG3' ' N ' ' A' ' 186' ' ' ARG . 10.9 ptp180 -62.93 -41.78 99.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.956 0.408 . . . . 2.54 110.721 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.45 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -64.38 -14.26 55.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 3.95 111.21 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 41.7 mt -50.92 -83.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.907 0.384 . . . . 1.52 111.031 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 188' ' ' THR . 1.7 t . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.354 -0.831 . . . . 3.05 111.27 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.427 -0.269 . . . . 7.46 112.427 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -166.97 -144.83 4.25 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.782 -0.723 . . . . 6.55 112.467 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 52.1 mt -68.38 -54.21 23.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.804 0.335 . . . . 7.86 110.627 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.424 ' HB3' ' HB2' ' B' ' 161' ' ' PHE . 58.8 m-85 -76.39 -39.61 53.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 6.6 110.414 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' B' ' 157' ' ' PHE . 10.2 t 80.71 -164.51 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.76 -0.655 . . . . 5.34 111.39 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.436 ' HA ' HD12 ' B' ' 162' ' ' LEU . . . -56.37 -25.2 48.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 4.29 111.531 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -51.38 -61.0 2.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.415 -0.357 . . . . 5.73 110.822 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.558 ' CZ ' ' CD1' ' B' ' 165' ' ' PHE . 32.1 t80 -56.59 -35.92 68.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.313 -0.403 . . . . 3.56 110.443 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' B' ' 159' ' ' ALA . 60.4 mt -63.72 -31.91 73.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 3.37 111.19 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -56.74 -36.88 70.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.346 . . . . 3.86 110.85 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 34.8 m -118.26 26.78 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 2.87 111.431 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . 0.558 ' CD1' ' CZ ' ' B' ' 161' ' ' PHE . 50.4 t80 -101.8 -65.84 0.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.416 -0.357 . . . . 2.48 111.027 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.492 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 60.4 mt -55.08 -44.91 99.87 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.304 -0.407 . . . . 2.14 111.446 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 55.9 Cg_exo -51.45 -54.09 5.96 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.258 1.972 . . . . 1.07 112.374 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 74.2 p -54.53 -41.67 69.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 1.59 111.009 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.417 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 59.7 mt -60.8 -52.66 64.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.329 -0.396 . . . . 1.09 111.132 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.416 ' CD1' ' O ' ' B' ' 166' ' ' LEU . 7.1 mp -62.89 -44.59 95.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.756 0.312 . . . . 0.72 110.918 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 94.7 mt -59.95 -43.89 94.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.329 -0.396 . . . . 0.5 110.824 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . 0.446 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 61.4 m -60.6 -48.97 79.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.31 111.012 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 41.9 m80 -61.42 -52.08 66.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.3 110.917 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 64.7 mt -59.67 -51.54 69.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.39 -0.368 . . . . 0.44 110.845 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.51 -51.99 65.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.46 111.483 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.426 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -51.93 -53.94 35.28 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.758 0.313 . . . . 0.25 111.3 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.418 HG13 ' HB1' ' A' ' 176' ' ' ALA . 67.4 mt -62.97 -44.59 99.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.31 110.703 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.97 -48.01 82.57 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.631 -0.795 . . . . 0.26 112.062 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 88.9 mt -53.96 -48.79 69.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 0.47 110.457 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.17 -48.24 81.39 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.704 -0.76 . . . . 0.27 112.654 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.473 ' CG1' ' HA2' ' A' ' 180' ' ' GLY . 52.5 mt -62.06 -48.82 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.735 0.302 . . . . 0.93 111.521 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.406 ' HA ' ' HG2' ' B' ' 185' ' ' ARG . 88.5 t80 -51.59 -52.25 48.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.321 -0.399 . . . . 1.52 111.297 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 58.6 mt -62.05 -46.65 95.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.321 -0.399 . . . . 1.1 111.203 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.39 -45.51 95.78 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.782 -0.723 . . . . 0.72 113.024 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' B' ' 182' ' ' TYR . 10.0 ptp180 -60.95 -17.76 53.21 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.685 0.254 . . . . 2.16 111.685 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -109.2 45.56 1.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.851 0.358 . . . . 3.82 110.859 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 62.4 mt -137.84 -85.2 0.3 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.059 -0.519 . . . . 1.63 111.214 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.277 -0.868 . . . . 2.31 111.217 -179.813 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.535 -0.226 . . . . 7.39 112.535 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -130.08 -178.69 15.55 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.864 -0.684 . . . . 6.02 112.483 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 57.3 mt -69.18 -59.3 3.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.897 0.38 . . . . 6.75 110.834 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -77.15 -62.41 1.66 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 5.45 110.727 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.434 ' O ' ' CG ' ' A' ' 162' ' ' LEU . 40.0 t 69.08 -77.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.964 -0.562 . . . . 5.17 111.17 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.35 -58.18 9.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.37 -0.377 . . . . 3.89 111.192 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 163' ' ' LYS . 14.3 mm-40 -57.23 -59.8 4.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.437 -0.347 . . . . 5.36 110.853 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.46 ' CZ ' ' CD1' ' A' ' 165' ' ' PHE . 91.5 t80 -51.95 -51.63 55.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.894 0.378 . . . . 3.21 110.549 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.434 ' CG ' ' O ' ' A' ' 158' ' ' SER . 53.6 mt -61.98 -26.47 68.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 3.31 110.35 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 160' ' ' GLU . 10.8 tppt? -56.39 -41.15 75.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.954 -0.566 . . . . 3.11 110.446 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 26.2 m -125.22 55.51 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.792 -0.64 . . . . 2.66 111.184 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.46 ' CD1' ' CZ ' ' A' ' 161' ' ' PHE . 83.7 t80 -144.25 -51.21 0.3 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.274 -0.421 . . . . 2.06 111.051 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.474 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 95.9 mt -52.75 -46.23 96.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 1.88 111.48 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 91.5 Cg_endo -81.64 -37.77 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.338 2.025 . . . . 0.98 112.528 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 53.8 m -48.14 -52.37 20.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 1.47 111.32 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.445 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 69.0 mt -61.3 -48.88 79.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.439 . . . . 0.73 111.008 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 89.2 mt -58.56 -49.77 76.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.63 111.077 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.31 -42.1 94.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.4 111.382 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.473 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 67.1 m -56.16 -53.39 57.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.739 0.304 . . . . 0.23 111.193 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.435 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 69.0 m80 -62.96 -51.69 65.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.351 -0.386 . . . . 0.29 110.765 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 95.7 mt -57.83 -51.88 67.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.47 111.241 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.69 -49.46 77.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.41 111.275 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.533 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -51.51 -52.92 42.83 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.854 0.359 . . . . 0.27 111.042 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 68.6 mt -57.45 -44.25 84.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.62 110.243 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.95 -44.01 82.42 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.719 -0.753 . . . . 0.28 111.916 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 75.6 mt -56.17 -52.54 64.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.958 0.409 . . . . 0.43 110.221 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.62 -45.11 68.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.566 -0.826 . . . . 0.29 112.07 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 48.0 mm -60.95 -42.44 92.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 0.89 110.806 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -55.14 -42.21 72.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 1.56 110.662 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.433 ' N ' HD13 ' A' ' 183' ' ' ILE . 3.7 mm -62.87 -52.99 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.83 110.864 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -63.43 -52.86 43.26 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.023 -0.608 . . . . 0.64 113.356 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.28 -26.44 12.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.701 0.286 . . . . 2.54 111.184 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.76 -22.11 65.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.406 -0.361 . . . . 3.95 110.977 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 187' ' ' LEU . 35.7 mt -55.25 -84.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.414 -0.357 . . . . 1.52 110.717 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.166 -0.921 . . . . 3.05 111.769 179.638 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.172 0 N-CA-C 112.498 -0.241 . . . . 7.46 112.498 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.65 165.46 28.73 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 6.55 112.52 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 52.0 mt -71.81 -65.9 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.921 0.391 . . . . 7.86 110.86 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.441 ' O ' ' N ' ' B' ' 159' ' ' ALA . 82.8 m-85 -77.73 -70.57 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.016 -0.538 . . . . 6.6 110.909 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 73.5 m 40.08 -90.04 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.106 -0.497 . . . . 5.34 112.137 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -56.31 -55.11 37.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.825 0.345 . . . . 4.29 111.101 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . 0.404 ' O ' HG22 ' B' ' 164' ' ' VAL . 36.8 tt0 -54.69 -43.63 72.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 5.73 111.004 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -59.5 -57.73 11.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 3.56 110.997 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 45.0 mt -63.29 -37.31 86.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 3.37 110.952 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -56.42 -37.81 70.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.462 . . . . 3.86 110.885 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.404 HG22 ' O ' ' B' ' 160' ' ' GLU . 21.8 m -101.36 30.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 2.87 111.014 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -128.4 -52.2 1.28 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.121 -0.491 . . . . 2.48 110.908 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.507 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 64.8 mt -57.83 -43.72 98.86 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 2.14 111.684 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 22.8 Cg_exo -64.77 -40.0 23.86 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.277 1.985 . . . . 1.07 112.25 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 63.5 m -49.75 -44.92 48.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 1.59 110.973 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.42 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 26.0 mt -52.73 -49.45 65.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 1.09 110.673 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.467 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.3 mp -59.96 -44.45 94.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 0.72 110.452 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.17 -41.72 98.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.5 110.605 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . 0.435 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 72.2 m -54.1 -49.73 68.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.31 110.637 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.473 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 66.9 m80 -60.26 -52.17 66.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.3 110.692 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.41 -52.41 65.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.44 110.994 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 76.6 mt -62.5 -43.83 97.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 0.46 110.937 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.511 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.41 -53.43 51.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.25 110.965 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.533 HG13 ' HB1' ' A' ' 176' ' ' ALA . 41.4 mt -62.64 -44.95 99.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.31 110.413 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.82 -51.15 46.82 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.674 -0.774 . . . . 0.26 111.892 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 97.0 mt -55.12 -42.95 73.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 0.47 110.092 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.23 -42.6 93.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.667 -0.777 . . . . 0.27 112.042 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 41.4 mm -58.18 -52.21 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.729 0.299 . . . . 0.93 110.601 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -51.71 -52.5 47.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 1.52 110.575 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 64.3 mt -62.89 -45.16 99.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.96 -0.564 . . . . 1.1 110.912 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.16 -52.36 50.28 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.979 -0.629 . . . . 0.72 112.999 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -53.37 -27.4 23.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.82 0.343 . . . . 2.16 110.87 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -111.24 58.11 0.62 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 3.82 111.124 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 16.7 mt -105.02 -83.17 0.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.124 -0.489 . . . . 1.63 110.874 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.302 -0.856 . . . . 2.31 111.192 179.941 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.62 -0.192 . . . . 7.39 112.62 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -131.74 172.08 21.05 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.736 -0.745 . . . . 6.02 112.637 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 56.7 mt -70.9 -60.51 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.911 0.386 . . . . 6.75 110.963 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.442 ' HB2' ' HB2' ' A' ' 161' ' ' PHE . 89.7 m-85 -76.75 -56.16 4.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.979 -0.555 . . . . 5.45 110.927 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.432 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 74.7 m 47.89 -90.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.994 -0.548 . . . . 5.17 111.545 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -52.77 -57.01 11.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.599 0.238 . . . . 3.89 111.528 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.546 ' O ' HG12 ' A' ' 164' ' ' VAL . 0.2 OUTLIER -57.36 -54.2 49.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.77 0.319 . . . . 5.36 110.71 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.442 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 20.9 t80 -46.22 -58.57 3.54 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.165 -0.47 . . . . 3.21 111.228 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 158' ' ' SER . 32.6 mt -60.27 -47.81 84.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 3.31 110.143 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -58.66 -21.01 53.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.904 -0.589 . . . . 3.11 110.814 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 160' ' ' GLU . 9.9 p -118.42 25.68 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.406 -0.361 . . . . 2.66 111.152 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -131.84 -61.27 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.374 -0.376 . . . . 2.06 111.365 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.501 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 85.3 mt -63.25 -47.09 85.52 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.441 -0.345 . . . . 1.88 111.786 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 72.7 Cg_endo -76.53 -24.69 10.26 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.185 1.923 . . . . 0.98 112.516 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 79.9 p -65.67 -42.41 91.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 1.47 110.922 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 80.1 mt -60.65 -49.87 75.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.73 110.846 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 95.2 mt -54.88 -51.1 67.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.297 -0.41 . . . . 0.63 110.769 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.5 -41.5 85.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.4 111.042 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.472 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 68.3 m -55.98 -52.88 62.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.76 0.314 . . . . 0.23 111.097 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.451 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 66.6 m80 -62.94 -52.57 62.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.29 110.905 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.0 mt -58.31 -52.23 66.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.47 110.841 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.4 -44.94 95.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.0 -0.546 . . . . 0.41 110.933 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.442 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -52.12 -52.37 52.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.27 110.822 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 68.9 mt -57.31 -42.64 80.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.268 -0.424 . . . . 0.62 110.128 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.3 -41.43 87.1 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.788 -0.72 . . . . 0.28 111.755 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 76.8 mt -59.45 -49.26 78.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.949 0.404 . . . . 0.43 110.199 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.8 -47.36 65.41 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.671 -0.776 . . . . 0.29 112.072 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.431 HD13 ' O ' ' B' ' 180' ' ' GLY . 32.6 mm -56.25 -46.45 81.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 0.89 110.841 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.409 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 88.8 t80 -57.59 -49.45 76.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 1.56 110.989 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 54.7 mt -62.78 -43.83 99.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.23 -0.441 . . . . 0.83 111.353 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.4 ' O ' ' HG ' ' A' ' 187' ' ' LEU . . . -62.34 -52.21 51.02 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.039 -0.601 . . . . 0.64 113.469 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -61.34 -20.78 63.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.767 0.284 . . . . 2.54 111.395 -179.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 28.4 mmt180 -74.35 -5.68 43.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.576 -0.284 . . . . 3.95 111.676 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 184' ' ' GLY . 22.6 mt -57.57 -83.44 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.902 0.382 . . . . 1.52 111.085 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 81.5 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.188 -0.91 . . . . 3.05 111.136 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.53 -0.228 . . . . 7.46 112.53 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -157.21 -174.74 27.31 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.653 -0.784 . . . . 6.55 112.694 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 26.5 mm -70.66 -66.05 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.265 0.555 . . . . 7.86 111.057 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.429 ' O ' ' N ' ' B' ' 159' ' ' ALA . 65.4 m-85 -75.84 -59.61 2.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.341 -0.845 . . . . 6.6 111.13 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.405 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 31.3 t 43.97 -91.29 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.134 -0.484 . . . . 5.34 111.351 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -60.03 -48.85 80.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.928 0.394 . . . . 4.29 110.992 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -57.98 -34.15 69.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.925 -0.579 . . . . 5.73 111.368 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -86.14 -44.43 12.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.711 0.291 . . . . 3.56 111.309 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' B' ' 158' ' ' SER . 92.7 mt -62.5 -43.69 98.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.408 -0.36 . . . . 3.37 111.105 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.455 ' HG3' HG23 ' B' ' 164' ' ' VAL . 17.9 ptpt -57.26 -28.45 62.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.374 -0.375 . . . . 3.86 110.633 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.615 ' O ' HG12 ' B' ' 164' ' ' VAL . 21.4 t -98.91 25.49 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 2.87 110.725 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -126.41 -47.54 1.58 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 2.48 110.858 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.487 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 85.9 mt -61.24 -45.55 95.39 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 2.14 111.272 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 94.2 Cg_endo -81.02 -27.26 3.07 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.31 2.007 . . . . 1.07 112.383 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 91.5 p -54.36 -42.8 70.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 1.59 110.87 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.406 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 81.8 mt -58.78 -49.6 77.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 1.09 110.643 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.468 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.0 mp -62.17 -47.11 85.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.046 -0.525 . . . . 0.72 110.724 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 79.6 mt -59.65 -43.63 93.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.5 110.822 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . 0.451 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 75.6 m -54.24 -50.2 67.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.269 -0.423 . . . . 0.31 110.607 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.472 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 56.6 m80 -62.26 -52.47 63.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.3 110.931 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 89.2 mt -58.62 -52.49 65.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.373 -0.376 . . . . 0.44 111.083 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 64.7 mt -62.3 -46.15 90.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.46 111.051 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.49 -53.02 57.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 0.25 110.907 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.434 HG13 ' HB1' ' A' ' 176' ' ' ALA . 72.6 mt -62.22 -42.02 93.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.188 -0.46 . . . . 0.31 110.533 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.06 -45.44 92.44 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.565 -0.826 . . . . 0.26 111.951 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.93 -46.0 85.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 0.47 110.236 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.431 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -54.62 -44.38 79.12 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.584 -0.817 . . . . 0.27 112.183 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 60.3 mt -60.91 -46.88 95.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.721 0.296 . . . . 0.93 111.034 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -55.58 -47.46 76.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 1.52 111.083 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 59.4 mt -61.25 -50.37 80.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 1.1 111.07 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -58.15 -51.29 59.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.83 -0.7 . . . . 0.72 112.712 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -62.07 -22.87 66.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.701 0.286 . . . . 2.16 111.285 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -93.55 43.08 1.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.935 0.397 . . . . 3.82 110.764 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 56.5 mt -138.03 -85.68 0.28 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 1.63 111.293 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 30.3 p . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.226 -0.892 . . . . 2.31 111.207 -179.59 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.368 -0.293 . . . . 7.39 112.368 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.04 179.62 38.47 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.656 -0.783 . . . . 6.02 112.604 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.408 ' O ' ' CD2' ' A' ' 157' ' ' PHE . 13.6 mm -69.04 -19.24 23.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.793 0.33 . . . . 6.75 111.158 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.438 ' O ' ' N ' ' A' ' 159' ' ' ALA . 30.1 m-85 -159.5 -67.66 0.08 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.18 -0.464 . . . . 5.45 110.53 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.417 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 74.9 m 40.19 -90.83 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.034 -0.53 . . . . 5.17 112.067 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.7 -52.45 64.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.752 0.31 . . . . 3.89 111.435 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.414 ' OE1' ' CE1' ' A' ' 157' ' ' PHE . 40.2 tt0 -55.94 -65.61 0.57 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.419 -0.355 . . . . 5.36 110.876 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.422 ' CB ' ' HB3' ' A' ' 157' ' ' PHE . 77.5 t80 -51.73 -51.11 58.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 3.21 110.856 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 158' ' ' SER . 87.7 mt -62.75 -33.28 74.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 3.31 111.297 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -57.16 -35.15 69.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.453 -0.34 . . . . 3.11 110.863 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 34.5 m -106.9 28.89 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.265 -0.425 . . . . 2.66 110.992 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.52 ' CZ ' HD11 ' A' ' 169' ' ' LEU . 61.8 t80 -133.06 -63.0 0.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 2.06 110.838 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.483 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 73.8 mt -49.12 -57.79 10.55 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 1.88 111.407 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 26.0 Cg_endo -61.8 -21.71 72.79 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.291 1.994 . . . . 0.98 112.329 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.5 t -74.21 -52.82 11.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 1.47 110.911 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.52 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 60.2 mt -62.61 -46.27 89.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.73 110.914 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.79 -52.36 49.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.27 -0.423 . . . . 0.63 110.635 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.4 mt -57.67 -43.66 85.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.243 -0.435 . . . . 0.4 110.745 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.426 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 75.6 m -57.51 -52.79 63.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.23 110.706 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.451 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 64.9 m80 -62.87 -51.89 65.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.29 110.746 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.49 -52.3 66.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 0.47 111.109 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 81.8 mt -53.71 -50.82 65.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.465 -0.334 . . . . 0.41 110.781 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.575 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -53.36 -52.28 59.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.27 110.697 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 81.4 mt -58.43 -42.86 85.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.62 110.232 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.0 -43.77 55.84 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.627 -0.797 . . . . 0.28 111.796 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.0 -43.27 99.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.007 0.432 . . . . 0.43 109.914 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -61.13 -45.59 96.25 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.657 -0.783 . . . . 0.29 112.137 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 48.7 mm -60.33 -46.04 95.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.891 0.377 . . . . 0.89 110.924 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.408 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 51.1 t80 -54.52 -50.2 68.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.063 -0.517 . . . . 1.56 110.844 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.79 -47.17 94.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.171 -0.468 . . . . 0.83 111.224 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.42 -52.69 47.41 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.818 -0.706 . . . . 0.64 112.969 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.1 OUTLIER -61.93 -15.48 43.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.563 0.221 . . . . 2.54 111.329 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -92.25 20.94 5.54 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.68 0.276 . . . . 3.95 110.984 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 49.0 mt -99.92 -83.64 0.43 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.914 0.387 . . . . 1.52 110.836 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.361 -0.828 . . . . 3.05 111.128 179.816 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.522 -0.231 . . . . 7.46 112.522 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 155.87 -159.63 29.43 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.7 -0.762 . . . . 6.55 112.536 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 53.3 mt -70.7 -49.97 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.916 0.389 . . . . 7.86 111.246 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' B' ' 159' ' ' ALA . 29.9 m-85 -75.85 -65.05 0.95 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.086 -0.507 . . . . 6.6 111.24 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.415 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 31.2 t 54.2 -87.53 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.107 -0.497 . . . . 5.34 110.905 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -56.55 -54.71 42.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.825 0.345 . . . . 4.29 111.023 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -55.79 -34.19 65.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 5.73 111.117 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -76.55 -55.23 5.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.353 -0.385 . . . . 3.56 111.018 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' B' ' 158' ' ' SER . 72.8 mt -62.96 -29.64 70.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 3.37 111.152 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -56.41 -36.7 69.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.411 . . . . 3.86 111.066 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 33.0 m -98.84 28.55 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 2.87 111.15 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -142.81 -46.78 0.32 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.319 -0.4 . . . . 2.48 111.147 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.489 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 82.8 mt -55.83 -59.03 12.69 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.168 -0.469 . . . . 2.14 111.823 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 10.5 Cg_endo -54.02 -44.41 49.55 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.418 2.079 . . . . 1.07 112.782 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 67.3 m -50.45 -43.28 55.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.431 -0.35 . . . . 1.59 111.071 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.13 -44.07 97.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.301 -0.409 . . . . 1.09 111.249 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.434 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.7 mp -60.74 -50.11 74.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.72 110.776 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 89.2 mt -53.65 -42.69 68.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.5 110.903 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . 0.451 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 74.7 m -58.44 -49.59 76.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.196 -0.456 . . . . 0.31 110.998 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.426 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 66.5 m80 -58.72 -52.61 64.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.3 111.101 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 82.5 mt -59.91 -52.46 65.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.369 -0.378 . . . . 0.44 111.13 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.58 -42.56 99.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 0.46 110.952 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.539 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -52.39 -52.76 51.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 0.25 111.338 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.575 HG13 ' HB1' ' A' ' 176' ' ' ALA . 31.6 mt -61.43 -42.64 94.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 0.31 110.628 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.46 -49.95 54.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.536 -0.84 . . . . 0.26 111.787 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 77.0 mt -55.86 -46.1 78.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 0.47 110.272 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.96 -41.89 69.18 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.639 -0.791 . . . . 0.27 112.019 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 41.9 mm -59.8 -52.13 64.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.866 0.365 . . . . 0.93 110.835 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.425 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 47.9 t80 -54.96 -50.82 67.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 1.52 110.803 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . 0.422 ' HA ' ' HG2' ' B' ' 186' ' ' ARG . 57.1 mt -62.01 -45.98 97.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 1.1 111.322 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -56.01 -49.82 64.99 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.825 -0.703 . . . . 0.72 112.481 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.425 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 10.6 ptp180 -61.0 -18.73 59.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.55 0.214 . . . . 2.16 111.255 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.422 ' HG2' ' HA ' ' B' ' 183' ' ' ILE . 13.3 ptm180 -113.6 42.14 2.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.884 0.374 . . . . 3.82 110.675 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 28.9 mt -91.77 -85.05 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 1.63 111.267 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.259 -0.877 . . . . 2.31 111.281 -179.906 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.403 -0.279 . . . . 7.39 112.403 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -82.27 158.22 37.72 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.678 -0.772 . . . . 6.02 112.577 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.526 HD12 ' N ' ' A' ' 156' ' ' ILE . 3.7 mp -74.28 -68.23 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.949 0.404 . . . . 6.75 110.562 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' A' ' 159' ' ' ALA . 85.9 m-85 -76.74 -56.06 4.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.963 -0.562 . . . . 5.45 110.776 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.418 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 74.2 m 41.16 -91.36 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.983 -0.553 . . . . 5.17 111.766 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -57.05 -51.86 67.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.771 0.319 . . . . 3.89 111.285 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -56.46 -48.89 76.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.442 . . . . 5.36 110.972 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.538 ' CZ ' ' CD1' ' A' ' 165' ' ' PHE . 76.5 t80 -61.57 -56.7 17.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 3.21 110.957 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 158' ' ' SER . 61.0 mt -61.01 -35.54 77.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 3.31 111.082 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -57.49 -27.25 62.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 3.11 111.384 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 34.8 m -134.26 25.97 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.76 0.314 . . . . 2.66 111.615 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.538 ' CD1' ' CZ ' ' A' ' 161' ' ' PHE . 81.7 t80 -120.68 -52.16 2.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.058 0.456 . . . . 2.06 110.16 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.505 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 84.5 mt -60.1 -43.97 95.35 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.834 -0.621 . . . . 1.88 111.421 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 88.2 Cg_exo -44.92 -53.1 5.53 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.23 1.953 . . . . 0.98 112.435 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 49.6 m -60.78 -45.7 93.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 1.47 111.216 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.512 HD11 ' CE2' ' A' ' 165' ' ' PHE . 26.0 mt -58.99 -46.23 88.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.389 -0.369 . . . . 0.73 111.12 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 65.6 mt -54.36 -52.06 62.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.329 -0.396 . . . . 0.63 110.639 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 86.9 mt -57.76 -43.89 85.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.4 110.688 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.446 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 58.2 m -56.1 -52.54 63.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.23 110.811 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.427 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 80.8 m80 -62.6 -52.09 64.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.29 110.978 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.9 mt -58.02 -52.53 65.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.361 -0.382 . . . . 0.47 110.951 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.4 mt -56.69 -45.49 81.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.299 -0.41 . . . . 0.41 110.832 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.523 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -56.49 -52.32 65.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 0.27 110.904 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 75.7 mt -57.83 -42.98 83.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.62 110.648 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.51 -45.06 67.54 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.697 -0.763 . . . . 0.28 112.255 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 79.5 mt -61.98 -49.8 74.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.836 0.35 . . . . 0.43 110.525 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.449 ' CA ' HG13 ' B' ' 181' ' ' ILE . . . -55.96 -51.76 53.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.727 -0.749 . . . . 0.29 112.595 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.411 HG12 ' O ' ' B' ' 180' ' ' GLY . 47.7 mt -59.19 -43.62 89.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.786 0.327 . . . . 0.89 111.172 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.444 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 34.1 t80 -53.75 -47.88 70.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.026 0.441 . . . . 1.56 110.577 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 72.9 mt -62.78 -48.0 90.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.069 -0.514 . . . . 0.83 111.099 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.402 ' HA2' ' HG ' ' A' ' 187' ' ' LEU . . . -61.06 -46.35 94.73 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.93 -0.652 . . . . 0.64 112.967 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 11.2 ptm180 -61.8 -28.69 69.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.029 0.442 . . . . 2.54 110.851 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -84.64 11.68 8.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.6 -0.727 . . . . 3.95 111.583 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.402 ' HG ' ' HA2' ' A' ' 184' ' ' GLY . 68.6 mt -79.15 -77.07 0.18 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.153 0.501 . . . . 1.52 110.818 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 68.0 p . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.261 -0.876 . . . . 3.05 111.109 179.924 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.557 -0.217 . . . . 7.46 112.557 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 159.55 -153.95 25.0 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.869 -0.681 . . . . 6.55 112.363 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 42.1 mt -70.15 -58.37 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.893 0.378 . . . . 7.86 110.823 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' B' ' 159' ' ' ALA . 49.4 m-85 -77.66 -75.32 0.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.05 -0.523 . . . . 6.6 110.918 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 28.7 t 39.91 -92.36 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.234 -0.439 . . . . 5.34 111.542 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -60.07 -46.34 89.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.939 0.4 . . . . 4.29 110.925 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' B' ' 163' ' ' LYS . 13.2 mm-40 -58.04 -34.68 70.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.84 -0.618 . . . . 5.73 111.54 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.404 ' HB2' ' HB3' ' B' ' 157' ' ' PHE . 46.0 t80 -87.64 -44.75 10.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.803 0.335 . . . . 3.56 111.496 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 69.8 mt -62.35 -35.97 80.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.305 -0.407 . . . . 3.37 111.457 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.436 ' HG3' HG23 ' B' ' 164' ' ' VAL . 17.7 ptpt -57.75 -22.38 46.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.707 0.289 . . . . 3.86 111.17 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.448 ' O ' HG12 ' B' ' 164' ' ' VAL . 3.8 t -106.16 26.34 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.902 0.382 . . . . 2.87 110.932 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -142.34 -45.48 0.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 2.48 111.009 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.502 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 76.1 mt -59.64 -47.29 97.95 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 2.14 111.922 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 68.2 Cg_endo -75.67 -32.46 4.65 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.141 1.894 . . . . 1.07 112.727 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 48.7 m -51.53 -42.41 61.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.901 0.381 . . . . 1.59 110.767 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 65.7 mt -62.31 -46.91 86.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 1.09 111.016 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.409 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.4 mp -59.52 -49.1 79.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.423 -0.353 . . . . 0.72 110.571 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 85.3 mt -52.56 -41.81 63.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.42 . . . . 0.5 110.387 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . 0.427 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 58.5 m -60.51 -51.81 67.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.52 . . . . 0.31 110.597 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.446 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 54.8 m80 -61.52 -51.95 66.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.122 -0.49 . . . . 0.3 110.809 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 93.1 mt -59.77 -52.23 66.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.33 -0.396 . . . . 0.44 110.794 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.23 -43.91 97.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.46 110.976 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.523 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -51.95 -52.47 50.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.25 111.074 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.514 HG13 ' HB1' ' A' ' 176' ' ' ALA . 52.3 mt -61.99 -46.78 95.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.434 -0.348 . . . . 0.31 110.591 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.23 -47.15 76.25 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.624 -0.798 . . . . 0.26 111.858 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 93.4 mt -54.23 -49.49 69.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.47 110.491 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.411 ' O ' HG12 ' A' ' 181' ' ' ILE . . . -56.41 -44.43 89.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.554 -0.831 . . . . 0.27 112.142 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.449 HG13 ' CA ' ' A' ' 180' ' ' GLY . 66.3 mt -61.43 -52.44 61.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.809 0.338 . . . . 0.93 110.791 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.518 ' CE2' ' NH2' ' B' ' 186' ' ' ARG . 46.5 t80 -56.7 -51.99 66.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.023 -0.535 . . . . 1.52 110.964 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 62.6 mt -62.39 -48.58 87.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.397 -0.365 . . . . 1.1 110.832 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.68 -52.36 48.82 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.839 -0.696 . . . . 0.72 112.973 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.416 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 1.4 ptp180 -53.68 -26.62 23.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.634 0.254 . . . . 2.16 111.521 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.518 ' NH2' ' CE2' ' B' ' 182' ' ' TYR . 68.9 mtm180 -104.62 57.0 0.7 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.901 0.381 . . . . 3.82 110.921 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 75.9 mt -150.37 -85.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.556 . . . . 1.63 111.375 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 29.8 p . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.365 -0.826 . . . . 2.31 111.222 -179.712 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.525 -0.23 . . . . 7.39 112.525 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -125.85 -176.6 14.57 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.838 -0.696 . . . . 6.02 112.425 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 28.6 mt -67.76 -59.65 3.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.82 0.343 . . . . 6.75 110.255 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.436 ' HB3' ' HB2' ' A' ' 161' ' ' PHE . 95.7 m-85 -78.14 -48.34 16.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.494 . . . . 5.45 110.361 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' ' 157' ' ' PHE . 14.6 t 76.2 -157.91 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.991 -0.549 . . . . 5.17 111.178 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -53.05 -22.59 6.11 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.552 -0.294 . . . . 3.89 111.406 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -56.05 -48.16 76.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.427 -0.351 . . . . 5.36 110.76 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' A' ' 157' ' ' PHE . 23.3 t80 -73.48 -45.43 54.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 3.21 110.777 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.43 -31.66 72.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.412 -0.358 . . . . 3.31 110.705 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -56.92 -23.93 48.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 3.11 110.936 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 32.7 m -121.22 27.4 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 2.66 110.837 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.483 ' CZ ' HD11 ' A' ' 169' ' ' LEU . 88.8 t80 -135.4 -51.03 0.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 2.06 111.115 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.502 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 84.3 mt -62.08 -44.38 89.21 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.386 . . . . 1.88 111.614 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 57.3 Cg_exo -51.76 -57.88 1.91 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.156 1.904 . . . . 0.98 112.505 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.6 t -51.03 -51.94 48.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.456 . . . . 1.47 111.118 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.483 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 39.8 mt -59.68 -51.35 70.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.365 -0.38 . . . . 0.73 110.912 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 91.7 mt -53.63 -49.59 67.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.63 110.75 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 97.2 mt -62.09 -43.0 99.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.4 110.921 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.429 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 69.3 m -57.3 -52.61 64.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.23 111.019 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.408 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 65.4 m80 -62.78 -52.52 62.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 0.29 111.242 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.8 mt -61.28 -52.1 66.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 0.47 111.354 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 171' ' ' LEU . 81.5 mt -57.49 -46.44 83.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.35 -0.386 . . . . 0.41 111.14 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.635 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -54.48 -52.57 61.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.927 0.394 . . . . 0.27 110.907 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.4 ' O ' HG12 ' A' ' 181' ' ' ILE . 68.9 mt -58.01 -43.87 85.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.244 -0.435 . . . . 0.62 110.336 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.68 -47.08 65.45 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.495 -0.86 . . . . 0.28 111.923 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 70.0 mt -55.82 -50.1 71.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.381 . . . . 0.43 110.398 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.446 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -54.74 -43.29 80.07 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.561 -0.828 . . . . 0.29 112.354 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 177' ' ' ILE . 40.7 mm -62.38 -49.2 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.912 0.387 . . . . 0.89 111.101 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.413 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 51.1 t80 -56.74 -50.4 72.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.952 -0.567 . . . . 1.56 111.343 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.414 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 58.3 mt -59.87 -46.36 93.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.83 111.305 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.19 -47.98 86.01 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.775 -0.726 . . . . 0.64 112.899 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 11.6 ptp180 -58.78 -28.88 66.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.661 0.267 . . . . 2.54 111.108 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 183' ' ' ILE . 34.4 ptt180 -93.99 37.49 1.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.372 . . . . 3.95 110.853 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 27.4 mt -112.73 -73.87 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.164 0.507 . . . . 1.52 110.668 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.318 -0.849 . . . . 3.05 111.768 179.886 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 112.535 -0.226 . . . . 7.46 112.535 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -161.47 -151.36 6.24 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.804 -0.712 . . . . 6.55 112.457 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 57.9 mt -69.95 -57.46 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.848 0.356 . . . . 7.86 110.905 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.424 ' O ' ' HB3' ' B' ' 158' ' ' SER . 53.3 m-85 -77.87 -71.58 0.41 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 6.6 110.75 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' B' ' 157' ' ' PHE . 21.7 t 72.17 -160.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.388 -0.369 . . . . 5.34 110.974 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.24 -23.71 15.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.371 -0.377 . . . . 4.29 110.997 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.66 -61.23 2.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.964 0.411 . . . . 5.73 110.511 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.414 ' CB ' ' HB3' ' B' ' 157' ' ' PHE . 25.8 t80 -56.99 -35.35 69.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.094 -0.503 . . . . 3.56 110.465 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 74.5 mt -64.69 -30.72 71.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 3.37 111.283 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -56.08 -29.05 60.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.76 0.314 . . . . 3.86 110.897 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 34.0 m -126.88 44.3 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 2.87 111.214 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -141.51 -67.62 0.4 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.327 -0.397 . . . . 2.48 111.154 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.484 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 74.0 mt -60.41 -59.4 13.96 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.112 -0.494 . . . . 2.14 111.816 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 6.1 Cg_exo -39.06 -31.84 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.791 2.327 . . . . 1.07 112.852 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 48.1 t -79.91 -44.8 19.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.865 0.364 . . . . 1.59 111.258 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 59.6 mt -62.31 -45.77 91.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 1.09 111.396 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.48 -51.67 68.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.324 -0.398 . . . . 0.72 111.247 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 92.8 mt -58.56 -41.71 86.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.385 -0.37 . . . . 0.5 111.05 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . 0.408 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 68.9 m -54.04 -52.32 61.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.31 111.382 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 62.9 m80 -61.55 -52.53 64.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.383 -0.371 . . . . 0.3 111.324 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 80.1 mt -55.74 -52.72 62.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.44 110.922 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.91 -47.41 83.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.114 -0.494 . . . . 0.46 111.362 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.576 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -55.09 -53.32 57.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.25 111.751 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.635 HG13 ' HB1' ' A' ' 176' ' ' ALA . 53.4 mt -62.58 -43.29 98.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 0.31 110.862 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.28 -47.99 83.68 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.611 -0.804 . . . . 0.26 112.126 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.413 ' O ' HD12 ' B' ' 183' ' ' ILE . 93.6 mt -55.14 -51.85 65.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.759 0.314 . . . . 0.47 110.583 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.47 -41.82 49.58 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.613 -0.803 . . . . 0.27 112.017 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.446 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 27.2 mm -59.43 -48.88 85.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.755 0.312 . . . . 0.93 110.624 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -51.68 -52.51 47.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 1.52 111.269 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . 0.542 HD12 ' H ' ' B' ' 183' ' ' ILE . 4.0 mp -63.57 -52.47 57.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.451 -0.341 . . . . 1.1 111.228 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.47 -52.57 48.11 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.905 -0.664 . . . . 0.72 113.469 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.464 ' CD ' ' HG3' ' B' ' 186' ' ' ARG . 0.7 OUTLIER -55.19 -20.21 9.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.546 0.213 . . . . 2.16 111.515 -179.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.464 ' HG3' ' CD ' ' B' ' 185' ' ' ARG . 49.9 mtp180 -108.07 37.03 2.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.817 0.341 . . . . 3.82 110.838 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 19.7 mt -89.78 -84.0 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 1.63 111.174 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . 0.403 HG23 ' OXT' ' B' ' 188' ' ' THR . 1.5 t . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.203 -0.903 . . . . 2.31 111.218 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 112.505 -0.238 . . . . 7.39 112.505 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -98.48 162.2 20.61 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 6.02 112.504 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 50.2 mt -71.33 -63.08 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.826 0.346 . . . . 6.75 111.114 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 159' ' ' ALA . 91.7 m-85 -76.49 -44.38 35.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 5.45 110.724 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.4 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 79.8 p 43.24 -88.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.849 -0.614 . . . . 5.17 112.129 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.56 -56.25 23.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.753 0.311 . . . . 3.89 111.454 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -55.69 -52.45 63.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.305 -0.407 . . . . 5.36 110.972 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.428 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 84.1 t80 -62.4 -50.84 69.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.883 0.373 . . . . 3.21 110.793 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 158' ' ' SER . 88.3 mt -62.47 -28.16 69.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.063 -0.517 . . . . 3.31 110.807 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -57.39 -38.85 74.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 3.11 110.87 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 34.5 m -112.06 20.03 6.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 2.66 111.569 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -97.72 -49.32 4.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.757 0.313 . . . . 2.06 110.637 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.499 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 75.6 mt -62.44 -44.25 87.08 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 1.88 111.173 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 31.5 Cg_exo -59.07 -47.56 17.32 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.121 1.881 . . . . 0.98 111.951 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.4 t -47.73 -47.47 30.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.28 -0.418 . . . . 1.47 110.992 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.415 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 29.3 mt -61.99 -51.32 68.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.73 110.724 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 87.6 mt -57.79 -51.94 67.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.63 110.634 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 95.2 mt -53.05 -47.13 68.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.4 110.484 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.42 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 70.3 m -51.96 -51.96 53.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.035 -0.529 . . . . 0.23 110.831 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.46 ' CD2' ' HB3' ' B' ' 172' ' ' SER . 58.3 m80 -61.51 -52.33 64.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.29 110.749 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 84.9 mt -57.19 -50.67 72.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.47 111.003 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.9 mt -59.78 -44.8 93.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.41 110.811 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.469 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -57.34 -52.68 64.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.429 . . . . 0.27 110.716 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.408 ' O ' HG12 ' A' ' 181' ' ' ILE . 71.0 mt -58.99 -42.66 86.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.48 . . . . 0.62 110.332 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.7 -43.15 53.52 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.587 -0.816 . . . . 0.28 111.796 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.02 -47.7 83.59 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.736 -0.468 . . . . 0.43 109.736 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -58.44 -49.23 78.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 0.29 112.224 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 177' ' ' ILE . 35.2 mm -53.27 -45.95 56.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.763 0.316 . . . . 0.89 110.88 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -58.4 -44.3 88.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 1.56 110.993 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 72.4 mt -62.7 -48.92 85.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.395 -0.366 . . . . 0.83 111.199 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.15 -52.11 52.1 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.927 -0.654 . . . . 0.64 112.846 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.427 ' HD3' ' N ' ' A' ' 186' ' ' ARG . 0.0 OUTLIER -60.56 -28.1 68.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.789 0.328 . . . . 2.54 110.97 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.427 ' N ' ' HD3' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -61.79 -31.87 72.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 3.95 110.713 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.435 HD23 ' N ' ' A' ' 187' ' ' LEU . 3.8 mt -72.1 -59.14 2.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.036 -0.529 . . . . 1.52 110.64 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.398 -0.81 . . . . 3.05 111.665 -179.958 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.087 0 N-CA-C 112.484 -0.246 . . . . 7.46 112.484 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 149.99 175.39 22.12 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.73 -0.748 . . . . 6.55 112.58 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 15.9 mm -69.93 -63.25 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.948 0.404 . . . . 7.86 111.082 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -76.53 -69.53 0.51 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.864 -0.607 . . . . 6.6 110.781 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.434 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 43.4 t 43.86 -97.19 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.215 -0.448 . . . . 5.34 110.899 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.88 -36.77 70.49 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.961 0.41 . . . . 4.29 110.492 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . 0.426 ' HA ' ' HE2' ' B' ' 163' ' ' LYS . 34.3 tt0 -59.89 -35.15 74.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.0 -0.546 . . . . 5.73 110.497 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -77.7 -38.97 46.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.807 -0.633 . . . . 3.56 110.793 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' B' ' 158' ' ' SER . 14.6 mt -63.01 -33.34 75.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 3.37 110.87 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.426 ' HE2' ' HA ' ' B' ' 160' ' ' GLU . 46.8 mtmt -56.31 -26.83 53.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.874 0.369 . . . . 3.86 110.966 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.48 47.25 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 2.87 111.055 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -142.03 -54.47 0.44 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 2.48 110.993 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.476 HD22 ' N ' ' B' ' 166' ' ' LEU . 3.1 mm? -71.46 -59.22 3.28 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 2.14 111.563 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 19.2 Cg_endo -59.43 -26.75 83.02 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.286 1.991 . . . . 1.07 112.414 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 51.7 m -62.26 -41.57 98.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.333 -0.394 . . . . 1.59 110.787 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.411 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 78.2 mt -60.39 -45.06 94.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 1.09 110.927 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.493 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.1 mp -62.34 -50.95 69.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.72 110.836 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.6 mt -58.15 -41.54 83.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.5 110.599 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 73.0 m -55.02 -52.19 63.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.031 -0.531 . . . . 0.31 111.1 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.42 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 71.6 m80 -60.58 -52.53 64.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.3 111.139 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 87.8 mt -59.98 -52.49 65.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.339 -0.392 . . . . 0.44 111.019 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.69 -42.88 99.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.134 -0.485 . . . . 0.46 111.021 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.469 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.04 -52.57 58.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.25 111.478 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.465 HG13 ' HB1' ' A' ' 176' ' ' ALA . 53.1 mt -62.23 -41.86 93.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.358 . . . . 0.31 110.9 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.08 -49.9 68.36 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.71 -0.757 . . . . 0.26 112.387 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 83.1 mt -58.47 -42.38 87.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.47 110.668 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.405 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -55.7 -49.88 63.54 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.723 -0.751 . . . . 0.27 112.36 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 55.7 mt -57.97 -45.15 87.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.859 0.362 . . . . 0.93 110.959 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -53.32 -50.9 64.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 1.52 110.693 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . 0.409 ' HA ' ' HG2' ' B' ' 186' ' ' ARG . 64.5 mt -62.3 -41.97 93.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.031 -0.531 . . . . 1.1 111.136 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.91 -49.07 79.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.904 -0.665 . . . . 0.72 112.842 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -61.14 -28.77 69.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.706 0.289 . . . . 2.16 111.373 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.409 ' HG2' ' HA ' ' B' ' 183' ' ' ILE . 8.0 ptm180 -95.36 28.86 2.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.881 0.372 . . . . 3.82 110.832 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 35.9 mt -84.61 -84.29 0.15 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 1.63 111.269 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 31.0 p . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.167 -0.921 . . . . 2.31 111.161 -179.62 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.475 -0.25 . . . . 7.39 112.475 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -143.15 164.89 27.14 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.681 -0.771 . . . . 6.02 112.355 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 61.8 mt -72.56 -66.35 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.797 0.332 . . . . 6.75 110.814 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.43 ' O ' ' N ' ' A' ' 159' ' ' ALA . 63.0 m-85 -78.09 -43.43 29.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.097 -0.501 . . . . 5.45 110.892 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.41 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 40.3 t 42.55 -90.66 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.95 -0.568 . . . . 5.17 111.923 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -57.35 -51.62 68.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.754 0.312 . . . . 3.89 111.371 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -56.2 -56.02 26.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 5.36 110.93 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.41 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 86.3 t80 -61.39 -50.62 72.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.147 -0.479 . . . . 3.21 111.022 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 158' ' ' SER . 87.1 mt -62.15 -32.42 73.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 3.31 111.144 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -56.49 -21.93 29.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 3.11 111.221 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 31.9 m -139.31 40.45 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.493 -0.321 . . . . 2.66 111.319 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -133.42 -61.8 0.8 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.32 -0.4 . . . . 2.06 111.025 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.498 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 91.7 mt -52.01 -46.37 92.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 1.88 111.628 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 74.1 Cg_endo -77.38 -32.16 3.12 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.059 1.839 . . . . 0.98 112.298 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.1 t -56.77 -42.74 79.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 1.47 110.57 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.61 -51.49 68.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.962 -0.563 . . . . 0.73 110.782 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 85.9 mt -52.57 -48.7 66.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.985 -0.552 . . . . 0.63 110.823 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 97.9 mt -55.97 -42.87 76.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.322 -0.399 . . . . 0.4 110.764 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.479 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 67.9 m -57.21 -52.47 65.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.23 110.871 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.417 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 73.0 m80 -62.2 -52.27 64.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.29 110.87 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.8 mt -59.0 -51.64 69.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.066 -0.516 . . . . 0.47 111.005 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 171' ' ' LEU . 85.1 mt -60.56 -42.41 96.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.41 111.008 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.623 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -56.06 -52.36 64.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.995 0.426 . . . . 0.27 110.875 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.45 -41.52 81.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.551 . . . . 0.62 110.469 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.04 -44.58 83.27 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.772 -0.728 . . . . 0.28 112.129 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 70.8 mt -61.06 -47.11 87.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.949 0.404 . . . . 0.43 110.355 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.445 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -52.68 -52.42 38.36 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.676 -0.773 . . . . 0.29 112.587 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 39.3 mt -61.96 -42.88 96.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 0.89 111.032 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.425 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 83.5 t80 -51.9 -52.08 52.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.016 0.436 . . . . 1.56 110.695 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 65.8 mt -63.5 -48.03 88.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.133 -0.485 . . . . 0.83 111.203 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.78 -52.85 45.4 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.983 -0.627 . . . . 0.64 113.692 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -54.98 -24.41 23.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.866 0.333 . . . . 2.54 110.801 -179.292 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 18.7 mtp-105 -81.98 -24.9 35.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 3.95 110.865 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 60.3 mt -65.68 -85.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.492 . . . . 1.52 111.015 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.357 -0.83 . . . . 3.05 111.206 -179.983 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.427 -0.269 . . . . 7.46 112.427 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -105.16 -144.17 12.52 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.835 -0.697 . . . . 6.55 112.594 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 44.8 mt -68.67 -39.74 80.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.889 0.376 . . . . 7.86 110.832 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.545 ' CD1' ' N ' ' B' ' 158' ' ' SER . 8.4 p90 -159.41 -48.63 0.05 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.998 -0.546 . . . . 6.6 110.724 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.545 ' N ' ' CD1' ' B' ' 157' ' ' PHE . 90.4 p 44.92 -172.56 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.01 -0.541 . . . . 5.34 112.024 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' B' ' 162' ' ' LEU . . . -51.37 -24.12 4.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.931 0.396 . . . . 4.29 110.933 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -53.67 -43.06 68.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.241 0.543 . . . . 5.73 110.735 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.565 ' CZ ' ' CD1' ' B' ' 165' ' ' PHE . 42.8 t80 -86.15 -33.2 20.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.524 -0.762 . . . . 3.56 110.753 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' B' ' 159' ' ' ALA . 84.0 mt -63.24 -42.32 99.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 3.37 111.122 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -57.4 -24.55 56.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.429 -0.351 . . . . 3.86 111.249 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 22.7 m -123.67 32.77 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 2.87 111.323 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . 0.565 ' CD1' ' CZ ' ' B' ' 161' ' ' PHE . 85.8 t80 -137.93 -61.95 0.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 2.48 111.336 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.481 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 73.6 mt -52.18 -46.03 93.85 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.366 -0.379 . . . . 2.14 111.809 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 87.0 Cg_endo -79.59 -35.48 0.79 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.257 1.972 . . . . 1.07 112.633 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 66.3 m -53.22 -44.13 67.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 1.59 111.08 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.413 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 84.5 mt -54.6 -51.13 66.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.28 -0.418 . . . . 1.09 111.177 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.452 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.4 mp -62.17 -46.14 90.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.387 -0.37 . . . . 0.72 110.854 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.3 -42.65 91.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.336 -0.393 . . . . 0.5 110.847 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . 0.417 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 68.3 m -56.87 -52.21 66.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.483 . . . . 0.31 111.005 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.479 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 66.8 m80 -62.54 -52.6 62.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.3 111.289 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.78 -52.56 64.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.359 . . . . 0.44 111.24 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 69.4 mt -62.46 -43.32 99.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.316 -0.402 . . . . 0.46 111.032 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.549 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -58.36 -52.7 64.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.25 111.142 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.623 HG13 ' HB1' ' A' ' 176' ' ' ALA . 82.7 mt -60.07 -42.34 89.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.428 -0.351 . . . . 0.31 110.418 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.57 -49.75 59.86 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.564 -0.827 . . . . 0.26 111.97 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 88.7 mt -56.25 -46.76 79.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.47 110.397 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.03 -42.98 55.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.526 -0.845 . . . . 0.27 111.812 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.445 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 17.7 mm -60.05 -51.87 67.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.836 0.35 . . . . 0.93 110.611 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.436 ' HA ' ' HG2' ' B' ' 185' ' ' ARG . 51.0 t80 -51.3 -49.48 61.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.792 -0.64 . . . . 1.52 111.224 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 61.1 mt -58.73 -52.45 59.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.212 -0.449 . . . . 1.1 111.324 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . 0.435 ' HA2' ' CD1' ' B' ' 187' ' ' LEU . . . -59.0 -52.38 53.72 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.882 -0.675 . . . . 0.72 113.098 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' B' ' 182' ' ' TYR . 6.1 ptp180 -55.37 -31.25 61.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.366 . . . . 2.16 111.141 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.429 ' N ' ' HG3' ' B' ' 185' ' ' ARG . 72.6 mtp85 -102.54 56.2 0.78 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.041 -0.527 . . . . 3.82 110.846 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . 0.435 ' CD1' ' HA2' ' B' ' 184' ' ' GLY . 50.1 mt -113.03 -84.55 0.59 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.944 -0.571 . . . . 1.63 111.266 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 27.7 p . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.258 -0.877 . . . . 2.31 111.327 -179.499 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.454 -0.258 . . . . 7.39 112.454 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -161.93 175.54 38.44 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.813 -0.708 . . . . 6.02 112.479 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 23.4 mm -69.82 -52.73 28.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.94 0.4 . . . . 6.75 111.07 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.465 ' HB2' ' CB ' ' A' ' 161' ' ' PHE . 63.1 m-85 -76.22 -29.83 57.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.88 -0.6 . . . . 5.45 111.056 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.8 p 81.26 -158.94 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.055 -0.521 . . . . 5.17 111.43 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 162' ' ' LEU . . . -51.78 -25.19 7.09 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.461 -0.336 . . . . 3.89 111.262 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -56.79 -44.84 82.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.368 -0.378 . . . . 5.36 110.425 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.539 ' CZ ' ' CD1' ' A' ' 165' ' ' PHE . 85.3 t80 -86.17 -40.2 15.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 3.21 110.685 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 159' ' ' ALA . 75.2 mt -61.72 -32.94 73.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.298 -0.41 . . . . 3.31 110.507 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -58.37 -24.9 61.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 3.11 110.898 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.9 m -131.68 43.56 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.194 -0.457 . . . . 2.66 111.116 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.539 ' CD1' ' CZ ' ' A' ' 161' ' ' PHE . 88.6 t80 -127.59 -53.86 1.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 2.06 110.692 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.489 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 87.3 mt -48.59 -55.69 18.28 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.182 -0.463 . . . . 1.88 111.175 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 32.7 Cg_endo -63.99 -37.66 42.17 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 121.895 1.73 . . . . 0.98 111.515 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 60.3 m -50.23 -48.96 54.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 1.47 110.68 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 78.1 mt -54.71 -50.7 67.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.507 . . . . 0.73 110.173 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.31 -42.92 96.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.05 -0.523 . . . . 0.63 110.208 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 76.5 mt -62.17 -41.27 98.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.961 -0.563 . . . . 0.4 110.635 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.428 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 73.6 m -55.85 -52.72 63.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.359 -0.382 . . . . 0.23 110.855 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.437 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 73.3 m80 -62.6 -52.09 64.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.29 110.929 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.5 mt -59.88 -52.55 64.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.226 -0.443 . . . . 0.47 111.21 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 75.0 mt -56.2 -46.02 79.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.41 110.542 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.504 ' HB3' ' HB1' ' B' ' 176' ' ' ALA . . . -52.41 -52.01 56.08 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.142 -0.481 . . . . 0.27 110.15 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 69.1 mt -58.85 -42.56 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 115.975 -0.557 . . . . 0.62 109.81 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.23 -43.65 64.18 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.654 -0.784 . . . . 0.28 111.724 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 78.5 mt -60.21 -46.01 91.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.95 0.405 . . . . 0.43 110.115 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -58.59 -43.59 96.04 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.554 -0.832 . . . . 0.29 112.029 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 45.6 mm -58.31 -44.41 88.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.899 0.381 . . . . 0.89 110.749 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.4 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 76.8 t80 -60.03 -49.54 77.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 1.56 110.741 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 57.9 mt -62.23 -48.92 86.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.83 111.31 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.2 -52.67 51.35 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.768 -0.729 . . . . 0.64 113.046 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.12 -17.93 59.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.707 0.289 . . . . 2.54 111.224 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 28.5 mmt180 -82.05 4.94 21.01 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.544 -0.298 . . . . 3.95 111.417 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 51.1 mt -75.8 -84.66 0.05 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.912 0.387 . . . . 1.52 111.063 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 188' ' ' THR . 2.2 t . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.336 -0.84 . . . . 3.05 111.227 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 112.482 -0.247 . . . . 7.46 112.482 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -142.96 169.35 25.69 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.665 -0.779 . . . . 6.55 112.409 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 51.9 mt -70.77 -55.55 13.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.949 0.404 . . . . 7.86 110.907 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -76.14 -41.34 50.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 6.6 110.686 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.42 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 67.9 m 40.13 -94.1 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.944 -0.571 . . . . 5.34 111.578 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.423 ' O ' ' CD ' ' B' ' 163' ' ' LYS . . . -58.96 -54.84 42.61 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.679 0.276 . . . . 4.29 111.195 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . 0.422 ' HA ' ' HG2' ' B' ' 163' ' ' LYS . 38.8 tt0 -53.95 -26.09 23.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.175 -0.466 . . . . 5.73 111.361 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -80.16 -42.6 23.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.818 0.342 . . . . 3.56 110.792 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' B' ' 158' ' ' SER . 22.4 mt -63.88 -26.1 68.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.421 . . . . 3.37 111.096 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.423 ' CD ' ' O ' ' B' ' 159' ' ' ALA . 20.5 mmmt -56.98 -36.87 70.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.017 0.437 . . . . 3.86 110.578 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 31.7 m -114.18 30.17 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.937 -0.574 . . . . 2.87 111.239 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . 0.42 ' HB3' ' HA ' ' B' ' 162' ' ' LEU . 52.9 t80 -120.06 -46.55 2.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.425 -0.352 . . . . 2.48 110.903 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.488 ' HB2' ' HD3' ' B' ' 167' ' ' PRO . 91.0 mt -50.32 -54.37 35.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 2.14 111.267 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.488 ' HD3' ' HB2' ' B' ' 166' ' ' LEU . 53.3 Cg_endo -68.6 -35.77 16.28 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.136 1.891 . . . . 1.07 112.176 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.5 t -50.87 -42.29 58.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 1.59 110.98 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.414 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 46.0 mt -54.13 -50.68 66.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.435 . . . . 1.09 110.68 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.48 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.0 mp -61.14 -44.12 97.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.72 110.386 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.05 -41.56 98.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.5 110.279 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . 0.437 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 73.6 m -55.06 -44.24 74.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.081 -0.509 . . . . 0.31 110.502 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.428 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 68.7 m80 -61.74 -52.54 63.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.3 110.846 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 94.4 mt -58.44 -52.56 65.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.862 0.363 . . . . 0.44 110.723 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.8 -42.2 99.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.073 -0.512 . . . . 0.46 111.204 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' A' ' 176' ' ' ALA . . . -59.11 -52.46 65.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.426 . . . . 0.25 111.573 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.441 HG13 ' HB1' ' A' ' 176' ' ' ALA . 87.0 mt -56.97 -45.54 83.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 0.31 110.648 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.8 -45.89 77.85 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.511 -0.852 . . . . 0.26 111.855 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 95.8 mt -55.78 -46.26 78.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.942 0.401 . . . . 0.47 110.143 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.15 -41.62 79.1 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.744 -0.741 . . . . 0.27 112.051 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 53.4 mt -61.11 -46.86 95.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.878 0.371 . . . . 0.93 110.803 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.431 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 89.0 t80 -59.7 -46.92 87.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.05 -0.523 . . . . 1.52 110.963 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . 0.4 ' O ' ' HG ' ' B' ' 187' ' ' LEU . 47.8 mt -62.99 -47.71 91.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.326 -0.397 . . . . 1.1 111.511 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . 0.432 ' HA2' ' CD1' ' B' ' 187' ' ' LEU . . . -55.09 -51.92 50.57 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 121.284 -0.484 . . . . 0.72 113.624 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.8 OUTLIER -60.07 -22.42 62.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.788 0.328 . . . . 2.16 111.366 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.45 ' O ' HD23 ' B' ' 187' ' ' LEU . 12.2 mmm180 -96.28 38.41 1.2 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.38 -0.373 . . . . 3.82 111.441 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . 0.45 HD23 ' O ' ' B' ' 186' ' ' ARG . 23.3 mt -127.0 -65.09 0.97 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.486 0.66 . . . . 1.63 110.426 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 34.7 p . . . . . 0 C--O 1.249 1.049 0 CA-C-N 114.882 -1.054 . . . . 2.31 111.325 -179.83 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.516 -0.234 . . . . 7.39 112.516 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -113.82 160.04 13.37 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.743 -0.741 . . . . 6.02 112.486 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 56.8 mt -71.4 -65.16 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 6.75 110.992 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.43 ' O ' ' N ' ' A' ' 159' ' ' ALA . 34.1 m-85 -77.69 -63.63 1.34 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.013 -0.54 . . . . 5.45 111.087 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.412 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 33.7 t 44.12 -90.55 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.095 -0.502 . . . . 5.17 111.569 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.7 -52.63 64.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.744 0.307 . . . . 3.89 110.932 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -57.28 -44.76 84.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 5.36 111.018 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -68.23 -51.61 43.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 3.21 111.102 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 158' ' ' SER . 92.5 mt -62.83 -29.74 70.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 3.31 111.192 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -57.91 -41.92 83.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.389 -0.369 . . . . 3.11 110.568 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 164' ' ' VAL . 5.2 t -98.99 40.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.049 -0.523 . . . . 2.66 110.756 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -131.3 -67.04 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 2.06 110.849 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.468 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 70.7 mt -50.66 -58.21 10.8 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.109 -0.496 . . . . 1.88 111.532 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 23.7 Cg_endo -61.67 -38.54 60.45 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.187 1.925 . . . . 0.98 112.237 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 57.7 m -53.69 -42.26 67.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 1.47 110.841 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.41 -51.01 69.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.73 110.915 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 89.5 mt -55.33 -48.57 73.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.63 110.905 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.9 mt -59.07 -42.72 91.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.4 111.082 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.484 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 67.9 m -55.97 -53.1 60.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.311 -0.404 . . . . 0.23 111.025 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.411 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 70.8 m80 -62.77 -52.5 62.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.29 110.832 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 78.9 mt -57.83 -51.72 68.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.47 111.309 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 73.9 mt -60.77 -45.54 93.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.367 -0.379 . . . . 0.41 111.175 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.474 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -56.1 -52.7 63.36 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.017 0.437 . . . . 0.27 110.67 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.407 ' O ' HG12 ' A' ' 181' ' ' ILE . 63.2 mt -59.55 -42.49 88.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.128 -0.487 . . . . 0.62 109.861 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.78 -42.06 52.14 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.639 -0.791 . . . . 0.28 111.553 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 83.7 mt -61.35 -46.2 91.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.075 0.464 . . . . 0.43 109.751 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -61.55 -44.08 98.45 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.643 -0.789 . . . . 0.29 112.291 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 177' ' ' ILE . 47.5 mm -60.81 -51.32 74.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.331 . . . . 0.89 110.958 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.415 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 81.1 t80 -51.85 -52.21 51.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 1.56 110.747 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.413 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 54.8 mt -62.53 -41.91 93.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.204 -0.453 . . . . 0.83 111.312 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.74 -44.92 97.37 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.957 -0.639 . . . . 0.64 113.347 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 8.0 ptp180 -61.18 -32.64 72.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.894 0.347 . . . . 2.54 111.384 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 183' ' ' ILE . 36.8 ptt180 -85.38 -15.94 41.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.654 0.264 . . . . 3.95 111.144 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.428 ' HA ' HD23 ' A' ' 187' ' ' LEU . 15.8 mt -64.46 -81.66 0.03 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.848 0.356 . . . . 1.52 110.965 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.569 ' OXT' HG23 ' A' ' 188' ' ' THR . 4.4 t . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.149 -0.929 . . . . 3.05 111.27 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.646 -0.181 . . . . 7.46 112.646 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -112.41 -179.66 19.62 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.677 -0.773 . . . . 6.55 112.451 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 48.6 mt -72.6 -68.92 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 7.86 110.936 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -78.11 -81.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.086 -0.506 . . . . 6.6 110.848 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.575 ' O ' ' HB3' ' B' ' 159' ' ' ALA . 7.3 t 77.98 139.34 0.07 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.031 -0.531 . . . . 5.34 110.797 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' B' ' 158' ' ' SER . . . 91.83 -67.69 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.68 -0.691 . . . . 4.29 110.527 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.66 -42.86 99.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.612 -0.722 . . . . 5.73 111.13 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -83.62 -35.71 24.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 3.56 111.09 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.59 -47.08 87.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.269 -0.423 . . . . 3.37 110.869 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.631 ' HG3' HG23 ' B' ' 164' ' ' VAL . 19.2 ptpt -57.4 -26.97 61.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 3.86 110.772 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.631 HG23 ' HG3' ' B' ' 163' ' ' LYS . 3.0 t -110.38 23.29 4.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.297 -0.411 . . . . 2.87 111.053 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . 0.4 ' O ' ' HB3' ' B' ' 168' ' ' SER . 85.3 t80 -136.65 -52.26 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.77 0.319 . . . . 2.48 111.046 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.478 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 64.4 mt -47.84 -57.36 10.29 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.42 . . . . 2.14 111.508 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 25.0 Cg_endo -61.83 -23.93 76.66 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.156 1.904 . . . . 1.07 112.456 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' B' ' 165' ' ' PHE . 35.4 t -65.41 -45.96 81.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.417 -0.356 . . . . 1.59 110.943 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 55.3 mt -54.86 -48.71 72.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 1.09 110.786 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.436 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.6 mp -57.87 -50.33 73.7 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.199 -0.455 . . . . 0.72 110.631 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 61.6 mt -59.05 -41.48 87.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.485 . . . . 0.5 110.651 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . 0.411 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 73.5 m -51.93 -50.32 61.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.31 110.889 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.484 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 60.6 m80 -61.18 -52.32 65.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.3 111.181 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 98.0 mt -60.91 -52.35 65.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.361 -0.381 . . . . 0.44 111.002 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.28 -43.73 98.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.46 111.039 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.474 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.41 -52.35 59.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.25 111.342 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.43 HG13 ' HB1' ' A' ' 176' ' ' ALA . 60.4 mt -60.95 -47.76 92.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.426 -0.352 . . . . 0.31 110.918 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.28 -51.1 43.87 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.639 -0.791 . . . . 0.26 112.164 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 97.3 mt -55.25 -46.86 76.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.973 0.416 . . . . 0.47 110.796 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.96 -42.9 82.08 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.669 -0.777 . . . . 0.27 112.545 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 58.2 mt -61.89 -51.1 76.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 0.93 111.019 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.405 ' O ' ' HG2' ' B' ' 185' ' ' ARG . 29.1 t80 -58.67 -49.85 76.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 1.52 110.812 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 73.7 mt -61.93 -46.02 97.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 1.1 111.101 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . 0.405 ' HA2' ' CD1' ' B' ' 187' ' ' LEU . . . -58.88 -49.54 77.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.639 -0.791 . . . . 0.72 112.415 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' B' ' 182' ' ' TYR . 12.2 ptm180 -60.01 -22.42 62.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.781 0.324 . . . . 2.16 111.08 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -99.53 35.0 2.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.897 0.38 . . . . 3.82 110.591 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . 0.405 ' CD1' ' HA2' ' B' ' 184' ' ' GLY . 77.4 mt -97.15 -85.43 0.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.98 -0.555 . . . . 1.63 111.348 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . 0.402 ' O ' HG23 ' B' ' 188' ' ' THR . 1.5 t . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.395 -0.812 . . . . 2.31 111.18 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.593 -0.203 . . . . 7.39 112.593 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 168.7 175.59 38.29 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.823 -0.703 . . . . 6.02 112.511 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 17.4 mm -70.96 -56.34 10.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.976 0.417 . . . . 6.75 111.023 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -76.27 -58.65 3.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.975 -0.557 . . . . 5.45 111.093 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.574 ' O ' ' HB3' ' A' ' 159' ' ' ALA . 87.8 p 53.22 108.41 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.127 -0.488 . . . . 5.17 111.296 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 158' ' ' SER . . . 95.86 -66.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.576 -0.738 . . . . 3.89 110.436 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.51 -29.69 66.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 5.36 110.556 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -99.47 -45.11 5.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.953 -0.567 . . . . 3.21 110.787 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 83.6 mt -62.1 -40.11 94.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 3.31 110.533 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 159' ' ' ALA . 40.0 ttmt -58.61 -38.36 77.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.969 -0.56 . . . . 3.11 110.854 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 164' ' ' VAL . 5.1 t -100.01 30.94 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 116.06 -0.518 . . . . 2.66 111.209 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.406 ' CZ ' HD11 ' A' ' 169' ' ' LEU . 18.9 t80 -148.22 -56.59 0.22 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.861 0.362 . . . . 2.06 110.964 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.489 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 60.1 mt -49.86 -54.21 34.59 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 1.88 111.43 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 56.3 Cg_endo -68.94 -38.08 10.21 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.218 1.945 . . . . 0.98 112.406 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 65.9 m -51.14 -50.73 58.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.265 -0.425 . . . . 1.47 110.839 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.406 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 85.5 mt -61.78 -51.91 66.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.151 -0.477 . . . . 0.73 111.005 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 83.7 mt -52.88 -51.45 61.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.27 -0.423 . . . . 0.63 110.987 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 79.3 mt -58.28 -42.32 86.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.339 -0.391 . . . . 0.4 111.011 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 65.2 m -59.7 -52.13 66.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.23 111.002 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.425 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 74.8 m80 -60.44 -51.83 67.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.29 111.02 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.3 mt -57.02 -52.25 66.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 0.47 111.12 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 74.1 mt -58.12 -49.46 76.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.41 111.137 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.579 ' HB3' ' HB1' ' B' ' 176' ' ' ALA . . . -51.34 -52.24 47.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.935 0.398 . . . . 0.27 110.673 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 70.6 mt -59.2 -41.97 85.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 0.62 110.13 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.66 -46.05 89.64 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.666 -0.778 . . . . 0.28 111.834 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 44.4 mt -55.71 -47.82 76.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.004 0.43 . . . . 0.43 110.077 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.444 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -55.18 -43.75 83.87 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.792 -0.718 . . . . 0.29 112.339 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 49.4 mm -58.34 -52.28 61.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.837 0.351 . . . . 0.89 111.068 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -53.95 -48.25 70.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 1.56 110.784 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.412 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 68.7 mt -62.1 -42.62 95.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.83 111.191 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.5 -47.14 91.59 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.867 -0.682 . . . . 0.64 112.984 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.436 ' HG3' ' N ' ' A' ' 186' ' ' ARG . 13.5 ptp180 -62.18 -40.8 97.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.552 0.215 . . . . 2.54 111.407 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.436 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 15.9 ptm180 -68.69 -8.77 45.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.654 -0.248 . . . . 3.95 111.46 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.6 mt -55.93 -84.25 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.839 0.352 . . . . 1.52 110.997 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 188' ' ' THR . 4.3 t . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.42 -0.8 . . . . 3.05 111.325 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.483 -0.247 . . . . 7.46 112.483 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -168.37 -170.48 33.11 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.761 -0.733 . . . . 6.55 112.432 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 45.0 mt -71.01 -60.74 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.856 0.36 . . . . 7.86 111.025 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.446 ' HB2' ' HB2' ' B' ' 161' ' ' PHE . 68.8 m-85 -76.33 -41.58 47.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 6.6 111.135 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 70.1 m 41.69 -89.25 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.986 -0.552 . . . . 5.34 112.189 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -54.95 -63.24 1.21 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.765 0.317 . . . . 4.29 111.4 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.4 -23.32 37.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 5.73 111.276 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.446 ' HB2' ' HB2' ' B' ' 157' ' ' PHE . 41.6 t80 -77.43 -54.81 5.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.415 -0.357 . . . . 3.56 110.922 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 34.3 mt -63.13 -36.93 85.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 3.37 110.868 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.452 ' NZ ' ' HB3' ' B' ' 163' ' ' LYS . 7.8 mtpm? -56.97 -19.52 18.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.499 . . . . 3.86 111.486 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 26.4 m -133.75 34.93 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.728 0.299 . . . . 2.87 111.297 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -131.34 -60.47 0.95 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.333 -0.394 . . . . 2.48 111.421 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.48 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 89.8 mt -63.72 -46.2 82.41 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.428 -0.351 . . . . 2.14 111.883 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 99.7 Cg_exo -42.24 -53.59 3.52 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.358 2.039 . . . . 1.07 112.564 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 42.5 t -57.86 -41.51 82.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.164 -0.471 . . . . 1.59 111.098 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.416 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 27.2 mt -59.24 -51.23 70.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.317 -0.401 . . . . 1.09 111.364 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.423 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.7 mp -59.86 -49.01 79.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.738 0.304 . . . . 0.72 110.972 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.99 -41.49 98.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 0.5 110.904 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . 0.425 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 73.0 m -57.95 -52.35 65.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.31 111.37 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 60.9 m80 -62.24 -52.45 63.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.333 -0.394 . . . . 0.3 111.358 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 97.5 mt -54.77 -53.07 59.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.921 0.391 . . . . 0.44 110.703 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.37 -49.33 74.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.962 -0.563 . . . . 0.46 110.993 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.579 ' HB1' ' HB3' ' A' ' 176' ' ' ALA . . . -51.74 -52.58 47.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.0 -0.546 . . . . 0.25 111.635 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.553 HG13 ' HB1' ' A' ' 176' ' ' ALA . 70.7 mt -62.04 -46.66 95.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.919 0.39 . . . . 0.31 110.668 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.16 -46.46 91.56 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.598 -0.81 . . . . 0.26 111.963 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 94.4 mt -55.24 -46.06 76.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.987 0.422 . . . . 0.47 110.212 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.14 -42.18 80.85 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.644 -0.789 . . . . 0.27 111.777 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.444 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 40.4 mm -58.0 -50.73 76.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.883 0.373 . . . . 0.93 110.589 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.404 ' O ' ' HG2' ' B' ' 186' ' ' ARG . 88.6 t80 -58.66 -49.76 76.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.008 -0.542 . . . . 1.52 111.237 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 50.4 mt -59.59 -51.34 73.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.367 -0.379 . . . . 1.1 111.335 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . 0.423 ' O ' ' HG ' ' B' ' 187' ' ' LEU . . . -62.37 -52.24 50.74 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.755 -0.736 . . . . 0.72 112.866 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.419 ' CG ' ' O ' ' B' ' 181' ' ' ILE . 0.0 OUTLIER -63.07 -13.68 38.97 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.667 0.247 . . . . 2.16 111.667 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' B' ' 182' ' ' TYR . 12.5 mmm180 -94.48 21.73 6.88 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.65 0.262 . . . . 3.82 111.127 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' B' ' 184' ' ' GLY . 7.1 mt -121.71 -66.08 1.07 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.165 0.507 . . . . 1.63 110.67 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.295 -0.859 . . . . 2.31 111.164 179.922 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.504 -0.238 . . . . 7.39 112.504 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -68.13 179.61 18.99 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.882 -0.675 . . . . 6.02 112.689 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.431 HG22 ' CE2' ' A' ' 157' ' ' PHE . 13.4 mm -69.5 -17.75 21.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.856 0.36 . . . . 6.75 111.39 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 159' ' ' ALA . 92.6 m-85 -156.21 -69.3 0.11 Allowed 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.236 -0.438 . . . . 5.45 110.745 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.422 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 80.0 p 44.39 -90.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.021 -0.536 . . . . 5.17 111.569 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -53.78 -54.49 37.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 3.89 111.17 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -56.39 -45.52 80.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 5.36 111.098 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.43 ' HB2' ' HB3' ' A' ' 157' ' ' PHE . 69.5 t80 -64.84 -54.83 24.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.394 -0.366 . . . . 3.21 111.059 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 158' ' ' SER . 21.4 mt -63.19 -33.36 75.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.395 -0.366 . . . . 3.31 110.982 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -57.07 -34.76 68.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 3.11 111.218 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.46 44.07 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 2.66 111.332 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' A' ' 161' ' ' PHE . 81.2 t80 -127.09 -65.66 0.94 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 2.06 110.863 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.514 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 55.4 mt -61.36 -43.75 90.55 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 1.88 111.354 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 23.0 Cg_exo -65.19 -36.13 38.1 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.382 2.055 . . . . 0.98 112.048 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.2 t -59.29 -43.81 92.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 1.47 110.904 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 65.3 mt -59.4 -50.15 75.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.514 . . . . 0.73 110.877 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 97.3 mt -55.39 -49.12 73.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.426 . . . . 0.63 110.734 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.9 mt -56.28 -41.97 76.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.4 110.755 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.472 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 72.9 m -57.49 -52.04 67.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 0.23 110.862 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.431 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 70.1 m80 -61.17 -50.55 72.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.29 110.815 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 92.8 mt -61.42 -52.14 65.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.47 111.119 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 66.6 mt -62.03 -43.62 98.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.332 -0.395 . . . . 0.41 111.089 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.462 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -51.84 -52.47 49.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.9 0.381 . . . . 0.27 110.623 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 66.4 mt -58.15 -41.95 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.62 110.246 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.64 -44.53 60.08 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.621 -0.799 . . . . 0.28 111.893 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 72.1 mt -61.32 -48.44 81.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.987 0.423 . . . . 0.43 110.322 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.66 -52.05 50.88 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.579 -0.82 . . . . 0.29 112.338 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 56.1 mt -53.66 -49.37 57.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.868 0.366 . . . . 0.89 110.954 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.422 ' O ' ' CG ' ' A' ' 186' ' ' ARG . 92.1 t80 -51.95 -51.43 57.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.507 . . . . 1.56 110.777 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 59.4 mt -62.7 -41.9 94.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.112 -0.494 . . . . 0.83 111.165 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.19 -52.62 48.41 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.941 -0.647 . . . . 0.64 113.265 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.07 -22.86 66.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.822 0.311 . . . . 2.54 111.005 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.422 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 1.5 mmp_? -67.28 -41.23 85.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.392 . . . . 3.95 110.935 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.402 ' N ' HD23 ' A' ' 187' ' ' LEU . 6.6 mt -52.21 -66.42 0.39 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.504 . . . . 1.52 110.664 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 81.4 p . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.278 -0.867 . . . . 3.05 111.088 179.921 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.45 -0.26 . . . . 7.46 112.45 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 167.48 179.36 40.25 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.624 -0.798 . . . . 6.55 112.511 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 48.7 mt -71.87 -66.21 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.9 0.381 . . . . 7.86 110.892 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.432 ' O ' ' N ' ' B' ' 159' ' ' ALA . 29.8 m-85 -77.56 -44.16 29.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.042 -0.526 . . . . 6.6 110.819 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 53.0 p 44.39 -89.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.849 -0.614 . . . . 5.34 111.953 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -58.33 -54.75 43.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.836 0.351 . . . . 4.29 111.469 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -54.99 -50.87 67.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.156 -0.475 . . . . 5.73 111.112 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.409 ' HB2' ' HB2' ' B' ' 157' ' ' PHE . 88.0 t80 -64.12 -49.59 71.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 3.56 111.217 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.33 -40.06 95.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 3.37 111.32 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -57.77 -32.96 68.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.282 -0.417 . . . . 3.86 111.309 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 32.4 m -112.82 28.0 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.731 0.301 . . . . 2.87 111.297 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -122.56 -52.41 1.92 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.333 -0.394 . . . . 2.48 110.806 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.481 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 85.9 mt -60.2 -45.6 97.75 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.12 -0.491 . . . . 2.14 111.525 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 89.3 Cg_endo -82.18 -26.57 2.77 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.383 2.055 . . . . 1.07 112.524 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 81.1 p -57.22 -48.56 78.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 1.59 110.929 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.424 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 84.0 mt -52.23 -49.4 64.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 1.09 111.049 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.474 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.2 mp -61.88 -47.99 82.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.36 -0.382 . . . . 0.72 111.082 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 90.2 mt -61.87 -44.74 96.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 0.5 111.141 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . 0.431 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 71.0 m -53.04 -52.11 59.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.318 -0.401 . . . . 0.31 110.979 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.472 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 61.6 m80 -60.48 -52.5 64.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.3 111.201 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 86.6 mt -60.29 -52.35 65.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.844 0.354 . . . . 0.44 111.236 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.17 -45.3 94.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.43 . . . . 0.46 111.208 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.462 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.28 -52.53 58.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.25 111.51 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.461 HG13 ' HB1' ' A' ' 176' ' ' ALA . 69.8 mt -59.14 -42.83 87.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.827 0.346 . . . . 0.31 110.799 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.56 -51.11 50.4 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.508 -0.853 . . . . 0.26 111.963 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 66.3 mt -56.38 -42.48 77.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.911 0.386 . . . . 0.47 110.256 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.56 -47.35 70.45 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.673 -0.775 . . . . 0.27 112.069 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 49.7 mt -57.4 -48.64 82.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.868 0.366 . . . . 0.93 110.69 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -54.0 -47.07 71.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 1.52 110.502 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 72.3 mt -62.4 -51.53 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.079 -0.51 . . . . 1.1 110.934 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . 0.417 ' HA2' ' CD1' ' B' ' 187' ' ' LEU . . . -62.19 -52.51 49.18 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.808 -0.71 . . . . 0.72 112.8 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -20.15 51.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.724 0.297 . . . . 2.16 111.073 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -105.96 49.29 0.81 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.949 0.404 . . . . 3.82 110.509 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . 0.417 ' CD1' ' HA2' ' B' ' 184' ' ' GLY . 70.0 mt -113.93 -84.74 0.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 1.63 111.315 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.108 -0.948 . . . . 2.31 111.09 -179.647 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.484 -0.247 . . . . 7.39 112.484 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 178.53 175.93 46.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.813 -0.708 . . . . 6.02 112.544 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 69.9 mt -70.6 -52.72 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 6.75 111.006 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.45 ' CB ' ' HB2' ' A' ' 161' ' ' PHE . 37.8 m-85 -76.34 -63.39 1.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.039 -0.528 . . . . 5.45 110.605 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.402 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 72.8 m 40.26 -91.11 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.073 -0.512 . . . . 5.17 111.865 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -57.87 -54.54 45.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.806 0.336 . . . . 3.89 110.986 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -55.9 -36.19 67.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.424 . . . . 5.36 110.702 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.45 ' HB2' ' CB ' ' A' ' 157' ' ' PHE . 55.1 t80 -72.23 -57.57 4.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.935 -0.575 . . . . 3.21 110.792 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 158' ' ' SER . 68.2 mt -63.46 -26.22 68.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 3.31 111.052 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 167' ' ' PRO . 40.0 ttmt -57.33 -29.59 64.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 3.11 110.802 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 164' ' ' VAL . 4.9 t -113.99 39.34 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 116.232 -0.44 . . . . 2.66 111.202 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.437 ' CE2' HD11 ' A' ' 169' ' ' LEU . 80.1 t80 -149.65 -54.74 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.474 -0.33 . . . . 2.06 111.624 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.481 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 76.1 mt -60.39 -45.0 97.43 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 112.281 0.474 . . . . 1.88 112.281 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 50.9 Cg_exo -53.5 -49.43 17.37 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.181 1.92 . . . . 0.98 112.391 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.8 t -57.34 -50.07 74.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 1.47 110.88 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.437 HD11 ' CE2' ' A' ' 165' ' ' PHE . 40.8 mt -62.16 -48.97 77.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 0.73 111.053 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 166' ' ' LEU . 64.6 mt -52.26 -51.8 56.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.875 0.369 . . . . 0.63 110.757 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.6 mt -56.43 -42.35 77.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 0.4 110.856 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.421 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 74.8 m -58.38 -52.55 65.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.42 . . . . 0.23 110.85 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.423 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 72.4 m80 -62.48 -51.97 65.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.29 110.744 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.65 -51.78 68.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.47 110.987 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.7 mt -60.19 -44.11 95.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.41 110.98 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.544 ' HB3' ' HB1' ' B' ' 176' ' ' ALA . . . -53.75 -52.37 60.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.27 110.788 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.402 ' O ' HG12 ' A' ' 181' ' ' ILE . 68.5 mt -55.47 -45.42 78.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 0.62 110.162 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.91 -42.15 59.84 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.505 -0.855 . . . . 0.28 111.825 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 68.2 mt -59.06 -48.09 82.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.979 0.419 . . . . 0.43 110.105 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.435 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -58.64 -46.51 93.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.677 -0.773 . . . . 0.29 112.344 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 177' ' ' ILE . 48.0 mm -59.73 -49.93 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.878 0.371 . . . . 0.89 111.081 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -51.88 -49.93 62.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 1.56 110.915 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.449 HD12 HD11 ' B' ' 181' ' ' ILE . 71.9 mt -62.56 -42.55 96.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.83 111.186 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.4 ' O ' ' HG ' ' A' ' 187' ' ' LEU . . . -62.2 -52.51 49.17 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.849 -0.691 . . . . 0.64 112.951 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -24.17 67.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 2.54 111.017 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -69.23 -37.55 78.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.445 . . . . 3.95 111.044 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.425 HD23 ' N ' ' A' ' 187' ' ' LEU . 6.3 mt -52.13 -37.62 54.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.083 0.468 . . . . 1.52 110.53 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 75.7 p . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.222 -0.894 . . . . 3.05 111.356 179.939 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.557 -0.217 . . . . 7.46 112.557 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -139.33 -153.83 6.2 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.743 -0.741 . . . . 6.55 112.493 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 9.6 mm -70.14 -48.26 62.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.934 0.397 . . . . 7.86 111.083 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.437 ' HB2' ' HB2' ' B' ' 161' ' ' PHE . 18.3 m-30 -77.04 -39.17 50.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.976 -0.556 . . . . 6.6 111.37 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.406 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 69.0 m 44.41 -90.01 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.089 -0.505 . . . . 5.34 111.761 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -56.14 -55.14 36.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.666 0.27 . . . . 4.29 111.517 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -56.05 -46.78 78.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.462 -0.336 . . . . 5.73 111.094 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.437 ' HB2' ' HB2' ' B' ' 157' ' ' PHE . 56.1 t80 -63.94 -53.52 49.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 3.56 110.992 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 158' ' ' SER . 89.2 mt -62.4 -32.07 72.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.487 . . . . 3.37 111.059 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -60.84 -25.99 67.03 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.178 -0.465 . . . . 3.86 110.587 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.15 28.62 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.433 . . . . 2.87 111.307 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -129.82 -44.01 1.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 2.48 110.853 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.5 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 87.3 mt -65.08 -43.33 66.53 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 2.14 111.54 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 17.9 Cg_endo -90.23 24.56 0.61 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.868 2.378 . . . . 1.07 112.405 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 55.0 m -114.07 -43.61 3.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.414 -0.357 . . . . 1.59 110.891 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.419 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 82.4 mt -61.5 -41.92 98.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 1.09 110.944 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.465 HD12 ' N ' ' B' ' 170' ' ' LEU . 6.3 mp -60.48 -47.25 86.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.72 110.979 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 48.5 mt -61.02 -41.74 97.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.303 -0.408 . . . . 0.5 110.731 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . 0.423 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 70.8 m -54.92 -51.36 66.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.31 110.937 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.421 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 67.0 m80 -61.66 -52.41 64.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.229 -0.441 . . . . 0.3 111.131 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 90.6 mt -55.39 -52.93 61.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.445 -0.343 . . . . 0.44 110.8 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.8 -45.04 94.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.46 110.979 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.544 ' HB1' ' HB3' ' A' ' 176' ' ' ALA . . . -54.67 -53.02 60.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.25 111.268 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 56.9 mt -62.19 -42.62 95.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.359 -0.382 . . . . 0.31 110.585 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.55 -46.51 81.11 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.61 -0.805 . . . . 0.26 111.9 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 94.9 mt -57.44 -47.94 80.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.37 . . . . 0.47 110.346 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.31 -43.53 64.95 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.572 -0.823 . . . . 0.27 112.34 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.449 HD11 HD12 ' A' ' 183' ' ' ILE . 40.0 mm -60.29 -49.87 82.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.872 0.367 . . . . 0.93 110.993 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -59.36 -47.97 83.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.54 . . . . 1.52 110.986 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . 0.409 ' O ' ' HG2' ' B' ' 186' ' ' ARG . 65.6 mt -62.17 -44.52 99.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 1.1 111.147 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.38 -46.83 93.05 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.831 -0.7 . . . . 0.72 112.92 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -62.53 -13.86 35.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.923 0.342 . . . . 2.16 111.923 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' B' ' 183' ' ' ILE . 33.5 ptt180 -106.5 29.84 6.54 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.814 0.34 . . . . 3.82 111.32 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 13.5 mt -118.57 -65.78 1.14 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.299 0.571 . . . . 1.63 110.51 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . 0.408 HG23 ' OXT' ' B' ' 188' ' ' THR . 1.5 t . . . . . 0 C--O 1.249 1.058 0 CA-C-N 115.281 -0.872 . . . . 2.31 111.269 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.527 -0.229 . . . . 7.39 112.527 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -112.3 179.86 19.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.697 -0.763 . . . . 6.02 112.758 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.428 HG22 ' CE2' ' A' ' 157' ' ' PHE . 9.5 mt -70.29 -25.51 27.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.996 0.426 . . . . 6.75 110.947 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 159' ' ' ALA . 70.4 m-85 -156.56 -43.33 0.07 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.853 -0.612 . . . . 5.45 110.795 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.411 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 66.9 m 50.02 -86.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.09 -0.505 . . . . 5.17 111.811 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -54.18 -57.06 12.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.578 0.227 . . . . 3.89 111.599 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -56.39 -59.93 4.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.728 0.299 . . . . 5.36 110.775 -179.659 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 165' ' ' PHE . 70.0 t80 -55.61 -50.91 68.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.272 -0.422 . . . . 3.21 111.009 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 158' ' ' SER . 88.1 mt -60.52 -39.7 88.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 3.31 111.124 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -58.66 -33.68 70.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 3.11 111.136 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.8 m -115.6 24.41 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.443 -0.344 . . . . 2.66 111.555 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 161' ' ' PHE . 90.2 t80 -118.44 -55.56 2.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.766 0.317 . . . . 2.06 110.883 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.48 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 83.8 mt -56.25 -45.39 99.92 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 1.88 111.539 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 96.8 Cg_endo -80.8 -37.66 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.207 1.938 . . . . 0.98 112.339 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 80.8 p -51.34 -47.56 62.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 1.47 110.89 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 96.7 mt -61.75 -47.66 84.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.419 . . . . 0.73 110.766 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 88.4 mt -55.21 -50.52 69.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 0.63 110.938 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.8 mt -57.29 -45.18 84.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.4 110.881 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.419 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 75.8 m -55.43 -51.93 65.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.288 -0.414 . . . . 0.23 110.703 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.424 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 77.2 m80 -61.95 -48.71 79.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.033 -0.53 . . . . 0.29 110.844 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 88.8 mt -58.99 -49.8 76.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.314 -0.403 . . . . 0.47 110.921 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 82.6 mt -59.92 -51.09 71.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.41 111.086 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.543 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -52.03 -52.65 49.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 0.27 110.933 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.28 -42.28 90.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.044 -0.525 . . . . 0.62 110.274 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.66 -44.64 60.22 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.579 -0.82 . . . . 0.28 112.102 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 50.8 mt -62.61 -52.53 63.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.859 0.361 . . . . 0.43 110.494 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.01 -52.14 45.28 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.732 -0.747 . . . . 0.29 112.545 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 59.3 mt -55.76 -41.56 66.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.813 0.339 . . . . 0.89 110.582 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -55.39 -43.27 75.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.123 -0.49 . . . . 1.56 110.596 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.402 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 4.7 mm -61.67 -48.71 87.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.938 0.399 . . . . 0.83 110.843 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -58.79 -50.8 63.66 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.963 -0.637 . . . . 0.64 112.933 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -55.43 -26.53 42.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.667 0.27 . . . . 2.54 111.387 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 183' ' ' ILE . 4.7 ptm85 -98.92 37.95 1.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.875 0.369 . . . . 3.95 110.978 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 27.1 mt -115.81 -70.14 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.297 0.57 . . . . 1.52 110.582 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 66.0 p . . . . . 0 C--O 1.249 1.064 0 CA-C-N 115.188 -0.914 . . . . 3.05 111.072 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.511 -0.236 . . . . 7.46 112.511 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -149.22 -169.68 16.03 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.634 -0.793 . . . . 6.55 112.709 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . 0.503 HG22 ' CE2' ' B' ' 157' ' ' PHE . 9.4 mm -70.19 -20.41 22.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.75 0.309 . . . . 7.86 111.347 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.503 ' CE2' HG22 ' B' ' 156' ' ' ILE . 96.1 m-85 -161.57 -58.65 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 6.6 110.853 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 29.1 t 46.36 -88.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.995 -0.548 . . . . 5.34 111.598 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -57.29 -55.88 29.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.872 0.367 . . . . 4.29 111.492 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -54.69 -27.96 44.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.252 -0.431 . . . . 5.73 111.609 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -88.62 -50.27 6.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.833 0.349 . . . . 3.56 111.128 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.69 -37.62 87.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 3.37 111.24 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -55.94 -23.2 30.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 3.86 111.041 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 31.4 m -131.17 45.5 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.335 -0.393 . . . . 2.87 111.072 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . 0.492 ' CZ ' HD11 ' B' ' 169' ' ' LEU . 34.5 t80 -139.96 -65.7 0.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 2.48 110.925 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.486 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 81.0 mt -49.82 -58.82 8.19 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 2.14 111.63 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 1.4 Cg_endo -42.83 -53.31 4.02 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.512 2.141 . . . . 1.07 112.587 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 51.0 m -52.13 -42.93 63.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.865 0.364 . . . . 1.59 111.175 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.492 HD11 ' CZ ' ' B' ' 165' ' ' PHE . 49.8 mt -61.99 -49.93 74.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 1.09 111.216 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.443 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.6 mp -61.68 -49.77 75.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.463 -0.335 . . . . 0.72 110.885 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 88.8 mt -57.34 -41.82 80.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.379 -0.373 . . . . 0.5 110.775 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . 0.424 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 67.5 m -57.21 -51.3 69.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.31 110.976 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.419 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 69.0 m80 -61.17 -52.47 64.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.335 -0.393 . . . . 0.3 111.017 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 88.2 mt -60.49 -52.3 65.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.907 0.384 . . . . 0.44 110.92 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.17 -42.61 99.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.065 -0.516 . . . . 0.46 110.948 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -53.6 -52.03 61.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.055 -0.52 . . . . 0.25 111.333 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.528 HG13 ' HB1' ' A' ' 176' ' ' ALA . 59.8 mt -60.44 -44.41 96.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.75 0.31 . . . . 0.31 110.853 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.58 -51.78 49.82 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.608 -0.806 . . . . 0.26 112.263 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.8 -41.98 78.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.756 0.312 . . . . 0.47 110.651 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.47 -49.32 74.2 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.712 -0.756 . . . . 0.27 112.197 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 60.3 mt -54.83 -50.98 56.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.93 110.756 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.418 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 80.3 t80 -53.05 -52.31 58.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.077 -0.51 . . . . 1.52 110.812 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 63.3 mt -62.26 -45.17 99.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 1.1 110.974 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -58.81 -48.66 84.13 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.764 -0.731 . . . . 0.72 112.688 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.418 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 6.9 ptp180 -58.91 -18.54 34.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.576 0.227 . . . . 2.16 111.376 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -108.19 49.35 0.81 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.914 0.388 . . . . 3.82 110.826 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 18.1 mt -111.39 -82.22 0.58 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 1.63 111.141 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 28.3 p . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.154 -0.927 . . . . 2.31 111.188 -179.727 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.591 -0.203 . . . . 7.39 112.591 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 154.45 166.7 15.39 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.836 -0.697 . . . . 6.02 112.336 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 61.8 mt -70.28 -54.37 18.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.862 0.363 . . . . 6.75 110.888 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 159' ' ' ALA . 87.5 m-85 -75.3 -61.08 2.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 5.45 110.787 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.409 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 39.8 t 43.49 -90.83 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.942 -0.572 . . . . 5.17 111.565 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.61 -52.8 63.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.736 0.303 . . . . 3.89 111.149 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.15 -37.06 71.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.342 -0.39 . . . . 5.36 110.994 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -75.21 -55.76 5.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 3.21 110.972 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 158' ' ' SER . 63.2 mt -62.39 -30.36 71.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 3.31 110.851 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -57.54 -35.02 69.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 3.11 110.958 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 29.0 m -125.57 52.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 2.66 111.279 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.576 ' CZ ' HD11 ' A' ' 169' ' ' LEU . 62.6 t80 -152.05 -47.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 2.06 111.085 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.499 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 89.4 mt -61.38 -56.97 28.62 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 1.88 111.797 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 11.3 Cg_endo -54.98 -48.38 21.5 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.224 1.949 . . . . 0.98 112.534 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.9 t -52.96 -52.74 57.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.445 -0.343 . . . . 1.47 111.169 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.576 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 42.0 mt -62.74 -51.4 67.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.324 -0.398 . . . . 0.73 111.569 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 93.0 mt -51.49 -52.17 48.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.475 -0.329 . . . . 0.63 111.153 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 83.5 mt -62.22 -42.78 99.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.395 -0.366 . . . . 0.4 111.137 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.414 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 72.2 m -62.13 -53.0 61.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.436 -0.347 . . . . 0.23 111.491 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.428 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 64.7 m80 -62.62 -53.11 59.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.496 -0.32 . . . . 0.29 111.185 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 95.8 mt -57.0 -52.48 65.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.416 -0.356 . . . . 0.47 111.098 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 171' ' ' LEU . 74.3 mt -56.53 -41.44 76.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.404 -0.362 . . . . 0.41 110.297 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.502 ' HB3' ' HB1' ' B' ' 176' ' ' ALA . . . -57.61 -48.58 79.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.151 -0.477 . . . . 0.27 110.746 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.418 HD12 ' HB2' ' B' ' 179' ' ' LEU . 18.2 mm -54.11 -46.35 66.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.934 0.397 . . . . 0.62 110.394 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.31 -42.02 81.47 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.673 -0.775 . . . . 0.28 111.882 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 80.6 mt -57.45 -48.78 78.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.8 0.333 . . . . 0.43 110.433 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -61.28 -51.78 55.9 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.827 -0.701 . . . . 0.29 112.551 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 56.1 mt -53.89 -48.73 62.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.788 0.328 . . . . 0.89 111.136 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.423 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 52.8 t80 -53.74 -49.79 67.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 1.56 110.876 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 70.5 mt -63.17 -42.23 95.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.151 -0.477 . . . . 0.83 111.385 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.4 -53.11 44.41 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.8 -0.714 . . . . 0.64 113.507 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -62.68 -17.26 60.29 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.712 0.264 . . . . 2.54 111.712 -179.711 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -86.33 -25.29 25.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.592 0.234 . . . . 3.95 111.525 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 14.9 mt -49.81 -61.04 2.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.326 0.584 . . . . 1.52 110.788 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.435 HG21 ' O ' ' B' ' 188' ' ' THR . 1.6 t . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.235 -0.888 . . . . 3.05 111.131 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.538 -0.225 . . . . 7.46 112.538 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -117.46 174.2 15.12 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.81 -0.71 . . . . 6.55 112.435 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 49.5 mt -71.98 -64.91 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 7.86 111.088 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -76.93 -76.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 6.6 110.762 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 64.3 m 62.49 -83.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 5.34 111.462 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.67 80.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.434 -0.348 . . . . 4.29 111.644 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . 0.401 ' HA ' ' HE3' ' B' ' 163' ' ' LYS . 17.7 mm-40 -56.6 -30.05 62.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 5.73 111.664 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -92.8 -48.99 6.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.79 0.328 . . . . 3.56 111.1 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 69.9 mt -63.66 -31.82 73.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.196 -0.456 . . . . 3.37 111.406 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.421 ' O ' ' CG ' ' B' ' 167' ' ' PRO . 16.2 ptpt -56.75 -23.12 40.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.506 -0.316 . . . . 3.86 111.175 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 20.3 t -96.77 -18.11 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 2.87 111.465 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . 0.519 ' CE2' HD11 ' B' ' 169' ' ' LEU . 35.3 t80 -89.58 -42.7 11.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.514 -0.312 . . . . 2.48 111.477 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.464 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 71.2 mt -57.31 -48.13 97.85 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.485 -0.325 . . . . 2.14 111.739 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 78.2 Cg_exo -40.77 -54.73 2.27 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.347 2.031 . . . . 1.07 112.638 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.6 m -56.35 -41.7 76.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.065 -0.516 . . . . 1.59 110.967 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.519 HD11 ' CE2' ' B' ' 165' ' ' PHE . 14.4 mt -62.1 -48.06 81.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.314 -0.403 . . . . 1.09 111.192 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.404 HD12 ' N ' ' B' ' 170' ' ' LEU . 8.1 mp -59.62 -49.66 76.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.743 0.306 . . . . 0.72 110.761 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 97.8 mt -54.32 -41.74 69.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.5 110.663 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . 0.428 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 59.8 m -59.95 -48.21 82.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.31 111.249 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.414 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 68.2 m80 -60.4 -52.08 66.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.3 110.958 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 74.0 mt -61.03 -52.46 64.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.359 . . . . 0.44 110.86 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.0 -44.12 97.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.46 110.901 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.502 ' HB1' ' HB3' ' A' ' 176' ' ' ALA . . . -52.81 -52.47 56.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.486 . . . . 0.25 110.897 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 88.2 mt -55.38 -44.6 76.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.177 -0.465 . . . . 0.31 110.285 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.77 -41.84 58.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.531 -0.842 . . . . 0.26 111.479 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.418 ' HB2' HD12 ' A' ' 177' ' ' ILE . 80.0 mt -59.2 -48.13 82.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.02 0.438 . . . . 0.47 110.288 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.51 -51.17 38.93 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.81 -0.709 . . . . 0.27 112.565 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.408 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 58.3 mt -57.59 -52.15 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.735 0.302 . . . . 0.93 110.946 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.405 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 60.4 t80 -52.6 -50.12 63.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 1.52 111.182 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . 0.425 ' O ' ' CD2' ' B' ' 187' ' ' LEU . 57.2 mt -62.75 -52.31 61.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 1.1 111.362 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.03 -50.72 64.82 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.983 -0.627 . . . . 0.72 113.333 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' B' ' 181' ' ' ILE . 0.0 OUTLIER -62.91 -11.4 18.27 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.031 0.382 . . . . 2.16 112.031 -179.578 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -103.06 17.09 24.9 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 111.7 0.259 . . . . 3.82 111.7 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . 0.425 ' CD2' ' O ' ' B' ' 183' ' ' ILE . 3.5 mt -113.6 -67.05 1.03 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.242 0.544 . . . . 1.63 110.719 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . 0.435 ' O ' HG21 ' A' ' 188' ' ' THR . 1.6 t . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.199 -0.905 . . . . 2.31 111.275 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 112.429 -0.268 . . . . 7.39 112.429 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 158.68 176.39 30.69 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.794 -0.717 . . . . 6.02 112.418 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.478 HD12 ' N ' ' A' ' 156' ' ' ILE . 4.0 mp -73.05 -63.75 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 6.75 110.532 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.439 ' O ' ' N ' ' A' ' 159' ' ' ALA . 26.7 m-85 -76.67 -55.19 5.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 5.45 110.893 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.401 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 29.5 t 42.53 -89.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.992 -0.549 . . . . 5.17 111.932 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -57.41 -54.61 44.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.825 0.345 . . . . 3.89 111.458 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.419 ' HA ' ' HE2' ' A' ' 163' ' ' LYS . 40.1 tt0 -55.47 -49.22 73.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.409 . . . . 5.36 110.973 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -66.16 -52.21 50.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.374 -0.376 . . . . 3.21 110.964 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 158' ' ' SER . 82.8 mt -62.63 -29.89 70.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.013 -0.54 . . . . 3.31 111.087 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.419 ' HE2' ' HA ' ' A' ' 160' ' ' GLU . 34.8 ttpt -57.53 -34.49 69.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.491 . . . . 3.11 111.055 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 30.0 m -113.19 42.07 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.311 -0.404 . . . . 2.66 111.149 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.439 ' CZ ' HD11 ' A' ' 169' ' ' LEU . 28.3 t80 -133.01 -55.16 0.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.056 -0.52 . . . . 2.06 110.794 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.505 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 61.2 mt -60.75 -44.66 95.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 1.88 111.484 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 87.5 Cg_exo -46.32 -44.41 20.25 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.422 2.082 . . . . 0.98 112.521 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 36.4 t -69.59 -41.96 75.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 1.47 111.048 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.439 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 53.1 mt -61.96 -44.22 97.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.73 110.669 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 96.8 mt -53.67 -51.29 63.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.63 110.651 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 83.9 mt -59.06 -45.24 91.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.126 -0.488 . . . . 0.4 111.087 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.423 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 69.9 m -53.53 -53.11 56.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.23 110.874 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.415 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 74.5 m80 -63.03 -52.12 64.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.29 110.939 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.4 mt -54.62 -52.56 61.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.47 110.932 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.55 -48.92 77.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.315 -0.402 . . . . 0.41 111.027 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.534 ' HB3' ' CB ' ' B' ' 176' ' ' ALA . . . -51.92 -52.99 46.11 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.215 -0.448 . . . . 0.27 111.165 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.508 ' O ' HD12 ' A' ' 181' ' ' ILE . 62.8 mt -58.14 -46.85 88.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.411 . . . . 0.62 110.058 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.08 -41.89 53.88 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.671 -0.776 . . . . 0.28 111.861 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 99.5 mt -58.94 -49.12 79.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.029 0.442 . . . . 0.43 110.458 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.439 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -55.03 -50.69 58.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.764 -0.731 . . . . 0.29 112.876 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.508 HD12 ' O ' ' A' ' 177' ' ' ILE . 4.0 mp -62.58 -46.01 97.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.802 0.334 . . . . 0.89 110.628 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.401 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 51.4 t80 -51.82 -52.73 47.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 1.56 110.975 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.76 -45.41 97.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.369 -0.378 . . . . 0.83 111.405 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.7 -52.48 50.5 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.928 -0.653 . . . . 0.64 113.263 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -61.06 -19.53 61.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.76 0.314 . . . . 2.54 110.98 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -91.86 19.6 6.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.397 -0.365 . . . . 3.95 110.988 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 49.8 mt -99.04 -82.74 0.43 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.933 0.397 . . . . 1.52 110.74 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.248 -0.882 . . . . 3.05 111.087 179.642 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.537 -0.225 . . . . 7.46 112.537 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -149.39 -165.35 12.3 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.779 -0.725 . . . . 6.55 112.532 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 13.5 mm -69.79 -63.48 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.033 0.444 . . . . 7.86 110.916 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.425 ' O ' ' HB3' ' B' ' 158' ' ' SER . 86.1 m-85 -76.85 -66.5 0.81 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.799 -0.637 . . . . 6.6 110.689 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' B' ' 157' ' ' PHE . 9.0 t 79.79 -161.59 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.103 -0.498 . . . . 5.34 111.067 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -55.32 -25.15 32.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.387 -0.369 . . . . 4.29 111.258 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . 0.426 ' HA ' ' HE2' ' B' ' 163' ' ' LYS . 41.6 mt-10 -52.21 -32.24 35.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.385 -0.37 . . . . 5.73 110.861 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -85.15 -39.1 18.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.023 -0.535 . . . . 3.56 110.559 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 90.7 mt -64.52 -32.88 74.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.936 -0.575 . . . . 3.37 111.169 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.426 ' HE2' ' HA ' ' B' ' 160' ' ' GLU . 48.4 mtmt -57.22 -31.6 65.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.29 -0.414 . . . . 3.86 111.231 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 35.7 m -118.15 41.23 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.427 -0.351 . . . . 2.87 111.495 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -151.68 -53.27 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 2.48 111.352 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.475 ' HB2' ' CD ' ' B' ' 167' ' ' PRO . 69.2 mt -60.79 -60.36 10.91 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 112.267 0.469 . . . . 2.14 112.267 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.475 ' CD ' ' HB2' ' B' ' 166' ' ' LEU . 5.7 Cg_exo -37.29 -54.16 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.085 2.523 . . . . 1.07 113.172 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 45.0 t -54.11 -44.83 71.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.565 -0.289 . . . . 1.59 111.403 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.403 ' CD2' ' CD2' ' A' ' 169' ' ' LEU . 26.6 mt -62.81 -48.37 79.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.009 0.374 . . . . 1.09 112.009 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.413 ' N ' HD12 ' B' ' 170' ' ' LEU . 8.1 mp -54.22 -51.97 62.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.736 0.303 . . . . 0.72 111.19 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.4 mt -62.34 -43.88 97.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.358 -0.383 . . . . 0.5 111.143 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . 0.415 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 75.1 m -58.18 -52.55 65.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.282 -0.417 . . . . 0.31 111.635 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.423 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 62.5 m80 -60.78 -52.55 64.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.446 -0.343 . . . . 0.3 111.378 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.5 mt -56.49 -51.4 68.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.408 -0.36 . . . . 0.44 111.272 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.38 -46.24 89.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.291 -0.413 . . . . 0.46 111.49 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . . . -59.62 -53.03 62.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.394 -0.366 . . . . 0.25 111.606 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.532 HG13 ' HB1' ' A' ' 176' ' ' ALA . 40.5 mt -62.19 -42.89 96.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.813 0.34 . . . . 0.31 110.726 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.34 -51.79 51.93 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.552 -0.832 . . . . 0.26 112.194 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.408 ' O ' HG12 ' B' ' 183' ' ' ILE . 95.5 mt -53.91 -51.23 64.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.787 0.327 . . . . 0.47 110.487 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.29 -42.49 49.77 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.58 -0.819 . . . . 0.27 112.422 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.439 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 29.6 mm -59.81 -47.65 90.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.711 0.291 . . . . 0.93 110.69 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.408 ' OH ' ' NH1' ' B' ' 186' ' ' ARG . 67.5 t80 -57.19 -52.14 66.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 1.52 110.912 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . 0.408 HG12 ' O ' ' B' ' 179' ' ' LEU . 13.1 mm -62.37 -44.69 99.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 1.1 111.201 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.84 -52.21 53.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.833 -0.698 . . . . 0.72 113.013 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.435 ' HG3' ' N ' ' B' ' 186' ' ' ARG . 8.1 ptp180 -55.17 -33.44 62.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 2.16 111.036 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.435 ' N ' ' HG3' ' B' ' 185' ' ' ARG . 77.5 mtp180 -108.52 57.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.296 -0.411 . . . . 3.82 111.043 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 30.8 mt -98.86 -83.95 0.41 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 1.63 111.124 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.185 -0.912 . . . . 2.31 111.229 -179.843 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.553 -0.219 . . . . 7.39 112.553 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -93.33 177.79 38.07 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.719 -0.753 . . . . 6.02 112.392 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 55.4 mt -70.58 -65.1 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.942 0.401 . . . . 6.75 110.69 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.4 ' HB3' ' HB2' ' A' ' 160' ' ' GLU . 59.2 m-85 -77.51 -70.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.973 -0.558 . . . . 5.45 110.745 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.2 t 66.03 -77.47 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.963 -0.562 . . . . 5.17 111.394 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.26 -51.8 66.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.107 -0.497 . . . . 3.89 111.572 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.4 ' HB2' ' HB3' ' A' ' 157' ' ' PHE . 1.2 mp0 -57.5 -57.37 12.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.386 -0.37 . . . . 5.36 111.102 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -62.5 -48.57 78.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 3.21 111.106 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 77.1 mt -62.64 -33.27 74.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.197 -0.456 . . . . 3.31 111.216 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -58.08 -28.83 64.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.306 -0.406 . . . . 3.11 111.253 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.81 37.83 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.445 -0.343 . . . . 2.66 111.536 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.492 ' CZ ' HD11 ' A' ' 169' ' ' LEU . 90.5 t80 -139.2 -57.51 0.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.39 . . . . 2.06 111.108 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.495 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 60.8 mt -57.68 -44.8 99.72 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 1.88 111.728 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 63.2 Cg_exo -51.16 -54.06 6.08 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.285 1.99 . . . . 0.98 112.308 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 86.7 p -53.18 -48.78 67.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 1.47 111.092 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.492 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 46.8 mt -62.08 -51.93 65.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.73 110.986 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 88.2 mt -55.42 -50.37 69.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.11 -0.495 . . . . 0.63 110.952 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 94.4 mt -57.32 -45.43 84.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.4 111.151 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.44 ' HB3' ' NE2' ' B' ' 173' ' ' HIS . 73.1 m -56.56 -53.23 60.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.872 0.368 . . . . 0.23 110.986 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.432 ' NE2' ' HB3' ' B' ' 172' ' ' SER . 77.7 m80 -63.02 -52.36 63.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.29 110.949 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.6 mt -58.86 -52.14 67.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.47 111.147 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 171' ' ' LEU . 77.1 mt -59.44 -46.93 87.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.39 . . . . 0.41 110.788 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.464 ' HB3' ' HB1' ' B' ' 176' ' ' ALA . . . -53.37 -52.24 59.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.262 -0.426 . . . . 0.27 110.781 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 86.1 mt -58.69 -41.78 83.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.255 -0.43 . . . . 0.62 110.332 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.96 -45.98 55.8 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.672 -0.775 . . . . 0.28 111.943 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 50.9 mt -62.14 -48.05 81.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.835 0.35 . . . . 0.43 110.516 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.06 -52.42 47.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.551 -0.833 . . . . 0.29 112.306 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' B' ' 180' ' ' GLY . 47.7 mt -60.35 -43.34 93.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.811 0.339 . . . . 0.89 111.091 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.419 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 78.5 t80 -53.72 -48.25 69.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.13 -0.486 . . . . 1.56 110.659 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.409 ' O ' ' HG2' ' A' ' 186' ' ' ARG . 76.5 mt -62.54 -41.55 92.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.83 111.106 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.09 -44.11 98.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.99 -0.624 . . . . 0.64 113.208 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 10.9 ptp180 -62.44 -39.09 92.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.83 0.315 . . . . 2.54 111.581 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 183' ' ' ILE . 10.5 ptm180 -69.94 -17.16 63.31 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.656 0.243 . . . . 3.95 111.656 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 57.2 mt -52.36 -83.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.887 0.375 . . . . 1.52 110.852 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.141 -0.933 . . . . 3.05 111.256 179.887 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 112.532 -0.227 . . . . 7.46 112.532 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -90.55 -173.15 44.41 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.755 -0.736 . . . . 6.55 112.455 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . 0.598 HG22 ' CE2' ' B' ' 157' ' ' PHE . 9.2 mm -69.75 -18.68 22.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.742 0.306 . . . . 7.86 111.394 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.598 ' CE2' HG22 ' B' ' 156' ' ' ILE . 87.1 m-85 -160.06 -71.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.888 0.375 . . . . 6.6 110.991 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.411 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 58.1 m 61.8 -91.91 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.114 -0.494 . . . . 5.34 110.885 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.24 -58.35 8.35 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.868 0.366 . . . . 4.29 110.953 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' B' ' 163' ' ' LYS . 41.5 tt0 -58.03 -21.78 46.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.065 -0.516 . . . . 5.73 111.095 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -86.52 -41.09 14.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.383 -0.371 . . . . 3.56 111.549 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.421 ' HA ' ' HB3' ' B' ' 165' ' ' PHE . 20.5 mt -62.41 -36.85 83.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.64 0.257 . . . . 3.37 111.138 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.498 ' HG3' HG23 ' B' ' 164' ' ' VAL . 18.1 ptpt -57.49 -20.7 32.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.517 -0.31 . . . . 3.86 111.076 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.498 HG23 ' HG3' ' B' ' 163' ' ' LYS . 66.0 t -108.76 -36.41 3.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.077 0.465 . . . . 2.87 110.568 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . 0.563 ' CZ ' HD21 ' B' ' 169' ' ' LEU . 80.5 t80 -56.06 -77.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.657 -0.701 . . . . 2.48 111.26 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.501 ' HB2' ' CD ' ' B' ' 167' ' ' PRO . 81.9 mt -38.48 -63.46 0.57 Allowed Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 112.706 0.632 . . . . 2.14 112.706 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.501 ' CD ' ' HB2' ' B' ' 166' ' ' LEU . 2.9 Cg_exo -38.17 -55.92 1.11 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.898 2.399 . . . . 1.07 113.011 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 48.8 m -60.32 -44.8 95.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.238 -0.437 . . . . 1.59 111.615 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.563 HD21 ' CZ ' ' B' ' 165' ' ' PHE . 7.1 mp -62.9 -49.08 76.22 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.238 0.459 . . . . 1.09 112.238 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.433 ' CD1' ' O ' ' B' ' 166' ' ' LEU . 7.4 mp -52.01 -50.51 61.21 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.759 -0.377 . . . . 0.72 110.661 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 89.9 mt -57.77 -41.57 82.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 0.5 110.462 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . 0.432 ' HB3' ' NE2' ' A' ' 173' ' ' HIS . 63.6 m -54.29 -45.8 72.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.435 . . . . 0.31 110.731 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.44 ' NE2' ' HB3' ' A' ' 172' ' ' SER . 77.0 m80 -60.0 -52.29 66.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.454 . . . . 0.3 110.905 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 83.2 mt -57.81 -52.66 64.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.412 . . . . 0.44 110.71 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 87.3 mt -62.69 -42.34 99.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.094 -0.503 . . . . 0.46 110.857 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.464 ' HB1' ' HB3' ' A' ' 176' ' ' ALA . . . -52.2 -52.37 52.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.25 111.352 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 53.9 mt -61.85 -45.59 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.421 . . . . 0.31 111.039 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.69 -51.24 53.95 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.565 -0.826 . . . . 0.26 112.109 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.4 ' O ' HG12 ' B' ' 183' ' ' ILE . 94.3 mt -54.46 -47.63 72.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.779 0.323 . . . . 0.47 110.349 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 181' ' ' ILE . . . -51.32 -43.41 51.45 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.602 -0.808 . . . . 0.27 111.919 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 58.7 mt -58.57 -49.68 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.898 0.38 . . . . 0.93 110.456 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.423 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 55.7 t80 -54.88 -50.94 67.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.943 -0.572 . . . . 1.52 111.078 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . 0.4 HG12 ' O ' ' B' ' 179' ' ' LEU . 16.0 mm -62.85 -44.82 99.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.968 0.413 . . . . 1.1 111.328 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . 0.445 ' HA2' ' CD1' ' B' ' 187' ' ' LEU . . . -61.28 -50.84 62.64 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.114 -0.565 . . . . 0.72 113.203 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.423 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 5.6 ptp180 -51.52 -31.24 23.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.752 0.31 . . . . 2.16 111.344 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -98.87 53.68 1.0 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.886 0.374 . . . . 3.82 110.871 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . 0.445 ' CD1' ' HA2' ' B' ' 184' ' ' GLY . 57.9 mt -111.38 -84.45 0.57 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.007 -0.542 . . . . 1.63 111.247 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.189 -0.91 . . . . 2.31 111.184 -179.752 . . . . . . . . 0 0 . 1 stop_ save_